{"cord_id": "8vp57c1o", "title": "Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2.", "abstract": ["Abstract Rapid, scalable, point-of-need, COVID-19 diagnostic testing is necessary to safely re-open economies and prevent future outbreaks.", "We developed an assay that detects single copies of SARS-CoV-2 virus directly from saliva and swab samples in 30 min using a simple, one-step protocol that utilizes only a heat block and microcentrifuge tube prefilled with a mixture containing the necessary reagents and has a sensitivity and specificity of 97% and 100%, respectively."]}
{"cord_id": "828s0mtz", "title": "The major genetic risk factor for severe COVID-19 is inherited from Neandertals", "abstract": ["A recent genetic association study (Ellinghaus et al.", "2020) identified a gene cluster on chromosome 3 as a risk locus for respiratory failure in SARS-CoV-2.", "Recent data comprising 3,199 hospitalized COVID-19 patients and controls reproduce this and find that it is the major genetic risk factor for severe SARS-CoV-2 infection and hospitalization (COVID-19 Host Genetics Initiative).", "Here, we show that the risk is conferred by a genomic segment of ~50 kb that is inherited from Neandertals and occurs at a frequency of ~30% in south Asia and ~8% in Europe."]}
{"cord_id": "hfbi7sk5", "title": "The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis", "abstract": ["Background.", "Respiratory failure is a key feature of severe Covid-19 and a critical driver of mortality, but for reasons poorly defined affects less than 10% of SARS-CoV-2 infected patients.", "Methods.", "We included 1,980 patients with Covid-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian and Barcelona) for a genome-wide association analysis.", "After quality control and exclusion of population outliers, 835 patients and 1,255 population-derived controls from Italy, and 775 patients and 950 controls from Spain were included in the final analysis.", "In total we analyzed 8,582,968 single-nucleotide polymorphisms (SNPs) and conducted a meta-analysis of both case-control panels.", "Results.", "We detected cross-replicating associations with rs11385942 at chromosome 3p21.31 and rs657152 at 9q34, which were genome-wide significant (P<5x10-8) in the meta-analysis of both study panels, odds ratio [OR], 1.77; 95% confidence interval [CI], 1.48 to 2.11; P=1.14x10-10 and OR 1.32 (95% CI, 1.20 to 1.47; P=4.95x10-8), respectively.", "Among six genes at 3p21.31, SLC6A20 encodes a known interaction partner with angiotensin converting enzyme 2 (ACE2).", "The association signal at 9q34 was located at the ABO blood group locus and a blood-group-specific analysis showed higher risk for A-positive individuals (OR=1.45, 95% CI, 1.20 to 1.75, P=1.48x10-4) and a protective effect for blood group O (OR=0.65, 95% CI, 0.53 to 0.79, P=1.06x10-5).", "Conclusions.", "We herein report the first robust genetic susceptibility loci for the development of respiratory failure in Covid-19.", "Identified variants may help guide targeted exploration of severe Covid-19 pathophysiology."]}
{"cord_id": "0vlzwksu", "title": "Seasonality and uncertainty in COVID-19 growth rates", "abstract": ["The virus causing COVID-19 has spread rapidly worldwide and threatens millions of lives.", "It remains unknown if summer weather will reduce its continued spread, thereby alleviating strains on hospitals and providing time for vaccine development.", "Early insights from laboratory studies of related coronaviruses predicted that COVID-19 would decline at higher temperatures, humidity, and ultraviolet light.", "Using current, fine-scaled weather data and global reports of infection we developed a model that explained 36% of variation in early growth rates before intervention, with 17% based on weather or demography and 19% based on country-specific effects.", "We found that ultraviolet light was most strongly associated with lower COVID-19 growth rates.", "Projections suggest that, in the absence of intervention, COVID-19 will decrease temporarily during summer, rebound by autumn, and peak next winter.", "However, uncertainty remains high and the probability of a weekly doubling rate remained >20% throughout the summer in the absence of control.", "Consequently, aggressive policy interventions will likely be needed in spite of seasonal trends."]}
{"cord_id": "1wdfyypl", "title": "Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study", "abstract": ["BACKGROUND: The risk of severe COVID-19 if an individual becomes infected is known to be higher in older individuals and those with underlying health conditions.", "Understanding the number of individuals at increased risk of severe COVID-19 and how this varies between countries should inform the design of possible strategies to shield or vaccinate those at highest risk.", "METHODS: We estimated the number of individuals at increased risk of severe disease (defined as those with at least one condition listed as \u201cat increased risk of severe COVID-19\u201d in current guidelines) by age (5-year age groups), sex, and country for 188 countries using prevalence data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 and UN population estimates for 2020.", "The list of underlying conditions relevant to COVID-19 was determined by mapping the conditions listed in GBD 2017 to those listed in guidelines published by WHO and public health agencies in the UK and the USA.", "We analysed data from two large multimorbidity studies to determine appropriate adjustment factors for clustering and multimorbidity.", "To help interpretation of the degree of risk among those at increased risk, we also estimated the number of individuals at high risk (defined as those that would require hospital admission if infected) using age-specific infection\u2013hospitalisation ratios for COVID-19 estimated for mainland China and making adjustments to reflect country-specific differences in the prevalence of underlying conditions and frailty.", "We assumed males were twice at likely as females to be at high risk.", "We also calculated the number of individuals without an underlying condition that could be considered at increased risk because of their age, using minimum ages from 50 to 70 years.", "We generated uncertainty intervals (UIs) for our estimates by running low and high scenarios using the lower and upper 95% confidence limits for country population size, disease prevalences, multimorbidity fractions, and infection\u2013hospitalisation ratios, and plausible low and high estimates for the degree of clustering, informed by multimorbidity studies.", "FINDINGS: We estimated that 1\u00b77 billion (UI 1\u00b70\u20132\u00b74) people, comprising 22% (UI 15\u201328) of the global population, have at least one underlying condition that puts them at increased risk of severe COVID-19 if infected (ranging from <5% of those younger than 20 years to >66% of those aged 70 years or older).", "We estimated that 349 million (186\u2013787) people (4% [3\u20139] of the global population) are at high risk of severe COVID-19 and would require hospital admission if infected (ranging from <1% of those younger than 20 years to approximately 20% of those aged 70 years or older).", "We estimated 6% (3\u201312) of males to be at high risk compared with 3% (2\u20137) of females.", "The share of the population at increased risk was highest in countries with older populations, African countries with high HIV/AIDS prevalence, and small island nations with high diabetes prevalence.", "Estimates of the number of individuals at increased risk were most sensitive to the prevalence of chronic kidney disease, diabetes, cardiovascular disease, and chronic respiratory disease.", "INTERPRETATION: About one in five individuals worldwide could be at increased risk of severe COVID-19, should they become infected, due to underlying health conditions, but this risk varies considerably by age.", "Our estimates are uncertain, and focus on underlying conditions rather than other risk factors such as ethnicity, socioeconomic deprivation, and obesity, but provide a starting point for considering the number of individuals that might need to be shielded or vaccinated as the global pandemic unfolds.", "FUNDING: UK Department for International Development, Wellcome Trust, Health Data Research UK, Medical Research Council, and National Institute for Health Research."]}
{"cord_id": "asnvwu1u", "title": "Dampened STING-Dependent Interferon Activation in Bats", "abstract": ["Compared with terrestrial mammals, bats have a longer lifespan and greater capacity to co-exist with a variety of viruses.", "In addition to cytosolic DNA generated by these viral infections, the metabolic demands of flight cause DNA damage and the release of self-DNA into the cytoplasm.", "However, whether bats have an altered DNA sensing/defense system to balance high cytosolic DNA levels remains an open question.", "We demonstrate that bats have a dampened interferon response due to the replacement of the highly conserved serine residue (S358) in STING, an essential adaptor protein in multiple DNA sensing pathways.", "Reversing this mutation by introducing S358 restored STING functionality, resulting in interferon activation and virus inhibition.", "Combined with previous reports on bat-specific changes of other DNA sensors such as TLR9, IFI16, and AIM2, our findings shed light on bat adaptation to flight, their long lifespan, and their unique capacity to serve as a virus reservoir."]}
{"cord_id": "38d6gb7o", "title": "A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing", "abstract": ["An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption(1,2).", "There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention.", "Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection.", "To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity- purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs).", "Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays.", "The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains."]}
{"cord_id": "oh6t9b98", "title": "Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020", "abstract": ["Globally, approximately 170,000 confirmed cases of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) have been reported, including an estimated 7,000 deaths in approximately 150 countries (1).", "On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic (2).", "Data from China have indicated that older adults, particularly those with serious underlying health conditions, are at higher risk for severe COVID-19-associated illness and death than are younger persons (3).", "Although the majority of reported COVID-19 cases in China were mild (81%), approximately 80% of deaths occurred among adults aged &#8805;60 years; only one (0.1%) death occurred in a person aged &#8804;19 years (3).", "In this report, COVID-19 cases in the United States that occurred during February 12-March 16, 2020 and severity of disease (hospitalization, admission to intensive care unit [ICU], and death) were analyzed by age group.", "As of March 16, a total of 4,226 COVID-19 cases in the United States had been reported to CDC, with multiple cases reported among older adults living in long-term care facilities (4).", "Overall, 31% of cases, 45% of hospitalizations, 53% of ICU admissions, and 80% of deaths associated with COVID-19 were among adults aged &#8805;65 years with the highest percentage of severe outcomes among persons aged &#8805;85 years.", "In contrast, no ICU admissions or deaths were reported among persons aged &#8804;19 years.", "Similar to reports from other countries, this finding suggests that the risk for serious disease and death from COVID-19 is higher in older age groups."]}
{"cord_id": "skambgbi", "title": "Quantity and Size Distribution of Cough-Generated Aerosol Particles Produced by Influenza Patients During and After Illness", "abstract": ["The question of whether influenza is transmitted to a significant degree by aerosols remains controversial, in part, because little is known about the quantity and size of potentially infectious airborne particles produced by people with influenza.", "In this study, the size and amount of aerosol particles produced by nine subjects during coughing were measured while they had influenza and after they had recovered, using a laser aerosol particle spectrometer with a size range of 0.35 to 10 \u03bcm.", "Individuals with influenza produce a significantly greater volume of aerosol when ill compared with afterward (p = 0.0143).", "When the patients had influenza, their average cough aerosol volume was 38.3 picoliters (pL) of particles per cough (SD 43.7); after patients recovered, the average volume was 26.4 pL per cough (SD 45.6).", "The number of particles produced per cough was also higher when subjects had influenza (average 75,400 particles/cough, SD 97,300) compared with afterward (average 52,200, SD 98,600), although the difference did not reach statistical significance (p = 0.1042).", "The average number of particles expelled per cough varied widely from patient to patient, ranging from 900 to 302,200 particles/cough while subjects had influenza and 1100 to 308,600 particles/cough after recovery.", "When the subjects had influenza, an average of 63% of each subject's cough aerosol particle volume in the detection range was in the respirable size fraction (SD 22%), indicating that these particles could reach the alveolar region of the lungs if inhaled by another person.", "This enhancement in aerosol generation during illness may play an important role in influenza transmission and suggests that a better understanding of this phenomenon is needed to predict the production and dissemination of influenza-laden aerosols by people infected with this virus.", "[Supplementary materials are available for this article.", "Go to the publisher's online edition of Journal of Occupational and Environmental Hygiene for the following free supplemental resources: a PDF file of demographic information, influenza test results, and volume and peak flow rate during each cough and a PDF file containing number and size of aerosol particles produced.]"]}
{"cord_id": "nl4ysbnr", "title": "[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]", "abstract": ["Objective: An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide.", "Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020.", "Methods: All COVID-19 cases reported through February 11, 2020 were extracted from China's Infectious Disease Information System.", "Analyses included: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis.", "Results: A total of 72 314 patient records-44 672 (61.8%) confirmed cases, 16 186 (22.4%) suspected cases, 10567 (14.6%) clinical diagnosed cases (Hubei only), and 889 asymptomatic cases (1.2%)-contributed data for the analysis.", "Among confirmed cases, most were aged 30-79 years (86.6%), diagnosed in Hubei (74.7%), and considered mild/mild pneumonia (80.9%).", "A total of 1 023 deaths occurred among confirmed cases for an overall case-fatality rate of 2.3%.", "The COVID-19 spread outward from Hubei sometime after December 2019 and by February 11, 2020, 1 386 counties across all 31 provinces were affected.", "The epidemic curve of onset of symptoms peaked in January 23-26, then began to decline leading up to February 11.", "A total of 1 716 health workers have become infected and 5 have died (0.3%).", "Conclusions: The COVID-19 epidemic has spread very quickly.", "It only took 30 days to expand from Hubei to the rest of Mainland China.", "With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic."]}
{"cord_id": "jjdtuofy", "title": "Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate", "abstract": ["As new cases of COVID-19 are being confirmed pressure is mounting to increase understanding of the factors underlying the spread the disease.", "Using data on local transmissions until the 23rd of March 2020, we develop an ensemble of 200 ecological niche models to project monthly variation in climate suitability for spread of SARS-CoV-2 throughout a typical climatological year.", "Although cases of COVID-19 are reported all over the world, most outbreaks display a pattern of clustering in relatively cool and dry areas.", "The predecessor SARS-CoV-1 was linked to similar climate conditions.", "Should the spread of SARS CoV-2 continue to follow current trends, asynchronous seasonal global outbreaks could be expected.", "According to the models, temperate warm and cold climates are more favorable to spread of the virus, whereas arid and tropical climates are less favorable.", "However, model uncertainties are still high across much of sub- Saharan Africa, Latin America and South East Asia.", "While models of epidemic spread utilize human demography and mobility as predictors, climate can also help constrain the virus.", "This is because the environment can mediate human-to-human transmission of SARS-CoV-2, and unsuitable climates can cause the virus to destabilize quickly, hence reducing its capacity to become epidemic."]}
{"cord_id": "ci6mv72z", "title": "Etiologic Subtypes of Ischemic Stroke in SARS-COV-2 Virus patients", "abstract": ["Objective: To describe the ischemic stroke etiopathogenesis related to COVID-19 in a cohort of NYC hospitals.", "Background: Extra-pulmonary involvement of COVID-19 has been reported in the hepatic, renal and hematological systems.", "Most neurological manifestations are non-focal but few have reported the characteristics of ischemic strokes or investigated its pathophysiology.", "Methods: Over the last 6 weeks, data from four centers in New York City were collected to review the possible ischemic stroke types seen in COVID-19 positive patients.", "Their presentation, demographics, other related vascular risk factors, associated laboratory and coagulation markers, as well as imaging and outcomes were collected.", "Results: In our study, age range of patients was 25-75 with no significant male preponderance.", "70% presented for acute hospitalization due the stroke.", "About a fifth did not have common risk factors for ischemic stroke like diabetes and hypertension.", "None had history of atrial fibrillation or smoking.", "50% had poor outcome with four ending in mortality and one in a critical condition due ARDS.", "All had high Neutrophil/Lymphocyte ratio except one who demonstrated some neurological recovery.", "In 70% of our cases, D-dimer levels were collected, and all showed mild to severe elevation.", "None of the emergent large vessel occlusion (LVO) cases had known cardiac risk factors but two out of five were found to have cardiac abnormalities during the course of their hospitalization.", "All LVOs had hypercoagulable lab markers especially elevated D-dimer and/or Fibrinogen.", "The LVO patients were younger and sicker with a median age of 46 and mean NIHSS of 24 as opposed to non-LVOs with a median age of 62 and mean NIHSS of 6 respectively.", "Conclusion: COVID-19 related ischemic events can be small vessel, branch emboli or large vessel occlusions.", "The latter is often associated with either a hypercoagulable state or cardio-embolism.", "Patient outcomes were worse when multi-organ or pulmonary system failure prevailed.", "Keywords: COVID-19, Acute Ischemic strokes, Emergent Large Vessel Occlusion, Mechanical Thrombectomy"]}
{"cord_id": "zozvt5y1", "title": "High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020", "abstract": ["On March 17, 2020, a member of a Skagit County, Washington, choir informed Skagit County Public Health (SCPH) that several members of the 122-member choir had become ill. Three persons, two from Skagit County and one from another area, had test results positive for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).", "Another 25 persons had compatible symptoms.", "SCPH obtained the choir's member list and began an investigation on March 18.", "Among 61 persons who attended a March 10 choir practice at which one person was known to be symptomatic, 53 cases were identified, including 33 confirmed and 20 probable cases (secondary attack rates of 53.3% among confirmed cases and 86.7% among all cases).", "Three of the 53 persons who became ill were hospitalized (5.7%), and two died (3.7%).", "The 2.5-hour singing practice provided several opportunities for droplet and fomite transmission, including members sitting close to one another, sharing snacks, and stacking chairs at the end of the practice.", "The act of singing, itself, might have contributed to transmission through emission of aerosols, which is affected by loudness of vocalization (1).", "Certain persons, known as superemitters, who release more aerosol particles during speech than do their peers, might have contributed to this and previously reported COVID-19 superspreading events (2-5).", "These data demonstrate the high transmissibility of SARS-CoV-2 and the possibility of superemitters contributing to broad transmission in certain unique activities and circumstances.", "It is recommended that persons avoid face-to-face contact with others, not gather in groups, avoid crowded places, maintain physical distancing of at least 6 feet to reduce transmission, and wear cloth face coverings in public settings where other social distancing measures are difficult to maintain."]}
{"cord_id": "ao3rr3lv", "title": "Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy", "abstract": ["Importance: In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic.", "Information about the clinical characteristics of infected patients who require intensive care is limited.", "Objective: To characterize patients with coronavirus disease 2019 (COVID-19) requiring treatment in an intensive care unit (ICU) in the Lombardy region of Italy.", "Design, Setting, and Participants: Retrospective case series of 1591 consecutive patients with laboratory-confirmed COVID-19 referred for ICU admission to the coordinator center (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) of the COVID-19 Lombardy ICU Network and treated at one of the ICUs of the 72 hospitals in this network between February 20 and March 18, 2020.", "Date of final follow-up was March 25, 2020.", "Exposures: SARS-CoV-2 infection confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swabs.", "Main Outcomes and Measures: Demographic and clinical data were collected, including data on clinical management, respiratory failure, and patient mortality.", "Data were recorded by the coordinator center on an electronic worksheet during telephone calls by the staff of the COVID-19 Lombardy ICU Network.", "Results: Of the 1591 patients included in the study, the median (IQR) age was 63 (56-70) years and 1304 (82%) were male.", "Of the 1043 patients with available data, 709 (68%) had at least 1 comorbidity and 509 (49%) had hypertension.", "Among 1300 patients with available respiratory support data, 1287 (99% [95% CI, 98%-99%]) needed respiratory support, including 1150 (88% [95% CI, 87%-90%]) who received mechanical ventilation and 137 (11% [95% CI, 9%-12%]) who received noninvasive ventilation.", "The median positive end-expiratory pressure (PEEP) was 14 (IQR, 12-16) cm H2O, and Fio2 was greater than 50% in 89% of patients.", "The median Pao2/Fio2 was 160 (IQR, 114-220).", "The median PEEP level was not different between younger patients (n = 503 aged &#8804;63 years) and older patients (n = 514 aged &#8805;64 years) (14 [IQR, 12-15] vs 14 [IQR, 12-16] cm H2O, respectively; median difference, 0 [95% CI, 0-0]; P = .94).", "Median Fio2 was lower in younger patients: 60% (IQR, 50%-80%) vs 70% (IQR, 50%-80%) (median difference, -10% [95% CI, -14% to 6%]; P = .006), and median Pao2/Fio2 was higher in younger patients: 163.5 (IQR, 120-230) vs 156 (IQR, 110-205) (median difference, 7 [95% CI, -8 to 22]; P = .02).", "Patients with hypertension (n = 509) were older than those without hypertension (n = 526) (median [IQR] age, 66 years [60-72] vs 62 years [54-68]; P < .001) and had lower Pao2/Fio2 (median [IQR], 146 [105-214] vs 173 [120-222]; median difference, -27 [95% CI, -42 to -12]; P = .005).", "Among the 1581 patients with ICU disposition data available as of March 25, 2020, 920 patients (58% [95% CI, 56%-61%]) were still in the ICU, 256 (16% [95% CI, 14%-18%]) were discharged from the ICU, and 405 (26% [95% CI, 23%-28%]) had died in the ICU.", "Older patients (n = 786; age &#8805;64 years) had higher mortality than younger patients (n = 795; age &#8804;63 years) (36% vs 15%; difference, 21% [95% CI, 17%-26%]; P < .001).", "Conclusions and Relevance: In this case series of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Lombardy, Italy, the majority were older men, a large proportion required mechanical ventilation and high levels of PEEP, and ICU mortality was 26%."]}
{"cord_id": "1bjdbpei", "title": "Temporal dynamics in viral shedding and transmissibility of COVID-19", "abstract": ["We report temporal patterns of viral shedding in 94 patients with laboratory-confirmed COVID-19 and modeled COVID-19 infectiousness profiles from a separate sample of 77 infector-infectee transmission pairs.", "We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset.", "We estimated that 44% (95% confidence interval, 25-69%) of secondary cases were infected during the index cases' presymptomatic stage, in settings with substantial household clustering, active case finding and quarantine outside the home.", "Disease control measures should be adjusted to account for probable substantial presymptomatic transmission."]}
{"cord_id": "qzcgciy1", "title": "Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area", "abstract": ["Importance: There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19).", "Objective: To describe the clinical characteristics and outcomes of patients with COVID-19 hospitalized in a US health care system.", "Design, Setting, and Participants: Case series of patients with COVID-19 admitted to 12 hospitals in New York City, Long Island, and Westchester County, New York, within the Northwell Health system.", "The study included all sequentially hospitalized patients between March 1, 2020, and April 4, 2020, inclusive of these dates.", "Exposures: Confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by positive result on polymerase chain reaction testing of a nasopharyngeal sample among patients requiring admission.", "Main Outcomes and Measures: Clinical outcomes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and death.", "Demographics, baseline comorbidities, presenting vital signs, and test results were also collected.", "Results: A total of 5700 patients were included (median age, 63 years [interquartile range {IQR}, 52-75; range, 0-107 years]; 39.7% female).", "The most common comorbidities were hypertension (3026; 56.6%), obesity (1737; 41.7%), and diabetes (1808; 33.8%).", "At triage, 30.7% of patients were febrile, 17.3% had a respiratory rate greater than 24 breaths/minute, and 27.8% received supplemental oxygen.", "The rate of respiratory virus co-infection was 2.1%.", "Outcomes were assessed for 2634 patients who were discharged or had died at the study end point.", "During hospitalization, 373 patients (14.2%) (median age, 68 years [IQR, 56-78]; 33.5% female) were treated in the intensive care unit care, 320 (12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidney replacement therapy, and 553 (21%) died.", "Mortality for those requiring mechanical ventilation was 88.1%.", "The median postdischarge follow-up time was 4.4 days (IQR, 2.2-9.3).", "A total of 45 patients (2.2%) were readmitted during the study period.", "The median time to readmission was 3 days (IQR, 1.0-4.5) for readmitted patients.", "Among the 3066 patients who remained hospitalized at the final study follow-up date (median age, 65 years [IQR, 54-75]), the median follow-up at time of censoring was 4.5 days (IQR, 2.4-8.1).", "Conclusions and Relevance: This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area."]}
{"cord_id": "8m06zdho", "title": "Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology", "abstract": ["Since its emergence and detection in Wuhan, China in late 2019, the novel coronavirus SARS-CoV-2 has spread to nearly every country around the world, resulting in hundreds of thousands of infections to date.", "The virus was first detected in the Pacific Northwest region of the United States in January, 2020, with subsequent COVID-19 outbreaks detected in all 50 states by early March.", "To uncover the sources of SARS-CoV-2 introductions and patterns of spread within the U.S., we sequenced nine viral genomes from early reported COVID-19 patients in Connecticut.", "Our phylogenetic analysis places the majority of these genomes with viruses sequenced from Washington state.", "By coupling our genomic data with domestic and international travel patterns, we show that early SARS-CoV-2 transmission in Connecticut was likely driven by domestic introductions.", "Moreover, the risk of domestic importation to Connecticut exceeded that of international importation by mid-March regardless of our estimated impacts of federal travel restrictions.", "This study provides evidence for widespread, sustained transmission of SARS-CoV-2 within the U.S. and highlights the critical need for local surveillance."]}
{"cord_id": "4eak8e8l", "title": "Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness", "abstract": ["RATIONALE: Medical masks are commonly used by sick individuals with influenza-like illness (ILI) to prevent spread of infections to others, but clinical efficacy data are absent.", "OBJECTIVE: Determine whether medical mask use by sick individuals with ILI protects well contacts from related respiratory infections.", "SETTING: 6 major hospitals in 2 districts of Beijing, China.", "DESIGN: Cluster randomised controlled trial.", "PARTICIPANTS: 245 index cases with ILI.", "INTERVENTION: Index cases with ILI were randomly allocated to medical mask (n=123) and control arms (n=122).", "Since 43 index cases in the control arm also used a mask during the study period, an as-treated post hoc analysis was performed by comparing outcomes among household members of index cases who used a mask (mask group) with household members of index cases who did not use a mask (no-mask group).", "MAIN OUTCOME MEASURE: Primary outcomes measured in household members were clinical respiratory illness, ILI and laboratory-confirmed viral respiratory infection.", "RESULTS: In an intention-to-treat analysis, rates of clinical respiratory illness (relative risk (RR) 0.61, 95% CI 0.18 to 2.13), ILI (RR 0.32, 95% CI 0.03 to 3.13) and laboratory-confirmed viral infections (RR 0.97, 95% CI 0.06 to 15.54) were consistently lower in the mask arm compared with control, although not statistically significant.", "A post hoc comparison between the mask versus no-mask groups showed a protective effect against clinical respiratory illness, but not against ILI and laboratory-confirmed viral respiratory infections.", "CONCLUSIONS: The study indicates a potential benefit of medical masks for source control, but is limited by small sample size and low secondary attack rates.", "Larger trials are needed to confirm efficacy of medical masks as source control.", "TRIAL REGISTRATION NUMBER: ACTRN12613000852752; Results."]}
{"cord_id": "4mp1iu55", "title": "An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study", "abstract": ["BACKGROUND: The Bergamo province, which is extensively affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, is a natural observatory of virus manifestations in the general population.", "In the past month we recorded an outbreak of Kawasaki disease; we aimed to evaluate incidence and features of patients with Kawasaki-like disease diagnosed during the SARS-CoV-2 epidemic.", "METHODS: All patients diagnosed with a Kawasaki-like disease at our centre in the past 5 years were divided according to symptomatic presentation before (group 1) or after (group 2) the beginning of the SARS-CoV-2 epidemic.", "Kawasaki- like presentations were managed as Kawasaki disease according to the American Heart Association indications.", "Kawasaki disease shock syndrome (KDSS) was defined by presence of circulatory dysfunction, and macrophage activation syndrome (MAS) by the Paediatric Rheumatology International Trials Organisation criteria.", "Current or previous infection was sought by reverse-transcriptase quantitative PCR in nasopharyngeal and oropharyngeal swabs, and by serological qualitative test detecting SARS-CoV-2 IgM and IgG, respectively.", "FINDINGS: Group 1 comprised 19 patients (seven boys, 12 girls; aged 3\u00b70 years [SD 2\u00b75]) diagnosed between Jan 1, 2015, and Feb 17, 2020.", "Group 2 included ten patients (seven boys, three girls; aged 7\u00b75 years [SD 3\u00b75]) diagnosed between Feb 18 and April 20, 2020; eight of ten were positive for IgG or IgM, or both.", "The two groups differed in disease incidence (group 1 vs group 2, 0\u00b73 vs ten per month), mean age (3\u00b70 vs 7\u00b75 years), cardiac involvement (two of 19 vs six of ten), KDSS (zero of 19 vs five of ten), MAS (zero of 19 vs five of ten), and need for adjunctive steroid treatment (three of 19 vs eight of ten; all p<0\u00b701).", "INTERPRETATION: In the past month we found a 30-fold increased incidence of Kawasaki-like disease.", "Children diagnosed after the SARS-CoV-2 epidemic began showed evidence of immune response to the virus, were older, had a higher rate of cardiac involvement, and features of MAS.", "The SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease.", "A similar outbreak of Kawasaki-like disease is expected in countries involved in the SARS-CoV-2 epidemic.", "FUNDING: None."]}
{"cord_id": "6oaks0kl", "title": "Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units", "abstract": ["Importance: The recent and ongoing coronavirus disease 2019 (COVID-19) pandemic has taken an unprecedented toll on adults critically ill with COVID-19 infection.", "While there is evidence that the burden of COVID-19 infection in hospitalized children is lesser than in their adult counterparts, to date, there are only limited reports describing COVID-19 in pediatric intensive care units (PICUs).", "Objective: To provide an early description and characterization of COVID-19 infection in North American PICUs, focusing on mode of presentation, presence of comorbidities, severity of disease, therapeutic interventions, clinical trajectory, and early outcomes.", "Design, Setting, and Participants: This cross-sectional study included children positive for COVID-19 admitted to 46 North American PICUs between March 14 and April 3, 2020. with follow-up to April 10, 2020.", "Main Outcomes and Measures: Prehospital characteristics, clinical trajectory, and hospital outcomes of children admitted to PICUs with confirmed COVID-19 infection.", "Results: Of the 48 children with COVID-19 admitted to participating PICUs, 25 (52%) were male, and the median (range) age was 13 (4.2-16.6) years.", "Forty patients (83%) had significant preexisting comorbidities; 35 (73%) presented with respiratory symptoms and 18 (38%) required invasive ventilation.", "Eleven patients (23%) had failure of 2 or more organ systems.", "Extracorporeal membrane oxygenation was required for 1 patient (2%).", "Targeted therapies were used in 28 patients (61%), with hydroxychloroquine being the most commonly used agent either alone (11 patients) or in combination (10 patients).", "At the completion of the follow-up period, 2 patients (4%) had died and 15 (31%) were still hospitalized, with 3 still requiring ventilatory support and 1 receiving extracorporeal membrane oxygenation.", "The median (range) PICU and hospital lengths of stay for those who had been discharged were 5 (3-9) days and 7 (4-13) days, respectively.", "Conclusions and Relevance: This early report describes the burden of COVID-19 infection in North American PICUs and confirms that severe illness in children is significant but far less frequent than in adults.", "Prehospital comorbidities appear to be an important factor in children.", "These preliminary observations provide an important platform for larger and more extensive studies of children with COVID-19 infection."]}
{"cord_id": "1dkkwt7h", "title": "Updated estimates of comorbidities associated with risk for COVID-19 complications based on US data", "abstract": ["We updated previous estimates (wwwnc.cdc.gov/eid/article/26/8/20-0679_article) of adults with any underlying condition increasing risk of complications from COVID-19 using recent US hospitalization data instead of mortality data from China.", "This substitutes obesity for cancer in the definition and increased the percentage of adults reporting more than 1 condition to 56.0% (95% CI 55.7-56.4).", "When controlled for all measures listed, factors increasing odds of reporting any of the underlying conditions include being male, older, African American, American Indian, household income <$25,000, < high school education, underinsurance, living in the South or Midwest (vs. West), plus the risk factors of ever smoking, sedentary lifestyle, and inadequate fruit and vegetable consumption.", "Population-attributable risk for the listed risk factors was 13.0%, 12.6%, and 15.0% respectively.", "Results have potential implications for policies based on risk-stratification of the population and for improvement of risk status through lifestyle change.", "National support for a health promotion campaign would be timely."]}
{"cord_id": "zoipx650", "title": "Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19", "abstract": ["BACKGROUND: Despite limited and conflicting data on the use of hydroxychloroquine in patients with Covid-19, the U.S. Food and Drug Administration has authorized the emergency use of this drug when clinical trials are unavailable or infeasible.", "Hydroxychloroquine, alone or in combination with azithromycin, is being widely used in Covid-19 therapy based on anecdotal and limited observational evidence.", "METHODS: We performed a retrospective analysis of data from patients hospitalized with confirmed SARS-CoV-2 infection in all United States Veterans Health Administration medical centers until April 11, 2020.", "Patients were categorized based on their exposure to hydroxychloroquine alone (HC) or with azithromycin (HC+AZ) as treatments in addition to standard supportive management for Covid-19.", "The two primary outcomes were death and the need for mechanical ventilation.", "We determined the association between treatment and the primary outcomes using competing risk hazard regression adjusting for clinical characteristics via propensity scores.", "Discharge and death were taken into account as competing risks and subdistribution hazard ratios are presented.", "RESULTS: A total of 368 patients were evaluated (HC, n=97; HC+AZ, n=113; no HC, n=158).", "Rates of death in the HC, HC+AZ, and no HC groups were 27.8%, 22.1%, 11.4%, respectively.", "Rates of ventilation in the HC, HC+AZ, and no HC groups were 13.3%, 6.9%, 14.1%, respectively.", "Compared to the no HC group, the risk of death from any cause was higher in the HC group (adjusted hazard ratio, 2.61; 95% CI, 1.10 to 6.17; P=0.03) but not in the HC+AZ group (adjusted hazard ratio, 1.14; 95% CI, 0.56 to 2.32; P=0.72).", "The risk of ventilation was similar in the HC group (adjusted hazard ratio, 1.43; 95% CI, 0.53 to 3.79; P=0.48) and in the HC+AZ group (adjusted hazard ratio, 0.43; 95% CI, 0.16 to 1.12; P=0.09), compared to the no HC group.", "CONCLUSIONS: In this study, we found no evidence that use of hydroxychloroquine, either with or without azithromycin, reduced the risk of mechanical ventilation in patients hospitalized with Covid-19.", "An association of increased overall mortality was identified in patients treated with hydroxychloroquine alone.", "These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs."]}
{"cord_id": "f5p37j7g", "title": "Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period", "abstract": ["It is urgent to understand the future of severe acute respiratory syndrome\u2013coronavirus 2 (SARS-CoV-2) transmission.", "We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission.", "We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave.", "Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded.", "To avoid this, prolonged or intermittent social distancing may be necessary into 2022.", "Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity.", "Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2.", "Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024."]}
{"cord_id": "01d8cqn4", "title": "Mental health outcomes among front and second line health workers associated with the COVID-19 pandemic in Italy.", "abstract": ["In this study, we report on mental health outcomes among health workers (HWs) involved with the COVID-19 pandemic in Italy.", "Data on mental health on 1379 HWs were collected between March 27th and March 31th 2020 using an on-line questionnaire spread throughout social networks, using a snowball technique along with sponsored social network advertisement.", "Key mental health outcomes were Post-Traumatic Stress Disorder symptoms (PTSD), severe depression, anxiety, insomnia and perceived stress.", "PTSD symptoms, severe depression, anxiety and insomnia, and high perceived stress were endorsed respectively by 681 (49.38%), 341 (24.73%), 273 (19.80%), 114 (8.27%) and 302 (21.90%) respondents.", "Regression analysis show that younger age, female gender, being a front-line HWs, having a colleague deceased, hospitalised or in quarantine were associated with poor mental health outcomes.", "This is the first report on mental health outcomes and associated risk factors among HWs associated with the COVID-19 pandemic in Italy, confirming a substantial proportion of health workers involved with the COVID-19 pandemic having mental health issues, in particular young women, first-line HWs."]}
{"cord_id": "4uiyj6lg", "title": "Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019", "abstract": ["IMPORTANCE: Health care workers exposed to coronavirus disease 2019 (COVID-19) could be psychologically stressed.", "OBJECTIVE: To assess the magnitude of mental health outcomes and associated factors among health care workers treating patients exposed to COVID-19 in China.", "DESIGN, SETTINGS, AND PARTICIPANTS: This cross-sectional, survey-based, region-stratified study collected demographic data and mental health measurements from 1257 health care workers in 34 hospitals from January 29, 2020, to February 3, 2020, in China.", "Health care workers in hospitals equipped with fever clinics or wards for patients with COVID-19 were eligible.", "MAIN OUTCOMES AND MEASURES: The degree of symptoms of depression, anxiety, insomnia, and distress was assessed by the Chinese versions of the 9-item Patient Health Questionnaire, the 7-item Generalized Anxiety Disorder scale, the 7-item Insomnia Severity Index, and the 22-item Impact of Event Scale\u2013Revised, respectively.", "Multivariable logistic regression analysis was performed to identify factors associated with mental health outcomes.", "RESULTS: A total of 1257 of 1830 contacted individuals completed the survey, with a participation rate of 68.7%.", "A total of 813 (64.7%) were aged 26 to 40 years, and 964 (76.7%) were women.", "Of all participants, 764 (60.8%) were nurses, and 493 (39.2%) were physicians; 760 (60.5%) worked in hospitals in Wuhan, and 522 (41.5%) were frontline health care workers.", "A considerable proportion of participants reported symptoms of depression (634 [50.4%]), anxiety (560 [44.6%]), insomnia (427 [34.0%]), and distress (899 [71.5%]).", "Nurses, women, frontline health care workers, and those working in Wuhan, China, reported more severe degrees of all measurements of mental health symptoms than other health care workers (eg, median [IQR] Patient Health Questionnaire scores among physicians vs nurses: 4.0 [1.0-7.0] vs 5.0 [2.0-8.0]; P = .007; median [interquartile range {IQR}] Generalized Anxiety Disorder scale scores among men vs women: 2.0 [0-6.0] vs 4.0 [1.0-7.0]; P < .001; median [IQR] Insomnia Severity Index scores among frontline vs second-line workers: 6.0 [2.0-11.0] vs 4.0 [1.0-8.0]; P < .001; median [IQR] Impact of Event Scale\u2013Revised scores among those in Wuhan vs those in Hubei outside Wuhan and those outside Hubei: 21.0 [8.5-34.5] vs 18.0 [6.0-28.0] in Hubei outside Wuhan and 15.0 [4.0-26.0] outside Hubei; P < .001).", "Multivariable logistic regression analysis showed participants from outside Hubei province were associated with lower risk of experiencing symptoms of distress compared with those in Wuhan (odds ratio [OR], 0.62; 95% CI, 0.43-0.88; P = .008).", "Frontline health care workers engaged in direct diagnosis, treatment, and care of patients with COVID-19 were associated with a higher risk of symptoms of depression (OR, 1.52; 95% CI, 1.11-2.09; P = .01), anxiety (OR, 1.57; 95% CI, 1.22-2.02; P < .001), insomnia (OR, 2.97; 95% CI, 1.92-4.60; P < .001), and distress (OR, 1.60; 95% CI, 1.25-2.04; P < .001).", "CONCLUSIONS AND RELEVANCE: In this survey of heath care workers in hospitals equipped with fever clinics or wards for patients with COVID-19 in Wuhan and other regions in China, participants reported experiencing psychological burden, especially nurses, women, those in Wuhan, and frontline health care workers directly engaged in the diagnosis, treatment, and care for patients with COVID-19."]}
{"cord_id": "dlpgq0rm", "title": "Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS\u2013coronavirus 2", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019.", "Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic.", "SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown.", "Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2.", "We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection.", "We found experimentally that cats are susceptible to airborne infection.", "Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control."]}
{"cord_id": "vibyd47l", "title": "Impact of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China", "abstract": ["Background: When a new infectious disease emerges, appropriate case definitions are important for clinical diagnosis and also for public health surveillance.", "Tracking case numbers over time allows us to determine speed of spread and the effectiveness of interventions.", "Changing case definitions during an epidemic can affect these inferences.", "Methods: We examined changes in the case definition for COVID-19 in mainland China during the first epidemic wave.", "We used simple models assuming exponential growth and then exponential decay to estimate how changes in the case definitions affected the numbers of cases reported each day.", "We then inferred how the epidemic curve would have appeared if the same case definition had been used throughout the epidemic.", "Findings: From January through to early March 2020, seven versions of the case definition for COVID-19 were issued by the National Health Commission in China.", "As of February 20, there were 55,508 confirmed cases reported in mainland China.", "We estimated that when the case definitions were changed from version 1 to 2, version 2 to 4 and version 4 to 5, the proportion of infections being detected as cases were increased by 7.1-fold (95% credible interval (CI): 4.8, 10.9), 2.8-fold (95% CI: 1.9, 4.2) and 4.2-fold (95% CI: 2.6, 7.3) respectively.", "If the fifth version of the case definition had been applied throughout the outbreak, we estimated that by February 20 there would have been 232,000 (95% CI: 161,000, 359,000) confirmed cases.", "Interpretation: The case definition was initially narrow, but was gradually broadened to allow detection of more cases as knowledge increased, particularly milder cases and those without epidemiological links to Wuhan or other known cases.", "This should be taken into account when making inferences on epidemic growth rates and doubling times, and therefore on the reproductive number, to avoid bias.", "Funding: Commissioned grant from the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region."]}
{"cord_id": "eo8rbcy2", "title": "High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2", "abstract": ["Severe acute respiratory syndrome coronavirus 2 is the causative agent of the ongoing coronavirus disease pandemic.", "Initial estimates of the early dynamics of the outbreak in Wuhan, China, suggested a doubling time of the number of infected persons of 6\u20137 days and a basic reproductive number (R(0)) of 2.2\u20132.7.", "We collected extensive individual case reports across China and estimated key epidemiologic parameters, including the incubation period (4.2 days).", "We then designed 2 mathematical modeling approaches to infer the outbreak dynamics in Wuhan by using high-resolution domestic travel and infection data.", "Results show that the doubling time early in the epidemic in Wuhan was 2.3\u20133.3 days.", "Assuming a serial interval of 6\u20139 days, we calculated a median R(0) value of 5.7 (95% CI 3.8\u20138.9).", "We further show that active surveillance, contact tracing, quarantine, and early strong social distancing efforts are needed to stop transmission of the virus."]}
{"cord_id": "g3hujz5o", "title": "TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes", "abstract": ["Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA are frequently observed in COVID-19 patients.", "However, it is unclear whether SARS-CoV-2 replicates in the human intestine and contributes to possible fecal-oral transmission.", "Here, we report productive infection of SARS-CoV-2 in ACE2(+) mature enterocytes in human small intestinal enteroids.", "Expression of two mucosa-specific serine proteases, TMPRSS2 and TMPRSS4, facilitated SARS-CoV-2 spike fusogenic activity and promoted virus entry into host cells.", "We also demonstrate that viruses released into the intestinal lumen were inactivated by simulated human colonic fluid, and infectious virus was not recovered from the stool specimens of COVID-19 patients.", "Our results highlight the intestine as a potential site of SARS-CoV-2 replication, which may contribute to local and systemic illness and overall disease progression."]}
{"cord_id": "hm332jqo", "title": "The emergence of SARS-CoV-2 in Europe and the US", "abstract": ["Accurate understanding of the global spread of emerging viruses is critically important for public health response and for anticipating and preventing future outbreaks.", "Here, we elucidate when, where and how the earliest sustained SARS-CoV-2 transmission networks became established in Europe and the United States (US).", "Our results refute prior findings erroneously linking cases in January 2020 with outbreaks that occurred weeks later.", "Instead, rapid interventions successfully prevented onward transmission of those early cases in Germany and Washington State.", "Other, later introductions of the virus from China to both Italy and Washington State founded the earliest sustained European and US transmission networks.", "Our analyses reveal an extended period of missed opportunity when intensive testing and contact tracing could have prevented SARS-CoV-2 from becoming established in the US and Europe."]}
{"cord_id": "2kvft8na", "title": "Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals", "abstract": ["The ongoing outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly on a global scale.", "Although it is clear that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through human respiratory droplets and direct contact, the potential for aerosol transmission is poorly understood1-3.", "Here we investigated the aerodynamic nature of SARS-CoV-2 by measuring viral RNA in aerosols in different areas of two Wuhan hospitals during the outbreak of COVID-19 in February and March 2020.", "The concentration of SARS-CoV-2 RNA in aerosols that was detected in isolation wards and ventilated patient rooms was very low, but it was higher in the toilet areas used by the patients.", "Levels of airborne SARS-CoV-2 RNA in the most public areas was undetectable, except in two areas that were prone to crowding; this increase was possibly due to individuals infected with SARS-CoV-2 in the crowd.", "We found that some medical staff areas initially had high concentrations of viral RNA with aerosol size distributions that showed peaks in the submicrometre and/or supermicrometre regions; however, these levels were reduced to undetectable levels after implementation of rigorous sanitization procedures.", "Although we have not established the infectivity of the virus detected in these hospital areas, we propose that SARS-CoV-2 may have the potential to be transmitted through aerosols.", "Our results indicate that room ventilation, open space, sanitization of protective apparel, and proper use and disinfection of toilet areas can effectively limit the concentration of SARS-CoV-2 RNA in aerosols.", "Future work should explore the infectivity of aerosolized virus."]}
{"cord_id": "xl07uq0s", "title": "Respiratory virus shedding in exhaled breath and efficacy of face masks", "abstract": ["We identified seasonal human coronaviruses, influenza viruses and rhinoviruses in exhaled breath and coughs of children and adults with acute respiratory illness.", "Surgical face masks significantly reduced detection of influenza virus RNA in respiratory droplets and coronavirus RNA in aerosols, with a trend toward reduced detection of coronavirus RNA in respiratory droplets.", "Our results indicate that surgical face masks could prevent transmission of human coronaviruses and influenza viruses from symptomatic individuals."]}
{"cord_id": "a1pa6g5c", "title": "A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender.", "abstract": ["Objective: To compare the difference of SARS-CoV-2 IgG antibody between male and female COVID-19 patients and figure out a possible explanation for different outcome between male and female patients.", "Methods: A total number of 331 patients confirmed SARS-CoV-2 infection were enrolled.", "The plasma of these patients were collected during hospitalization and were detected for SARS-CoV-2 IgG antibody.", "Afterwards, the difference of IgG antibody between male and female patients was analyzed.", "Results: The level of IgG antibody in mild, general and recovering patients showed on difference between male and female.", "In severe status, the average IgG antibody level in female patients tended to be higher than that of in male patients.", "Compared with male patients, most of the female patients generated a relatively high level of SARS-CoV-2 IgG antibody in severe status.", "In addition, the generation of IgG antibody in female tended to be stronger than male patients in disease early phase.", "Conclusions: The inconsistent of SARS-CoV-2 IgG antibody generation in male and female patients may account for the different outcome of COVID-19 between gender."]}
{"cord_id": "qdkhr8ch", "title": "Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020", "abstract": ["From January 21 through February 23, 2020, a total of 14 cases of coronavirus disease 2019 (COVID-19) were diagnosed in six U.S. states, including 12 cases in travelers arriving from China and two in household contacts of persons with confirmed infections.", "An additional 39 cases were identified in persons repatriated from affected areas outside the United States (1).", "Starting in late February, reports of cases with no recent travel to affected areas or links to known cases signaled the initiation of pandemic spread in the United States (2).", "By mid-March, transmission of SARS-CoV-2, the virus that causes COVID-19, had accelerated, with rapidly increasing case counts indicating established transmission in the United States.", "Ongoing traveler importation of SARS-CoV-2, attendance at professional and social events, introduction into facilities or settings prone to amplification, and challenges in virus detection all contributed to rapid acceleration of transmission during March.", "Public health responses included intensive efforts to detect cases and trace contacts, and implementation of multiple community mitigation strategies.", "Because most of the population remains susceptible to infection, recognition of factors associated with amplified spread during the early acceleration period will help inform future decisions as locations in the United States scale back some components of mitigation and strengthen systems to detect a potential transmission resurgence.", "U.S. circulation of SARS-CoV-2 continues, and sustained efforts will be needed to prevent future spread within the United States."]}
{"cord_id": "ymvag1lk", "title": "Modeling shield immunity to reduce COVID-19 epidemic spread", "abstract": ["The COVID-19 pandemic has precipitated a global crisis, with more than 1,430,000 confirmed cases and more than 85,000 confirmed deaths globally as of 9 April 20201-4.", "Mitigation and suppression of new infections have emerged as the two predominant public health control strategies5.", "Both strategies focus on reducing new infections by limiting human-to-human interactions, which could be both socially and economically unsustainable in the long term.", "We have developed and analyzed an epidemiological intervention model that leverages serological tests6,7 to identify and deploy recovered individuals8 as focal points for sustaining safer interactions via interaction substitution, developing what we term 'shield immunity' at the population scale.", "The objective of a shield immunity strategy is to help to sustain the interactions necessary for the functioning of essential goods and services9 while reducing the probability of transmission.", "Our shield immunity approach could substantively reduce the length and reduce the overall burden of the current outbreak, and can work synergistically with social distancing.", "The present model highlights the value of serological testing as part of intervention strategies, in addition to its well-recognized roles in estimating prevalence10,11 and in the potential development of plasma-based therapies12-15."]}
{"cord_id": "m5ji2gu4", "title": "Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)", "abstract": ["Importance: Virus infection has been widely described as one of the most common causes of myocarditis.", "However, less is known about the cardiac involvement as a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.", "Objective: To describe the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from the influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms.", "Design, Setting, and Participant: This case report describes an otherwise healthy 53-year-old woman who tested positive for COVID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19.", "The patient did not show any respiratory involvement during the clinical course.", "Exposure: Cardiac involvement with COVID-19.", "Main Outcomes and Measures: Detection of cardiac involvement with an increase in levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin T, echocardiography changes, and diffuse biventricular myocardial edema and late gadolinium enhancement on cardiac magnetic resonance imaging.", "Results: An otherwise healthy 53-year-old white woman presented to the emergency department with severe fatigue.", "She described fever and dry cough the week before.", "She was afebrile but hypotensive; electrocardiography showed diffuse ST elevation, and elevated high-sensitivity troponin T and NT-proBNP levels were detected.", "Findings on chest radiography were normal.", "There was no evidence of obstructive coronary disease on coronary angiography.", "Based on the COVID-19 outbreak, a nasopharyngeal swab was performed, with a positive result for SARS-CoV-2 on real-time reverse transcriptase-polymerase chain reaction assay.", "Cardiac magnetic resonance imaging showed increased wall thickness with diffuse biventricular hypokinesis, especially in the apical segments, and severe left ventricular dysfunction (left ventricular ejection fraction of 35%).", "Short tau inversion recovery and T2-mapping sequences showed marked biventricular myocardial interstitial edema, and there was also diffuse late gadolinium enhancement involving the entire biventricular wall.", "There was a circumferential pericardial effusion that was most notable around the right cardiac chambers.", "These findings were all consistent with acute myopericarditis.", "She was treated with dobutamine, antiviral drugs (lopinavir/ritonavir), steroids, chloroquine, and medical treatment for heart failure, with progressive clinical and instrumental stabilization.", "Conclusions and Relevance: This case highlights cardiac involvement as a complication associated with COVID-19, even without symptoms and signs of interstitial pneumonia."]}
{"cord_id": "z9uu4sj7", "title": "Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease", "abstract": ["Coronavirus disease 2019 (COVID-19) is characterized by a high incidence of acute respiratory failure.", "The underlying immunopathology of that failure and how it compares to other causes of severe respiratory distress, such as influenza virus infection, are not fully understood.", "Here we addressed this by developing a prospective observational cohort of COVID-19 and influenza subjects with varying degrees of disease severity and assessing the quality and magnitude of their immune responses at the cellular and protein level.", "Additionally, we performed single-cell RNA transcriptional profiling of peripheral blood mononuclear cells from select subjects.", "The cohort consists of 79 COVID-19 subjects, 26 influenza subjects, and 15 control subjects, including 35 COVID-19 and 7 influenza subjects with acute respiratory failure.", "While COVID-19 subjects exhibited largely equivalent or greater activated lymphocyte counts compared to influenza subjects, they had fewer monocytes and lower surface HLA-class II expression on monocytes compared to influenza subjects and controls.", "At least two distinct immune profiles were observed by cytokine levels in severe COVID-19 patients: 3 of 71 patients were characterized by extreme inflammation, with greater than or equal to ~50% of the 35 cytokines measured greater than 2 standard deviations from the mean level of other severe patients (both influenza and COVID-19); the other immune profile, which characterized 68 of 71 subjects, had a mixed inflammatory signature, where 28 of 35 cytokines in COVID-19 patients had lower mean cytokine levels, though not all were statistically significant.", "Only 2 cytokines were higher in COVID-19 subjects compared to influenza subjects (IL-6 and IL-8).", "Influenza and COVID-19 patients could be distinguished statistically based on cytokine module expression, particularly after controlling for the significant effects of age on cytokine expression, but again with lower levels of most cytokines in COVID-19 subjects.", "Further, high circulating levels of IL-1RA and IL-6 were associated with increased odds of intubation in the combined influenza and COVID-19 cohort [OR = 3.93 and 4.30, respectively] as well as among only COVID-19 patients.", "Single cell transcriptional profiling of COVID-19 and influenza subjects with respiratory failure identified profound suppression in type I and type II interferon signaling in COVID-19 patients across multiple clusters.", "In contrast, COVID-19 cell clusters were enriched for alterations in metabolic, stress, and apoptotic pathways.", "These alterations were consistent with an increased glucocorticoid response in COVID-19 patients compared to influenza.", "When considered across the spectrum of innate and adaptive immune profiles, the immune pathologies underlying severe influenza and COVID-19 are substantially distinct.", "The majority of COVID-19 patients with acute respiratory failure do not have a cytokine storm phenotype but instead exhibit profound type I and type II IFN immunosuppression when compared to patients with acute influenza.", "Upregulation of a small number of inflammatory mediators, including IL-6, predicts acute respiratory failure in both COVID-19 and influenza patients."]}
{"cord_id": "9rgv88qf", "title": "An inflammatory cytokine signature helps predict COVID-19 severity and death", "abstract": ["The COVID-19 pandemic caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to more than 100,000 deaths in the United States.", "Several studies have revealed that the hyper-inflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients.", "However, predictive biomarkers of pathogenic inflammation to help guide targetable immune pathways are critically lacking.", "We implemented a rapid multiplex cytokine assay to measure serum IL-6, IL-8, TNF-, and IL-1{beta} in hospitalized COVID-19 patients upon admission to the Mount Sinai Health System in New York.", "Patients (n=1484) were followed up to 41 days (median 8 days) and clinical information, laboratory test results and patient outcomes were collected.", "In 244 patients, cytokine measurements were repeated over time, and effect of drugs could be assessed.", "Kaplan-Meier methods were used to compare survival by cytokine strata, followed by Cox regression models to evaluate the independent predictive value of baseline cytokines.", "We found that high serum IL-6, IL-8, and TNF- levels at the time of hospitalization were strong and independent predictors of patient survival.", "Importantly, when adjusting for disease severity score, common laboratory inflammation markers, hypoxia and other vitals, demographics, and a range of comorbidities, IL-6 and TNF- serum levels remained independent and significant predictors of disease severity and death.", "We propose that serum IL-6 and TNF- levels should be considered in the management and treatment of COVID-19 patients to stratify prospective clinical trials, guide resource allocation and inform therapeutic options.", "We also propose that patients with high IL-6 and TNF- levels should be assessed for combinatorial blockade of pathogenic inflammation in this disease."]}
{"cord_id": "7ftu9b9q", "title": "Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study", "abstract": ["Background While there are no treatments with proven efficacy for patients with severe coronavirus disease 2019 (COVID 19), tocilizumab has been proposed as a candidate therapy, especially among patients with higher systemic inflammation.", "Methods We conducted a cohort study of patients hospitalized with COVID 19 in Spain.", "The primary outcome was time to death and the secondary outcome time to intensive care unit admission (ICU) or death.", "We used inverse probability weighting to fit marginal structural models adjusted for time varying covariates to determine the causal relationship between tocilizumab use and the outcomes.", "Results A total of 1,229 and 10,673 person/days were analyzed.", "In the adjusted marginal structural models, a significant interaction between tocilizumab use and high C reactive protein (CRP) levels was detected.", "Tocilizumab was associated with decreased risk of death (aHR 0.34, 95% CI 0.16 to 0.72, p=0.005) and ICU admission or death (aHR 0.38, 95% CI 0.19 to 0.81, p=0.011) among patients with baseline CRP >150 mg/L, but not among those with CRP [\u2264]150 mg/L.", "Exploratory subgroup analyses yielded point estimates that were consistent with these findings.", "Conclusions In this large observational study, tocilizumab was associated with a lower risk of death or ICU or death in patients with higher CRP levels.", "While the results of ongoing clinical trials of tocilizumab in patients with COVID 19 will be important to establish its safety and efficacy, our findings have implications for the design of future clinical trials and support the use of tocilizumab among subjects with higher CRP levels."]}
{"cord_id": "vdd88nwl", "title": "Tocilizumab for treatment of mechanically ventilated patients with COVID-19", "abstract": ["BACKGROUND: Severe COVID-19 can manifest in rapid decompensation and respiratory failure with elevated inflammatory markers.", "This presentation is consistent with cytokine release syndrome in chimeric antigen receptor T cell therapy, for which IL-6 blockade is approved treatment.", "METHODS: We assessed effectiveness and safety of IL-6 blockade with tocilizumab in a single-center cohort of patients with COVID-19 requiring mechanical ventilation.", "The primary endpoint was survival probability post-intubation; secondary analyses included an ordinal illness severity scale integrating superinfections.", "Outcomes in patients who received tocilizumab compared to tocilizumab-untreated controls were evaluated using multivariable Cox regression with propensity score inverse probability weighting (IPTW).", "FINDINGS: 154 patients were included, of whom 78 received tocilizumab and 76 did not.", "Median follow-up was 47 days (range 28-67).", "Baseline characteristics were similar between groups, although tocilizumab-treated patients were younger (mean 55 vs. 60 years), less likely to have chronic pulmonary disease (10% vs. 28%), and had lower D-dimer values at time of intubation (median 2.4 vs. 6.5 mg/dL).", "In IPTW-adjusted models, tocilizumab was associated with a 45% reduction in hazard of death [hazard ratio 0.55 (95% CI 0.33, 0.90)] and improved status on the ordinal outcome scale [odds ratio per 1-level increase: 0.59 (0.36, 0.95)].", "Though tocilizumab was associated with an increased proportion of patients with superinfections (54% vs. 26%; p<0.001), there was no difference in 28-day case fatality rate among tocilizumab-treated patients with versus without superinfection [22% vs. 15%; p=0.42].", "INTERPRETATION: In this cohort of mechanically ventilated COVID-19 patients, tocilizumab was associated with a decreased likelihood of death despite higher superinfection occurrence.", "Randomized controlled trials are urgently needed to confirm these findings."]}
{"cord_id": "3p2cuxk0", "title": "Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages", "abstract": ["The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide.", "Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients.", "Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair.", "However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV.", "Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19."]}
{"cord_id": "mweeepam", "title": "Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor", "abstract": ["The 2002\u20133 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV) was one of the most significant public health events in recent history(1).", "An ongoing outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV)(2) suggests that this group of viruses remains a major threat and that their distribution is wider than previously recognized.", "Although bats have been suggested as the natural reservoirs of both viruses(3\u20135), attempts to isolate the progenitor virus of SARS-CoV from bats have been unsuccessful.", "Diverse SARS-like coronaviruses (SL-CoVs) have now been reported from bats in China, Europe and Africa(5\u20138), but none are considered a direct progenitor of SARS-CoV because of their phylogenetic disparity from this virus and the inability of their spike proteins (S) to use the SARS-CoV cellular receptor molecule, the human angiotensin converting enzyme II (ACE2)(9,10).", "Here, we report whole genome sequences of two novel bat CoVs from Chinese horseshoe bats (Family: Rhinolophidae) in Yunnan, China; RsSHC014 and Rs3367.", "These viruses are far more closely related to SARS-CoV than any previously identified bat CoVs, particularly in the receptor binding domain (RDB) of the S protein.", "Most importantly, we report the first recorded isolation of a live SL-CoV (bat SL-CoV-WIV1) from bat fecal samples in Vero E6 cells, which has typical coronavirus morphology, 99.9% sequence identity to Rs3367 and uses the ACE2s from human, civet and Chinese horseshoe bat for cell entry.", "Preliminary in vitro testing indicates that WIV1 also has a broad species tropism.", "Our results provide the strongest evidence to date that Chinese horseshoe bats are natural reservoirs of SARS-CoV, and that intermediate hosts may not be necessary for direct human infection by some bat SL-CoVs.", "They also highlight the importance of pathogen discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness."]}
{"cord_id": "8prg1goh", "title": "Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City", "abstract": ["Background: Little is known about factors associated with hospitalization and critical illness in Covid-19 positive patients.", "Methods: We conducted a cross-sectional analysis of all patients with laboratory-confirmed Covid-19 treated at a single academic health system in New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2020.", "Primary outcomes were hospitalization and critical illness (intensive care, mechanical ventilation, hospice and/or death).", "We conducted multivariable logistic regression to identify risk factors for adverse outcomes, and maximum information gain decision tree classifications to identify key splitters.", "Results: Among 4,103 Covid-19 patients, 1,999 (48.7%) were hospitalized, of whom 981/1,999 (49.1%) have been discharged home, and 292/1,999 (14.6%) have died or were discharged to hospice.", "Of 445 patients requiring mechanical ventilation, 162/445 (36.4%) have died.", "Strongest hospitalization risks were age [\u2265]75 years (OR 66.8, 95% CI, 44.7-102.6), age 65-74 (OR 10.9, 95% CI, 8.35-14.34), BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and heart failure (OR 4.3 95% CI, 1.9-11.2).", "Strongest critical illness risks were admission oxygen saturation <88% (OR 6.99, 95% CI 4.5-11.0), d-dimer>2500 (OR 6.9, 95% CI, 3.2-15.2), ferritin >2500 (OR 6.9, 95% CI, 3.2-15.2), and C-reactive protein (CRP) >200 (OR 5.78, 95% CI, 2.6-13.8).", "In the decision tree for admission, the most important features were age >65 and obesity; for critical illness, the most important was SpO2<88, followed by procalcitonin >0.5, troponin <0.1 (protective), age >64 and CRP>200.", "Conclusions: Age and comorbidities are powerful predictors of hospitalization; however, admission oxygen impairment and markers of inflammation are most strongly associated with critical illness."]}
{"cord_id": "bypmewsg", "title": "[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]", "abstract": ["Objective: To explore the clinical characteristics and prognosis of the new coronavirus 2019-nCoV patients combined with cardiovascular disease (CVD).", "Methods: A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020.", "They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint.", "The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection.", "Results: Compared with the general group, the lymphocyte count (0.74\u00d710(9) (0.34\u00d710(9), 0.94\u00d710(9))/L vs. 0.99\u00d710(9) (0.71\u00d710(9), 1.29\u00d710(9))/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u00b5g/L vs. 0.11 (0.06,0.20)\u00b5g/L, P<0.001) were significantly higher in the critical group.", "The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m(2) vs. 22.0 (20.0, 24.0) kg/m(2), P=0.003).", "Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%).", "Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m(2), which was significantly higher than that of survivors (18.95% (18/95), P<0.001).", "Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors.", "There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all P>0.05).", "Conclusion: COVID-19 patients combined with CVD are associated with a higher risk of mortality.", "Critical patients are characterized with lower lymphocyte counts.", "Higher BMI are more often seen in critical patients and non-survivor.", "ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD.", "Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events."]}
{"cord_id": "drto66xt", "title": "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records", "abstract": ["BACKGROUND: Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population.", "Limited data are available for pregnant women with COVID-19 pneumonia.", "This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection.", "METHODS: Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant women with laboratory-confirmed COVID-19 pneumonia (ie, with maternal throat swab samples that were positive for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan 20 to Jan 31, 2020.", "Evidence of intrauterine vertical transmission was assessed by testing for the presence of SARS-CoV-2 in amniotic fluid, cord blood, and neonatal throat swab samples.", "Breastmilk samples were also collected and tested from patients after the first lactation.", "FINDINGS: All nine patients had a caesarean section in their third trimester.", "Seven patients presented with a fever.", "Other symptoms, including cough (in four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also observed.", "Fetal distress was monitored in two cases.", "Five of nine patients had lymphopenia (<1\u00b70 \u00d7 10\u2079 cells per L).", "Three patients had increased aminotransferase concentrations.", "None of the patients developed severe COVID-19 pneumonia or died, as of Feb 4, 2020.", "Nine livebirths were recorded.", "No neonatal asphyxia was observed in newborn babies.", "All nine livebirths had a 1-min Apgar score of 8\u20139 and a 5-min Apgar score of 9\u201310.", "Amniotic fluid, cord blood, neonatal throat swab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negative for the virus.", "INTERPRETATION: The clinical characteristics of COVID-19 pneumonia in pregnant women were similar to those reported for non-pregnant adult patients who developed COVID-19 pneumonia.", "Findings from this small group of cases suggest that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy.", "FUNDING: Hubei Science and Technology Plan, Wuhan University Medical Development Plan."]}
{"cord_id": "54754u0s", "title": "The online competition between pro- and anti-vaccination views", "abstract": ["Distrust in scientific expertise1-14 is dangerous.", "Opposition to vaccination with a future vaccine against SARS-CoV-2, the causal agent of COVID-19, for example, could amplify outbreaks2-4, as happened for measles in 20195,6.", "Homemade remedies7,8 and falsehoods are being shared widely on the Internet, as well as dismissals of expert advice9-11.", "There is a lack of understanding about how this distrust evolves at the system level13,14.", "Here we provide a map of the contention surrounding vaccines that has emerged from the global pool of around three billion Facebook users.", "Its core reveals a multi-sided landscape of unprecedented intricacy that involves nearly 100 million individuals partitioned into highly dynamic, interconnected clusters across cities, countries, continents and languages.", "Although smaller in overall size, anti-vaccination clusters manage to become highly entangled with undecided clusters in the main online network, whereas pro-vaccination clusters are more peripheral.", "Our theoretical framework reproduces the recent explosive growth in anti-vaccination views, and predicts that these views will dominate in a decade.", "Insights provided by this framework can inform new policies and approaches to interrupt this shift to negative views.", "Our results challenge the conventional thinking about undecided individuals in issues of contention surrounding health, shed light on other issues of contention such as climate change11, and highlight the key role of network cluster dynamics in multi-species ecologies15."]}
{"cord_id": "iimx8nt8", "title": "Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data", "abstract": ["OBJECTIVE: To assess the effectiveness of hydroxychloroquine in patients admitted to hospital with coronavirus disease 2019 (covid-19) pneumonia who require oxygen.", "DESIGN: Comparative observational study using data collected from routine care.", "SETTING: Four French tertiary care centres providing care to patients with covid-19 pneumonia between 12 March and 31 March 2020.", "PARTICIPANTS: 181 patients aged 18-80 years with documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia who required oxygen but not intensive care.", "INTERVENTIONS: Hydroxychloroquine at a dose of 600 mg/day within 48 hours of admission to hospital (treatment group) versus standard care without hydroxychloroquine (control group).", "MAIN OUTCOME MEASURES: The primary outcome was survival without transfer to the intensive care unit at day 21.", "Secondary outcomes were overall survival, survival without acute respiratory distress syndrome, weaning from oxygen, and discharge from hospital to home or rehabilitation (all at day 21).", "Analyses were adjusted for confounding factors by inverse probability of treatment weighting.", "RESULTS: In the main analysis, 84 patients who received hydroxychloroquine within 48 hours of admission to hospital (treatment group) were compared with 89 patients who did not receive hydroxychloroquine (control group).", "Eight additional patients received hydroxychloroquine more than 48 hours after admission.", "In the weighted analyses, the survival rate without transfer to the intensive care unit at day 21 was 76% in the treatment group and 75% in the control group (weighted hazard ratio 0.9, 95% confidence interval 0.4 to 2.1).", "Overall survival at day 21 was 89% in the treatment group and 91% in the control group (1.2, 0.4 to 3.3).", "Survival without acute respiratory distress syndrome at day 21 was 69% in the treatment group compared with 74% in the control group (1.3, 0.7 to 2.6).", "At day 21, 82% of patients in the treatment group had been weaned from oxygen compared with 76% in the control group (weighted risk ratio 1.1, 95% confidence interval 0.9 to 1.3).", "Eight patients in the treatment group (10%) experienced electrocardiographic modifications that required discontinuation of treatment.", "CONCLUSIONS: Hydroxychloroquine has received worldwide attention as a potential treatment for covid-19 because of positive results from small studies.", "However, the results of this study do not support its use in patients admitted to hospital with covid-19 who require oxygen."]}
{"cord_id": "pscfmt4l", "title": "RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis", "abstract": ["BACKGROUND: Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit.", "Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.", "METHODS: We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19.", "The registry comprised data from 671 hospitals in six continents.", "We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2.", "Patients who received one of the treatments of interest within 48 h of diagnosis were included in one of four treatment groups (chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide), and patients who received none of these treatments formed the control group.", "Patients for whom one of the treatments of interest was initiated more than 48 h after diagnosis or while they were on mechanical ventilation, as well as patients who received remdesivir, were excluded.", "The main outcomes of interest were in-hospital mortality and the occurrence of de-novo ventricular arrhythmias (non-sustained or sustained ventricular tachycardia or ventricular fibrillation).", "FINDINGS: 96\u00e2\u0080\u0088032 patients (mean age 53\u00b78 years, 46\u00b73% women) with COVID-19 were hospitalised during the study period and met the inclusion criteria.", "Of these, 14\u00e2\u0080\u0088888 patients were in the treatment groups (1868 received chloroquine, 3783 received chloroquine with a macrolide, 3016 received hydroxychloroquine, and 6221 received hydroxychloroquine with a macrolide) and 81\u00e2\u0080\u0088144 patients were in the control group.", "10\u00e2\u0080\u0088698 (11\u00b71%) patients died in hospital.", "After controlling for multiple confounding factors (age, sex, race or ethnicity, body-mass index, underlying cardiovascular disease and its risk factors, diabetes, underlying lung disease, smoking, immunosuppressed condition, and baseline disease severity), when compared with mortality in the control group (9\u00b73%), hydroxychloroquine (18\u00b70%; hazard ratio 1\u00b7335, 95% CI 1\u00b7223-1\u00b7457), hydroxychloroquine with a macrolide (23\u00b78%; 1\u00b7447, 1\u00b7368-1\u00b7531), chloroquine (16\u00b74%; 1\u00b7365, 1\u00b7218-1\u00b7531), and chloroquine with a macrolide (22\u00b72%; 1\u00b7368, 1\u00b7273-1\u00b7469) were each independently associated with an increased risk of in-hospital mortality.", "Compared with the control group (0\u00b73%), hydroxychloroquine (6\u00b71%; 2\u00b7369, 1\u00b7935-2\u00b7900), hydroxychloroquine with a macrolide (8\u00b71%; 5\u00b7106, 4\u00b7106-5\u00b7983), chloroquine (4\u00b73%; 3\u00b7561, 2\u00b7760-4\u00b7596), and chloroquine with a macrolide (6\u00b75%; 4\u00b7011, 3\u00b7344-4\u00b7812) were independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalisation.", "INTERPRETATION: We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19.", "Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.", "FUNDING: William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital."]}
{"cord_id": "2e1zd80i", "title": "Social Capital and Health-Protective Behavior Intentions in an Influenza Pandemic", "abstract": ["Health-protective behaviors, such as receiving a vaccine, wearing a face mask, and washing hands frequently, can reduce the risk of contracting influenza.", "However, little is known about how social capital may influence health-protective behavior in the general population.", "This study examined whether each of the social capital dimensions (bonding, bridging, and linking) contributed to the intention to adopt any of the health-protective behaviors in an influenza pandemic.", "The data of this study were from the 2014 Taiwan Social Change Survey.", "A stratified, three-stage probability proportional-to-size sampling from across the nation, was conducted to select adults aged 20 years and older (N = 1,745).", "Bonding social capital was measured by the frequency of neighborly contact and support.", "Bridging social capital was measured based on association membership.", "Linking social capital was measured according to general government trust and trust in the government\u2019s capacity to counter an influenza pandemic.", "Binary logistic regressions were used to assess the multivariate associations between social capital and behavioral intention.", "The study results indicate that social capital may influence the response to influenza pandemic.", "Specifically, the intention to receive a vaccine and to wash hands more frequently were associated with the linking dimension and the bonding dimension of social capital, while the intention to wear a face mask was associated with all forms of social capital.", "The findings of this study suggest that government credibility and interpersonal networks may play a crucial role in health-protective behavior.", "This study provides new insights into how to improve the effectiveness of influenza prevention campaigns."]}
{"cord_id": "f1ckv4bk", "title": "Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China", "abstract": ["Intense non-pharmaceutical interventions were put in place in China to stop transmission of the novel coronavirus disease (COVID-19).", "As transmission intensifies in other countries, the interplay between age, contact patterns, social distancing, susceptibility to infection, and COVID-19 dynamics remains unclear.", "To answer these questions, we analyze contact surveys data for Wuhan and Shanghai before and during the outbreak and contact tracing information from Hunan Province.", "Daily contacts were reduced 7-8-fold during the COVID-19 social distancing period, with most interactions restricted to the household.", "We find that children 0-14 years are less susceptible to SARS-CoV-2 infection than adults 15-64 years of age (odd ratio 0.34, 95%CI 0.24-0.49), while in contrast, individuals over 65 years are more susceptible to infection (odd ratio 1.47, 95%CI: 1.12-1.92).", "Based on these data, we build a transmission model to study the impact of social distancing and school closure on transmission.", "We find that social distancing alone, as implemented in China during the outbreak, is sufficient to control COVID-19.", "While proactive school closures cannot interrupt transmission on their own, they can reduce peak incidence by 40-60% and delay the epidemic."]}
{"cord_id": "hlktf15o", "title": "Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies", "abstract": ["Summary Coronaviruses make use of a large envelope protein called spike (S) to engage host cell receptors and catalyze membrane fusion.", "Because of the vital role that these S proteins play, they represent a vulnerable target for the development of therapeutics.", "Here, we describe the isolation of single-domain antibodies (VHHs) from a llama immunized with prefusion-stabilized coronavirus spikes.", "These VHHs neutralize MERS-CoV or SARS-CoV-1 S pseudotyped viruses, respectively.", "Crystal structures of these VHHs bound to their respective viral targets reveal two distinct epitopes, but both VHHs interfere with receptor binding.", "We also show cross-reactivity between the SARS-CoV-1 S-directed VHH and SARS-CoV-2 S and demonstrate that this cross-reactive VHH neutralizes SARS-CoV-2 S pseudotyped viruses as a bivalent human IgG Fc-fusion.", "These data provide a molecular basis for the neutralization of pathogenic betacoronaviruses by VHHs and suggest that these molecules may serve as useful therapeutics during coronavirus outbreaks."]}
{"cord_id": "8ljnxihr", "title": "Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial", "abstract": ["BACKGROUND: Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic.", "We assessed the efficacy and safety of combined interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin for treating patients with COVID-19.", "METHODS: This was a multicentre, prospective, open-label, randomised, phase 2 trial in adults with COVID-19 who were admitted to six hospitals in Hong Kong.", "Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 mg every 12 h, ribavirin 400 mg every 12 h, and three doses of 8 million international units of interferon beta-1b on alternate days (combination group) or to 14 days of lopinavir 400 mg and ritonavir 100 mg every 12 h (control group).", "The primary endpoint was the time to providing a nasopharyngeal swab negative for severe acute respiratory syndrome coronavirus 2 RT-PCR, and was done in the intention-to-treat population.", "The study is registered with ClinicalTrials.gov, NCT04276688.", "FINDINGS: Between Feb 10 and March 20, 2020, 127 patients were recruited; 86 were randomly assigned to the combination group and 41 were assigned to the control group.", "The median number of days from symptom onset to start of study treatment was 5 days (IQR 3\u20137).", "The combination group had a significantly shorter median time from start of study treatment to negative nasopharyngeal swab (7 days [IQR 5\u201311]) than the control group (12 days [8\u201315]; hazard ratio 4\u00b737 [95% CI 1\u00b786\u201310\u00b724], p=0\u00b70010).", "Adverse events included self-limited nausea and diarrhoea with no difference between the two groups.", "One patient in the control group discontinued lopinavir\u2013ritonavir because of biochemical hepatitis.", "No patients died during the study.", "INTERPRETATION: Early triple antiviral therapy was safe and superior to lopinavir\u2013ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19.", "Future clinical study of a double antiviral therapy with interferon beta-1b as a backbone is warranted.", "FUNDING: The Shaw-Foundation, Richard and Carol Yu, May Tam Mak Mei Yin, and Sanming Project of Medicine."]}
{"cord_id": "veeavho5", "title": "Differential Effects of Intervention Timing on COVID-19 Spread in the United States", "abstract": ["Assessing the effects of early non-pharmaceutical interventions(1\u20135) on COVID-19 spread in the United States is crucial for understanding and planning future control measures to combat the ongoing pandemic(6\u201310).", "Here we use county-level observations of reported infections and deaths(11), in conjunction with human mobility data(12) and a metapopulation transmission model(13,14), to quantify changes of disease transmission rates in US counties from March 15, 2020 to May 3, 2020.", "We find significant reductions of the basic reproductive numbers in major metropolitan areas in association with social distancing and other control measures.", "Counterfactual simulations indicate that, had these same control measures been implemented just 1\u20132 weeks earlier, a substantial number of cases and deaths could have been averted.", "Specifically, nationwide, 56.5% [95% Cl: 48.1%\u221265.9%] of reported infections and 54.0% [95% Cl: 43.6%\u221263.8%] of reported deaths as of May 3, 2020 could have been avoided if the same control measures had been implemented just one week earlier.", "We also examine the effects of delays in re-implementing social distancing following a relaxation of control measures.", "A longer response time results in a stronger rebound of infections and death.", "Our findings underscore the importance of early intervention and aggressive response in controlling the COVID-19 pandemic."]}
{"cord_id": "uj5deryi", "title": "Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial", "abstract": ["BACKGROUND: A vaccine to protect against COVID-19 is urgently needed.", "We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain.", "METHODS: We did a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of an Ad5 vectored COVID-19 vaccine in Wuhan, China.", "Healthy adults aged between 18 and 60 years were sequentially enrolled and allocated to one of three dose groups (5 \u00d7 10(10), 1 \u00d7 10(11), and 1\u00b75 \u00d7 10(11) viral particles) to receive an intramuscular injection of vaccine.", "The primary outcome was adverse events in the 7 days post-vaccination.", "Safety was assessed over 28 days post-vaccination.", "Specific antibodies were measured with ELISA, and the neutralising antibody responses induced by vaccination were detected with SARS-CoV-2 virus neutralisation and pseudovirus neutralisation tests.", "T-cell responses were assessed by enzyme-linked immunospot and flow-cytometry assays.", "This study is registered with ClinicalTrials.gov, NCT04313127.", "FINDINGS: Between March 16 and March 27, 2020, we screened 195 individuals for eligibility.", "Of them, 108 participants (51% male, 49% female; mean age 36\u00b73 years) were recruited and received the low dose (n=36), middle dose (n=36), or high dose (n=36) of the vaccine.", "All enrolled participants were included in the analysis.", "At least one adverse reaction within the first 7 days after the vaccination was reported in 30 (83%) participants in the low dose group, 30 (83%) participants in the middle dose group, and 27 (75%) participants in the high dose group.", "The most common injection site adverse reaction was pain, which was reported in 58 (54%) vaccine recipients, and the most commonly reported systematic adverse reactions were fever (50 [46%]), fatigue (47 [44%]), headache (42 [39%]), and muscle pain (18 [17%].", "Most adverse reactions that were reported in all dose groups were mild or moderate in severity.", "No serious adverse event was noted within 28 days post-vaccination.", "ELISA antibodies and neutralising antibodies increased significantly at day 14, and peaked 28 days post-vaccination.", "Specific T-cell response peaked at day 14 post-vaccination.", "INTERPRETATION: The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination.", "Humoral responses against SARS-CoV-2 peaked at day 28 post-vaccination in healthy adults, and rapid specific T-cell responses were noted from day 14 post-vaccination.", "Our findings suggest that the Ad5 vectored COVID-19 vaccine warrants further investigation.", "FUNDING: National Key R&D Program of China, National Science and Technology Major Project, and CanSino Biologics."]}
{"cord_id": "zueghgx5", "title": "Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing", "abstract": ["The newly emergent human virus SARS-CoV-2 is resulting in high fatality rates and incapacitated health systems.", "Preventing further transmission is a priority.", "We analyzed key parameters of epidemic spread to estimate the contribution of different transmission routes and determine requirements for case isolation and contact-tracing needed to stop the epidemic.", "We conclude that viral spread is too fast to be contained by manual contact tracing, but could be controlled if this process was faster, more efficient and happened at scale.", "A contact-tracing App which builds a memory of proximity contacts and immediately notifies contacts of positive cases can achieve epidemic control if used by enough people.", "By targeting recommendations to only those at risk, epidemics could be contained without need for mass quarantines (\u2018lock-downs\u2019) that are harmful to society.", "We discuss the ethical requirements for an intervention of this kind."]}
{"cord_id": "m6pth0tu", "title": "Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China", "abstract": ["Importance: Data are lacking whether patients with hypertension who are taking angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have increased severity or risk of mortality during hospitalization for coronavirus disease 2019 (COVID-19).", "Objective: To investigate the association between ACEIs/ARBs and severity of illness and mortality in patients with hypertension hospitalized for COVID-19 infection.", "Design, Setting, and Participants: Retrospective, single-center case series of the 1178 hospitalized patients with COVID-19 infections at the Central Hospital of Wuhan, China, from January 15 to March 15, 2020.", "Main Outcomes and Measures: COVID-19 was confirmed by real-time reverse transcription-polymerase chain reaction and epidemiologic, clinical, radiologic, laboratory, and drug therapy data were analyzed in all patients.", "The percentage of patients with hypertension taking ACEIs/ARBs was compared between those with severe vs nonsevere illness and between survivors vs nonsurvivors.", "Results: Of the 1178 patients with COVID-19, the median age was 55.5 years (interquartile range, 38-67 years) and 545 (46.3%) were men.", "The overall in-hospital mortality was 11.0%.", "There were 362 patients with hypertension (30.7% of the total group; median age, 66.0 years [interquartile range, 59-73 years]; 189 [52.2%] were men), of whom 115 (31.8%) were taking ACEI/ARBs.", "The in-hospital mortality in the patients with hypertension was 21.3%.", "The percentage of patients with hypertension taking ACEIs/ARBs did not differ between those with severe and nonsevere infections (32.9% vs 30.7%; P = .65) nor did it differ between nonsurvivors and survivors (27.3% vs 33.0%; P = .34).", "Similar findings were observed when data were analyzed for patients taking ACEIs and those taking ARBs.", "Conclusions and Relevance: This study provides clinical data on the association between ACEIs/ARBs and outcomes in patients with hypertension hospitalized with COVID-19 infections, suggesting that ACEIs/ARBs are not associated with the severity or mortality of COVID-19 in such patients.", "These data support current guidelines and societal recommendations for treating hypertension during the COVID-19 pandemic."]}
{"cord_id": "4nmw69co", "title": "OpenSAFELY: factors associated with COVID-19 death in 17 million patients", "abstract": ["COVID-19 has rapidly affected mortality worldwide1.", "There is unprecedented urgency to understand who is most at risk of severe outcomes, requiring new approaches for timely analysis of large datasets.", "Working on behalf of NHS England, here we created OpenSAFELY: a secure health analytics platform covering 40% of all patients in England, holding patient data within the existing data centre of a major primary care electronic health records vendor.", "Primary care records of 17,278,392 adults were pseudonymously linked to 10,926 COVID-19-related deaths.", "COVID-19-related death was associated with: being male (hazard ratio (HR) 1.59, 95% confidence interval (CI) 1.53-1.65); older age and deprivation (both with a strong gradient); diabetes; severe asthma; and various other medical conditions.", "Compared with people with white ethnicity, Black and South Asian people were at higher risk even after adjustment for other factors (HR 1.48, 1.30-1.69 and 1.44, 1.32-1.58, respectively).", "We have quantified a range of clinical risk factors for COVID-19-related death in the largest cohort study conducted by any country to date.", "OpenSAFELY is rapidly adding further patients' records; we will update and extend results regularly."]}
{"cord_id": "w49ay5xn", "title": "Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020", "abstract": ["As of June 16, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in 2,104,346 cases and 116,140 deaths in the United States.", "* During pregnancy, women experience immunologic and physiologic changes that could increase their risk for more severe illness from respiratory infections (1,2).", "To date, data to assess the prevalence and severity of COVID-19 among pregnant U.S. women and determine whether signs and symptoms differ among pregnant and nonpregnant women are limited.", "During January 22-June 7, as part of COVID-19 surveillance, CDC received reports of 326,335 women of reproductive age (15-44 years) who had positive test results for SARS-CoV-2, the virus that causes COVID-19.", "Data on pregnancy status were available for 91,412 (28.0%) women with laboratory-confirmed infections; among these, 8,207 (9.0%) were pregnant.", "Symptomatic pregnant and nonpregnant women with COVID-19 reported similar frequencies of cough (>50%) and shortness of breath (30%), but pregnant women less frequently reported headache, muscle aches, fever, chills, and diarrhea.", "Chronic lung disease, diabetes mellitus, and cardiovascular disease were more commonly reported among pregnant women than among nonpregnant women.", "Among women with COVID-19, approximately one third (31.5%) of pregnant women were reported to have been hospitalized compared with 5.8% of nonpregnant women.", "After adjusting for age, presence of underlying medical conditions, and race/ethnicity, pregnant women were significantly more likely to be admitted to the intensive care unit (ICU) (aRR = 1.5, 95% confidence interval [CI] = 1.2-1.8) and receive mechanical ventilation (aRR = 1.7, 95% CI = 1.2-2.4).", "Sixteen (0.2%) COVID-19-related deaths were reported among pregnant women aged 15-44 years, and 208 (0.2%) such deaths were reported among nonpregnant women (aRR = 0.9, 95% CI = 0.5-1.5).", "These findings suggest that among women of reproductive age with COVID-19, pregnant women are more likely to be hospitalized and at increased risk for ICU admission and receipt of mechanical ventilation compared with nonpregnant women, but their risk for death is similar.", "To reduce occurrence of severe illness from COVID-19, pregnant women should be counseled about the potential risk for severe illness from COVID-19, and measures to prevent infection with SARS-CoV-2 should be emphasized for pregnant women and their families."]}
{"cord_id": "2y88gzji", "title": "Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease.", "abstract": ["Abstract Background Rapid COVID-19 diagnosis in hospital is essential for patient management and identification of infectious patients to limit the potential for nosocomial transmission.", "The diagnosis is complicated by 30-50% of COVID-19 hospital admissions with negative nose/throat swabs negative for SARS-CoV-2 nucleic acid, frequently after the first week of illness when SARS-CoV-2 antibody responses become detectable.", "We assessed the diagnostic accuracy of combined rapid antibody point of care (POC) and nucleic acid assays for suspected COVID-19 disease in the emergency department.", "Methods We developed (i) an in vitro neutralization assay using a lentivirus expressing a genome encoding luciferase and pseudotyped with spike protein and (ii) an ELISA test to detect IgG antibodies to nucleocapsid (N) and spike (S) proteins from SARS-CoV-2.", "We tested two promising candidate lateral flow rapid fingerprick test with bands for IgG and IgM.", "We then prospectively recruited participants with suspected moderate to severe COVID-19 and tested for SARS-CoV-2 nucleic acid in a combined nasal/throat swab using the standard laboratory RT-PCR and a validated rapid nucleic acid test.", "Additionally, serum collected at admission was retrospectively tested by in vitro neutralization, ELISA and the candidate POC antibody tests.", "We determined the sensitivity and specificity of the individual and combined rapid POC diagnostic tests against a composite gold standard of neutralisation and the standard laboratory RT-PCR.", "Results 45 participants had specimens tested for nucleic acid in nose/throat swabs as well as stored sera for antibodies.", "Serum neutralisation assay, SARS-CoV-2 Spike IgG ELISA and the POC antibody test results were concordant.", "Using the composite gold standard, prevalence of COVID-19 disease was 53.3% (24/45).", "Median age was 73.5 (IQR 54.0-86.5) years in those with COVID-19 disease by our gold standard and 63.0 (IQR 41.0-72.0) years in those without disease.", "Median duration of symptoms was 7 days (IQR 1-8) in those with infection.", "The overall sensitivity of rapid NAAT diagnosis was 79.2% (95CI 57.8-92.9%) and 50.0% (11.8-88.2) at days 8-28.", "Sensitivity and specificity of the combined rapid POC diagnostic tests reached 100% (95CI 85.8-100) and 94.7% (95CI 74.0-99.0) overall.", "Conclusions Dual point of care SARS-CoV-2 testing can significantly improve diagnostic sensitivity, whilst maintaining high specificity.", "Rapid combined tests have the potential to transform our management of COVID-19, including inflammatory manifestations where nucleic acid test results are negative.", "A rapid combined approach will also aid recruitment into clinical trials and in prescribing therapeutics, particularly where potentially harmful immune modulators (including steroids) are used."]}
{"cord_id": "nc0bsilq", "title": "A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures", "abstract": ["Coronaviruses are prone to emergence into new host species most recently evidenced by SARS-CoV-2, the causative agent of the COVID-19 pandemic.", "Small animal models that recapitulate SARS-CoV-2 disease are desperately needed to rapidly evaluate medical countermeasures (MCMs).", "SARS-CoV-2 cannot infect wildtype laboratory mice due to inefficient interactions between the viral spike (S) protein and the murine ortholog of the human receptor, ACE2.", "We used reverse genetics to remodel the S and mACE2 binding interface resulting in a recombinant virus (SARS-CoV-2 MA) that could utilize mACE2 for entry.", "SARS-CoV-2 MA replicated in both the upper and lower airways of both young adult and aged BALB/c mice.", "Importantly, disease was more severe in aged mice, and showed more clinically relevant phenotypes than those seen in hACE2 transgenic mice.", "We then demonstrated the utility of this model through vaccine challenge studies in immune competent mice with native expression of mACE2.", "Lastly, we show that clinical candidate interferon (IFN) lambda-1a can potently inhibit SARS-CoV-2 replication in primary human airway epithelial cells in vitro, and both prophylactic and therapeutic administration diminished replication in mice.", "Our mouse-adapted SARS-CoV-2 model demonstrates age-related disease pathogenesis and supports the clinical use of IFN lambda-1a treatment in human COVID-19 infections."]}
{"cord_id": "z3qp4wen", "title": "A Study Quantifying the Hand-to-Face Contact Rate and Its Potential Application to Predicting Respiratory Tract Infection", "abstract": ["A substantial portion of human respiratory tract infection is thought to be transmitted via contaminated hand contact with the mouth, eyes, and/or nostrils.", "Thus, a key risk factor for infection transmission should be the rate of hand contact with these areas termed target facial membranes.", "A study was conducted in which 10 subjects were each videotaped for 3 hr while performing office-type work in isolation from other persons.", "The number of contacts to the eyes, nostrils, and lips was scored during subsequent viewing of the tapes.", "The total contacts per subject had sample mean x = 47 and sample standard deviation s = 34.", "The average total contact rate per hour was 15.7.", "The authors developed a relatively simple algebraic model for estimating the dose of pathogens transferred to target facial membranes during a defined exposure period.", "The model considers the rate of pathogen transfer to the hands via contact with contaminated environmental surfaces, and the rate of pathogen loss from the hands due to pathogen die-off and transfer from the hands to environmental surfaces and to target facial membranes during touching.", "The estimation of infection risk due to this dose also is discussed.", "A hypothetical but plausible example involving influenza A virus transmission is presented to illustrate the model."]}
{"cord_id": "oo3ykjro", "title": "Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure", "abstract": ["Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines.", "By replacing conventional phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly.", "Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death.", "However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity.", "Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, if they have a high baseline risk of natural infection, and if during the trial they receive frequent monitoring and, following any infection, the best available care."]}
{"cord_id": "c2hgkbg6", "title": "Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York", "abstract": ["PURPOSE: New York State (NYS) is an epicenter of the SARS-CoV-2 pandemic in the United States.", "Reliable estimates of cumulative incidence in the population are critical to tracking the extent of transmission and informing policies.", "METHODS: We conducted a statewide seroprevalence study among a 15,101 patron convenience sample at 99 grocery stores in 26 counties throughout NYS.", "SARS-CoV-2 cumulative incidence was estimated from antibody reactivity by first post-stratification weighting then adjusting by antibody test characteristics.", "The percent diagnosed was estimated by dividing diagnoses by estimated infection-experienced adults.", "RESULTS: Based on 1,887 of 15,101 reactive results (12.5%), estimated cumulative incidence through March 29 was 14.0% (95% CI: 13.3-14.7%), corresponding to 2,139,300 (95% CI: 2,035,800-2,242,800) infection-experienced adults.", "Cumulative incidence was highest in New York City (NYC) 22.7% (95% CI: 21.5-24.0%) and higher among Hispanic/Latino (29.2%), non-Hispanic black/African American (20.2%), and non-Hispanic Asian (12.4%) than non-Hispanic white adults (8.1%, p<.0001).", "An estimated 8.9% (95% CI: 8.4-9.3%) of infections in NYS were diagnosed, with diagnosis highest among adults \u226555 years (11.3%, 95% CI: 10.4-12.2%).", "CONCLUSIONS: From the largest US serosurvey to date, we estimated > 2 million adult New York residents were infected through late March, with substantial disparities, although cumulative incidence remained below herd immunity thresholds.", "Monitoring, testing, and contact tracing remain essential public health strategies."]}
{"cord_id": "svi7syld", "title": "The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission", "abstract": ["Speech droplets generated by asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are increasingly considered to be a likely mode of disease transmission.", "Highly sensitive laser light scattering observations have revealed that loud speech can emit thousands of oral fluid droplets per second.", "In a closed, stagnant air environment, they disappear from the window of view with time constants in the range of 8 to 14 min, which corresponds to droplet nuclei of ca.", "4 \u03bcm diameter, or 12- to 21-\u03bcm droplets prior to dehydration.", "These observations confirm that there is a substantial probability that normal speaking causes airborne virus transmission in confined environments."]}
{"cord_id": "mo4luyx6", "title": "Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019.", "Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic.", "SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown.", "Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2.", "We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but efficiently in ferrets and cats.", "We found that the virus transmits in cats via respiratory droplets.", "Our study provides important insights into the animal reservoirs of SARS-CoV-2 and animal management for COVID-19 control."]}
{"cord_id": "jhkq4xvy", "title": "Can a toilet promote virus transmission? From a fluid dynamics perspective", "abstract": ["Currently, a novel coronavirus named \u201cSARS-CoV-2\u201d is spreading rapidly across the world, causing a public health crisis, economic losses, and panic.", "Fecal\u2013oral transmission is a common transmission route for many viruses, including SARS-CoV-2.", "Blocking the path of fecal\u2013oral transmission, which occurs commonly in toilet usage, is of fundamental importance in suppressing the spread of viruses.", "However, to date, efforts at improving sanitary safety in toilet use have been insufficient.", "It is clear from daily experience that flushing a toilet generates strong turbulence within the bowl.", "Will this flushing-induced turbulent flow expel aerosol particles containing viruses out of the bowl?", "This paper adopts computational fluid dynamics to explore and visualize the characteristics of fluid flow during toilet flushing and the influence of flushing on the spread of virus aerosol particles.", "The volume-of-fluid (VOF) model is used to simulate two common flushing processes (single-inlet flushing and annular flushing), and the VOF\u2013discrete phase model (DPM) method is used to model the trajectories of aerosol particles during flushing.", "The simulation results are alarming in that massive upward transport of virus particles is observed, with 40%\u201360% of particles reaching above the toilet seat, leading to large-scale virus spread.", "Suggestions concerning safer toilet use and recommendations for a better toilet design are also provided."]}
{"cord_id": "9h3rkoz9", "title": "SARS-CoV-2 was already spreading in France in late December 2019", "abstract": ["The COVID-19 epidemic is believed to have started in late January 2020 in France.", "Here we report a case of a patient hospitalised in December 2019 in an intensive care unit in a hospital in the north of Paris for haemoptysis with no aetiological diagnosis.", "RT-PCR was performed retrospectively on the stored respiratory sample and confirmed the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.", "Based on this result, it appears that the COVID-19 epidemic started much earlier in France."]}
{"cord_id": "h9gj814e", "title": "Survival of Severe Acute Respiratory Syndrome Coronavirus", "abstract": ["Background.", "The primary modes of transmission of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) appear to be direct mucus membrane contact with infectious droplets and through exposure to formites.", "Knowledge of the survival characteristics of the virus is essential for formulating appropriate infection-control measures.", "Methods.", "Survival of SARS-CoV strain GVU6109 was studied in stool and respiratory specimens.", "Survival of the virus on different environmental surfaces, including a laboratory request form, an impervious disposable gown, and a cotton nondisposable gown, was investigated.", "The virucidal effects of sodium hypochlorite, house detergent, and a peroxygen compound (Virkon S; Antec International) on the virus were also studied.", "Results.", "SARS-CoV GVU6109 can survive for 4 days in diarrheal stool samples with an alkaline pH, and it can remain infectious in respiratory specimens for >7 days at room temperature.", "Even at a relatively high concentration (10(4) tissue culture infective doses/mL), the virus could not be recovered after drying of a paper request form, and its infectivity was shown to last longer on the disposable gown than on the cotton gown.", "All disinfectants tested were shown to be able to reduce the virus load by >3 log within 5 min.", "Conclusions.", "Fecal and respiratory samples can remain infectious for a long period of time at room temperature.", "The risk of infection via contact with droplet-contaminated paper is small.", "Absorbent material, such as cotton, is preferred to nonabsorptive material for personal protective clothing for routine patient care where risk of large spillage is unlikely.", "The virus is easily inactivated by commonly used disinfectants."]}
{"cord_id": "bjnlq50r", "title": "Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis", "abstract": ["BACKGROUND: Despite possibly higher risk of severe outcomes from COVID-19 among people with intellectual and developmental disabilities (IDD), there has been limited reporting of COVID-19 trends for this population.", "OBJECTIVE: To compare COVID-19 trends among people with and without IDD, overall and stratified by age.", "METHODS: Data from the TriNetX COVID-19 Research Network platform was used to identify COVID-19 patients.", "Analysis focused on trends in comorbidities, number of cases, number of deaths, and case-fatality rate among patients with and without IDD who had a positive diagnosis for COVID-19 through May 14, 2020.", "RESULTS: People with IDD had higher prevalence of specific comorbidities associated with poorer COVID-19 outcomes.", "Distinct age-related differences in COVID-19 trends were present among those with IDD, with a higher concentration of COVID-19 cases at younger ages.", "In addition, while the overall case-fatality rate was similar for those with IDD (5.1%) and without IDD (5.4%), these rates differed by age: ages &#8804;17 - IDD 1.6%, without IDD <0.01%; ages 18-74 - IDD 4.5%, without IDD 2.7%; ages &#8805;75- IDD 21.1%, without IDD, 20.7%.", "CONCLUSIONS: Though of concern for all individuals, COVID-19 appears to present a greater risk to people with IDD, especially at younger ages.", "Future research should seek to document COVID-19 trends among people with IDD, with particular attention to age related trends."]}
{"cord_id": "8egln9pr", "title": "Learning as We Go: An Examination of the Statistical Accuracy of COVID19 Daily Death Count Predictions", "abstract": ["This paper provides a formal evaluation of the predictive performance of a model (and its various updates) developed by the Institute for Health Metrics and Evaluation (IHME) for predicting daily deaths attributed to COVID19 for each state in the United States.", "The IHME models have received extensive attention in social and mass media, and have influenced policy makers at the highest levels of the United States government.", "For effective policy making the accurate assessment of uncertainty, as well as accurate point predictions, are necessary because the risks inherent in a decision must be taken into account, especially in the present setting of a novel disease affecting millions of lives.", "To assess the accuracy of the IHME models, we examine both forecast accuracy as well as the predictive performance of the 95% prediction intervals provided by the IHME models.", "We find that the initial IHME model underestimates the uncertainty surrounding the number of daily deaths substantially.", "Specifically, the true number of next day deaths fell outside the IHME prediction intervals as much as 70% of the time, in comparison to the expected value of 5%.", "In addition, we note that the performance of the initial model does not improve with shorter forecast horizons.", "Regarding the updated models, our analyses indicate that the later models do not show any improvement in the accuracy of the point estimate predictions.", "In fact, there is some evidence that this accuracy has actually decreased over the initial models.", "Moreover, when considering the updated models, while we observe a larger percentage of states having actual values lying inside the 95% prediction intervals (PI), our analysis suggests that this observation may be attributed to the widening of the PIs.", "The width of these intervals calls into question the usefulness of the predictions to drive policy making and resource allocation."]}
{"cord_id": "zknmfgsh", "title": "Evolutionary history, potential intermediate animal host, and cross\u2010species analyses of SARS\u2010CoV\u20102", "abstract": ["To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed.", "To explore the potential intermediate animal host of the SARS\u2010CoV\u20102 virus, we reanalyzed virome data sets from pangolins and representative SARS\u2010related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene.", "We performed phylogenetic, split network, transmission network, likelihood\u2010mapping, and comparative analyses of the genomes.", "Based on Bayesian time\u2010scaled phylogenetic analysis using the tip\u2010dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS\u2010CoV\u20102, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 \u00d7 10(\u22123) substitutions per site per year, respectively.", "Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS\u2010CoV\u20102 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378).", "We also identified a unique peptide (PRRA) insertion in the human SARS\u2010CoV\u20102 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility.", "Interestingly, the coronavirus carried by pangolins did not have the RRAR motif.", "Therefore, we concluded that the human SARS\u2010CoV\u20102 virus, which is responsible for the recent outbreak of COVID\u201019, did not come directly from pangolins."]}
{"cord_id": "8caqxfxv", "title": "Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study", "abstract": ["Abstract An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its caused coronavirus disease 2019 (COVID-19) has been reported in China since December 2019.", "More than 16% of patients developed acute respiratory distress syndrome, and the fatality ratio was about 1%\u20132%.", "No specific treatment has been reported.", "Herein, we examine the effects of Favipiravir (FPV) versus Lopinavir (LPV)/ritonavir (RTV) for the treatment of COVID-19.", "Patients with laboratory-confirmed COVID-19 who received oral FPV (Day 1: 1600 mg twice daily; Days 2\u201314: 600 mg twice daily) plus interferon (IFN)-\u03b1 by aerosol inhalation (5 million U twice daily) were included in the FPV arm of this study, whereas patients who were treated with LPV/RTV (Days 1\u201314: 400 mg/100 mg twice daily) plus IFN-\u03b1 by aerosol inhalation (5 million U twice daily) were included in the control arm.", "Changes in chest computed tomography (CT), viral clearance, and drug safety were compared between the two groups.", "For the 35 patients enrolled in the FPV arm and the 45 patients in the control arm, all baseline characteristics were comparable between the two arms.", "A shorter viral clearance time was found for the FPV arm versus the control arm (median (interquartile range, IQR), 4 (2.5\u20139) d versus 11 (8\u201313) d, P < 0.001).", "The FPV arm also showed significant improvement in chest imaging compared with the control arm, with an improvement rate of 91.43% versus 62.22% (P = 0.004).", "After adjustment for potential confounders, the FPV arm also showed a significantly higher improvement rate in chest imaging.", "Multivariable Cox regression showed that FPV was independently associated with faster viral clearance.", "In addition, fewer adverse reactions were found in the FPV arm than in the control arm.", "In this open-label nonrandomized control study, FPV showed significantly better treatment effects on COVID-19 in terms of disease progression and viral clearance; if causal, these results should be important information for establishing standard treatment guidelines to combat the SARS-CoV-2 infection."]}
{"cord_id": "a2ktiude", "title": "Mechanistic Transmission Modeling of COVID-19 on the Diamond Princess Cruise Ship Demonstrates the Importance of Aerosol Transmission", "abstract": ["Background The current prevailing position is that coronavirus disease 2019 (COVID-19) is transmitted primarily through large respiratory droplets within close proximity (i.e., 1-2 m) of infected individuals.", "However, quantitative information on the relative importance of specific transmission pathways of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (i.e., droplets, aerosols, and fomites across short- and long-range distances) remains limited.", "Methods To evaluate the relative importance of multiple transmission routes for SARS-CoV-2, we leveraged detailed information available from the Diamond Princess Cruise Ship outbreak that occurred in early 2020.", "We developed a framework that combines stochastic Markov chain and negative exponential dose-response modeling with available empirical data on mechanisms of SARS-CoV-2 dynamics and human behaviors, which informs a modified version of the Reed-Frost epidemic model to predict daily and cumulative daily case counts on the ship.", "We modeled 21,600 scenarios to generate a matrix of solutions across a full range of assumptions for eight unknown or uncertain epidemic and mechanistic transmission factors, including the magnitude of droplet and aerosol emissions from infected individuals, the infectious dose for deposition of droplets and aerosols to the upper and lower respiratory tracts, and others.", "Findings A total of 132 model iterations met acceptability criteria (R2 > 0.95 for modeled vs. reported cumulative daily cases and R2 > 0 for daily cases).", "Analyzing only these successful model iterations yields insights into the likely values for uncertain parameters and quantifies the likely contributions of each defined mode of transmission.", "Mean estimates of the contributions of short-range, long-range, and fomite transmission modes to infected cases aboard the ship across the entire simulation time period were 35%, 35%, and 30%, respectively.", "Mean estimates of the contributions of large respiratory droplets and small respiratory aerosols were 41% and 59%.", "Short-range transmission was the dominant mode after passenger quarantine began, albeit due primarily to aerosol transmission, not droplets.", "Interpretation Our results demonstrate that aerosol inhalation was likely the dominant contributor to COVID-19 transmission among passengers aboard the Diamond Princess Cruise Ship.", "Moreover, close-range and long-range transmission likely contributed similarly to disease progression aboard the ship, with fomite transmission playing a smaller role.", "The passenger quarantine also affected the importance of each mode, demonstrating the impacts of the interventions.", "Although cruise ships represent unique built environments with high ventilation rates and no air recirculation, these findings underscore the importance of implementing public health measures that target the control of inhalation of aerosols in addition to ongoing measures targeting control of large droplet and fomite transmission, not only aboard cruise ships but in other indoor environments as well."]}
{"cord_id": "mazqe344", "title": "Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event", "abstract": ["During the 2020 COVID-19 pandemic, an outbreak occurred following attendance of a symptomatic index case at a regular weekly rehearsal on 10 March of the Skagit Valley Chorale (SVC).", "After that rehearsal, 53 members of the SVC among 61 in attendance were confirmed or strongly suspected to have contracted COVID-19 and two died.", "Transmission by the airborne route is likely.", "It is vital to identify features of cases such as this so as to better understand the factors that promote superspreading events.", "Based on a conditional assumption that transmission during this outbreak was by inhalation of respiratory aerosol, we use the available evidence to infer the emission rate of airborne infectious quanta from the primary source.", "We also explore how the risk of infection would vary with several influential factors: the rates of removal of respiratory aerosol by ventilation; deposition onto surfaces; and viral decay.", "The results indicate an emission rate of the order of a thousand quanta per hour (mean [interquartile range] for this event = 970 [680-1190] quanta per hour) and demonstrate that the risk of infection is modulated by ventilation conditions, occupant density, and duration of shared presence with an infectious individual."]}
{"cord_id": "4zdo92gm", "title": "Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020", "abstract": ["Importance: Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimate the prevalence of infection in affected communities.", "Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected.", "Objective: To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the US.", "Design, Setting, and Participants: This cross-sectional study performed serologic testing on a convenience sample of residual sera obtained from persons of all ages.", "The serum was collected from March 23 through May 12, 2020, for routine clinical testing by 2 commercial laboratory companies.", "Sites of collection were San Francisco Bay area, California; Connecticut; south Florida; Louisiana; Minneapolis-St Paul-St Cloud metro area, Minnesota; Missouri; New York City metro area, New York; Philadelphia metro area, Pennsylvania; Utah; and western Washington State.", "Exposures: Infection with SARS-CoV-2.", "Main Outcomes and Measures: The presence of antibodies to SARS-CoV-2 spike protein was estimated using an enzyme-linked immunosorbent assay, and estimates were standardized to the site populations by age and sex.", "Estimates were adjusted for test performance characteristics (96.0% sensitivity and 99.3% specificity).", "The number of infections in each site was estimated by extrapolating seroprevalence to site populations; estimated infections were compared with the number of reported coronavirus disease 2019 (COVID-19) cases as of last specimen collection date.", "Results: Serum samples were tested from 16\u00e2\u0080\u00af025 persons, 8853 (55.2%) of whom were women; 1205 (7.5%) were 18 years or younger and 5845 (36.2%) were 65 years or older.", "Most specimens from each site had no evidence of antibodies to SARS-CoV-2.", "Adjusted estimates of the proportion of persons seroreactive to the SARS-CoV-2 spike protein antibodies ranged from 1.0% in the San Francisco Bay area (collected April 23-27) to 6.9% of persons in New York City (collected March 23-April 1).", "The estimated number of infections ranged from 6 to 24 times the number of reported cases; for 7 sites (Connecticut, Florida, Louisiana, Missouri, New York City metro area, Utah, and western Washington State), an estimated greater than 10 times more SARS-CoV-2 infections occurred than the number of reported cases.", "Conclusions and Relevance: During March to early May 2020, most persons in 10 diverse geographic sites in the US had not been infected with SARS-CoV-2 virus.", "The estimated number of infections, however, was much greater than the number of reported cases in all sites.", "The findings may reflect the number of persons who had mild or no illness or who did not seek medical care or undergo testing but who still may have contributed to ongoing virus transmission in the population."]}
{"cord_id": "biho913w", "title": "COVID-19: in the footsteps of Ernest Shackleton", "abstract": ["We describe what we believe is the first instance of complete COVID-19 testing of all passengers and crew on an isolated cruise ship during the current COVID-19 pandemic.", "Of the 217 passengers and crew on board, 128 tested positive for COVID-19 on reverse transcription-PCR (59%).", "Of the COVID-19-positive patients, 19% (24) were symptomatic; 6.2% (8) required medical evacuation; 3.1% (4) were intubated and ventilated; and the mortality was 0.8% (1).", "The majority of COVID-19-positive patients were asymptomatic (81%, 104 patients).", "We conclude that the prevalence of COVID-19 on affected cruise ships is likely to be significantly underestimated, and strategies are needed to assess and monitor all passengers to prevent community transmission after disembarkation."]}
{"cord_id": "ajlpb9li", "title": "The neuroinvasive potential of SARS\u2010CoV2 may play a role in the respiratory failure of COVID\u201019 patients", "abstract": ["Following the severe acute respiratory syndrome coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV), another highly pathogenic coronavirus named SARS\u2010CoV\u20102 (previously known as 2019\u2010nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world.", "This virus shares highly homological sequence with SARS\u2010CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID\u201019) with clinical symptoms similar to those reported for SARS\u2010CoV and MERS\u2010CoV.", "The most characteristic symptom of patients with COVID\u201019 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously.", "Additionally, some patients with COVID\u201019 also showed neurologic signs, such as headache, nausea, and vomiting.", "Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases.", "The infection of SARS\u2010CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected.", "Furthermore, some coronaviruses have been demonstrated able to spread via a synapse\u2010connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways.", "Considering the high similarity between SARS\u2010CoV and SARS\u2010CoV2, it remains to make clear whether the potential invasion of SARS\u2010CoV2 is partially responsible for the acute respiratory failure of patients with COVID\u201019.", "Awareness of this may have a guiding significance for the prevention and treatment of the SARS\u2010CoV\u20102\u2010induced respiratory failure."]}
{"cord_id": "8ko7mmu3", "title": "Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis", "abstract": ["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and is spread person-to-person through close contact.", "We aimed to investigate the effects of physical distance, face masks, and eye protection on virus transmission in health-care and non-health-care (eg, community) settings.", "METHODS: We did a systematic review and meta-analysis to investigate the optimum distance for avoiding person-to-person virus transmission and to assess the use of face masks and eye protection to prevent transmission of viruses.", "We obtained data for SARS-CoV-2 and the betacoronaviruses that cause severe acute respiratory syndrome, and Middle East respiratory syndrome from 21 standard WHO-specific and COVID-19-specific sources.", "We searched these data sources from database inception to May 3, 2020, with no restriction by language, for comparative studies and for contextual factors of acceptability, feasibility, resource use, and equity.", "We screened records, extracted data, and assessed risk of bias in duplicate.", "We did frequentist and Bayesian meta-analyses and random-effects meta-regressions.", "We rated the certainty of evidence according to Cochrane methods and the GRADE approach.", "This study is registered with PROSPERO, CRD42020177047.", "FINDINGS: Our search identified 172 observational studies across 16 countries and six continents, with no randomised controlled trials and 44 relevant comparative studies in health-care and non-health-care settings (n=25 697 patients).", "Transmission of viruses was lower with physical distancing of 1 m or more, compared with a distance of less than 1 m (n=10 736, pooled adjusted odds ratio [aOR] 0\u00b718, 95% CI 0\u00b709 to 0\u00b738; risk difference [RD] \u221210\u00b72%, 95% CI \u221211\u00b75 to \u22127\u00b75; moderate certainty); protection was increased as distance was lengthened (change in relative risk [RR] 2\u00b702 per m; p(interaction)=0\u00b7041; moderate certainty).", "Face mask use could result in a large reduction in risk of infection (n=2647; aOR 0\u00b715, 95% CI 0\u00b707 to 0\u00b734, RD \u221214\u00b73%, \u221215\u00b79 to \u221210\u00b77; low certainty), with stronger associations with N95 or similar respirators compared with disposable surgical masks or similar (eg, reusable 12\u201316-layer cotton masks; p(interaction)=0\u00b7090; posterior probability >95%, low certainty).", "Eye protection also was associated with less infection (n=3713; aOR 0\u00b722, 95% CI 0\u00b712 to 0\u00b739, RD \u221210\u00b76%, 95% CI \u221212\u00b75 to \u22127\u00b77; low certainty).", "Unadjusted studies and subgroup and sensitivity analyses showed similar findings.", "INTERPRETATION: The findings of this systematic review and meta-analysis support physical distancing of 1 m or more and provide quantitative estimates for models and contact tracing to inform policy.", "Optimum use of face masks, respirators, and eye protection in public and health-care settings should be informed by these findings and contextual factors.", "Robust randomised trials are needed to better inform the evidence for these interventions, but this systematic appraisal of currently best available evidence might inform interim guidance.", "FUNDING: World Health Organization."]}
{"cord_id": "qi1henyy", "title": "To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic", "abstract": ["Face mask use by the general public for limiting the spread of the COVID-19 pandemic is controversial, though increasingly recommended, and the potential of this intervention is not well understood.", "We develop a compartmental model for assessing the community-wide impact of mask use by the general, asymptomatic public, a portion of which may be asymptomatically infectious.", "Model simulations, using data relevant to COVID-19 dynamics in the US states of New York and Washington, suggest that broad adoption of even relatively ineffective face masks may meaningfully reduce community transmission of COVID-19 and decrease peak hospitalizations and deaths.", "Moreover, mask use decreases the effective transmission rate in nearly linear proportion to the product of mask effectiveness (as a fraction of potentially infectious contacts blocked) and coverage rate (as a fraction of the general population), while the impact on epidemiologic outcomes (death, hospitalizations) is highly nonlinear, indicating masks could synergize with other non-pharmaceutical measures.", "Notably, masks are found to be useful with respect to both preventing illness in healthy persons and preventing asymptomatic transmission.", "Hypothetical mask adoption scenarios, for Washington and New York state, suggest that immediate near universal (80%) adoption of moderately (50%) effective masks could prevent on the order of 17\u201345% of projected deaths over two months in New York, while decreasing the peak daily death rate by 34\u201358%, absent other changes in epidemic dynamics.", "Even very weak masks (20% effective) can still be useful if the underlying transmission rate is relatively low or decreasing: In Washington, where baseline transmission is much less intense, 80% adoption of such masks could reduce mortality by 24\u201365% (and peak deaths 15\u201369%), compared to 2\u20139% mortality reduction in New York (peak death reduction 9\u201318%).", "Our results suggest use of face masks by the general public is potentially of high value in curtailing community transmission and the burden of the pandemic.", "The community-wide benefits are likely to be greatest when face masks are used in conjunction with other non-pharmaceutical practices (such as social-distancing), and when adoption is nearly universal (nation-wide) and compliance is high."]}
{"cord_id": "vpqwkmlv", "title": "Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces", "abstract": ["Previous studies have demonstrated that SARS-CoV-2 is stable on surfaces for extended periods under indoor conditions.", "In the present study, simulated sunlight rapidly inactivated SARS-CoV-2 suspended in either simulated saliva or culture media and dried on stainless steel coupons.", "Ninety percent of infectious virus was inactivated every 6.8 minutes in simulated saliva and every 14.3 minutes in culture media when exposed to simulated sunlight representative of the summer solstice at 40\u00b0N latitude at sea level on a clear day.", "Significant inactivation also occurred, albeit at a slower rate, under lower simulated sunlight levels.", "The present study provides the first evidence that sunlight may rapidly inactivate SARS-CoV-2 on surfaces, suggesting that persistence, and subsequently exposure risk, may vary significantly between indoor and outdoor environments.", "Additionally, these data indicate that natural sunlight may be effective as a disinfectant for contaminated nonporous materials."]}
{"cord_id": "jk37ej4c", "title": "Indoor transmission of SARS-CoV-2", "abstract": ["Background: By early April 2020, the COVID-19 pandemic had infected nearly one million people and had spread to nearly all countries worldwide.", "It is essential to understand where and how SARS-CoV-2 is transmitted.", "Methods: Case reports were extracted from the local Municipal Health Commissions of 320 prefectural cities (municipalities) in China, not including Hubei province, between 4 January and 11 February 2020.", "We identified all outbreaks involving three or more cases and reviewed the major characteristics of the enclosed spaces in which the outbreaks were reported and associated indoor environmental issues.", "Results: Three hundred and eighteen outbreaks with three or more cases were identified, involving 1245 confirmed cases in 120 prefectural cities.", "We divided the venues in which the outbreaks occurred into six categories: homes, transport, food, entertainment, shopping, and miscellaneous.", "Among the identified outbreaks, 53.8% involved three cases, 26.4% involved four cases, and only 1.6% involved ten or more cases.", "Home outbreaks were the dominant category (254 of 318 outbreaks; 79.9%), followed by transport (108; 34.0%; note that many outbreaks involved more than one venue category).", "Most home outbreaks involved three to five cases.", "We identified only a single outbreak in an outdoor environment, which involved two cases.", "Conclusions: All identified outbreaks of three or more cases occurred in an indoor environment, which confirms that sharing indoor space is a major SARS-CoV-2 infection risk."]}
{"cord_id": "8g40ukml", "title": "Interferon-\u03b2-1a Inhibition of Severe Acute Respiratory Syndrome\u2013Coronavirus 2 In Vitro When Administered After Virus Infection", "abstract": ["The ongoing coronavirus disease 2019 pandemic has forced the clinical and scientific community to try drug repurposing of existing antiviral agents as a quick option against severe acute respiratory syndrome\u2013coronavirus 2 (SARS-CoV-2).", "Under this scenario, interferon (IFN) \u03b2-1a, whose antiviral potential is already known, and which is a drug currently used in the clinical management of multiple sclerosis, may represent as a potential candidate.", "In this report, we demonstrate that IFN-\u03b2-1a was highly effective in inhibiting in vitro SARS-CoV-2 replication at clinically achievable concentration when administered after virus infection."]}
{"cord_id": "gbkgzvc8", "title": "Infection and Rapid Transmission of SARS-CoV-2 in Ferrets", "abstract": ["The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide.", "To prevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV-2 is a high priority.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication.", "Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets.", "Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs.", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines."]}
{"cord_id": "je585xia", "title": "COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020", "abstract": ["During January 26\u2013February 10, 2020, an outbreak of 2019 novel coronavirus disease in an air-conditioned restaurant in Guangzhou, China, involved 3 family clusters.", "The airflow direction was consistent with droplet transmission.", "To prevent the spread of the virus in restaurants, we recommend increasing the distance between tables and improving ventilation."]}
{"cord_id": "7kevqevo", "title": "Racial and Ethnic Disparities in Population Level Covid-19 Mortality", "abstract": ["Background: Current reporting of Covid-19 mortality data by race and ethnicity across the United States could bias our understanding of population-mortality disparities.", "Moreover, stark differences in age distribution by race and ethnicity groups are seldom accounted for in analyses.", "Methods: To address these gaps, we conducted a cross-sectional study using publicly-reported Covid-19 mortality data to assess the quality of race and ethnicity data (Black, Latinx, white), and estimated age-adjusted disparities using a random effects meta-analytic approach.", "Results: We found only 28 states, and NYC, reported race and ethnicity-stratified Covid-19 mortality along with large variation in the percent of missing race and ethnicity data by state.", "Aggregated relative risk of death estimates for Black compared to the white population was 3.57 (95% CI: 2.84-4.48).", "Similarly, Latinx population displayed 1.88 (95% CI: 1.61-2.19) times higher risk of death than white patients.", "Discussion: In states providing race and ethnicity data, we identified significant population-level Covid-19 mortality disparities.", "We demonstrated the importance of adjusting for age differences across population groups to prevent underestimating disparities in younger population groups.", "The availability of high-quality and comprehensive race and ethnicity data is necessary to address factors contributing to inequity in Covid-19 mortality."]}
{"cord_id": "z7u4n1f0", "title": "Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020", "abstract": ["Since SARS-CoV-2, the novel coronavirus that causes coronavirus disease 2019 (COVID-19), was first detected in December 2019 (1), approximately 1.3 million cases have been reported worldwide (2), including approximately 330,000 in the United States (3).", "To conduct population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in the United States, the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) was created using the existing infrastructure of the Influenza Hospitalization Surveillance Network (FluSurv-NET) (4) and the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET).", "This report presents age-stratified COVID-19-associated hospitalization rates for patients admitted during March 1-28, 2020, and clinical data on patients admitted during March 1-30, 2020, the first month of U.S. surveillance.", "Among 1,482 patients hospitalized with COVID-19, 74.5% were aged &#8805;50 years, and 54.4% were male.", "The hospitalization rate among patients identified through COVID-NET during this 4-week period was 4.6 per 100,000 population.", "Rates were highest (13.8) among adults aged &#8805;65 years.", "Among 178 (12%) adult patients with data on underlying conditions as of March 30, 2020, 89.3% had one or more underlying conditions; the most common were hypertension (49.7%), obesity (48.3%), chronic lung disease (34.6%), diabetes mellitus (28.3%), and cardiovascular disease (27.8%).", "These findings suggest that older adults have elevated rates of COVID-19-associated hospitalization and the majority of persons hospitalized with COVID-19 have underlying medical conditions.", "These findings underscore the importance of preventive measures (e.g., social distancing, respiratory hygiene, and wearing face coverings in public settings where social distancing measures are difficult to maintain)\u0086 to protect older adults and persons with underlying medical conditions, as well as the general public.", "In addition, older adults and persons with serious underlying medical conditions should avoid contact with persons who are ill and immediately contact their health care provider(s) if they have symptoms consistent with COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html) (5).", "Ongoing monitoring of hospitalization rates, clinical characteristics, and outcomes of hospitalized patients will be important to better understand the evolving epidemiology of COVID-19 in the United States and the clinical spectrum of disease, and to help guide planning and prioritization of health care system resources."]}
{"cord_id": "kjl04qy5", "title": "Household Secondary Attack Rate of COVID-19 and Associated Determinants", "abstract": ["BACKGROUND: As of April 2, 2020, the global reported number of COVID-19 cases has crossed over 1 million with more than 55,000 deaths.", "The household transmissibility of SARS-CoV-2, the causative pathogen, remains elusive.", "METHODS: Based on a comprehensive contact-tracing dataset from Guangzhou, we estimated both the population-level effective reproductive number and individual-level secondary attack rate (SAR) in the household setting.", "We assessed age effects on transmissibility and the infectivity of COVID-19 cases during their incubation period.", "RESULTS: A total of 195 unrelated clusters with 212 primary cases, 137 nonprimary (secondary or tertiary) cases and 1938 uninfected close contacts were traced.", "We estimated the household SAR to be 13.8% (95% CI: 11.1\u201317.0%) if household contacts are defined as all close relatives and 19.3% (95% CI: 15.5\u201323.9%) if household contacts only include those at the same residential address as the cases, assuming a mean incubation period of 4 days and a maximum infectious period of 13 days.", "The odds of infection among children (<20 years old) was only 0.26 (95% CI: 0.13\u20130.54) times of that among the elderly (\u226560 years old).", "There was no gender difference in the risk of infection.", "COVID-19 cases were at least as infectious during their incubation period as during their illness.", "On average, a COVID-19 case infected 0.48 (95% CI: 0.39\u20130.58) close contacts.", "Had isolation not been implemented, this number increases to 0.62 (95% CI: 0.51\u20130.75).", "The effective reproductive number in Guangzhou dropped from above 1 to below 0.5 in about 1 week.", "CONCLUSION: SARS-CoV-2 is more transmissible in households than SARS-CoV and MERS-CoV, and the elderly \u226560 years old are the most vulnerable to household transmission.", "Case finding and isolation alone may be inadequate to contain the pandemic and need to be used in conjunction with heightened restriction of human movement as implemented in Guangzhou."]}
{"cord_id": "vxavox24", "title": "Suppression of COVID-19 outbreak in the municipality of Vo, Italy", "abstract": ["On the 21st of February 2020 a resident of the municipality of Vo, a small town near Padua, died of pneumonia due to SARS-CoV-2 infection.", "This was the first COVID-19 death detected in Italy since the emergence of SARS-CoV-2 in the Chinese city of Wuhan, Hubei province.", "In response, the regional authorities imposed the lockdown of the whole municipality for 14 days.", "We collected information on the demography, clinical presentation, hospitalization, contact network and presence of SARS-CoV-2 infection in nasopharyngeal swabs for 85.9% and 71.5% of the population of Vo at two consecutive time points.", "On the first survey, which was conducted around the time the town lockdown started, we found a prevalence of infection of 2.6% (95% confidence interval (CI) 2.1-3.3%).", "On the second survey, which was conducted at the end of the lockdown, we found a prevalence of 1.2% (95% CI 0.8-1.8%).", "Notably, 43.2% (95% CI 32.2-54.7%) of the confirmed SARS-CoV-2 infections detected across the two surveys were asymptomatic.", "The mean serial interval was 6.9 days (95% CI 2.6-13.4).", "We found no statistically significant difference in the viral load (as measured by genome equivalents inferred from cycle threshold data) of symptomatic versus asymptomatic infections (p-values 0.6 and 0.2 for E and RdRp genes, respectively, Exact Wilcoxon-Mann-Whitney test).", "Contact tracing of the newly infected cases and transmission chain reconstruction revealed that most new infections in the second survey were infected in the community before the lockdown or from asymptomatic infections living in the same household.", "This study sheds new light on the frequency of asymptomatic SARS-CoV-2 infection and their infectivity (as measured by the viral load) and provides new insights into its transmission dynamics, the duration of viral load detectability and the efficacy of the implemented control measures."]}
{"cord_id": "kxze0470", "title": "Possible Central Nervous System Infection by SARS Coronavirus", "abstract": ["On day 22 of illness, generalized tonic-clonic convulsion developed in a 32-year-old woman with severe acute respiratory syndrome (SARS).", "Cerebrospinal fluid tested positive for SARS coronavirus (SARS-CoV) by reverse transcriptase\u2013polymerase chain reaction.", "SARS-CoV may have caused an infection in the central nervous system in this patient."]}
{"cord_id": "hncf2qe8", "title": "Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin", "abstract": ["Cross-species transmission of viruses from wildlife animal reservoirs poses a marked threat to human and animal health(1).", "Bats have been recognized as one of the most important reservoirs for emerging viruses and the transmission of a coronavirus that originated in bats to humans via intermediate hosts was responsible for the high-impact emerging zoonosis, severe acute respiratory syndrome (SARS)(2\u201310).", "Here we provide virological, epidemiological, evolutionary and experimental evidence that a novel HKU2-related bat coronavirus, swine acute diarrhoea syndrome coronavirus (SADS-CoV), is the aetiological agent that was responsible for a large-scale outbreak of fatal disease in pigs in China that has caused the death of 24,693 piglets across four farms.", "Notably, the outbreak began in Guangdong province in the vicinity of the origin of the SARS pandemic.", "Furthermore, we identified SADS-related CoVs with 96\u201398% sequence identity in 9.8% (58 out of 591) of anal swabs collected from bats in Guangdong province during 2013\u20132016, predominantly in horseshoe bats (Rhinolophus spp.)", "that are known reservoirs of SARS-related CoVs.", "We found that there were striking similarities between the SADS and SARS outbreaks in geographical, temporal, ecological and aetiological settings.", "This study highlights the importance of identifying coronavirus diversity and distribution in bats to mitigate future outbreaks that could threaten livestock, public health and economic growth."]}
{"cord_id": "yn8nzezq", "title": "Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak", "abstract": ["An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in the city of Wuhan in China and has widely spread worldwide.", "Currently, it is vital to explore potential intermediate hosts of SARS-CoV-2 to control COVID-19 spread.", "Therefore, we reinvestigated published data from pangolin lung samples from which SARS-CoV-like CoVs were detected by Liu et al.", "[1].", "We found genomic and evolutionary evidence of the occurrence of a SARS-CoV-2-like CoV (named Pangolin-CoV) in dead Malayan pangolins.", "Pangolin-CoV is 91.02% and 90.55% identical to SARS-CoV-2 and BatCoV RaTG13, respectively, at the whole-genome level.", "Aside from RaTG13, Pangolin-CoV is the most closely related CoV to SARS-CoV-2.", "The S1 protein of Pangolin-CoV is much more closely related to SARS-CoV-2 than to RaTG13.", "Five key amino acid residues involved in the interaction with human ACE2 are completely consistent between Pangolin-CoV and SARS-CoV-2, but four amino acid mutations are present in RaTG13.", "Both Pangolin-CoV and RaTG13 lost the putative furin recognition sequence motif at S1/S2 cleavage site that can be observed in the SARS-CoV-2.", "Conclusively, this study suggests that pangolin species are a natural reservoir of SARS-CoV-2-like CoVs."]}
{"cord_id": "qydo3yr9", "title": "Strategies for mitigating an influenza pandemic", "abstract": ["Development of strategies for mitigating the severity of a new influenza pandemic is now a top global public health priority.", "Influenza prevention and containment strategies can be considered under the broad categories of antiviral, vaccine and non-pharmaceutical (case isolation, household quarantine, school or workplace closure, restrictions on travel) measures(1).", "Mathematical models are powerful tools for exploring this complex landscape of intervention strategies and quantifying the potential costs and benefits of different options(2,3,4,5).", "Here we use a large-scale epidemic simulation(6) to examine intervention options should initial containment(6,7) of a novel influenza outbreak fail, using Great Britain and the United States as examples.", "We find that border restrictions and/or internal travel restrictions are unlikely to delay spread by more than 2\u20133 weeks unless more than 99% effective.", "School closure during the peak of a pandemic can reduce peak attack rates by up to 40%, but has little impact on overall attack rates, whereas case isolation or household quarantine could have a significant impact, if feasible.", "Treatment of clinical cases can reduce transmission, but only if antivirals are given within a day of symptoms starting.", "Given enough drugs for 50% of the population, household-based prophylaxis coupled with reactive school closure could reduce clinical attack rates by 40\u201350%.", "More widespread prophylaxis would be even more logistically challenging but might reduce attack rates by over 75%.", "Vaccine stockpiled in advance of a pandemic could significantly reduce attack rates even if of low efficacy.", "Estimates of policy effectiveness will change if the characteristics of a future pandemic strain differ substantially from those seen in past pandemics.", "SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nature04795) contains supplementary material, which is available to authorized users."]}
{"cord_id": "h2h4bnd5", "title": "Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak", "abstract": ["Background The ongoing outbreak of COVID-19 has spread rapidly and sparked global concern.", "While the transmission of SARS-CoV-2 through human respiratory droplets and contact with infected persons is clear, the aerosol transmission of SARS-CoV-2 has been little studied.", "Methods Thirty-five aerosol samples of three different types (total suspended particle, size segregated and deposition aerosol) were collected in Patient Areas (PAA) and Medical Staff Areas (MSA) of Renmin Hospital of Wuhan University (Renmin) and Wuchang Fangcang Field Hospital (Fangcang), and Public Areas (PUA) in Wuhan, China during COVID-19 outbreak.", "A robust droplet digital polymerase chain reaction (ddPCR) method was employed to quantitate the viral SARS-CoV-2 RNA genome and determine aerosol RNA concentration.", "Results The ICU, CCU and general patient rooms inside Renmin, patient hall inside Fangcang had undetectable or low airborne SARS-CoV-2 concentration but deposition samples inside ICU and air sample in Fangcang patient toilet tested positive.", "The airborne SARS-CoV-2 in Fangcang MSA had bimodal distribution with higher concentration than those in Renmin during the outbreak but turned negative after patients number reduced and rigorous sanitization implemented.", "PUA had undetectable airborne SARS-CoV-2 concentration but obviously increased with accumulating crowd flow.", "Conclusions Room ventilation, open space, proper use and disinfection of toilet can effectively limit aerosol transmission of SARS-CoV-2.", "Gathering of crowds with asymptomatic carriers is a potential source of airborne SARS-CoV-2.", "The virus aerosol deposition on protective apparel or floor surface and their subsequent resuspension is a potential transmission pathway and effective sanitization is critical in minimizing aerosol transmission of SARS-CoV-2."]}
{"cord_id": "f4hj35dr", "title": "Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period", "abstract": ["There is an urgent need to project how transmission of the novel betacoronavirus SARS-CoV-2 will unfold in coming years.", "These dynamics will depend on seasonality, the duration of immunity, and the strength of cross-immunity to/from the other human coronaviruses.", "Using data from the United States, we measured how these factors affect transmission of human betacoronaviruses HCoV-OC43 and HCoV-HKU1.", "We then built a mathematical model to simulate transmission of SARS-CoV-2 through the year 2025.", "We project that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after an initial pandemic wave.", "We summarize the full range of plausible transmission scenarios and identify key data still needed to distinguish between them, most importantly longitudinal serological studies to determine the duration of immunity to SARS-CoV-2."]}
{"cord_id": "5trox1i5", "title": "Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays", "abstract": ["Background: The SARS-CoV-2 pandemic caused >1 million infections during January-March 2020.", "There is an urgent need for robust antibody detection approaches to support diagnostics, vaccine development, safe individual release from quarantine and population lock-down exit strategies.", "The early promise of lateral flow immunoassay (LFIA) devices has been questioned following concerns about sensitivity and specificity.", "Methods: We used a panel of plasma samples designated SARS-CoV-2 positive (from SARS-CoV-2 RT-PCR-positive individuals; n=40) and negative (samples banked in the UK prior to December-2019 (n=142)).", "We tested plasma for SARS-Cov-2 IgM and IgG antibodies by ELISA and using nine different commercially available LFIA devices.", "Results: ELISA detected SARS-CoV-2 IgM or IgG in 34/40 individuals with an RT-PCR-confirmed diagnosis of SARS-CoV-2 infection (sensitivity 85%, 95%CI 70-94%), vs 0/50 pre-pandemic controls (specificity 100% [95%CI 93-100%]).", "IgG levels were detected in 31/31 RT-PCR-positive individuals tested \u226510 days after symptom onset (sensitivity 100%, 95%CI 89-100%).", "IgG titres rose during the 3 weeks post symptom onset and began to fall by 8 weeks, but remained above the detection threshold.", "Point estimates for the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively.", "Within the limits of the study size, the performance of most LFIA devices was similar.", "Conclusions: The performance of current LFIA devices is inadequate for most individual patient applications.", "ELISA can be calibrated to be specific for detecting and quantifying SARS-CoV-2 IgM and IgG and is highly sensitive for IgG from 10 days following symptoms onset."]}
{"cord_id": "3e2soc6w", "title": "Transmission dynamics of 2019 novel coronavirus (2019-nCoV)", "abstract": ["Background Since December 29, 2019, pneumonia infection with 2019-nCoV has rapidly spread out from Wuhan, Hubei Province, China to most others provinces and other counties.", "However, the transmission dynamics of 2019-nCoV remain unclear.", "Methods Data of confirmed 2019-nCoV cases before January 23, 2020 were collected from medical records, epidemiological investigations or official websites.", "Data of severe acute respiratory syndrome (SARS) cases in Guangdong Province during 2002-2003 were obtained from Guangdong Provincial Center for Disease Control and Prevention (GDCDC).", "Exponential Growth (EG) and maximum likelihood estimation (ML) were applied to estimate the reproductive number (R) of 2019-nCoV and SARS.", "Findings As of January 23, 2020, a total of 830 confirmed 2019-nCoV cases were identified across China, and 9 cases were reported overseas.", "The average incubation duration of 2019-nCoV infection was 4.8days.", "The average period from onset of symptoms to isolation of 2019-nCoV and SARS cases were 2.9 and 4.2 days, respectively.", "The R values of 2019-nCoV were 2.90 (95%CI: 2.32-3.63) and 2.92 (95%CI: 2.28-3.67) estimated using EG and ML respectively, while the corresponding R values of SARS-CoV were 1.77 (95%CI: 1.37-2.27) and 1.85 (95%CI: 1.32-2.49).", "We observe a decreasing trend of the period from onset to isolation and R values of both 2019-nCoV and SARS-CoV.", "Interpretation The 2019-nCoV may have a higher pandemic risk than SARS broken out in 2003.", "The implemented public-health efforts have significantly decreased the pandemic risk of 2019-nCoV.", "However, more rigorous control and prevention strategies and measures to contain its further spread.", "Funding National Key Research and Development Program of China, Science and Technology Program of Guangdong Province, and Guangzhou Science and technology Plan Project."]}
{"cord_id": "ecxji8x8", "title": "New blood tests for antibodies could show true scale of coronavirus pandemic", "abstract": ["How many COVID-19 cases have gone undetected?", "And are those who had mild cases of the disease\u2014perhaps so mild they dismissed it as a cold or allergies\u2014immune to new infections?", "If so, they could slow the spread of the burgeoning pandemic Labs and companies around the world have raced to develop antibody tests, and a few have been used in small studies and received commercial approval, including several from China But so far, large-scale data from such tests\u2014for example showing what fraction of people in the hard-hit city of Wuhan, China, might now be immune\u2014is still lacking or at least not public Scientists hope that will soon change as more tests become available"]}
{"cord_id": "46la29tm", "title": "SARS Antibody Test for Serosurveillance", "abstract": ["A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SARS) by helping identify undetected chains of disease transmission.", "The assay was developed by epitope mapping, using synthetic peptides from the spike, membrane, and nucleocapsid protein sequences of SARS-associated coronavirus.", "The new peptide ELISA consistently detected seroconversion by week 2 of onset of fever, and seropositivity remained through day 100.", "Specificity was 100% on normal blood donor samples, on serum samples associated with infection by other pathogens, and on an interference panel.", "The peptide-based test has advantages of safety, standardization, and automation over previous immunoassays for SARS.", "The assay was used for a retrospective survey of healthy healthcare workers in Taiwan who treated SARS patients.", "Asymptomatic seroconversions were detected in two hospitals that had nosocomial disease."]}
{"cord_id": "m40kwgcg", "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", "abstract": ["BACKGROUND: In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China.", "We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.", "METHODS: In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020.", "Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data.", "Outcomes were followed up until Jan 25, 2020.", "FINDINGS: Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market.", "The average age of the patients was 55\u00b75 years (SD 13\u00b71), including 67 men and 32 women.", "2019-nCoV was detected in all patients by real-time RT-PCR.", "50 (51%) patients had chronic diseases.", "Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient).", "According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax.", "17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure.", "INTERPRETATION: The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome.", "In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia.", "Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection.", "FUNDING: National Key R&D Program of China."]}
{"cord_id": "p5cab562", "title": "COVID-19: ICU delirium management during SARS-CoV-2 pandemic", "abstract": ["The novel coronavirus, SARS-CoV-2-causing Coronavirus Disease 19 (COVID-19), emerged as a public health threat in December 2019 and was declared a pandemic by the World Health Organization in March 2020.", "Delirium, a dangerous untoward prognostic development, serves as a barometer of systemic injury in critical illness.", "The early reports of 25% encephalopathy from China are likely a gross underestimation, which we know occurs whenever delirium is not monitored with a valid tool.", "Indeed, patients with COVID-19 are at accelerated risk for delirium due to at least seven factors including (1) direct central nervous system (CNS) invasion, (2) induction of CNS inflammatory mediators, (3) secondary effect of other organ system failure, (4) effect of sedative strategies, (5) prolonged mechanical ventilation time, (6) immobilization, and (7) other needed but unfortunate environmental factors including social isolation and quarantine without family.", "Given early insights into the pathobiology of the virus, as well as the emerging interventions utilized to treat the critically ill patients, delirium prevention and management will prove exceedingly challenging, especially in the intensive care unit (ICU).", "The main focus during the COVID-19 pandemic lies within organizational issues, i.e., lack of ventilators, shortage of personal protection equipment, resource allocation, prioritization of limited mechanical ventilation options, and end-of-life care.", "However, the standard of care for ICU patients, including delirium management, must remain the highest quality possible with an eye towards long-term survival and minimization of issues related to post-intensive care syndrome (PICS).", "This article discusses how ICU professionals (e.g., physicians, nurses, physiotherapists, pharmacologists) can use our knowledge and resources to limit the burden of delirium on patients by reducing modifiable risk factors despite the imposed heavy workload and difficult clinical challenges posed by the pandemic."]}
{"cord_id": "vp80nm1b", "title": "Demographic and attitudinal determinants of protective behaviours during a pandemic: A review", "abstract": ["Purpose.", "A new strain of H1N1 influenza, also known as swine flu was confirmed in the UK in May 2009 and has spread to over 100 countries around the world causing the World Health Organization to declare a global flu pandemic.", "The primary objectives of this review are to identify the key demographic and attitudinal determinants of three types of protective behaviour during a pandemic: preventive, avoidant, and management of illness behaviours, in order to describe conceptual frameworks in which to better understand these behaviours and to inform future communications and interventions in the current outbreak of swine flu and subsequent influenza pandemics.", "Methods.", "Web of Science and PubMed databases were searched for references to papers on severe acute respiratory syndrome, avian influenza/flu, H5N1, swine influenza/flu, H1N1, and pandemics.", "Forward searching of the identified references was also carried out.", "In addition, references were gleaned from an expert panel of the Behaviour and Communications sub\u2010group of the UK Scientific Pandemic Influenza Advisory Group.", "Papers were included if they reported associations between demographic factors, attitudes, and a behavioural measure (reported, intended, or actual behaviour).", "Results.", "Twenty\u2010six papers were identified that met the study inclusion criteria.", "The studies were of variable quality and most lacked an explicit theoretical framework.", "Most were cross\u2010sectional in design and therefore not predictive over time.", "The research shows that there are demographic differences in behaviour: being older, female and more educated, or non\u2010White, is associated with a higher chance of adopting the behaviours.", "There is evidence that greater levels of perceived susceptibility to and perceived severity of the diseases and greater belief in the effectiveness of recommended behaviours to protect against the disease are important predictors of behaviour.", "There is also evidence that greater levels of state anxiety and greater trust in authorities are associated with behaviour.", "Conclusions.", "The findings from this review can be broadly explained by theories of health behaviour.", "However, theoretically driven prospective studies are required to further clarify the relationship between demographic factors, attitudes, and behaviour.", "The findings suggest that intervention studies and communication strategies should focus on particular demographic groups and on raising levels of perceived threat of the pandemic disease and belief in the effectiveness of measures designed to protect against it."]}
{"cord_id": "39mfts0g", "title": "Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study", "abstract": ["BACKGROUND: A range of public health measures have been implemented to suppress local transmission of coronavirus disease 2019 (COVID-19) in Hong Kong.", "We examined the effect of these interventions and behavioural changes of the public on the incidence of COVID-19, as well as on influenza virus infections, which might share some aspects of transmission dynamics with COVID-19.", "METHODS: We analysed data on laboratory-confirmed COVID-19 cases, influenza surveillance data in outpatients of all ages, and influenza hospitalisations in children.", "We estimated the daily effective reproduction number (R(t)) for COVID-19 and influenza A H1N1 to estimate changes in transmissibility over time.", "Attitudes towards COVID-19 and changes in population behaviours were reviewed through three telephone surveys done on Jan 20\u201323, Feb 11\u201314, and March 10\u201313, 2020.", "FINDINGS: COVID-19 transmissibility measured by R(t) has remained at approximately 1 for 8 weeks in Hong Kong.", "Influenza transmission declined substantially after the implementation of social distancing measures and changes in population behaviours in late January, with a 44% (95% CI 34\u201353%) reduction in transmissibility in the community, from an estimated R(t) of 1\u00b728 (95% CI 1\u00b726\u20131\u00b730) before the start of the school closures to 0\u00b772 (0\u00b770\u20130\u00b774) during the closure weeks.", "Similarly, a 33% (24\u201343%) reduction in transmissibility was seen based on paediatric hospitalisation rates, from an R(t) of 1\u00b710 (1\u00b706\u20131\u00b712) before the start of the school closures to 0\u00b773 (0\u00b768\u20130\u00b777) after school closures.", "Among respondents to the surveys, 74\u00b75%, 97\u00b75%, and 98\u00b78% reported wearing masks when going out, and 61\u00b73%, 90\u00b72%, and 85\u00b71% reported avoiding crowded places in surveys 1 (n=1008), 2 (n=1000), and 3 (n=1005), respectively.", "INTERPRETATION: Our study shows that non-pharmaceutical interventions (including border restrictions, quarantine and isolation, distancing, and changes in population behaviour) were associated with reduced transmission of COVID-19 in Hong Kong, and are also likely to have substantially reduced influenza transmission in early February, 2020.", "FUNDING: Health and Medical Research Fund, Hong Kong."]}
{"cord_id": "w2c01295", "title": "Testing the Efficacy of Homemade Masks: Would They Protect in an Influenza Pandemic?", "abstract": ["OBJECTIVE: This study examined homemade masks as an alternative to commercial face masks.", "METHODS: Several household materials were evaluated for the capacity to block bacterial and viral aerosols.", "Twenty-one healthy volunteers made their own face masks from cotton t-shirts; the masks were then tested for fit.", "The number of microorganisms isolated from coughs of healthy volunteers wearing their homemade mask, a surgical mask, or no mask was compared using several air-sampling techniques.", "RESULTS: The median-fit factor of the homemade masks was one-half that of the surgical masks.", "Both masks significantly reduced the number of microorganisms expelled by volunteers, although the surgical mask was 3 times more effective in blocking transmission than the homemade mask.", "CONCLUSION: Our findings suggest that a homemade mask should only be considered as a last resort to prevent droplet transmission from infected individuals, but it would be better than no protection.", "(Disaster Med Public Health Preparedness.", "2013;0:1\u20136)"]}
{"cord_id": "2tu707ng", "title": "Potential interventions for novel coronavirus in China: A systematic review", "abstract": ["An outbreak of a novel coronavirus (COVID\u201019 or 2019\u2010CoV) infection has posed significant threats to international health and the economy.", "In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease.", "Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA\u2010virus infection and we have found that general treatments, coronavirus\u2010specific treatments, and antiviral treatments should be useful in fighting COVID\u201019.", "We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA\u2010virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers.", "In addition, convalescent plasma should be given to COVID\u201019 patients if it is available.", "In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID\u201019 if the infection is uncontrollable."]}
{"cord_id": "9h45c2di", "title": "Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study", "abstract": ["BACKGROUND: As of June 8, 2020, the global reported number of COVID-19 cases had reached more than 7 million with over 400\u00e2\u0080\u0088000 deaths.", "The household transmissibility of the causative pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains unclear.", "We aimed to estimate the secondary attack rate of SARS-CoV-2 among household and non-household close contacts in Guangzhou, China, using a statistical transmission model.", "METHODS: In this retrospective cohort study, we used a comprehensive contact tracing dataset from the Guangzhou Center for Disease Control and Prevention to estimate the secondary attack rate of COVID-19 (defined as the probability that an infected individual will transmit the disease to a susceptible individual) among household and non-household contacts, using a statistical transmission model.", "We considered two alternative definitions of household contacts in the analysis: individuals who were either family members or close relatives, such as parents and parents-in-law, regardless of residential address, and individuals living at the same address regardless of relationship.", "We assessed the demographic determinants of transmissibility and the infectivity of COVID-19 cases during their incubation period.", "FINDINGS: Between Jan 7, 2020, and Feb 18, 2020, we traced 195 unrelated close contact groups (215 primary cases, 134 secondary or tertiary cases, and 1964 uninfected close contacts).", "By identifying households from these groups, assuming a mean incubation period of 5 days, a maximum infectious period of 13 days, and no case isolation, the estimated secondary attack rate among household contacts was 12\u00b74% (95% CI 9\u00b78-15\u00b74) when household contacts were defined on the basis of close relatives and 17\u00b71% (13\u00b73-21\u00b78) when household contacts were defined on the basis of residential address.", "Compared with the oldest age group (&#8805;60 years), the risk of household infection was lower in the youngest age group (<20 years; odds ratio [OR] 0\u00b723 [95% CI 0\u00b711-0\u00b746]) and among adults aged 20-59 years (OR 0\u00b764 [95% CI 0\u00b743-0\u00b797]).", "Our results suggest greater infectivity during the incubation period than during the symptomatic period, although differences were not statistically significant (OR 0\u00b761 [95% CI 0\u00b727-1\u00b738]).", "The estimated local reproductive number (R) based on observed contact frequencies of primary cases was 0\u00b75 (95% CI 0\u00b741-0\u00b762) in Guangzhou.", "The projected local R, had there been no isolation of cases or quarantine of their contacts, was 0\u00b76 (95% CI 0\u00b749-0\u00b774) when household was defined on the basis of close relatives.", "INTERPRETATION: SARS-CoV-2 is more transmissible in households than SARS-CoV and Middle East respiratory syndrome coronavirus.", "Older individuals (aged &#8805;60 years) are the most susceptible to household transmission of SARS-CoV-2.", "In addition to case finding and isolation, timely tracing and quarantine of close contacts should be implemented to prevent onward transmission during the viral incubation period.", "FUNDING: US National Institutes of Health, Science and Technology Plan Project of Guangzhou, Project for Key Medicine Discipline Construction of Guangzhou Municipality, Key Research and Development Program of China."]}
{"cord_id": "f74q6nwj", "title": "Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020", "abstract": ["Importance: Efforts to track the severity and public health impact of coronavirus disease 2019 (COVID-19) in the United States have been hampered by state-level differences in diagnostic test availability, differing strategies for prioritization of individuals for testing, and delays between testing and reporting.", "Evaluating unexplained increases in deaths due to all causes or attributed to nonspecific outcomes, such as pneumonia and influenza, can provide a more complete picture of the burden of COVID-19.", "Objective: To estimate the burden of all deaths related to COVID-19 in the United States from March to May 2020.", "Design, Setting, and Population: This observational study evaluated the numbers of US deaths from any cause and deaths from pneumonia, influenza, and/or COVID-19 from March 1 through May 30, 2020, using public data of the entire US population from the National Center for Health Statistics (NCHS).", "These numbers were compared with those from the same period of previous years.", "All data analyzed were accessed on June 12, 2020.", "Main Outcomes and Measures: Increases in weekly deaths due to any cause or deaths due to pneumonia/influenza/COVID-19 above a baseline, which was adjusted for time of year, influenza activity, and reporting delays.", "These estimates were compared with reported deaths attributed to COVID-19 and with testing data.", "Results: There were approximately 781\u00e2\u0080\u00af000 total deaths in the United States from March 1 to May 30, 2020, representing 122\u00e2\u0080\u00af300 (95% prediction interval, 116\u00e2\u0080\u00af800-127\u00e2\u0080\u00af000) more deaths than would typically be expected at that time of year.", "There were 95\u00e2\u0080\u00af235 reported deaths officially attributed to COVID-19 from March 1 to May 30, 2020.", "The number of excess all-cause deaths was 28% higher than the official tally of COVID-19-reported deaths during that period.", "In several states, these deaths occurred before increases in the availability of COVID-19 diagnostic tests and were not counted in official COVID-19 death records.", "There was substantial variability between states in the difference between official COVID-19 deaths and the estimated burden of excess deaths.", "Conclusions and Relevance: Excess deaths provide an estimate of the full COVID-19 burden and indicate that official tallies likely undercount deaths due to the virus.", "The mortality burden and the completeness of the tallies vary markedly between states."]}
{"cord_id": "7n6pva1l", "title": "Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection", "abstract": ["Antibody (Ab) responses to SARS-CoV-2 can be detected in most infected individuals 10-15 days following the onset of COVID-19 symptoms.", "However, due to the recent emergence of this virus in the human population it is not yet known how long these Ab responses will be maintained or whether they will provide protection from re-infection.", "Using sequential serum samples collected up to 94 days post onset of symptoms (POS) from 65 RT-qPCR confirmed SARS-CoV-2-infected individuals, we show seroconversion in >95% of cases and neutralizing antibody (nAb) responses when sampled beyond 8 days POS.", "We demonstrate that the magnitude of the nAb response is dependent upon the disease severity, but this does not affect the kinetics of the nAb response.", "Declining nAb titres were observed during the follow up period.", "Whilst some individuals with high peak ID50 (>10,000) maintained titres >1,000 at >60 days POS, some with lower peak ID50 had titres approaching baseline within the follow up period.", "A similar decline in nAb titres was also observed in a cohort of seropositive healthcare workers from Guy's and St Thomas' Hospitals.", "We suggest that this transient nAb response is a feature shared by both a SARS-CoV-2 infection that causes low disease severity and the circulating seasonal coronaviruses that are associated with common colds.", "This study has important implications when considering widespread serological testing, Ab protection against re-infection with SARS-CoV-2 and the durability of vaccine protection."]}
{"cord_id": "eml8uilb", "title": "Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion", "abstract": ["Background.", "In the background of the current COVID-19 pandemic, serological tests are being used to assess past infection and immunity against SARS-CoV-2.", "This knowledge is paramount to determine the transmission dynamics of SARS-CoV-2 through the post pandemic period.", "Several individuals belonging to households with an index COVID-19 patient, reported symptoms of COVID-19 but discrepant serology results.", "Methods.", "Here we investigated the humoral and cellular immune responses against SARS-CoV-2 in seven families, including nine index patients and eight contacts, who had evidence of serological discordances within the households.", "Ten unexposed healthy donors were enrolled as controls.", "Results.", "All index patients recovered from a mild COVID-19.", "They all developed anti-SARS-CoV-2 antibodies and a significant T cell response detectable up to 69 days after symptom onset.", "Six of the eight contacts reported COVID-19 symptoms within 1 to 7 days after the index patients but all were SARS-CoV-2 seronegative.", "Six out of eight contacts developed a SARS-CoV-2-specific T cell response against structural and/or accessory proteins that lasts up to 80 days post symptom onset suggesting a past SARS-CoV-2 infection.", "Conclusion.", "Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion.", "T cell responses may be more sensitive indicators of SARS-Co-V-2 exposure than antibodies.", "Our results indicate that epidemiological data relying only on the detection of SARS-CoV-2 antibodies may lead to a substantial underestimation of prior exposure to the virus"]}
{"cord_id": "o877uul1", "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin", "abstract": ["Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats(1\u20134).", "Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans(5\u20137).", "Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China.", "The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020.", "Full-length genome sequences were obtained from five patients at an early stage of the outbreak.", "The sequences are almost identical and share 79.6% sequence identity to SARS-CoV.", "Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus.", "Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV.", "In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients.", "Notably, we confirmed that 2019-nCoV uses the same cell entry receptor\u2014angiotensin converting enzyme II (ACE2)\u2014as SARS-CoV."]}
{"cord_id": "6y6crqrf", "title": "Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)", "abstract": ["Estimation of the prevalence and contagiousness of undocumented novel coronavirus [severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)] infections is critical for understanding the overall prevalence and pandemic potential of this disease.", "Here, we use observations of reported infection within China, in conjunction with mobility data, a networked dynamic metapopulation model, and Bayesian inference, to infer critical epidemiological characteristics associated with SARS-CoV-2, including the fraction of undocumented infections and their contagiousness.", "We estimate that 86% of all infections were undocumented [95% credible interval (CI): 82-90%] before the 23 January 2020 travel restrictions.", "The transmission rate of undocumented infections per person was 55% the transmission rate of documented infections (95% CI: 46-62%), yet, because of their greater numbers, undocumented infections were the source of 79% of the documented cases.", "These findings explain the rapid geographic spread of SARS-CoV-2 and indicate that containment of this virus will be particularly challenging."]}
{"cord_id": "hiuepglh", "title": "Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins", "abstract": ["The ongoing outbreak of viral pneumonia in China and across the world is associated with a new coronavirus, SARS-CoV-21.", "This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale of wild animals may be the source of zoonotic infection2.", "Although bats are probable reservoir hosts for SARS-CoV-2, the identity of any intermediate host that may have facilitated transfer to humans is unknown.", "Here we report the identification of SARS-CoV-2-related coronaviruses in Malayan pangolins (Manis javanica) seized in anti-smuggling operations in southern China.", "Metagenomic sequencing identified pangolin-associated coronaviruses that belong to two sub-lineages of SARS-CoV-2-related coronaviruses, including one that exhibits strong similarity in the receptor-binding domain to SARS-CoV-2.", "The discovery of multiple lineages of pangolin coronavirus and their similarity to SARS-CoV-2 suggests that pangolins should be considered as possible hosts in the emergence of new coronaviruses and should be removed from wet markets to prevent zoonotic transmission."]}
{"cord_id": "fb62dwga", "title": "Presence of SARS-Coronavirus-2 in sewage", "abstract": ["In the current COVID-19 pandemic, a significant proportion of cases shed SARS-Coronavirus-2 (SARS-CoV-2) with their faeces.", "To determine if SARS-CoV-2 is present in sewage during the emergence of COVID-19 in the Netherlands, sewage samples of 7 cities and the airport were tested using RT-PCR against three fragments of the nucleocapsid protein gene (N1-3) and one fragment of the envelope protein gene (E).", "No SARS-CoV-2 was detected in samples of February 6, three weeks before the first case was reported in the Netherlands on February 27.", "On March 5, the N1 fragment was detected in sewage of five sites.", "On March 15/16, the N1 fragment was detected in sewage of six sites, and the N3 and E fragment were detected at 5 and 4 sites respectively.", "This is the first report of detection of SARS-CoV-2 in sewage.", "The detection of the virus in sewage, even when the COVID-19 incidence is low, indicates that sewage surveillance could be a sensitive tool to monitor the circulation of the virus in the population."]}
{"cord_id": "atnxkvy6", "title": "SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases", "abstract": ["Wastewater surveillance may represent a complementary approach to measure the presence and even prevalence of infectious diseases when the capacity for clinical testing is limited.", "Moreover, aggregate, population-wide data can help inform modeling efforts.", "We tested wastewater collected at a major urban treatment facility in Massachusetts and found the presence of SARS-CoV-2 at high titers in the period from March 18 - 25 using RT-qPCR.", "We then confirmed the identity of the PCR product by direct DNA sequencing.", "Viral titers observed were significantly higher than expected based on clinically confirmed cases in Massachusetts as of March 25.", "The reason for the discrepancy is not yet clear, however, and until further experiments are complete, these data do not necessarily indicate that clinical estimates are incorrect.", "Our approach is scalable and may be useful in modeling the SARS-CoV-2 pandemic and future outbreaks."]}
{"cord_id": "9pb2eqoa", "title": "A cluster randomised trial of cloth masks compared with medical masks in healthcare workers", "abstract": ["OBJECTIVE: The aim of this study was to compare the efficacy of cloth masks to medical masks in hospital healthcare workers (HCWs).", "The null hypothesis is that there is no difference between medical masks and cloth masks.", "SETTING: 14 secondary-level/tertiary-level hospitals in Hanoi, Vietnam.", "PARTICIPANTS: 1607 hospital HCWs aged \u226518 years working full-time in selected high-risk wards.", "INTERVENTION: Hospital wards were randomised to: medical masks, cloth masks or a control group (usual practice, which included mask wearing).", "Participants used the mask on every shift for 4 consecutive weeks.", "MAIN OUTCOME MEASURE: Clinical respiratory illness (CRI), influenza-like illness (ILI) and laboratory-confirmed respiratory virus infection.", "RESULTS: The rates of all infection outcomes were highest in the cloth mask arm, with the rate of ILI statistically significantly higher in the cloth mask arm (relative risk (RR)=13.00, 95% CI 1.69 to 100.07) compared with the medical mask arm.", "Cloth masks also had significantly higher rates of ILI compared with the control arm.", "An analysis by mask use showed ILI (RR=6.64, 95% CI 1.45 to 28.65) and laboratory-confirmed virus (RR=1.72, 95% CI 1.01 to 2.94) were significantly higher in the cloth masks group compared with the medical masks group.", "Penetration of cloth masks by particles was almost 97% and medical masks 44%.", "CONCLUSIONS: This study is the first RCT of cloth masks, and the results caution against the use of cloth masks.", "This is an important finding to inform occupational health and safety.", "Moisture retention, reuse of cloth masks and poor filtration may result in increased risk of infection.", "Further research is needed to inform the widespread use of cloth masks globally.", "However, as a precautionary measure, cloth masks should not be recommended for HCWs, particularly in high-risk situations, and guidelines need to be updated.", "TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry: ACTRN12610000887077."]}
{"cord_id": "lvqgu6j3", "title": "Travel", "abstract": ["Travel changes people and places.", "The traveler can be the target and sufferer from microbial threats; the traveler can also provide the microbial transport system.", "Traveling humans alter infectious diseases patterns by introducing pathogenic microbes or resistance, or virulence factors into new populations.", "The movement of pathogenic microbes through history has been intimately linked to the capacity of humans to travel and to migrate to new locations.", "Today, humans have the capacity to reach virtually any city in the world within a day or two.", "Travel to tropical and developing countries are increasing more rapidly than travel to developed countries, and all projections suggest that human travel will continue to increase in the foreseeable future.", "Infectious diseases influence decisions about travel and trade; and travelers change the epidemiology of infectious diseases.", "Travel has played an essential role in the movement of HIV/AIDS throughout the world.", "Rapid international air travel moved the virus that causes SARS to multiple countries within weeks.", "Travel has been and will continue to be important in the movement of human influenza.", "Travel consists of sequential shared environments, often with people from diverse regions of the world.", "It should be considered a loop, and not just an origin and destination.", "Travel has created extensively interconnected world in terms of microbial threats."]}
{"cord_id": "aj2ixlo7", "title": "Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020", "abstract": ["Presymptomatic transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), might pose challenges for disease control.", "The first case of COVID-19 in Singapore was detected on January 23, 2020, and by March 16, a total of 243 cases had been confirmed, including 157 locally acquired cases.", "Clinical and epidemiologic findings of all COVID-19 cases in Singapore through March 16 were reviewed to determine whether presymptomatic transmission might have occurred.", "Presymptomatic transmission was defined as the transmission of SARS-CoV-2 from an infected person (source patient) to a secondary patient before the source patient developed symptoms, as ascertained by exposure and symptom onset dates, with no evidence that the secondary patient had been exposed to anyone else with COVID-19.", "Seven COVID-19 epidemiologic clusters in which presymptomatic transmission likely occurred were identified, and 10 such cases within these clusters accounted for 6.4% of the 157 locally acquired cases.", "In the four clusters for which the date of exposure could be determined, presymptomatic transmission occurred 1-3 days before symptom onset in the presymptomatic source patient.", "To account for the possibility of presymptomatic transmission, officials developing contact tracing protocols should strongly consider including a period before symptom onset.", "Evidence of presymptomatic transmission of SARS-CoV-2 underscores the critical role social distancing, including avoidance of congregate settings, plays in controlling the COVID-19 pandemic."]}
{"cord_id": "bmmdygbs", "title": "Surgical mask filter and fit performance", "abstract": ["BACKGROUND: Surgical masks have been used since the early 1900s to minimize infection of surgical wounds from wearer-generated bacteria.", "There is ongoing debate, however, whether surgical masks can meet the expectations of respiratory protection devices.", "The goal of this study was to evaluate the filter performance and facial fit of a sample of surgical masks.", "METHODS: Filter penetration was measured for at least 3 replicates of 9 surgical masks using monodisperse latex sphere aerosols (0.895, 2.0, and 3.1 \u03bcm) at 6 L/min and 0.075-\u03bcm sodium chloride particles at 84 L/min.", "Facial fit was measured on 20 subjects for the 5 masks with lowest particle penetration, using both qualitative and quantitative fit tests.", "RESULTS: Masks typically used in dental settings collected particles with significantly lower efficiency than those typically used in hospital settings.", "All subjects failed the unassisted qualitative fit test on the first exercise (normal breathing).", "Eighteen subjects failed the assisted qualitative fit tests; 60% failed on the first exercise.", "Quantitative fit factors ranged from 2.5 to 9.6.", "CONCLUSION: None of these surgical masks exhibited adequate filter performance and facial fit characteristics to be considered respiratory protection devices."]}
{"cord_id": "hmw9p6m3", "title": "A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?", "abstract": ["Bats are the natural reservoirs of a number of high-impact viral zoonoses.", "We present a quantitative analysis to address the hypothesis that bats are unique in their propensity to host zoonotic viruses based on a comparison with rodents, another important host order.", "We found that bats indeed host more zoonotic viruses per species than rodents, and we identified life-history and ecological factors that promote zoonotic viral richness.", "More zoonotic viruses are hosted by species whose distributions overlap with a greater number of other species in the same taxonomic order (sympatry).", "Specifically in bats, there was evidence for increased zoonotic viral richness in species with smaller litters (one young), greater longevity and more litters per year.", "Furthermore, our results point to a new hypothesis to explain in part why bats host more zoonotic viruses per species: the stronger effect of sympatry in bats and more viruses shared between bat species suggests that interspecific transmission is more prevalent among bats than among rodents.", "Although bats host more zoonotic viruses per species, the total number of zoonotic viruses identified in bats (61) was lower than in rodents (68), a result of there being approximately twice the number of rodent species as bat species.", "Therefore, rodents should still be a serious concern as reservoirs of emerging viruses.", "These findings shed light on disease emergence and perpetuation mechanisms and may help lead to a predictive framework for identifying future emerging infectious virus reservoirs."]}
{"cord_id": "qpvke1ov", "title": "Household Materials Selection for Homemade Cloth Face Coverings and Their Filtration Efficiency Enhancement with Triboelectric Charging", "abstract": ["[Image: see text] The COVID-19 pandemic is currently causing a severe disruption and shortage in the global supply chain of necessary personal protective equipment (e.g., N95 respirators).", "The U.S. CDC has recommended use of household cloth by the general public to make cloth face coverings as a method of source control.", "We evaluated the filtration properties of natural and synthetic materials using a modified procedure for N95 respirator approval.", "Common fabrics of cotton, polyester, nylon, and silk had filtration efficiency of 5\u201325%, polypropylene spunbond had filtration efficiency 6\u201310%, and paper-based products had filtration efficiency of 10\u201320%.", "An advantage of polypropylene spunbond is that it can be simply triboelectrically charged to enhance the filtration efficiency (from 6 to >10%) without any increase in pressure (stable overnight and in humid environments).", "Using the filtration quality factor, fabric microstructure, and charging ability, we are able to provide an assessment of suggested fabric materials for homemade facial coverings."]}
{"cord_id": "8ul1rplx", "title": "Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020", "abstract": ["An estimated 30 million passengers are transported on 272 cruise ships worldwide each year* (1).", "Cruise ships bring diverse populations into proximity for many days, facilitating transmission of respiratory illness (2).", "SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) was first identified in Wuhan, China, in December 2019 and has since spread worldwide to at least 187 countries and territories.", "Widespread COVID-19 transmission on cruise ships has been reported as well (3).", "Passengers on certain cruise ship voyages might be aged &#8805;65 years, which places them at greater risk for severe consequences of SARS-CoV-2 infection (4).", "During February-March 2020, COVID-19 outbreaks associated with three cruise ship voyages have caused more than 800 laboratory-confirmed cases among passengers and crew, including 10 deaths.", "Transmission occurred across multiple voyages of several ships.", "This report describes public health responses to COVID-19 outbreaks on these ships.", "COVID-19 on cruise ships poses a risk for rapid spread of disease, causing outbreaks in a vulnerable population, and aggressive efforts are required to contain spread.", "All persons should defer all cruise travel worldwide during the COVID-19 pandemic."]}
{"cord_id": "fpn6quqs", "title": "Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea", "abstract": ["During 24 days in Cheonan, South Korea, 112 persons were infected with severe acute respiratory syndrome coronavirus 2 associated with fitness dance classes at 12 sports facilities.", "Intense physical exercise in densely populated sports facilities could increase risk for infection.", "Vigorous exercise in confined spaces should be minimized during outbreaks."]}
{"cord_id": "r07mv2ka", "title": "Serial Interval of COVID-19 among Publicly Reported Confirmed Cases", "abstract": ["We estimate the distribution of serial intervals for 468 confirmed cases of coronavirus disease reported in China as of February 8, 2020.", "The mean interval was 3.96 days (95% CI 3.53\u20134.39 days), SD 4.75 days (95% CI 4.46\u20135.07 days); 12.6% of case reports indicated presymptomatic transmission."]}
{"cord_id": "944pn0k9", "title": "Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China", "abstract": ["BACKGROUND We described the epidemiological features of the coronavirus disease 2019 (Covid-19) outbreak, and evaluated the impact of non-pharmaceutical interventions on the epidemic in Wuhan, China.", "METHODS Individual-level data on 25,961 laboratory-confirmed Covid-19 cases reported through February 18, 2020 were extracted from the municipal Notifiable Disease Report System.", "Based on key events and interventions, we divided the epidemic into four periods: before January 11, January 11-22, January 23 - February 1, and February 2-18.", "We compared epidemiological characteristics across periods and different demographic groups.", "We developed a susceptible-exposed-infectious-recovered model to study the epidemic and evaluate the impact of interventions.", "RESULTS The median age of the cases was 57 years and 50.3% were women.", "The attack rate peaked in the third period and substantially declined afterwards across geographic regions, sex and age groups, except for children (age <20) whose attack rate continued to increase.", "Healthcare workers and elderly people had higher attack rates and severity risk increased with age.", "The effective reproductive number dropped from 3.86 (95% credible interval 3.74 to 3.97) before interventions to 0.32 (0.28 to 0.37) post interventions.", "The interventions were estimated to prevent 94.5% (93.7 to 95.2%) infections till February 18.", "We found that at least 59% of infected cases were unascertained in Wuhan, potentially including asymptomatic and mild-symptomatic cases.", "CONCLUSIONS Considerable countermeasures have effectively controlled the Covid-19 outbreak in Wuhan.", "Special efforts are needed to protect vulnerable populations, including healthcare workers, elderly and children.", "Estimation of unascertained cases has important implications on continuing surveillance and interventions."]}
{"cord_id": "hz1rmj7u", "title": "Public Attitudes, Behaviors, and Beliefs Related to COVID-19, Stay-at-Home Orders, Nonessential Business Closures, and Public Health Guidance - United States, New York City, and Los Angeles, May 5-12, 2020", "abstract": ["SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is thought to be transmitted mainly by person-to-person contact (1).", "Implementation of nationwide public health orders to limit person-to-person interaction and of guidance on personal protective practices can slow transmission (2,3).", "Such strategies can include stay-at-home orders, business closures, prohibitions against mass gatherings, use of cloth face coverings, and maintenance of a physical distance between persons (2,3).", "To assess and understand public attitudes, behaviors, and beliefs related to this guidance and COVID-19, representative panel surveys were conducted among adults aged &#8805;18 years in New York City (NYC) and Los Angeles, and broadly across the United States during May 5-12, 2020.", "Most respondents in the three cohorts supported stay-at-home orders and nonessential business closures* (United States, 79.5%; New York City, 86.7%; and Los Angeles, 81.5%), reported always or often wearing cloth face coverings in public areas (United States, 74.1%, New York City, 89.6%; and Los Angeles 89.8%), and believed that their state's restrictions were the right balance or not restrictive enough (United States, 84.3%; New York City, 89.7%; and Los Angeles, 79.7%).", "Periodic assessments of public attitudes, behaviors, and beliefs can guide evidence-based public health decision-making and related prevention messaging about mitigation strategies needed as the COVID-19 pandemic evolves."]}
{"cord_id": "m1mwt3o1", "title": "Proteomic and Metabolomic Characterization of COVID-19 Patient Sera", "abstract": ["Summary Early detection and effective treatment of severe COVID-19 patients remain major challenges.", "Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals.", "We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients.", "The model was validated using ten independent patients, seven of which were correctly classified.", "Targeted proteomics and metabolomics assays were employed to further validate this molecular classifier in a second test cohort of 19 new COVID-19 patients, leading to 16 correct assignments.", "We identified molecular changes in the sera of COVID-19 patients compared to other groups implicating dysregulation of macrophage, platelet degranulation and complement system pathways, and massive metabolic suppression.", "This study revealed characteristic protein and metabolite changes in the sera of severe COVID-19 patients, which might be used in selection of potential blood biomarkers for severity evaluation."]}
{"cord_id": "9tiaods7", "title": "High COVID-19 Attack Rate Among Attendees at Events at a Church - Arkansas, March 2020", "abstract": ["On March 16, 2020, the day that national social distancing guidelines were released (1), the Arkansas Department of Health (ADH) was notified of two cases of coronavirus disease 2019 (COVID-19) from a rural county of approximately 25,000 persons; these cases were the first identified in this county.", "The two cases occurred in a husband and wife; the husband is the pastor at a local church (church A).", "The couple (the index cases) attended church-related events during March 6-8, and developed nonspecific respiratory symptoms and fever on March 10 (wife) and 11 (husband).", "Before his symptoms had developed, the husband attended a Bible study group on March 11.", "Including the index cases, 35 confirmed COVID-19 cases occurred among 92 (38%) persons who attended events held at church A during March 6-11; three patients died.", "The age-specific attack rates among persons aged &#8804;18 years, 19-64 years, and &#8805;65 years were 6.3%, 59.4%, and 50.0%, respectively.", "During contact tracing, at least 26 additional persons with confirmed COVID-19 cases were identified among community members who reported contact with church A attendees and likely were infected by them; one of the additional persons was hospitalized and subsequently died.", "This outbreak highlights the potential for widespread transmission of SARS-CoV-2, the virus that causes COVID-19, both at group gatherings during church events and within the broader community.", "These findings underscore the opportunity for faith-based organizations to prevent COVID-19 by following local authorities' guidance and the U.S. Government's Guidelines: Opening Up America Again (2) regarding modification of activities to prevent virus transmission during the COVID-19 pandemic."]}
{"cord_id": "2lu9z5b2", "title": "Duration of Antibody Responses after Severe Acute Respiratory Syndrome", "abstract": ["Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G\u2013positive percentage and titers occurred in the third year.", "Thus, SARS patients might be susceptible to reinfection >3 years after initial exposure."]}
{"cord_id": "sy8sloqo", "title": "Severe acute respiratory syndrome-related coronavirus: The species and its viruses \u2013 a statement of the Coronavirus Study Group", "abstract": ["The present outbreak of lower respiratory tract infections, including respiratory distress syndrome, is the third spillover, in only two decades, of an animal coronavirus to humans resulting in a major epidemic.", "Here, the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the official classification of viruses and taxa naming (taxonomy) of the Coronaviridae family, assessed the novelty of the human pathogen tentatively named 2019-nCoV.", "Based on phylogeny, taxonomy and established practice, the CSG formally recognizes this virus as a sister to severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus and designates it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "To facilitate communication, the CSG further proposes to use the following naming convention for individual isolates: SARS-CoV-2/Isolate/Host/Date/Location.", "The spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined.", "The independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying the entire (virus) species to complement research focused on individual pathogenic viruses of immediate significance.", "This research will improve our understanding of virus-host interactions in an ever-changing environment and enhance our preparedness for future outbreaks."]}
{"cord_id": "tdqtikbh", "title": "Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review", "abstract": ["Importance: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment.", "Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection.", "Observations: No proven effective therapies for this virus currently exist.", "The rapidly expanding knowledge regarding SARS-CoV-2 virology provides a significant number of potential drug targets.", "The most promising therapy is remdesivir.", "Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials.", "Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended.", "Current clinical evidence does not support stopping angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients with COVID-19.", "Conclusions and Relevance: The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918.", "The speed and volume of clinical trials launched to investigate potential therapies for COVID-19 highlight both the need and capability to produce high-quality evidence even in the middle of a pandemic.", "No therapies have been shown effective to date."]}
{"cord_id": "nzat41wu", "title": "Social distancing strategies for curbing the COVID-19 epidemic", "abstract": ["The SARS-CoV-2 pandemic is straining healthcare resources worldwide, prompting social distancing measures to reduce transmission intensity.", "The amount of social distancing needed to curb the SARS-CoV-2 epidemic in the context of seasonally varying transmission remains unclear.", "Using a mathematical model, we assessed that one-time interventions will be insufficient to maintain COVID-19 prevalence within the critical care capacity of the United States.", "Seasonal variation in transmission will facilitate epidemic control during the summer months but could lead to an intense resurgence in the autumn.", "Intermittent distancing measures can maintain control of the epidemic, but without other interventions, these measures may be necessary into 2022.", "Increasing critical care capacity could reduce the duration of the SARS-CoV-2 epidemic while ensuring that critically ill patients receive appropriate care."]}
{"cord_id": "twmdchmw", "title": "Coronavirus Disease Outbreak in Call Center, South Korea", "abstract": ["We describe the epidemiology of a coronavirus disease (COVID-19) outbreak in a call center in South Korea.", "We obtained information on demographic characteristics by using standardized epidemiologic investigation forms.", "We performed descriptive analyses and reported the results as frequencies and proportions for categoric variables.", "Of 1,143 persons who were tested for COVID-19, a total of 97 (8.5%, 95% CI 7.0%-10.3%) had confirmed cases.", "Of these, 94 were working in an 11th-floor call center with 216 employees, translating to an attack rate of 43.5% (95% CI 36.9%-50.4%).", "The household secondary attack rate among symptomatic case-patients was 16.2% (95% CI 11.6%- 22.0%).", "Of the 97 persons with confirmed COVID-19, only 4 (1.9%) remained asymptomatic within 14 days of quarantine, and none of their household contacts acquired secondary infections.", "Extensive contact tracing, testing all contacts, and early quarantine blocked further transmission and might be effective for containing rapid outbreaks in crowded work settings."]}
{"cord_id": "ip9geldg", "title": "Estimates of the severity of coronavirus disease 2019: a model-based analysis", "abstract": ["BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude.", "We aimed to provide robust estimates, accounting for censoring and ascertainment biases.", "METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2020), and for cases outside of mainland China (from government or ministry of health websites and media reports for 37 countries, as well as Hong Kong and Macau, until Feb 25, 2020).", "These individual-case data were used to estimate the time between onset of symptoms and outcome (death or discharge from hospital).", "We next obtained age-stratified estimates of the case fatality ratio by relating the aggregate distribution of cases to the observed cumulative deaths in China, assuming a constant attack rate by age and adjusting for demography and age-based and location-based under-ascertainment.", "We also estimated the case fatality ratio from individual line-list data on 1334 cases identified outside of mainland China.", "Using data on the prevalence of PCR-confirmed cases in international residents repatriated from China, we obtained age-stratified estimates of the infection fatality ratio.", "Furthermore, data on age-stratified severity in a subset of 3665 cases from China were used to estimate the proportion of infected individuals who are likely to require hospitalisation.", "FINDINGS: Using data on 24 deaths that occurred in mainland China and 165 recoveries outside of China, we estimated the mean duration from onset of symptoms to death to be 17\u00b78 days (95% credible interval [CrI] 16\u00b79\u201319\u00b72) and to hospital discharge to be 24\u00b77 days (22\u00b79\u201328\u00b71).", "In all laboratory confirmed and clinically diagnosed cases from mainland China (n=70 117), we estimated a crude case fatality ratio (adjusted for censoring) of 3\u00b767% (95% CrI 3\u00b756\u20133\u00b780).", "However, after further adjusting for demography and under-ascertainment, we obtained a best estimate of the case fatality ratio in China of 1\u00b738% (1\u00b723\u20131\u00b753), with substantially higher ratios in older age groups (0\u00b732% [0\u00b727\u20130\u00b738] in those aged <60 years vs 6\u00b74% [5\u00b77\u20137\u00b72] in those aged \u226560 years), up to 13\u00b74% (11\u00b72\u201315\u00b79) in those aged 80 years or older.", "Estimates of case fatality ratio from international cases stratified by age were consistent with those from China (parametric estimate 1\u00b74% [0\u00b74\u20133\u00b75] in those aged <60 years [n=360] and 4\u00b75% [1\u00b78\u201311\u00b71] in those aged \u226560 years [n=151]).", "Our estimated overall infection fatality ratio for China was 0\u00b766% (0\u00b739\u20131\u00b733), with an increasing profile with age.", "Similarly, estimates of the proportion of infected individuals likely to be hospitalised increased with age up to a maximum of 18\u00b74% (11\u00b70\u20137\u00b76) in those aged 80 years or older.", "INTERPRETATION: These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death.", "FUNDING: UK Medical Research Council."]}
{"cord_id": "tyhwtt7j", "title": "Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV", "abstract": ["Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness.", "Since SARS- CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions.", "Unfortunately, there are few tools available to functionally test these novel viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak.", "Here we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent 2019-nCoV, for receptor usage and their ability to infect cell types from different species.", "We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor.", "We also demonstrate how different lineage B viruses can recombine to gain entry into human cells and confirm that human ACE2 is the receptor for the recently emerging 2019-nCoV."]}
{"cord_id": "byh09alo", "title": "Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study", "abstract": ["Background: Nearly 30,000 patients with coronavirus disease-2019 (COVID-19) have been hospitalized in New York City as of April 14th, 2020.", "Data on the epidemiology, clinical course, and outcomes of critically ill patients with COVID-19 in this setting are needed.", "Methods: We prospectively collected clinical, biomarker, and treatment data on critically ill adults with laboratory-confirmed-COVID-19 admitted to two hospitals in northern Manhattan between March 2nd and April 1st, 2020.", "The primary outcome was in-hospital mortality.", "Secondary outcomes included frequency and duration of invasive mechanical ventilation, frequency of vasopressor use and renal-replacement-therapy, and time to clinical deterioration following hospital admission.", "The relationship between clinical risk factors, biomarkers, and in-hospital mortality was modeled using Cox-proportional-hazards regression.", "Each patient had at least 14 days of observation.", "Results: Of 1,150 adults hospitalized with COVID-19 during the study period, 257 (22%) were critically ill.", "The median age was 62 years (interquartile range [IQR] 51-72); 170 (66%) were male.", "Two-hundred twelve (82%) had at least one chronic illness, the most common of which were hypertension (63%; 162/257) and diabetes mellitus (36%; 92/257).", "One-hundred-thirty-eight patients (54%) were obese, and 13 (5%) were healthcare workers.", "As of April 14th, 2020, in-hospital mortality was 33% (86/257); 47% (122/257) of patients remained hospitalized.", "Two-hundred-one (79%) patients received invasive mechanical ventilation (median 13 days [IQR 9-17]), and 54% (138/257) and 29% (75/257) required vasopressors and renal-replacement-therapy, respectively.", "The median time to clinical deterioration following hospital admission was 3 days (IQR 1-6).", "Older age, hypertension, chronic lung disease, and higher concentrations of interleukin-6 and d-dimer at admission were independently associated with in-hospital mortality.", "Conclusions: Critical illness among patients hospitalized with COVID-19 in New York City is common and associated with a high frequency of invasive mechanical ventilation, extra-pulmonary organ dysfunction, and substantial in-hospital mortality."]}
{"cord_id": "4hmecfi0", "title": "Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2", "abstract": ["We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.", "To date we have identified thirteen mutations in Spike that are accumulating.", "Mutations are considered in a broader phylogenetic context, geographically, and over time, to provide an early warning system to reveal mutations that may confer selective advantages in transmission or resistance to interventions.", "Each one is evaluated for evidence of positive selection, and the implications of the mutation are explored through structural modeling.", "The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February, and when introduced to new regions it rapidly becomes the dominant form.", "Also, we present evidence of recombination between locally circulating strains, indicative of multiple strain infections.", "These finding have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions."]}
{"cord_id": "ytsqfqvh", "title": "Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study", "abstract": ["Background: A range of public health measures have been implemented to delay and reduce local transmission of COVID-19 in Hong Kong, and there have been major changes in behaviours of the general public.", "We examined the effect of these interventions and behavioral changes on the incidence of COVID-19 as well as on influenza virus infections which may share some aspects of transmission dynamics with COVID-19.", "Methods: We reviewed policy interventions and measured changes in population behaviours through two telephone surveys, on January 20-23 and February 11-14.", "We analysed data on laboratory-confirmed COVID-19 cases, influenza surveillance data in outpatients of all ages, and influenza hospitalisations in children.", "We estimated the daily effective reproduction number (R_t), for COVID-19 and influenza A(H1N1).", "Findings: COVID-19 transmissibility has remained at or below 1, indicating successful containment to date.", "Influenza transmission declined substantially after the implementation of social distancing measures and changes in population behaviours in late January, with a 44% (95% confidence interval, CI: 34% to 53%) reduction in transmissibility in the community, and a 33% (95% CI: 24% to 43%) reduction in transmissibility based on paediatric hospitalization rates.", "In the two surveys we estimated that 74.5% and 97.5% of the general adult population wore masks when going out, and 61.3% and 90.2% avoided going to crowded places, respectively.", "Implications: Containment measures, social distancing measures and changes in population behaviour have successfully prevented spread of COVID-19.", "The social distancing measures and behavioural changes led to a substantial reduction in influenza transmission in early February 2020.", "However, it may be challenging to avoid fatigue and sustain these measures and population behaviours as COVID-19 continues to spread globally.", "Funding: Health and Medical Research Fund, Hong Kong"]}
{"cord_id": "5sz3u8i4", "title": "Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020", "abstract": ["On March 13, 2020, the United States declared a national emergency in response to the coronavirus disease 2019 (COVID-19) pandemic.", "Subsequently, states enacted stay-at-home orders to slow the spread of SARS-CoV-2, the virus that causes COVID-19, and reduce the burden on the U.S. health care system.", "CDC* and the Centers for Medicare & Medicaid Services (CMS)\u0086 recommended that health care systems prioritize urgent visits and delay elective care to mitigate the spread of COVID-19 in health care settings.", "By May 2020, national syndromic surveillance data found that emergency department (ED) visits had declined 42% during the early months of the pandemic (1).", "This report describes trends in ED visits for three acute life-threatening health conditions (myocardial infarction [MI, also known as heart attack], stroke, and hyperglycemic crisis), immediately before and after declaration of the COVID-19 pandemic as a national emergency.", "These conditions represent acute events that always necessitate immediate emergency care, even during a public health emergency such as the COVID-19 pandemic.", "In the 10 weeks following the emergency declaration (March 15-May 23, 2020), ED visits declined 23% for MI, 20% for stroke, and 10% for hyperglycemic crisis, compared with the preceding 10-week period (January 5-March 14, 2020).", "EDs play a critical role in diagnosing and treating life-threatening conditions that might result in serious disability or death.", "Persons experiencing signs or symptoms of serious illness, such as severe chest pain, sudden or partial loss of motor function, altered mental state, signs of extreme hyperglycemia, or other life-threatening issues, should seek immediate emergency care, regardless of the pandemic.", "Clear, frequent, highly visible communication from public health and health care professionals is needed to reinforce the importance of timely care for medical emergencies and to assure the public that EDs are implementing infection prevention and control guidelines that help ensure the safety of their patients and health care personnel."]}
{"cord_id": "6l614ws4", "title": "Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial", "abstract": ["Importance: Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are needed.", "Objective: To evaluate the efficacy and adverse effects of convalescent plasma therapy for patients with COVID-19.", "Design, Setting, and Participants: Open-label, multicenter, randomized clinical trial performed in 7 medical centers in Wuhan, China, from February 14, 2020, to April 1, 2020, with final follow-up April 28, 2020.", "The trial included 103 participants with laboratory-confirmed COVID-19 that was severe (respiratory distress and/or hypoxemia) or life-threatening (shock, organ failure, or requiring mechanical ventilation).", "The trial was terminated early after 103 of a planned 200 patients were enrolled.", "Intervention: Convalescent plasma in addition to standard treatment (n = 52) vs standard treatment alone (control) (n = 51), stratified by disease severity.", "Main Outcomes and Measures: Primary outcome was time to clinical improvement within 28 days, defined as patient discharged alive or reduction of 2 points on a 6-point disease severity scale (ranging from 1 [discharge] to 6 [death]).", "Secondary outcomes included 28-day mortality, time to discharge, and the rate of viral polymerase chain reaction (PCR) results turned from positive at baseline to negative at up to 72 hours.", "Results: Of 103 patients who were randomized (median age, 70 years; 60 [58.3%] male), 101 (98.1%) completed the trial.", "Clinical improvement occurred within 28 days in 51.9% (27/52) of the convalescent plasma group vs 43.1% (22/51) in the control group (difference, 8.8% [95% CI, -10.4% to 28.0%]; hazard ratio [HR], 1.40 [95% CI, 0.79-2.49]; P = .26).", "Among those with severe disease, the primary outcome occurred in 91.3% (21/23) of the convalescent plasma group vs 68.2% (15/22) of the control group (HR, 2.15 [95% CI, 1.07-4.32]; P = .03); among those with life-threatening disease the primary outcome occurred in 20.7% (6/29) of the convalescent plasma group vs 24.1% (7/29) of the control group (HR, 0.88 [95% CI, 0.30-2.63]; P = .83) (P for interaction = .17).", "There was no significant difference in 28-day mortality (15.7% vs 24.0%; OR, 0.65 [95% CI, 0.29-1.46]; P = .30) or time from randomization to discharge (51.0% vs 36.0% discharged by day 28; HR, 1.61 [95% CI, 0.88-2.93]; P = .12).", "Convalescent plasma treatment was associated with a negative conversion rate of viral PCR at 72 hours in 87.2% of the convalescent plasma group vs 37.5% of the control group (OR, 11.39 [95% CI, 3.91-33.18]; P < .001).", "Two patients in the convalescent plasma group experienced adverse events within hours after transfusion that improved with supportive care.", "Conclusion and Relevance: Among patients with severe or life-threatening COVID-19, convalescent plasma therapy added to standard treatment, compared with standard treatment alone, did not result in a statistically significant improvement in time to clinical improvement within 28 days.", "Interpretation is limited by early termination of the trial, which may have been underpowered to detect a clinically important difference.", "Trial Registration: Chinese Clinical Trial Registry: ChiCTR2000029757."]}
{"cord_id": "dwd86zc3", "title": "Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel", "abstract": ["Full genome sequences are increasingly used to track the geographic spread and transmission dynamics of viral pathogens.", "Here, with a focus on Israel, we sequenced 212 SARS-CoV-2 sequences and use them to perform a comprehensive analysis to trace the origins and spread of the virus.", "A phylogenetic analysis including thousands of globally sampled sequences allowed us to infer multiple independent introductions into Israel, followed by local transmission.", "Returning travelers from the U.S. contributed dramatically more to viral spread relative to their proportion in incoming infected travelers.", "Using phylodynamic analysis, we estimated that the basic reproduction number of the virus was initially around ~2.0-2.6, dropping by two-thirds following the implementation of social distancing measures.", "A comparison between reported and model-estimated case numbers indicated high levels of transmission heterogeneity in SARS-CoV-2 spread, with between 1-10% of infected individuals resulting in 80% of secondary infections.", "Overall, our findings underscore the ability of this virus to efficiently transmit between and within countries, as well as demonstrate the effectiveness of social distancing measures for reducing its spread."]}
{"cord_id": "4w0zezt4", "title": "Neurological Implications of COVID-19 Infections", "abstract": ["The magnitude of the COVID-19 pandemic will result in substantial neurological disease, whether through direct infection (rare), para-infectious complications (less rare), or critical illness more generally (common).", "Here, we raise the importance of stringent diagnosis and data collection regarding neurological complications of COVID-19; we urge caution in the over-diagnosis of neurological disease where it does not exist, but equally strongly encourage the concerted surveillance for such conditions.", "Additional to the direct neurological complications of COVID-19 infection, neurological patients are at risk of harm from both structural limitations (such as number of intensive care beds), and a hesitancy to treat with certain necessary medications given risk of nosocomial COVID-19 infection.", "We therefore also outline the specific management of patients with neuroinflammatory diseases in the context of the pandemic.", "This article describes the implications of COVID-19 on neurological disease and advertises the Neurocritical Care Society\u2019s international data collection collaborative that seeks to align data elements."]}
{"cord_id": "htcqp9fz", "title": "Short-Term Birth Sequelae of the 1918\u20131920 Influenza Pandemic in the United States: State-Level Analysis", "abstract": ["This paper examines short-term birth sequelae of the influenza pandemic of 1918\u20131920 in the United States using monthly data on births and all-cause deaths for 19 US states in conjunction with data on maternal deaths, stillbirths, and premature births.", "The data on births and all-cause deaths are adjusted for seasonal and trend effects, and the residual components of the 2 time series coinciding with the timing of peak influenza mortality are examined for these sequelae.", "Notable findings include: 1) a drop in births in the 3 months following peak mortality; 2) a reversion in births to normal levels occurring 5\u20137 months after peak mortality; and 3) a steep drop in births occurring 9\u201310 months after peak mortality.", "Interpreted in the context of parallel data showing elevated premature births, stillbirths, and maternal mortality during times of peak influenza mortality, these findings suggest that the main impacts of the 1918\u20131920 influenza on reproduction occurred through: 1) impaired conceptions, possibly due to effects on fertility and behavioral changes; 2) an increase in the preterm delivery rate during the peak of the pandemic; and 3) elevated maternal and fetal mortality, resulting in late-term losses in pregnancy."]}
{"cord_id": "50ym7h4t", "title": "Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia", "abstract": ["BACKGROUND: Three months ago, severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) broke out in Wuhan, China, and spread rapidly around the world.", "Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism (VTE) prevalence is still rarely mentioned.", "OBJECTIVES: To determine the incidence of VTE in patients with severe NCP.", "METHODS: In this study, 81 severe NCP patients in the intensive care unit (ICU) of Union Hospital (Wuhan, China) were enrolled.", "The results of conventional coagulation parameters and lower limb vein ultrasonography of these patients were retrospectively collected and analyzed.", "RESULTS: The incidence of VTE in these patients was 25% (20/81), of which 8 patients with VTE events died.", "The VTE group was different from the non\u2010VTE group in age, lymphocyte counts, activated partial thromboplastin time (APTT), D\u2010dimer, etc.", "If 1.5 \u00b5g/mL was used as the D\u2010dimer cut\u2010off value to predicting VTE, the sensitivity was 85.0%, the specificity was 88.5%, and the negative predictive value (NPV) was 94.7%.", "CONCLUSIONS: The incidence of VTE in patients with severe NCP is 25% (20/81), which may be related to poor prognosis.", "The significant increase of D\u2010dimer in severe NCP patients is a good index for identifying high\u2010risk groups of VTE."]}
{"cord_id": "5o9bbspc", "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "abstract": ["Abstract Background Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients.", "We evaluate the role of hydroxychloroquine on respiratory viral loads.", "Patients and methods French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.", "Depending on their clinical presentation, azithromycin was added to the treatment.", "Untreated patients from another center and cases refusing the protocol were included as negative controls.", "Presence and absence of virus at Day6-post inclusion was considered the end point.", "Results Six patients were asymptomatic, 22 had upper respiratory tract infection symptoms and eight had lower respiratory tract infection symptoms.", "Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D6-post inclusion compared to controls, and much lower average carrying duration than reported of untreated patients in the literature.", "Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.", "Conclusion Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin."]}
{"cord_id": "5yscqct1", "title": "Identifying airborne transmission as the dominant route for the spread of COVID-19", "abstract": ["Various mitigation measures have been implemented to fight the coronavirus disease 2019 (COVID-19) pandemic, including widely adopted social distancing and mandated face covering.", "However, assessing the effectiveness of those intervention practices hinges on the understanding of virus transmission, which remains uncertain.", "Here we show that airborne transmission is highly virulent and represents the dominant route to spread the disease.", "By analyzing the trend and mitigation measures in Wuhan, China, Italy, and New York City, from January 23 to May 9, 2020, we illustrate that the impacts of mitigation measures are discernable from the trends of the pandemic.", "Our analysis reveals that the difference with and without mandated face covering represents the determinant in shaping the pandemic trends in the three epicenters.", "This protective measure alone significantly reduced the number of infections, that is, by over 78,000 in Italy from April 6 to May 9 and over 66,000 in New York City from April 17 to May 9.", "Other mitigation measures, such as social distancing implemented in the United States, are insufficient by themselves in protecting the public.", "We conclude that wearing of face masks in public corresponds to the most effective means to prevent interhuman transmission, and this inexpensive practice, in conjunction with simultaneous social distancing, quarantine, and contact tracing, represents the most likely fighting opportunity to stop the COVID-19 pandemic.", "Our work also highlights the fact that sound science is essential in decision-making for the current and future public health pandemics."]}
{"cord_id": "9mact9br", "title": "Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study", "abstract": ["Summary Background Rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, prompted heightened surveillance in Shenzhen, China.", "The resulting data provide a rare opportunity to measure key metrics of disease course, transmission, and the impact of control measures.", "Methods From Jan 14 to Feb 12, 2020, the Shenzhen Center for Disease Control and Prevention identified 391 SARS-CoV-2 cases and 1286 close contacts.", "We compared cases identified through symptomatic surveillance and contact tracing, and estimated the time from symptom onset to confirmation, isolation, and admission to hospital.", "We estimated metrics of disease transmission and analysed factors influencing transmission risk.", "Findings Cases were older than the general population (mean age 45 years) and balanced between males (n=187) and females (n=204).", "356 (91%) of 391 cases had mild or moderate clinical severity at initial assessment.", "As of Feb 22, 2020, three cases had died and 225 had recovered (median time to recovery 21 days; 95% CI 20\u201322).", "Cases were isolated on average 4\u00b76 days (95% CI 4\u00b71\u20135\u00b70) after developing symptoms; contact tracing reduced this by 1\u00b79 days (95% CI 1\u00b71\u20132\u00b77).", "Household contacts and those travelling with a case were at higher risk of infection (odds ratio 6\u00b727 [95% CI 1\u00b749\u201326\u00b733] for household contacts and 7\u00b706 [1\u00b743\u201334\u00b791] for those travelling with a case) than other close contacts.", "The household secondary attack rate was 11\u00b72% (95% CI 9\u00b71\u201313\u00b78), and children were as likely to be infected as adults (infection rate 7\u00b74% in children <10 years vs population average of 6\u00b76%).", "The observed reproductive number (R) was 0\u00b74 (95% CI 0\u00b73\u20130\u00b75), with a mean serial interval of 6\u00b73 days (95% CI 5\u00b72\u20137\u00b76).", "Interpretation Our data on cases as well as their infected and uninfected close contacts provide key insights into the epidemiology of SARS-CoV-2.", "This analysis shows that isolation and contact tracing reduce the time during which cases are infectious in the community, thereby reducing the R. The overall impact of isolation and contact tracing, however, is uncertain and highly dependent on the number of asymptomatic cases.", "Moreover, children are at a similar risk of infection to the general population, although less likely to have severe symptoms; hence they should be considered in analyses of transmission and control.", "Funding Emergency Response Program of Harbin Institute of Technology, Emergency Response Program of Peng Cheng Laboratory, US Centers for Disease Control and Prevention."]}
{"cord_id": "2tl0mtb8", "title": "Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS\u2010CoV\u20102 infection", "abstract": ["OBJECTIVE: This study aimed to assess the presence of novel coronavirus in tears and conjunctival secretions of SARS\u2013CoV\u20102\u2010infected patients.", "METHODS: A prospective interventional case series study was performed, and 30 confirmed novel coronavirus pneumonia (NCP) patients were selected at the First Affiliated Hospital of Zhejiang University from 26 January 2020 to 9 February 2020.", "At an interval of 2 to 3 days, tear and conjunctival secretions were collected twice with disposable sampling swabs for reverse\u2010transcription polymerase chain reaction (RT\u2010PCR) assay.", "RESULTS: Twenty\u2010one common\u2010type and nine severe\u2010type NCP patients were enrolled.", "Two samples of tear and conjunctival secretions were obtained from the only one patient with conjunctivitis yielded positive RT\u2010PCR results.", "Fifty\u2010eight samples from other patents were all negative.", "CONCLUSION: We speculate that SARS\u2010CoV\u20102 may be detected in the tears and conjunctival secretions in NCP patients with conjunctivitis."]}
{"cord_id": "klyyzusj", "title": "Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial", "abstract": ["BACKGROUND: No therapeutics have yet been proven effective for the treatment of mild-illness caused by SARS-CoV-2.", "We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be more efficacious than no-treatment for outpatients with mild Covid-19.", "METHODS: We conducted a multicenter, open label, randomized controlled trial in Catalonia (Spain) between March 17, and May 26, 2020.", "Eligible Covid-19 cases were non-hospitalized adult patients with recently confirmed SARS-CoV-2 infection and less than five days of symptoms.", "Patients were assigned to receive HCQ (800 mg on day 1, followed by 400 mg once daily for 6 days) or no antiviral treatment (not-placebo controlled).", "Study outcomes were the reduction of viral RNA load in nasopharyngeal swabs up to 7 days after treatment start, patient disease progression using the WHO scale up to 28 days, and time to complete resolution of symptoms.", "Adverse events were assessed up to 28 days.", "RESULTS: A total of 293 patients were eligible for intention-to-treat analysis: 157 in the control arm and 136 in the intervention arm.", "The mean age was 41.6 years (SD 12.6), mean viral load at baseline was 7.90 (SD 1.82) Log10 copies/mL, and median time from symptom onset to randomization was 3 days.", "No significant differences were found in the mean reduction of viral load at day 3 (-1.41 vs. -1.41 Log10 copies/mL in the control and intervention arm, respectively; difference 0.01 [95% CI -0.28;0.29]) or at day 7 (-3.37 vs. -3.44; d -0.07 [-0.44;0.29]).", "This treatment regimen did not reduce risk of hospitalization (7.1%, control vs. 5.9%, intervention; RR 0.75 [0.32;1.77]) nor shortened the time to complete resolution of symptoms (12 days, control vs. 10 days, intervention; p = 0.38).", "No relevant treatment-related AEs were reported.", "CONCLUSIONS: In patients with mild Covid-19, no benefit was observed with HCQ beyond the usual care."]}
{"cord_id": "1pplybpr", "title": "Transplacental transmission of SARS-CoV-2 infection", "abstract": ["SARS-CoV-2 outbreak is the first pandemic of the century.", "SARS-CoV-2 infection is transmitted through droplets; other transmission routes are hypothesized but not confirmed.", "So far, it is unclear whether and how SARS-CoV-2 can be transmitted from the mother to the fetus.", "We demonstrate the transplacental transmission of SARS-CoV-2 in a neonate born to a mother infected in the last trimester and presenting with neurological compromise.", "The transmission is confirmed by comprehensive virological and pathological investigations.", "In detail, SARS-CoV-2 causes: (1) maternal viremia, (2) placental infection demonstrated by immunohistochemistry and very high viral load; placental inflammation, as shown by histological examination and immunohistochemistry, and (3) neonatal viremia following placental infection.", "The neonate is studied clinically, through imaging, and followed up.", "The neonate presented with neurological manifestations, similar to those described in adult patients."]}
{"cord_id": "9vzep698", "title": "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review", "abstract": ["Importance: The current rapid worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection justifies the global effort to identify effective preventive strategies and optimal medical management.", "While data are available for adult patients with coronavirus disease 2019 (COVID-19), limited reports have analyzed pediatric patients infected with SARS-CoV-2.", "Objective: To evaluate currently reported pediatric cases of SARS-CoV-2 infection.", "Evidence Review: An extensive search strategy was designed to retrieve all articles published from December 1, 2019, to March 3, 2020, by combining the terms coronavirus and coronavirus infection in several electronic databases (PubMed, Cochrane Library, and CINAHL), and following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.", "Retrospective cross-sectional and case-control studies, case series and case reports, bulletins, and national reports about the pediatric SARS-CoV-2 infection were included.", "The risk of bias for eligible observational studies was assessed according to the Strengthening the Reporting of Observational Studies in Epidemiology reporting guideline.", "Findings: A total of 815 articles were identified.", "Eighteen studies with 1065 participants (444 patients were younger than 10 years, and 553 were aged 10 to 19 years) with confirmed SARS-CoV-2 infection were included in the final analysis.", "All articles reflected research performed in China, except for 1 clinical case in Singapore.", "Children at any age were mostly reported to have mild respiratory symptoms, namely fever, dry cough, and fatigue, or were asymptomatic.", "Bronchial thickening and ground-glass opacities were the main radiologic features, and these findings were also reported in asymptomatic patients.", "Among the included articles, there was only 1 case of severe COVID-19 infection, which occurred in a 13-month-old infant.", "No deaths were reported in children aged 0 to 9 years.", "Available data about therapies were limited.", "Conclusions and Relevance: To our knowledge, this is the first systematic review that assesses and summarizes clinical features and management of children with SARS-CoV-2 infection.", "The rapid spread of COVID-19 across the globe and the lack of European and US data on pediatric patients require further epidemiologic and clinical studies to identify possible preventive and therapeutic strategies."]}
{"cord_id": "5sfojk7y", "title": "Relationship between the ABO Blood Group and the COVID-19 Susceptibility", "abstract": ["The novel coronavirus disease-2019 (COVID-19) has been spreading around the world rapidly and declared as a pandemic by WHO.", "Here, we compared the ABO blood group distribution in 2,173 patients with COVID-19 confirmed by SARS-CoV-2 test from three hospitals in Wuhan and Shenzhen, China with that in normal people from the corresponding regions.", "The results showed that blood group A was associated with a higher risk for acquiring COVID-19 compared with non-A blood groups, whereas blood group O was associated with a lower risk for the infection compared with non-O blood groups.", "This is the first observation of an association between the ABO blood type and COVID-19.", "It should be emphasized, however, that this is an early study with limitations.", "It would be premature to use this study to guide clinical practice at this time, but it should encourage further investigation of the relationship between the ABO blood group and the COVID-19 susceptibility."]}
{"cord_id": "9n7bkayx", "title": "A human monoclonal antibody blocking SARS-CoV-2 infection", "abstract": ["The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19).", "Vaccines and targeted therapeutics for treatment of this disease are currently lacking.", "Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture.", "This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19."]}
{"cord_id": "lvd6f6rz", "title": "Antibody Response and Disease Severity in Healthcare Worker MERS Survivors", "abstract": ["We studied antibody response in 9 healthcare workers in Jeddah, Saudi Arabia, who survived Middle East respiratory syndrome, by using serial ELISA and indirect immunofluorescence assay testing.", "Among patients who had experienced severe pneumonia, antibody was detected for >18 months after infection.", "Antibody longevity was more variable in patients who had experienced milder disease."]}
{"cord_id": "ax87r0bj", "title": "Seasonality of infectious diseases and severe acute respiratory syndrome\u2013what we don't know can hurt us", "abstract": ["Summary The novel severe acute respiratory syndrome (SARS) coronavirus caused severe disease and heavy economic losses before apparently coming under complete control.", "Our understanding of the forces driving seasonal disappearance and recurrence of infectious diseases remains fragmentary, thus limiting any predictions about whether, or when, SARS will recur.", "It is true that most established respiratory pathogens of human beings recur in wintertime, but a new appreciation for the high burden of disease in tropical areas reinforces questions about explanations resting solely on cold air or low humidity.", "Seasonal variation in host physiology may also contribute.", "Newly emergent zoonotic diseases such as ebola or pandemic strains of influenza have recurred in unpredictable patterns.", "Most established coronaviruses exhibit winter seasonality, with a unique ability to establish persistent infections in a minority of infected animals.", "Because SARS coronavirus RNA can be detected in the stool of some individuals for at least 9 weeks, recurrence of SARS from persistently shedding human or animal reservoirs is biologically plausible."]}
{"cord_id": "785jckvw", "title": "Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma", "abstract": ["Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality.", "It is critical to find new treatments.", "Objective: To determine whether convalescent plasma transfusion may be beneficial in the treatment of critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.", "Design, Setting, and Participants: Case series of 5 critically ill patients with laboratory-confirmed COVID-19 and acute respiratory distress syndrome (ARDS) who met the following criteria: severe pneumonia with rapid progression and continuously high viral load despite antiviral treatment; Pao2/Fio2 <300; and mechanical ventilation.", "All 5 were treated with convalescent plasma transfusion.", "The study was conducted at the infectious disease department, Shenzhen Third People's Hospital in Shenzhen, China, from January 20, 2020, to March 25, 2020; final date of follow-up was March 25, 2020.", "Clinical outcomes were compared before and after convalescent plasma transfusion.", "Exposures: Patients received transfusion with convalescent plasma with a SARS-CoV-2-specific antibody (IgG) binding titer greater than 1:1000 (end point dilution titer, by enzyme-linked immunosorbent assay [ELISA]) and a neutralization titer greater than 40 (end point dilution titer) that had been obtained from 5 patients who recovered from COVID-19.", "Convalescent plasma was administered between 10 and 22 days after admission.", "Main Outcomes and Measures: Changes of body temperature, Sequential Organ Failure Assessment (SOFA) score (range 0-24, with higher scores indicating more severe illness), Pao2/Fio2, viral load, serum antibody titer, routine blood biochemical index, ARDS, and ventilatory and extracorporeal membrane oxygenation (ECMO) supports before and after convalescent plasma transfusion.", "Results: All 5 patients (age range, 36-65 years; 2 women) were receiving mechanical ventilation at the time of treatment and all had received antiviral agents and methylprednisolone.", "Following plasma transfusion, body temperature normalized within 3 days in 4 of 5 patients, the SOFA score decreased, and Pao2/Fio2 increased within 12 days (range, 172-276 before and 284-366 after).", "Viral loads also decreased and became negative within 12 days after the transfusion, and SARS-CoV-2-specific ELISA and neutralizing antibody titers increased following the transfusion (range, 40-60 before and 80-320 on day 7).", "ARDS resolved in 4 patients at 12 days after transfusion, and 3 patients were weaned from mechanical ventilation within 2 weeks of treatment.", "Of the 5 patients, 3 have been discharged from the hospital (length of stay: 53, 51, and 55 days), and 2 are in stable condition at 37 days after transfusion.", "Conclusions and Relevance: In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status.", "The limited sample size and study design preclude a definitive statement about the potential effectiveness of this treatment, and these observations require evaluation in clinical trials."]}
{"cord_id": "mo7734w5", "title": "A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV", "abstract": ["The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus.", "We therefore determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein at 3.1-angstrom resolution.", "CR3022 targets a highly conserved epitope, distal from the receptor binding site, that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV.", "Structural modeling further demonstrates that the binding epitope can only be accessed by CR3022 when at least two RBDs on the trimeric S protein are in the \"up\" conformation and slightly rotated.", "These results provide molecular insights into antibody recognition of SARS-CoV-2."]}
{"cord_id": "pscw933i", "title": "Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020", "abstract": ["To determine distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards in Wuhan, China, we tested air and surface samples.", "Contamination was greater in intensive care units than general wards.", "Virus was widely distributed on floors, computer mice, trash cans, and sickbed handrails and was detected in air \u22484 m from patients."]}
{"cord_id": "vrl9gtcp", "title": "First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment", "abstract": ["BACKGROUND: As of March 18, 2020, 13 415 confirmed cases and 120 deaths related to coronavirus disease 2019 (COVID-19) in mainland China, outside Hubei province\u2014the epicentre of the outbreak\u2014had been reported.", "Since late January, massive public health interventions have been implemented nationwide to contain the outbreak.", "We provide an impact assessment of the transmissibility and severity of COVID-19 during the first wave in mainland Chinese locations outside Hubei.", "METHODS: We estimated the instantaneous reproduction number (R(t)) of COVID-19 in Beijing, Shanghai, Shenzhen, Wenzhou, and the ten Chinese provinces that had the highest number of confirmed COVID-19 cases; and the confirmed case-fatality risk (cCFR) in Beijing, Shanghai, Shenzhen, and Wenzhou, and all 31 Chinese provinces.", "We used a susceptible\u2013infectious\u2013recovered model to show the potential effects of relaxing containment measures after the first wave of infection, in anticipation of a possible second wave.", "FINDINGS: In all selected cities and provinces, the R(t) decreased substantially since Jan 23, when control measures were implemented, and have since remained below 1.", "The cCFR outside Hubei was 0\u00b798% (95% CI 0\u00b782\u20131\u00b716), which was almost five times lower than that in Hubei (5\u00b791%, 5\u00b773\u20136\u00b709).", "Relaxing the interventions (resulting in R(t) >1) when the epidemic size was still small would increase the cumulative case count exponentially as a function of relaxation duration, even if aggressive interventions could subsequently push disease prevalence back to the baseline level.", "INTERPRETATION: The first wave of COVID-19 outside of Hubei has abated because of aggressive non-pharmaceutical interventions.", "However, given the substantial risk of viral reintroduction, particularly from overseas importation, close monitoring of R(t) and cCFR is needed to inform strategies against a potential second wave to achieve an optimal balance between health and economic protection.", "FUNDING: Health and Medical Research Fund, Hong Kong, China."]}
{"cord_id": "8syhdtzk", "title": "Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries", "abstract": ["To date, non-pharmacological interventions (NPI) have been the mainstay for controlling the coronavirus disease-2019 (COVID-19) pandemic.", "While NPIs are effective in preventing health systems overload, these long-term measures are likely to have significant adverse economic consequences.", "Therefore, many countries are currently considering to lift the NPIs\u2014increasing the likelihood of disease resurgence.", "In this regard, dynamic NPIs, with intervals of relaxed social distancing, may provide a more suitable alternative.", "However, the ideal frequency and duration of intermittent NPIs, and the ideal \u201cbreak\u201d when interventions can be temporarily relaxed, remain uncertain, especially in resource-poor settings.", "We employed a multivariate prediction model, based on up-to-date transmission and clinical parameters, to simulate outbreak trajectories in 16 countries, from diverse regions and economic categories.", "In each country, we then modelled the impacts on intensive care unit (ICU) admissions and deaths over an 18-month period for following scenarios: (1) no intervention, (2) consecutive cycles of mitigation measures followed by a relaxation period, and (3) consecutive cycles of suppression measures followed by a relaxation period.", "We defined these dynamic interventions based on reduction of the mean reproduction number during each cycle, assuming a basic reproduction number (R(0)) of 2.2 for no intervention, and subsequent effective reproduction numbers (R) of 0.8 and 0.5 for illustrative dynamic mitigation and suppression interventions, respectively.", "We found that dynamic cycles of 50-day mitigation followed by a 30-day relaxation reduced transmission, however, were unsuccessful in lowering ICU hospitalizations below manageable limits.", "By contrast, dynamic cycles of 50-day suppression followed by a 30-day relaxation kept the ICU demands below the national capacities.", "Additionally, we estimated that a significant number of new infections and deaths, especially in resource-poor countries, would be averted if these dynamic suppression measures were kept in place over an 18-month period.", "This multi-country analysis demonstrates that intermittent reductions of R below 1 through a potential combination of suppression interventions and relaxation can be an effective strategy for COVID-19 pandemic control.", "Such a \u201cschedule\u201d of social distancing might be particularly relevant to low-income countries, where a single, prolonged suppression intervention is unsustainable.", "Efficient implementation of dynamic suppression interventions, therefore, confers a pragmatic option to: (1) prevent critical care overload and deaths, (2) gain time to develop preventive and clinical measures, and (3) reduce economic hardship globally.", "ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-020-00649-w) contains supplementary material, which is available to authorized users."]}
{"cord_id": "53j3ly3v", "title": "Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals", "abstract": ["The World Health Organization has declared SARS-CoV-2 virus outbreak a worldwide pandemic.", "However, there is very limited understanding on the immune responses, especially adaptive immune responses to SARS-CoV-2 infection.", "Here, we collected blood from COVID-19 patients who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific humoral and cellular immunity in eight newly discharged patients.", "Follow-up analysis on another cohort of six patients 2 weeks post discharge also revealed high titers of immunoglobulin G (IgG) antibodies.", "In all 14 patients tested, 13 displayed serum-neutralizing activities in a pseudotype entry assay.", "Notably, there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells.", "Our work provides a basis for further analysis of protective immunity to SARS-CoV-2, and understanding the pathogenesis of COVID-19, especially in the severe cases.", "It also has implications in developing an effective vaccine to SARS-CoV-2 infection."]}
{"cord_id": "rbgoabfk", "title": "Effectiveness of convalescent plasma therapy in severe COVID-19 patients", "abstract": ["Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19).", "In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively.", "One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents.", "The primary endpoint was the safety of CP transfusion.", "The second endpoints were the improvement of clinical symptoms and laboratory parameters within 3 d after CP transfusion.", "The median time from onset of illness to CP transfusion was 16.5 d. After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640).", "The clinical symptoms were significantly improved along with increase of oxyhemoglobin saturation within 3 d. Several parameters tended to improve as compared to pretransfusion, including increased lymphocyte counts (0.65 \u00d7 10(9)/L vs. 0.76 \u00d7 10(9)/L) and decreased C-reactive protein (55.98 mg/L vs. 18.13 mg/L).", "Radiological examinations showed varying degrees of absorption of lung lesions within 7 d. The viral load was undetectable after transfusion in seven patients who had previous viremia.", "No severe adverse effects were observed.", "This study showed CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases.", "The optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials."]}
{"cord_id": "rm7q689v", "title": "COVID-19 Confirmed Case Incidence Age Shift to Young Persons Age 0-19 and 20-39 Years Over Time: Washington State March - April 2020", "abstract": ["Background: As the coronavirus (COVID-19) epidemic passes the peak infection rate in some states and counties a phased re-opening with changes of stay-at-home restrictions and social distancing recommendations may lead to an increase of non-essential work, social activities and gathering, especially among younger persons.", "Methods: A longitudinal cohort analysis of Washington State Department of Health COVID-19 confirmed case age distribution March 1-April 19 2020 for proportional change over time using chi square tests for significance (N = 13,934).", "Results: From March 1st to April 19, 2020 age distribution shifted with a 10% decline in cases age 60 years and older and a 20% increase in age 0-19/20-39 years (chi-square = 223.10, p <.001).", "Number of cases over the eight-week analysis period were 0-19 years n = 515, 20-39 years n = 4078, 40-59 years n =4788, 60-79 years n = 3221, 80+ years n = 1332.", "New cases increased steadily among 0-19 and 20-39-year olds.", "After the peak (March 22, 2020), there was no decline among age 0-19 and a lesser decline among age 20-39 than older groups.", "As incidence declined in older age groups, the combined percentage of cases age 0-19 and 20-39 increased from 20% to 40% of total cases.", "Conclusions: Increased COVID-19 infection among children and young adults is not without serious morbidity and mortality risk to them and others they may come in contact with, indicating a targeted approach for awareness and safety measures is advisable to reduce incidence among the supposedly less vulnerable but more mobile young population age 0-19 and 20-39 years."]}
{"cord_id": "ap9fkfgm", "title": "Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow", "abstract": ["Abstract Plasma therapy consists in bringing to a patient in need \u2013 in general suffering a severe, resistant to current therapy, and even lethal infection \u2013 plasma or specific, fractioned, antibodies, along with other immunoglobulins and possibly healing factors that can be obtained from immunized blood donors; donors (voluntary and benevolent) can be either actively immunized individuals or convalescent persons.", "Plasma therapy has been used since the Spanish flu in 1917\u20131918, and regularly then when viral epidemics threatened vulnerable populations, the last reported occurrence being the 2013\u20132015 Ebola virus outbreak in West Africa.", "The precise action mechanism of plasma therapy is not fully delineated as it may function beyond purified, neutralizing antibodies."]}
{"cord_id": "j3b964oz", "title": "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice", "abstract": ["Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19.", "Herein, we show that the ribonucleoside analog \u03b2-D-N(4)-hydroxycytidine (NHC, EIDD-1931) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir.", "In mice infected with SARS-CoV or MERS-CoV, both prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC-prodrug (\u03b2-D-N(4)-hydroxycytidine-5\u2032-isopropyl ester), improved pulmonary function, and reduced virus titer and body weight loss.", "Decreased MERS-CoV yields in vitro and in vivo were associated with increased transition mutation frequency in viral but not host cell RNA, supporting a mechanism of lethal mutagenesis in CoV.", "The potency of NHC/EIDD-2801 against multiple coronaviruses and oral bioavailability highlight its potential utility as an effective antiviral against SARS-CoV-2 and other future zoonotic coronaviruses."]}
{"cord_id": "8udyoutb", "title": "Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients", "abstract": ["The pandemic Coronavirus-disease 19 (COVID-19) is characterized by a heterogeneous clinical course.", "While most patients experience only mild symptoms, a relevant proportion develop severe disease progression with increasing hypoxia up to acute respiratory distress syndrome.", "The substantial number of patients with severe disease have strained intensive care capacities to an unprecedented level.", "Owing to the highly variable course and lack of reliable predictors for deterioration, we aimed to identify variables that allow the prediction of patients with a high risk of respiratory failure and need of mechanical ventilation Patients with PCR proven symptomatic COVID-19 infection hospitalized at our institution from 29th February to 27th March 2020 (n=40) were analyzed for baseline clinical and laboratory findings.", "Patients requiring mechanical ventilation 13/40 (32.5%) did not differ in age, comorbidities, radiological findings, respiratory rate or qSofa score.", "However, elevated interleukin-6 (IL-6) was strongly associated with the need for mechanical ventilation (p=1.2.10-5).", "In addition, the maximal IL-6 level (cutoff 80 pg/ml) for each patient during disease predicted respiratory failure with high accuracy (p=1.7.10-8, AUC=0.98).", "The risk of respiratory failure for patients with IL-6 levels of \u2265 80 pg/ml was 22 times higher compared to patients with lower IL-6 levels.", "In the current situation with overwhelmed intensive care units and overcrowded emergency rooms, correct triage of patients in need of intensive care is crucial.", "Our study shows that IL-6 is an effective marker that might be able to predict upcoming respiratory failure with high accuracy and help physicians correctly allocate patients at an early stage."]}
{"cord_id": "xa5iy0ra", "title": "Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination", "abstract": ["The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics.", "These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries."]}
{"cord_id": "otp1atui", "title": "No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial", "abstract": ["Background Treatments are urgently needed to prevent respiratory failure and deaths from coronavirus disease 2019 (COVID-19).", "Hydroxychloroquine (HCQ) has received worldwide attention because of positive results from small studies.", "Methods We used data collected from routine care of all adults in 4 French hospitals with documented SARS-CoV-2 pneumonia and requiring oxygen \u2265 2 L/min to emulate a target trial aimed at assessing the effectiveness of HCQ at 600 mg/day.", "The composite primary endpoint was transfer to intensive care unit (ICU) within 7 days from inclusion and/or death from any cause.", "Analyses were adjusted for confounding factors by inverse probability of treatment weighting.", "Results This study included 181 patients with SARS-CoV-2 pneumonia; 84 received HCQ within 48 hours of admission (HCQ group) and 97 did not (no-HCQ group).", "Initial severity was well balanced between the groups.", "In the weighted analysis, 20.2% patients in the HCQ group were transferred to the ICU or died within 7 days vs 22.1% in the no-HCQ group (16 vs 21 events, relative risk [RR] 0.91, 95% CI 0.47-1.80).", "In the HCQ group, 2.8% of the patients died within 7 days vs 4.6% in the no-HCQ group (3 vs 4 events, RR 0.61, 95% CI 0.13-2.89), and 27.4% and 24.1%, respectively, developed acute respiratory distress syndrome within 7 days (24 vs 23 events, RR 1.14, 95% CI 0.65-2.00).", "Eight patients receiving HCQ (9.5%) experienced electrocardiogram modifications requiring HCQ discontinuation.", "Interpretation These results do not support the use of HCQ in patients hospitalised for documented SARS-CoV-2-positive hypoxic pneumonia."]}
{"cord_id": "0tto8b0k", "title": "Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State", "abstract": ["Importance: Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19).", "However, there are limited data on efficacy and associated adverse events.", "Objective: To describe the association between use of hydroxychloroquine, with or without azithromycin, and clinical outcomes among hospital inpatients diagnosed with COVID-19.", "Design, Setting, and Participants: Retrospective multicenter cohort study of patients from a random sample of all admitted patients with laboratory-confirmed COVID-19 in 25 hospitals, representing 88.2% of patients with COVID-19 in the New York metropolitan region.", "Eligible patients were admitted for at least 24 hours between March 15 and 28, 2020.", "Medications, preexisting conditions, clinical measures on admission, outcomes, and adverse events were abstracted from medical records.", "The date of final follow-up was April 24, 2020.", "Exposures: Receipt of both hydroxychloroquine and azithromycin, hydroxychloroquine alone, azithromycin alone, or neither.", "Main Outcomes and Measures: Primary outcome was in-hospital mortality.", "Secondary outcomes were cardiac arrest and abnormal electrocardiogram findings (arrhythmia or QT prolongation).", "Results: Among 1438 hospitalized patients with a diagnosis of COVID-19 (858 [59.7%] male, median age, 63 years), those receiving hydroxychloroquine, azithromycin, or both were more likely than those not receiving either drug to have diabetes, respiratory rate >22/min, abnormal chest imaging findings, O2 saturation lower than 90%, and aspartate aminotransferase greater than 40 U/L.", "Overall in-hospital mortality was 20.3% (95% CI, 18.2%-22.4%).", "The probability of death for patients receiving hydroxychloroquine + azithromycin was 189/735 (25.7% [95% CI, 22.3%-28.9%]), hydroxychloroquine alone, 54/271 (19.9% [95% CI, 15.2%-24.7%]), azithromycin alone, 21/211 (10.0% [95% CI, 5.9%-14.0%]), and neither drug, 28/221 (12.7% [95% CI, 8.3%-17.1%]).", "In adjusted Cox proportional hazards models, compared with patients receiving neither drug, there were no significant differences in mortality for patients receiving hydroxychloroquine + azithromycin (HR, 1.35 [95% CI, 0.76-2.40]), hydroxychloroquine alone (HR, 1.08 [95% CI, 0.63-1.85]), or azithromycin alone (HR, 0.56 [95% CI, 0.26-1.21]).", "In logistic models, compared with patients receiving neither drug cardiac arrest was significantly more likely in patients receiving hydroxychloroquine + azithromycin (adjusted OR, 2.13 [95% CI, 1.12-4.05]), but not hydroxychloroquine alone (adjusted OR, 1.91 [95% CI, 0.96-3.81]) or azithromycin alone (adjusted OR, 0.64 [95% CI, 0.27-1.56]), .", "In adjusted logistic regression models, there were no significant differences in the relative likelihood of abnormal electrocardiogram findings.", "Conclusions and Relevance: Among patients hospitalized in metropolitan New York with COVID-19, treatment with hydroxychloroquine, azithromycin, or both, compared with neither treatment, was not significantly associated with differences in in-hospital mortality.", "However, the interpretation of these findings may be limited by the observational design."]}
{"cord_id": "i8xdywet", "title": "Bat Flight and Zoonotic Viruses", "abstract": ["Bats are sources of high viral diversity and high-profile zoonotic viruses worldwide.", "Although apparently not pathogenic in their reservoir hosts, some viruses from bats severely affect other mammals, including humans.", "Examples include severe acute respiratory syndrome coronaviruses, Ebola and Marburg viruses, and Nipah and Hendra viruses.", "Factors underlying high viral diversity in bats are the subject of speculation.", "We hypothesize that flight, a factor common to all bats but to no other mammals, provides an intensive selective force for coexistence with viral parasites through a daily cycle that elevates metabolism and body temperature analogous to the febrile response in other mammals.", "On an evolutionary scale, this host\u2013virus interaction might have resulted in the large diversity of zoonotic viruses in bats, possibly through bat viruses adapting to be more tolerant of the fever response and less virulent to their natural hosts."]}
{"cord_id": "k36rymkv", "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "abstract": ["BACKGROUND: Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described.", "METHODS: In this retrospective, multicentre cohort study, we included all adult inpatients (\u226518 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020.", "Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors.", "We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death.", "FINDINGS: 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital.", "91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients).", "Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1\u00b710, 95% CI 1\u00b703\u20131\u00b717, per year increase; p=0\u00b70043), higher Sequential Organ Failure Assessment (SOFA) score (5\u00b765, 2\u00b761\u201312\u00b723; p<0\u00b70001), and d-dimer greater than 1 \u03bcg/mL (18\u00b742, 2\u00b764\u2013128\u00b755; p=0\u00b70033) on admission.", "Median duration of viral shedding was 20\u00b70 days (IQR 17\u00b70\u201324\u00b70) in survivors, but SARS-CoV-2 was detectable until death in non-survivors.", "The longest observed duration of viral shedding in survivors was 37 days.", "INTERPRETATION: The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 \u03bcg/mL could help clinicians to identify patients with poor prognosis at an early stage.", "Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.", "FUNDING: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development."]}
{"cord_id": "v08cs51n", "title": "Review of Bats and SARS", "abstract": ["Bats have been identified as a natural reservoir for an increasing number of emerging zoonotic viruses, including henipaviruses and variants of rabies viruses.", "Recently, we and another group independently identified several horseshoe bat species (genus Rhinolophus) as the reservoir host for a large number of viruses that have a close genetic relationship with the coronavirus associated with severe acute respiratory syndrome (SARS).", "Our current research focused on the identification of the reservoir species for the progenitor virus of the SARS coronaviruses responsible for outbreaks during 2002\u20132003 and 2003\u20132004.", "In addition to SARS-like coronaviruses, many other novel bat coronaviruses, which belong to groups 1 and 2 of the 3 existing coronavirus groups, have been detected by PCR.", "The discovery of bat SARS-like coronaviruses and the great genetic diversity of coronaviruses in bats have shed new light on the origin and transmission of SARS coronaviruses."]}
{"cord_id": "nz3ww2fp", "title": "Potential Effects of Coronaviruses on the Cardiovascular System: A Review", "abstract": ["Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level.", "Coronaviruses are known to affect the cardiovascular system.", "We review the basics of coronaviruses, with a focus on COVID-19, along with their effects on the cardiovascular system.", "Observations: Coronavirus disease 2019 can cause a viral pneumonia with additional extrapulmonary manifestations and complications.", "A large proportion of patients have underlying cardiovascular disease and/or cardiac risk factors.", "Factors associated with mortality include male sex, advanced age, and presence of comorbidities including hypertension, diabetes mellitus, cardiovascular diseases, and cerebrovascular diseases.", "Acute cardiac injury determined by elevated high-sensitivity troponin levels is commonly observed in severe cases and is strongly associated with mortality.", "Acute respiratory distress syndrome is also strongly associated with mortality.", "Conclusions and Relevance: Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias.", "Extensive efforts are underway to find specific vaccines and antivirals against SARS-CoV-2.", "Meanwhile, cardiovascular risk factors and conditions should be judiciously controlled per evidence-based guidelines."]}
{"cord_id": "777z09h2", "title": "Evidence for Limited Early Spread of COVID-19 Within the United States, January-February 2020", "abstract": ["From January 21 through February 23, 2020, public health agencies detected 14 U.S. cases of coronavirus disease 2019 (COVID-19), all related to travel from China (1,2).", "The first nontravel-related U.S. case was confirmed on February 26 in a California resident who had become ill on February 13 (3).", "Two days later, on February 28, a second nontravel-related case was confirmed in the state of Washington (4,5).", "Examination of four lines of evidence provides insight into the timing of introduction and early transmission of SARS-CoV-2, the virus that causes COVID-19, into the United States before the detection of these two cases.", "First, syndromic surveillance based on emergency department records from counties affected early by the pandemic did not show an increase in visits for COVID-19-like illness before February 28.", "Second, retrospective SARS-CoV-2 testing of approximately 11,000 respiratory specimens from several U.S. locations beginning January 1 identified no positive results before February 20.", "Third, analysis of viral RNA sequences from early cases suggested that a single lineage of virus imported directly or indirectly from China began circulating in the United States between January 18 and February 9, followed by several SARS-CoV-2 importations from Europe.", "Finally, the occurrence of three cases, one in a California resident who died on February 6, a second in another resident of the same county who died February 17, and a third in an unidentified passenger or crew member aboard a Pacific cruise ship that left San Francisco on February 11, confirms cryptic circulation of the virus by early February.", "These data indicate that sustained, community transmission had begun before detection of the first two nontravel-related U.S. cases, likely resulting from the importation of a single lineage of virus from China in late January or early February, followed by several importations from Europe.", "The widespread emergence of COVID-19 throughout the United States after February highlights the importance of robust public health systems to respond rapidly to emerging infectious threats."]}
{"cord_id": "vr11maos", "title": "Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China", "abstract": ["Importance: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide.", "Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue.", "However, to our knowledge, it has not been reported that patients with COVID-19 had any neurologic manifestations.", "Objective: To study the neurologic manifestations of patients with COVID-19.", "Design, Setting, and Participants: This is a retrospective, observational case series.", "Data were collected from January 16, 2020, to February 19, 2020, at 3 designated special care centers for COVID-19 (Main District, West Branch, and Tumor Center) of the Union Hospital of Huazhong University of Science and Technology in Wuhan, China.", "The study included 214 consecutive hospitalized patients with laboratory-confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 infection.", "Main Outcomes and Measures: Clinical data were extracted from electronic medical records, and data of all neurologic symptoms were checked by 2 trained neurologists.", "Neurologic manifestations fell into 3 categories: central nervous system manifestations (dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizure), peripheral nervous system manifestations (taste impairment, smell impairment, vision impairment, and nerve pain), and skeletal muscular injury manifestations.", "Results: Of 214 patients (mean [SD] age, 52.7 [15.5] years; 87 men [40.7%]) with COVID-19, 126 patients (58.9%) had nonsevere infection and 88 patients (41.1%) had severe infection according to their respiratory status.", "Overall, 78 patients (36.4%) had neurologic manifestations.", "Compared with patients with nonsevere infection, patients with severe infection were older, had more underlying disorders, especially hypertension, and showed fewer typical symptoms of COVID-19, such as fever and cough.", "Patients with more severe infection had neurologic manifestations, such as acute cerebrovascular diseases (5 [5.7%] vs 1 [0.8%]), impaired consciousness (13 [14.8%] vs 3 [2.4%]), and skeletal muscle injury (17 [19.3%] vs 6 [4.8%]).", "Conclusions and Relevance: Patients with COVID-19 commonly have neurologic manifestations.", "During the epidemic period of COVID-19, when seeing patients with neurologic manifestations, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission."]}
{"cord_id": "b063j3f9", "title": "Age-dependent effects in the transmission and control of COVID-19 epidemics", "abstract": ["The COVID-19 pandemic has shown a markedly low proportion of cases among children1-4.", "Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both.", "We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea.", "We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10- to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years.", "Accordingly, we find that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low.", "Our age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings.", "In countries with younger population structures-such as many low-income countries-the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity.", "Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic."]}
{"cord_id": "73b58lcm", "title": "We shouldn\u2019t worry when a virus mutates during disease outbreaks", "abstract": ["Mutation.", "The word naturally conjures fears of unexpected and freakish changes.", "Ill-informed discussions of mutations thrive during virus outbreaks, including the ongoing spread of SARS-CoV-2.", "In reality, mutations are a natural part of the virus life cycle and rarely impact outbreaks dramatically."]}
{"cord_id": "uzbb6vyc", "title": "Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe", "abstract": ["Following the detection of the new coronavirus1 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its spread outside of China, Europe has experienced large epidemics of coronavirus disease 2019 (COVID-19).", "In response, many European countries have implemented non-pharmaceutical interventions, such as the closure of schools and national lockdowns.", "Here we study the effect of major interventions across 11 European countries for the period from the start of the COVID-19 epidemics until 4 May 2020, when lockdowns started to be lifted.", "Our model calculates backwards from observed deaths to estimate transmission that occurred several weeks previously, allowing for the time lag between infection and death.", "We use partial pooling of information between countries, with both individual and shared effects on the time-varying reproduction number (Rt).", "Pooling allows for more information to be used, helps to overcome idiosyncrasies in the data and enables more-timely estimates.", "Our model relies on fixed estimates of some epidemiological parameters (such as the infection fatality rate), does not include importation or subnational variation and assumes that changes in Rt are an immediate response to interventions rather than gradual changes in behaviour.", "Amidst the ongoing pandemic, we rely on death data that are incomplete, show systematic biases in reporting and are subject to future consolidation.", "We estimate that-for all of the countries we consider here-current interventions have been sufficient to drive Rt below 1 (probability Rt < 1.0 is greater than 99%) and achieve control of the epidemic.", "We estimate that across all 11 countries combined, between 12 and 15 million individuals were infected with SARS-CoV-2 up to 4 May 2020, representing between 3.2% and 4.0% of the population.", "Our results show that major non-pharmaceutical interventions-and lockdowns in particular-have had a large effect on reducing transmission.", "Continued intervention should be considered to keep transmission of SARS-CoV-2 under control."]}
{"cord_id": "2ehuuvnx", "title": "COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study", "abstract": ["BACKGROUND: To date, few data on paediatric COVID-19 have been published, and most reports originate from China.", "This study aimed to capture key data on children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across Europe to inform physicians and health-care service planning during the ongoing pandemic.", "METHODS: This multicentre cohort study involved 82 participating health-care institutions across 25 European countries, using a well established research network\u2014the Paediatric Tuberculosis Network European Trials Group (ptbnet)\u2014that mainly comprises paediatric infectious diseases specialists and paediatric pulmonologists.", "We included all individuals aged 18 years or younger with confirmed SARS-CoV-2 infection, detected at any anatomical site by RT-PCR, between April 1 and April 24, 2020, during the initial peak of the European COVID-19 pandemic.", "We explored factors associated with need for intensive care unit (ICU) admission and initiation of drug treatment for COVID-19 using univariable analysis, and applied multivariable logistic regression with backwards stepwise analysis to further explore those factors significantly associated with ICU admission.", "FINDINGS: 582 individuals with PCR-confirmed SARS-CoV-2 infection were included, with a median age of 5\u00b70 years (IQR 0\u00b75\u201312\u00b70) and a sex ratio of 1\u00b715 males per female.", "145 (25%) had pre-existing medical conditions.", "363 (62%) individuals were admitted to hospital.", "48 (8%) individuals required ICU admission, 25 (4%) mechanical ventilation (median duration 7 days, IQR 2\u201311, range 1\u201334), 19 (3%) inotropic support, and one (<1%) extracorporeal membrane oxygenation.", "Significant risk factors for requiring ICU admission in multivariable analyses were being younger than 1 month (odds ratio 5\u00b706, 95% CI 1\u00b772\u201314\u00b787; p=0\u00b70035), male sex (2\u00b712, 1\u00b706\u20134\u00b721; p=0\u00b7033), pre-existing medical conditions (3\u00b727, 1\u00b767\u20136\u00b742; p=0\u00b70015), and presence of lower respiratory tract infection signs or symptoms at presentation (10\u00b746, 5\u00b716\u201321\u00b723; p<0\u00b70001).", "The most frequently used drug with antiviral activity was hydroxychloroquine (40 [7%] patients), followed by remdesivir (17 [3%] patients), lopinavir\u2013ritonavir (six [1%] patients), and oseltamivir (three [1%] patients).", "Immunomodulatory medication used included corticosteroids (22 [4%] patients), intravenous immunoglobulin (seven [1%] patients), tocilizumab (four [1%] patients), anakinra (three [1%] patients), and siltuximab (one [<1%] patient).", "Four children died (case-fatality rate 0\u00b769%, 95% CI 0\u00b720\u20131\u00b782); at study end, the remaining 578 were alive and only 25 (4%) were still symptomatic or requiring respiratory support.", "INTERPRETATION: COVID-19 is generally a mild disease in children, including infants.", "However, a small proportion develop severe disease requiring ICU admission and prolonged ventilation, although fatal outcome is overall rare.", "The data also reflect the current uncertainties regarding specific treatment options, highlighting that additional data on antiviral and immunomodulatory drugs are urgently needed.", "FUNDING: ptbnet is supported by Deutsche Gesellschaft f\u00fcr Internationale Zusammenarbeit."]}
{"cord_id": "y43prnko", "title": "The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence", "abstract": ["Please cite this paper as: bin\u2010Reza et al.", "(2012) The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence.", "Influenza and Other Respiratory Viruses 6(4), 257\u2013267.", "There are limited data on the use of masks and respirators to reduce transmission of influenza.", "A systematic review was undertaken to help inform pandemic influenza guidance in the United Kingdom.", "The initial review was performed in November 2009 and updated in June 2010 and January 2011.", "Inclusion criteria included randomised controlled trials and quasi\u2010experimental and observational studies of humans published in English with an outcome of laboratory\u2010confirmed or clinically\u2010diagnosed influenza and other viral respiratory infections.", "There were 17 eligible studies.", "Six of eight randomised controlled trials found no significant differences between control and intervention groups (masks with or without hand hygiene; N95/P2 respirators).", "One household trial found that mask wearing coupled with hand sanitiser use reduced secondary transmission of upper respiratory infection/influenza\u2010like illness/laboratory\u2010confirmed influenza compared with education; hand sanitiser alone resulted in no reduction.", "One hospital\u2010based trial found a lower rate of clinical respiratory illness associated with non\u2010fit\u2010tested N95 respirator use compared with medical masks.", "Eight of nine retrospective observational studies found that mask and/or respirator use was independently associated with a reduced risk of severe acute respiratory syndrome (SARS).", "Findings, however, may not be applicable to influenza and many studies were suboptimal.", "None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection.", "Some evidence suggests that mask use is best undertaken as part of a package of personal protection especially hand hygiene.", "The effectiveness of masks and respirators is likely linked to early, consistent and correct usage."]}
{"cord_id": "ok33bqqg", "title": "Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City", "abstract": ["By conducting a retrospective, cross-sectional analysis of SARS-CoV-2 seroprevalence in a sentinel group (enriched for SARS-CoV-2 infections) and a screening group (representative of the general population) using >5,000 plasma samples from patients at Mount Sinai Hospital in New York City (NYC), we identified seropositive samples as early as in the week ending February 23, 2020.", "A stark increase in seropositivity in the sentinel group started the week ending March 22 and in the screening group in the week ending March 29.", "By the week ending April 19, the seroprevalence in the screening group reached 19.3%, which is well below the estimated 67% needed to achieve community immunity to SARS-CoV-2.", "These data potentially suggest an earlier than previously documented introduction of SARS-CoV-2 into the NYC metropolitan area."]}
{"cord_id": "35meen0h", "title": "Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study", "abstract": ["COVID-19 has spread to most countries in the world.", "Puzzlingly, the impact of the disease is different in different countries.", "These differences are attributed to differences in cultural norms, mitigation efforts, and health infrastructure.", "Here we propose that national differences in COVID-19 impact could be partially explained by the different national policies respect to Bacillus Calmette-Guerin (BCG) childhood vaccination.", "BCG vaccination has been reported to offer broad protection to respiratory infections.", "We compared large number of countries BCG vaccination policies with the morbidity and mortality for COVID-19.", "We found that countries without universal policies of BCG vaccination (Italy, Nederland, USA) have been more severely affected compared to countries with universal and long-standing BCG policies.", "Countries that have a late start of universal BCG policy (Iran, 1984) had high mortality, consistent with the idea that BCG protects the vaccinated elderly population.", "We also found that BCG vaccination also reduced the number of reported COVID-19 cases in a country.", "The combination of reduced morbidity and mortality makes BCG vaccination a potential new tool in the fight against COVID-19."]}
{"cord_id": "y8di9jme", "title": "SARS among Critical Care Nurses, Toronto", "abstract": ["To determine factors that predispose or protect healthcare workers from severe acute respiratory syndrome (SARS), we conducted a retrospective cohort study among 43 nurses who worked in two Toronto critical care units with SARS patients.", "Eight of 32 nurses who entered a SARS patient\u2019s room were infected.", "The probability of SARS infection was 6% per shift worked.", "Assisting during intubation, suctioning before intubation, and manipulating the oxygen mask were high-risk activities.", "Consistently wearing a mask (either surgical or particulate respirator type N95) while caring for a SARS patient was protective for the nurses, and consistent use of the N95 mask was more protective than not wearing a mask.", "Risk was reduced by consistent use of a surgical mask, but not significantly.", "Risk was lower with consistent use of a N95 mask than with consistent use of a surgical mask.", "We conclude that activities related to intubation increase SARS risk and use of a mask (particularly a N95 mask) is protective."]}
{"cord_id": "lw31801a", "title": "Virological assessment of hospitalized patients with COVID-2019", "abstract": ["Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in late 20191,2.", "Initial outbreaks in China involved 13.8% of cases with severe courses, and 6.1% of cases with critical courses3.", "This severe presentation may result from the virus using a virus receptor that is expressed predominantly in the lung2,4; the same receptor tropism is thought to have determined the pathogenicity-but also aided in the control-of severe acute respiratory syndrome (SARS) in 20035.", "However, there are reports of cases of COVID-19 in which the patient shows mild upper respiratory tract symptoms, which suggests the potential for pre- or oligosymptomatic transmission6-8.", "There is an urgent need for information on virus replication, immunity and infectivity in specific sites of the body.", "Here we report a detailed virological analysis of nine cases of COVID-19 that provides proof of active virus replication in tissues of the upper respiratory tract.", "Pharyngeal virus shedding was very high during the first week of symptoms, with a peak at 7.11 \u00d7 108 RNA copies per throat swab on day 4.", "Infectious virus was readily isolated from samples derived from the throat or lung, but not from stool samples-in spite of high concentrations of virus RNA.", "Blood and urine samples never yielded virus.", "Active replication in the throat was confirmed by the presence of viral replicative RNA intermediates in the throat samples.", "We consistently detected sequence-distinct virus populations in throat and lung samples from one patient, proving independent replication.", "The shedding of viral RNA from sputum outlasted the end of symptoms.", "Seroconversion occurred after 7 days in 50% of patients (and by day 14 in all patients), but was not followed by a rapid decline in viral load.", "COVID-19 can present as a mild illness of the upper respiratory tract.", "The confirmation of active virus replication in the upper respiratory tract has implications for the containment of COVID-19."]}
{"cord_id": "uecosx5i", "title": "Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections", "abstract": ["The clinical features and immune responses of asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have not been well described.", "We studied 37 asymptomatic individuals in the Wanzhou District who were diagnosed with RT-PCR-confirmed SARS-CoV-2 infections but without any relevant clinical symptoms in the preceding 14 d and during hospitalization.", "Asymptomatic individuals were admitted to the government-designated Wanzhou People's Hospital for centralized isolation in accordance with policy1.", "The median duration of viral shedding in the asymptomatic group was 19 d (interquartile range (IQR), 15-26 d).", "The asymptomatic group had a significantly longer duration of viral shedding than the symptomatic group (log-rank P = 0.028).", "The virus-specific IgG levels in the asymptomatic group (median S/CO, 3.4; IQR, 1.6-10.7) were significantly lower (P = 0.005) relative to the symptomatic group (median S/CO, 20.5; IQR, 5.8-38.2) in the acute phase.", "Of asymptomatic individuals, 93.3% (28/30) and 81.1% (30/37) had reduction in IgG and neutralizing antibody levels, respectively, during the early convalescent phase, as compared to 96.8% (30/31) and 62.2% (23/37) of symptomatic patients.", "Forty percent of asymptomatic individuals became seronegative and 12.9% of the symptomatic group became negative for IgG in the early convalescent phase.", "In addition, asymptomatic individuals exhibited lower levels of 18 pro- and anti-inflammatory cytokines.", "These data suggest that asymptomatic individuals had a weaker immune response to SARS-CoV-2 infection.", "The reduction in IgG and neutralizing antibody levels in the early convalescent phase might have implications for immunity strategy and serological surveys."]}
{"cord_id": "ugkrquzw", "title": "Convergent antibody responses to SARS-CoV-2 in convalescent individuals", "abstract": ["During the COVID-19 pandemic, SARS-CoV-2 infected millions of people and claimed hundreds of thousands of lives.", "Virus entry into cells depends on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein (S).", "Although there is no vaccine, it is likely that antibodies will be essential for protection.", "However, little is known about the human antibody response to SARS-CoV-21-5.", "Here we report on 149 COVID-19 convalescent individuals.", "Plasmas collected an average of 39 days after the onset of symptoms had variable half-maximal pseudovirus neutralizing titres: less than 1:50 in 33% and below 1:1,000 in 79%, while only 1% showed titres above 1:5,000.", "Antibody sequencing revealed expanded clones of RBD-specific memory B cells expressing closely related antibodies in different individuals.", "Despite low plasma titres, antibodies to three distinct epitopes on RBD neutralized at half-maximal inhibitory concentrations (IC50 values) as low as single digit nanograms per millitre.", "Thus, most convalescent plasmas obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity.", "Nevertheless, rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective."]}
{"cord_id": "oydib3p6", "title": "SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation", "abstract": ["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, and rapidly spread worldwide.", "Previous studies suggested cat could be a potential susceptible animal of SARS-CoV-2.", "Here, we investigated the infection of SARS-CoV-2 in cats by detecting specific serum antibodies.", "A cohort of serum samples were collected from cats in Wuhan, including 102 sampled after COVID-19 outbreak, and 39 prior to the outbreak.", "15 of 102 (14.7%) cat sera collected after the outbreak were positive for the receptor binding domain (RBD) of SARS-CoV-2 by indirect enzyme linked immunosorbent assay (ELISA).", "Among the positive samples, 11 had SARS-CoV-2 neutralizing antibodies with a titer ranging from 1/20 to 1/1080.", "No serological cross-reactivity was detected between the SARS-CoV-2 and type I or II feline infectious peritonitis virus (FIPV).", "Our data demonstrates that SARS-CoV-2 has infected cat population in Wuhan during the outbreak."]}
{"cord_id": "w15txaip", "title": "Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19", "abstract": ["Severe acute respiratory syndrome coronavirus 2 was isolated from feces of a patient in China with coronavirus disease who died.", "Confirmation of infectious virus in feces affirms the potential for fecal-oral or fecal-respiratory transmission and warrants further study."]}
{"cord_id": "dnxhtbxn", "title": "Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019", "abstract": ["A novel coronavirus (nCoV-2019) was the cause of an outbreak of respiratory illness detected in Wuhan, Hubei Province, China in December of 2019.", "Genomic analyses of nCoV-2019 determined a 96% resemblance with a coronavirus isolated from a bat in 2013 (RaTG13); however, the receptor binding motif (RBM) of these two genomes share low sequence similarity.", "This divergence suggests a possible alternative source for the RBM coding sequence in nCoV-2019.", "We identified high sequence similarity in the RBM between nCoV-2019 and a coronavirus genome reconstructed from a viral metagenomic dataset from pangolins possibly indicating a more complex origin for nCoV-2019."]}
{"cord_id": "doi8buyw", "title": "Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study", "abstract": ["BACKGROUND: Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), and systemic inflammation is high.", "In areas of pandemic outbreak, the number of patients can exceed maximum capacity of intensive care units (ICUs), and, thus, these individuals often receive non-invasive ventilation outside of the ICU.", "Effective treatments for this population are needed urgently.", "Anakinra is a recombinant interleukin-1 receptor antagonist that might be beneficial in this patient population.", "METHODS: We conducted a retrospective cohort study at the San Raffaele Hospital in Milan, Italy.", "We included consecutive patients (aged \u226518 years) with COVID-19, moderate-to-severe ARDS, and hyperinflammation (defined as serum C-reactive protein \u2265100 mg/L, ferritin \u2265900 ng/mL, or both) who were managed with non-invasive ventilation outside of the ICU and who received standard treatment of 200 mg hydroxychloroquine twice a day orally and 400 mg lopinavir with 100 mg ritonavir twice a day orally.", "We compared survival, mechanical ventilation-free survival, changes in C-reactive protein, respiratory function, and clinical status in a cohort of patients who received additional treatment with anakinra (either 5 mg/kg twice a day intravenously [high dose] or 100 mg twice a day subcutaneously [low dose]) with a retrospective cohort of patients who did not receive anakinra (referred to as the standard treatment group).", "All outcomes were assessed at 21 days.", "This study is part of the COVID-19 Biobank study, which is registered with ClinicalTrials.gov, NCT04318366.", "FINDINGS: Between March 17 and March 27, 2020, 29 patients received high-dose intravenous anakinra, non-invasive ventilation, and standard treatment.", "Between March 10 and March 17, 2020, 16 patients received non-invasive ventilation and standard treatment only and comprised the comparison group for this study.", "A further seven patients received low-dose subcutaneous anakinra in addition to non-invasive ventilation and standard treatment; however, anakinra treatment was interrupted after 7 days because of a paucity of effects on serum C-reactive protein and clinical status.", "At 21 days, treatment with high-dose anakinra was associated with reductions in serum C-reactive protein and progressive improvements in respiratory function in 21 (72%) of 29 patients; five (17%) patients were on mechanical ventilation and three (10%) died.", "In the standard treatment group, eight (50%) of 16 patients showed respiratory improvement at 21 days; one (6%) patient was on mechanical ventilation and seven (44%) died.", "At 21 days, survival was 90% in the high-dose anakinra group and 56% in the standard treatment group (p=0\u00b7009).", "Mechanical ventilation-free survival was 72% in the anakinra group versus 50% in the standard treatment group (p=0\u00b715).", "Bacteraemia occurred in four (14%) of 29 patients receiving high-dose anakinra and two (13%) of 16 patients receiving standard treatment.", "Discontinuation of anakinra was not followed by inflammatory relapses.", "INTERPRETATION: In this retrospective cohort study of patients with COVID-19 and ARDS managed with non-invasive ventilation outside of the ICU, treatment with high-dose anakinra was safe and associated with clinical improvement in 72% of patients.", "Confirmation of efficacy will require controlled trials.", "FUNDING: None."]}
{"cord_id": "q8l3ra55", "title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial", "abstract": ["Aims: Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in vitro.", "However, evidence regarding its effects in patients is limited.", "This study aims to evaluate the efficacy of hydroxychloroquine (HCQ) in the treatment of patients with COVID-19.", "Main methods: From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University.", "All participants were randomized in a parallel-group trial, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ.", "Key findings: For the 62 COVID-19 patients, 46.8% (29 of 62) were male and 53.2% (33 of 62) were female, the mean age was 44.7 (15.3) years.", "No difference in the age and sex distribution between the control group and the HCQ group.", "But for TTCR, the body temperature recovery time and the cough remission time were significantly shortened in the HCQ treatment group.", "Besides, a larger proportion of patients with improved pneumonia in the HCQ treatment group (80.6%, 25 of 31) compared with the control group (54.8%, 17 of 31).", "Notably, all 4 patients progressed to severe illness that occurred in the control group.", "However, there were 2 patients with mild adverse reactions in the HCQ treatment group.", "Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia."]}
{"cord_id": "mryazbnq", "title": "Severe Acute Respiratory Syndrome Coronavirus 2\u2212Specific Antibody Responses in Coronavirus Disease Patients", "abstract": ["A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic.", "Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed.", "Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies.", "We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein\u2013specific, and nucleocapsid-specific antibodies.", "Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs.", "We demonstrated that most PCR-confirmed SARS-CoV-2\u2013infected persons seroconverted by 2 weeks after disease onset.", "We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity.", "Overall, the validated assays described can be instrumental for detection of SARS-CoV-2\u2013specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies."]}
{"cord_id": "844229sb", "title": "Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review", "abstract": ["The current pandemic of COVID-19 has lead to conflicting opinions on whether wearing facemasks outside of health care facilities protects against the infection.", "To better understand the value of wearing facemasks we undertook a rapid systematic review of existing scientific evidence about development of respiratory illness, linked to use of facemasks in community settings.", "METHODS: We included all study designs.", "There were 31 eligible studies (including 12 RCTs).", "Narrative synthesis and random-effects meta-analysis of attack rates for primary and secondary prevention in 28 studies were performed.", "Results were reported by design, setting and type of face barrier in primary prevention, and by who wore the facemask (index patient or well contacts) in secondary prevention trials.", "The preferred outcome was influenza-like illness (ILI) but similar outcomes were pooled with ILI when ILI was unavailable.", "GRADE quality assessment was based on RCTs with support from observational studies.", "RESULTS: Where specific information was available, most studies reported about use of medical grade (surgical paper masks).", "In 3 RCTs, wearing a facemask may very slightly reduce the odds of developing ILI/respiratory symptoms, by around 6% (OR 0.94, 95% CI 0.75 to 1.19, I2 29%, low certainty evidence).", "Greater effectiveness was suggested by observational studies.", "When both house-mates and an infected household member wore facemasks the odds of further household members becoming ill may be modestly reduced by around 19% (OR 0.81, 95%CI 0.48 to 1.37, I 2 45%, 5 RCTs, low certainty evidence).", "The protective effect was very small if only the well person(OR 0.93, 95% CI 0.68 to 1.28, I2 11%, 2 RCTs, low uncertainty evidence) or the infected person wore the facemask (very low certainty evidence).", "DISCUSSION: Based on the RCTs we would conclude that wearing facemasks can be very slightly protective against primary infection from casual community contact, and modestly protective against household infections when both infected and uninfected members wear facemasks.", "However, the RCTs often suffered from poor compliance and controls using facemasks.", "Across observational studies the evidence in favour of wearing facemasks was stronger.", "We expect RCTs to under-estimate the protective effect and observational studies to exaggerate it.", "The evidence is not sufficiently strong to support widespread use of facemasks as a protective measure against COVID-19.", "However, there is enough evidence to support the use of facemasks for short periods of time by particularly vulnerable individuals when in transient higher risk situations.", "Further high quality trials are needed to assess when wearing a facemask in the community is most likely to be protective."]}
{"cord_id": "3jnhboif", "title": "Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial", "abstract": ["OBJECTIVE: To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).", "DESIGN: Multicentre, open label, randomised controlled trial.", "SETTING: 16 government designated covid-19 treatment centres in China, 11 to 29 February 2020.", "PARTICIPANTS: 150 patients admitted to hospital with laboratory confirmed covid-19 were included in the intention to treat analysis (75 patients assigned to hydroxychloroquine plus standard of care, 75 to standard of care alone).", "INTERVENTIONS: Hydroxychloroquine administrated at a loading dose of 1200 mg daily for three days followed by a maintenance dose of 800 mg daily (total treatment duration: two or three weeks for patients with mild to moderate or severe disease, respectively).", "MAIN OUTCOME MEASURE: Negative conversion of severe acute respiratory syndrome coronavirus 2 by 28 days, analysed according to the intention to treat principle.", "Adverse events were analysed in the safety population in which hydroxychloroquine recipients were participants who received at least one dose of hydroxychloroquine and hydroxychloroquine non-recipients were those managed with standard of care alone.", "RESULTS: Of 150 patients, 148 had mild to moderate disease and two had severe disease.", "The mean duration from symptom onset to randomisation was 16.6 (SD 10.5; range 3-41) days.", "A total of 109 (73%) patients (56 standard of care; 53 standard of care plus hydroxychloroquine) had negative conversion well before 28 days, and the remaining 41 (27%) patients (19 standard of care; 22 standard of care plus hydroxychloroquine) were censored as they did not reach negative conversion of virus.", "The probability of negative conversion by 28 days in the standard of care plus hydroxychloroquine group was 85.4% (95% confidence interval 73.8% to 93.8%), similar to that in the standard of care group (81.3%, 71.2% to 89.6%).", "The difference between groups was 4.1% (95% confidence interval \u201310.3% to 18.5%).", "In the safety population, adverse events were recorded in 7/80 (9%) hydroxychloroquine non-recipients and in 21/70 (30%) hydroxychloroquine recipients.", "The most common adverse event in the hydroxychloroquine recipients was diarrhoea, reported in 7/70 (10%) patients.", "Two hydroxychloroquine recipients reported serious adverse events.", "CONCLUSIONS: Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital with mainly persistent mild to moderate covid-19.", "Adverse events were higher in hydroxychloroquine recipients than in non-recipients.", "TRIAL REGISTRATION: ChiCTR2000029868."]}
{"cord_id": "mw0wb8a8", "title": "Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan Pangolins", "abstract": ["The outbreak of 2019-nCoV in the central Chinese city of Wuhan at the end of 2019 poses unprecedent public health challenges to both China and the rest world1.", "The new coronavirus shares high sequence identity to SARS-CoV and a newly identified bat coronavirus2.", "While bats may be the reservoir host for various coronaviruses, whether 2019-nCoV has other hosts is still ambiguous.", "In this study, one coronavirus isolated from Malayan pangolins showed 100%, 98.2%, 96.7% and 90.4% amino acid identity with 2019-nCoV in the E, M, N and S genes, respectively.", "In particular, the receptor-binding domain of the S protein of the Pangolin-CoV is virtually identical to that of 2019-nCoV, with one amino acid difference.", "Comparison of available genomes suggests 2019-nCoV might have originated from the recombination of a Pangolin-CoV-like virus with a Bat-CoV-RaTG13-like virus.", "Infected pangolins showed clinical signs and histopathological changes, and the circulating antibodies reacted with the S protein of 2019-nCoV.", "The isolation of a coronavirus that is highly related to 2019-nCoV in the pangolins suggests that these animals have the potential to act as the intermediate host of 2019-nCoV.", "The newly identified coronavirus in the most-trafficked mammal could represent a continuous threat to public health if wildlife trade is not effectively controlled."]}
{"cord_id": "10o85pz2", "title": "Identification and Monitoring of International Travelers During the Initial Phase of an Outbreak of COVID-19 - California, February 3-March 17, 2020", "abstract": ["The threat of introduction of coronavirus disease 2019 (COVID-19) into the United States with the potential for community transmission prompted U.S. federal officials in February 2020 to screen travelers from China, and later Iran, and collect and transmit their demographic and contact information to states for follow-up.", "During February 5-March 17, 2020, the California Department of Public Health (CDPH) received and transmitted contact information for 11,574 international travelers to 51 of 61 local health jurisdictions at a cost of 1,694 hours of CDPH personnel time.", "If resources permitted, local health jurisdictions contacted travelers, interviewed them, and oversaw 14 days of quarantine, self-monitoring, or both, based on CDC risk assessment criteria for COVID-19.", "Challenges encountered during follow-up included errors in the recording of contact information and variation in the availability of resources in local health jurisdictions to address the substantial workload.", "Among COVID-19 patients reported to CDPH, three matched persons previously reported as travelers to CDPH.", "Despite intensive effort, the traveler screening system did not effectively prevent introduction of COVID-19 into California.", "Effectiveness of COVID-19 screening and monitoring in travelers to California was limited by incomplete traveler information received by federal officials and transmitted to states, the number of travelers needing follow-up, and the potential for presymptomatic and asymptomatic transmission.", "More efficient methods of collecting and transmitting passenger data, including electronic provision of flight manifests by airlines to federal officials and flexible text-messaging tools, would help local health jurisdictions reach out to all at-risk travelers quickly, thereby facilitating timely testing, case identification, and contact investigations.", "State and local health departments should weigh the resources needed to implement incoming traveler monitoring against community mitigation activities, understanding that the priorities of each might shift during the COVID-19 pandemic."]}
{"cord_id": "1u4hyc0k", "title": "Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden", "abstract": ["The Public Health Agency of Sweden has analyzed how many pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been treated in intensive care units (ICU) in Sweden between 19 March and 20 April 2020 compared with non-pregnant women of similar age.", "Cases were identified in a special reporting module within the Swedish Intensive Care Registry (SIR).", "Fifty-three women aged 20-45 years with SARS-CoV-2 were reported in SIR, and 13 of these women were either pregnant or postpartum (<1 week).", "The results indicate that the risk of being admitted to ICU may be higher in pregnant and postpartum women with laboratory-confirmed SARS-CoV-2 in Sweden, compared with non-pregnant women of similar age."]}
{"cord_id": "qd0m9aeg", "title": "Individualizing Risk Prediction for Positive COVID-19 Testing: Results from 11,672 Patients", "abstract": ["BACKGROUND: Coronavirus disease-2019 (COVID-19) is sweeping the globe.", "Despite multiple case-series, actionable knowledge to tailor decision-making proactively is missing.", "RESEARCH QUESTION: Can a statistical model accurately predict infection with COVID-19?", "STUDY DESIGN AND METHODS: We developed a prospective registry of all patients tested for COVID-19 in Cleveland Clinic to create individualized risk prediction models.", "We focus here on the likelihood of a positive nasal or oropharyngeal COVID-19 test.", "A least absolute shrinkage and selection operator logistic regression algorithm was constructed that removed variables that were not contributing to the model's cross-validated concordance index.", "After external validation in a temporally and geographically distinct cohort, the statistical prediction model was illustrated as a nomogram and deployed in an online risk calculator.", "RESULTS: In the development cohort, 11,672 patients fulfilled study criteria, including 818 patients (7.0%) who tested positive for COVID-19; in the validation cohort, 2295 patients fulfilled criteria, including 290 patients who tested positive for COVID-19.", "Male, African American, older patients, and those with known COVID-19 exposure were at higher risk of being positive for COVID-19.", "Risk was reduced in those who had pneumococcal polysaccharide or influenza vaccine or who were on melatonin, paroxetine, or carvedilol.", "Our model had favorable discrimination (c-statistic = 0.863 in the development cohort and 0.840 in the validation cohort) and calibration.", "We present sensitivity, specificity, negative predictive value, and positive predictive value at different prediction cutoff points.", "The calculator is freely available at https://riskcalc.org/COVID19.", "INTERPRETATION: Prediction of a COVID-19 positive test is possible and could help direct health care resources.", "We demonstrate relevance of age, race, sex, and socioeconomic characteristics in COVID-19 susceptibility and suggest a potential modifying role of certain common vaccinations and drugs that have been identified in drug-repurposing studies."]}
{"cord_id": "s8fm5rfa", "title": "Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy", "abstract": ["The practice of social distancing and wearing masks has been popular worldwide in combating the contraction of COVID-19.", "Undeniably, although such practices help control the COVID-19 pandemic to a greater extent, the complete control of viral-laden droplet and aerosol transmission by such practices is poorly understood.", "This review paper intends to outline the literature concerning the transmission of viral-laden droplets and aerosols in different environmental settings and demonstrates the behavior of droplets and aerosols resulted from a cough-jet of an infected person in various confined spaces.", "The case studies that have come out in different countries have, with prima facie evidence, manifested that the airborne transmission plays a profound role in contracting susceptible hosts.", "Interestingly, the nosocomial transmission by airborne SARS-CoV-2 viral-laden aerosols in healthcare facilities may be plausible.", "Hence, clearly defined, science-based administrative, clinical, and physical measures are of paramount importance to eradicate the COVID-19 pandemic from the world."]}
{"cord_id": "8n4vklsf", "title": "Serial interval of novel coronavirus (COVID-19) infections", "abstract": ["Abstract Objective To estimate the serial interval of novel coronavirus (COVID-19) from information on 28 infector-infectee pairs.", "Methods We collected dates of illness onset for primary cases (infectors) and secondary cases (infectees) from published research articles and case investigation reports.", "We subjectively ranked the credibility of the data and performed analyses on both the full dataset (n = 28) and a subset of pairs with highest certainty in reporting (n = 18).", "In addition, we adjust for right truncation of the data as the epidemic is still in its growth phase.", "Results Accounting for right truncation and analyzing all pairs, we estimated the median serial interval at 4.0 days (95% credible interval [CrI]: 3.1, 4.9).", "Limiting our data to only the most certain pairs, the median serial interval was estimated at 4.6 days (95% CrI: 3.5, 5.9).", "Conclusions The serial interval of COVID-19 is close to or shorter than its median incubation period.", "This suggests that a substantial proportion of secondary transmission may occur prior to illness onset.", "The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias."]}
{"cord_id": "p3dex2to", "title": "Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)", "abstract": ["Objective: To identify common features of cases with novel coronavirus disease (COVID-19) so as to better understand what factors promote secondary transmission including superspreading events.", "Methods: A total of 110 cases were examined among eleven clusters and sporadic cases, and investigated who acquired infection from whom.", "The clusters included four in Tokyo and one each in Aichi, Fukuoka, Hokkaido, Ishikawa, Kanagawa and Wakayama prefectures.", "The number of secondary cases generated by each primary case was calculated using contact tracing data.", "Results: Of the 110 cases examined, 27 (24.6%) were primary cases who generated secondary cases.", "The odds that a primary case transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment (95% confidence interval [CI]: 6.0, 57.9).", "Conclusions: It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events.", "Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease."]}
{"cord_id": "yge1wvxi", "title": "The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: Evidence of heterogeneity among 229E\u2010related strains", "abstract": ["Strains of human coronavirus (HCV) isolated between 1974 and 1976 have been studied in vitro and in volunteers.", "All strains caused colds in volunteers, and those cultivable in tissue culture (TC) produced significantly more coryza and less sore throat than strains growing only in organ culture (OC).", "The TC strains were serologically related to 229E, but these isolates produced colds with a frequency and severity that contrasted with the effects of 229E itself.", "Tests on volunteers' preinfection sera showed that the prevalence of antibody to 229E had increased during the period 1961\u20131979 and that during 1977\u20131979 only 11% of subjects had no neutralising antibody against 229E.", "Susceptibility to the 229E\u2010related isolates PR and TO was associated with low preinfection serum neutralising antibody against the homologous virus, and paired sera frequently showed fourfold or greater antibody rises, most commonly against the homologous strain.", "Volunteers infected with TO were immune when reinoculated with the same strain approximately 1 year later, but other similar volunteers were at least partly susceptible to infection with a heterologous 229E\u2010related virus after similar time intervals.", "Although the strains of HCV that were grown in tissue culture were all related to the prototype 229E, they appeared not to be identical with it, and this heterogeneity is probably a significant factor in the epidemiology of HCV infections."]}
{"cord_id": "7euuk8bl", "title": "Longitudinal profile of antibodies against SARS\u2010coronavirus in SARS patients and their clinical significance", "abstract": ["Background: Severe acute respiratory syndrome (SARS) is a newly discovered disease caused by a novel coronavirus.", "The present study studied the longitudinal profile of antibodies against SARS\u2010coronavirus (SARS\u2010CoV) in SARS patients and evaluated the clinical significance of these antibodies.", "Methods: Two methods, ELISA and indirect immunofluorescent assay, were used for the detection of the anti\u2010SARS\u2010CoV IgG and IgM in 335 serial sera from 98 SARS patients.", "In 18 patients, serum antibody profiles were investigated and antibody neutralization tests were performed from 7 to 720 days after the onset of symptoms.", "Results: The ratios of positive IgG/IgM by ELISA were 0/0, 45.4/39.4, 88.6/71.4, 96/88, 100/48.6, 100/30.9, 100/17.1, 100/0 per cent, respectively, on 1\u20137, 8\u201314, 15\u201321, 22\u201328, 29\u201360, 61\u201390, 91\u2013180 and 181\u2013720 days after the onset of symptoms.", "Antibodies were not detected within the first 7 days of illness, but IgG titre increased dramatically on day 15, reaching a peak on day 60, and remained high until day 180 from when it declined gradually until day 720.", "IgM was detected on day 15 and rapidly reached a peak, then declined gradually until it was undetectable on day 180.", "Neutralizing viral antibodies were demonstrated in the convalescence sera from SARS patients.", "Conclusion: The persistence of detectable IgG antibodies and neutralizing viral antibodies for up to 720 days suggest that SARS patients may be protected from recurrent SARS\u2010CoV infection for up to 2 years."]}
{"cord_id": "fp9q8ayj", "title": "N95 Mask Decontamination using Standard Hospital Sterilization Technologies", "abstract": ["The response to the COVID19 epidemic is generating severe shortages of personal protective equipment around the world.", "In particular, the supply of N95 respirator masks has become severely depleted with supplies having to be rationed and health care workers having to use masks for prolonged periods in many countries.", "We sought to test the ability of 4 different decontamination methods including autoclave treatment, ethylene oxide gassing, ionized hydrogen peroxide fogging and vaporized hydrogen peroxide exposure to decontaminate 4 different N95 masks of experimental contamination with SARS-CoV-2 or vesicular stomatitis virus as a surrogate.", "In addition, we sought to determine whether masks would tolerate repeated cycles of decontamination while maintaining structural and functional integrity.", "We found that one cycle of treatment with all modalities was effective in decontamination and was associated with no structural or functional deterioration.", "Vaporized hydrogen peroxide treatment was tolerated to at least 5 cycles by masks.", "Most notably, standard autoclave treatment was associated with no loss of structural or functional integrity to a minimum of 10 cycles for the 3 pleated mask models.", "The molded N95 mask however tolerated only 1 cycle.", "This last finding may be of particular use to institutions globally due to the virtually universal accessibility of autoclaves in health care settings."]}
{"cord_id": "i0ijbt7i", "title": "Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to be mostly transmitted by medium-to-large sized respiratory droplets although airborne transmission is theoretically possible in healthcare settings involving aerosol-generating procedures.", "Exposure to respiratory droplets can theoretically be reduced by surgical mask usage.", "However, there is a lack of experimental evidence supporting surgical mask usage for prevention of COVID-19.", "METHODS: We used a well-established golden Syrian hamster SARS-CoV-2 model.", "We placed SARS-CoV-2-challenged index hamsters and na\u00efve hamsters into closed system units each comprising two different cages separated by a polyvinyl chloride air porous partition with unidirectional airflow within the isolator.", "The effect of a surgical mask partition placed in between the cages was investigated.", "Besides clinical scoring, hamster specimens were tested for viral load, histopathology, and viral nucleocapsid antigen expression.", "RESULTS: Non-contact transmission was found in 66.7% (10/15) of exposed na\u00efve hamsters.", "Surgical mask partition for challenged index or na\u00efve hamsters significantly reduced transmission to 25% (6/24, P=0.018).", "Surgical mask partition for challenged index hamsters significantly reduced transmission to only 16.7% (2/12, P=0.019) of exposed na\u00efve hamsters.", "Unlike the severe COVID-19 manifestations of challenged hamsters, infected na\u00efve hamsters had lower clinical scores, milder histopathological changes, and lower viral nucleocapsid antigen expression in respiratory tract tissues.", "CONCLUSIONS: SARS-CoV-2 could be transmitted by respiratory droplets or airborne droplet nuclei in the hamster model.", "Such transmission could be reduced by surgical mask usage, especially when masks were worn by infected individuals."]}
{"cord_id": "7t31ofb4", "title": "Humoral Response Dynamics Following Infection with SARS-CoV-2", "abstract": ["Objectives To understand humoral dynamics following SARS-CoV-2 infection Design Prospective Cohort Study Setting Great Ormond Street Hospital (Central London Paediatric Hospital) Participants 67 healthcare workers aged >18 years who provided monthly serial serological samples from 29th April 2020 until 30th June 2020.", "Main outcome measures The change in monthly serial antibody titers to SARS-CoV-2 nucleoprotein (N), spike protein and the receptor binding domain of the spike protein.", "Results The mean estimated half-life of the nucleoprotein antibody was 52 days (95% CI 42-65).", "The spike and RBD antibody had significantly longer mean half-lives of 81 days (95% CI 61-111) and 83 days (95% CI 55-137) respectively.", "An ACE-2 receptor competition assay demonstrated significant correlation between the spike and RBD antibody titers and ACE2 receptor blocking in-vitro.", "The time to a negative nucleoprotein antibody test for 50% of the seropositive population was predicted to be 195 days (95% CI 163-236).", "Conclusions After SARS-CoV-2 infection, the predicted half-life of nucleoprotein antibody was 52 days with 50% of seropositives becoming seronegative to this antibody at 195 days.", "Widely used serological tests including the Public Health England endorsed assay that depend on the nucleoprotein antibody will therefore underestimate the true prevalence of infection within a year following the majority of infections."]}
{"cord_id": "z68tl88x", "title": "An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area", "abstract": ["Objective To investigate the efficacy and safety of recombinant human interferon alpha1b (rhIFN-\u03b1) nasal drops in healthy medical staff to prevent 2019 novel coronavirus disease (COVID-19).", "Methods A prospective, open-label study was conducted.", "Starting January 21, 2020, at Taihe Hospital in Shiyan City, Hubei Province, 2944 medical staff members were recruited and allocated into a low-risk group or a high-risk group according to whether they were directly exposed to the coronavirus.", "Participants in the low-risk group received rhIFN-\u03b1 nasal drops (2-3 drops/nostril/time, 4 times/day) for 28 days; those in the high-risk group received rhIFN-\u03b1 nasal drops combined with thymosin-\u03b11 (1.6 mg, hypodermic injection, once a week).", "The primary outcome was new-onset COVID-19 over 28 days.", "The secondary outcome was new-onset fever or respiratory symptoms but with negative pulmonary images.", "The results were compared with the number of new cases in medical staff in the same areas of Hubei Province (including Wuhan) during the same period.", "Adverse reactions to interferon nasal drops were also observed.", "Results Among the 2944 subjects in our study, 2415 were included in the low-risk group, including 997 doctors and 1418 nurses with average ages of 37.38 and 33.56 years, respectively; 529 were included in the high-risk group, including 122 doctors and 407 nurses with average ages of 35.24 and 32.16 years, respectively.", "The 28-day incidence of COVID-19 was zero in both the high- and low-risk groups.", "The 28-day incidence of new-onset clinical symptoms with negative images for pneumonia was also zero in both the high- and low-risk groups.", "As controls, a total of 2035 medical personnel with confirmed COVID-19 pneumonia from the same area (Hubei Province) was observed between January 21 to February 23, 2020.", "There were no serious adverse effects in the 2944 subjects treated during the intervention period.", "Conclusion In this investigator-initiated open-label study, we observed that rhIFN-\u03b1 nasal drops can effectively prevent COVID-19 in treated medical personnel.", "Our results also indicate that rhIFN-\u03b1 nasal drops have potential promise for protecting susceptible healthy people during the coronavirus pandemic."]}
{"cord_id": "pq75mafr", "title": "The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak", "abstract": ["Motivated by the rapid spread of COVID-19 in Mainland China, we use a global metapopulation disease transmission model to project the impact of travel limitations on the national and international spread of the epidemic.", "The model is calibrated based on internationally reported cases, and shows that at the start of the travel ban from Wuhan on 23 January 2020, most Chinese cities had already received many infected travelers.", "The travel quarantine of Wuhan delayed the overall epidemic progression by only 3 to 5 days in Mainland China, but has a more marked effect at the international scale, where case importations were reduced by nearly 80% until mid February.", "Modeling results also indicate that sustained 90% travel restrictions to and from Mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community."]}
{"cord_id": "px70bft2", "title": "Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak", "abstract": ["Backgrounds An ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia hit a major city of China, Wuhan, December 2019 and subsequently reached other provinces/regions of China and countries.", "We present estimates of the basic reproduction number, R0, of 2019-nCoV in the early phase of the outbreak.", "Methods Accounting for the impact of the variations in disease reporting rate, we modelled the epidemic curve of 2019-nCoV cases time series, in mainland China from January 10 to January 24, 2020, through the exponential growth.", "With the estimated intrinsic growth rate (\u03b3), we estimated R0 by using the serial intervals (SI) of two other well-known coronavirus diseases, MERS and SARS, as approximations for the true unknown SI.", "Findings The early outbreak data largely follows the exponential growth.", "We estimated that the mean R0 ranges from 2.24 (95%CI: 1.96-2.55) to 3.58 (95%CI: 2.89-4.39) associated with 8-fold to 2-fold increase in the reporting rate.", "We demonstrated that changes in reporting rate substantially affect estimates of R0.", "Conclusion The mean estimate of R0 for the 2019-nCoV ranges from 2.24 to 3.58, and significantly larger than 1.", "Our findings indicate the potential of 2019-nCoV to cause outbreaks."]}
{"cord_id": "cio7lheh", "title": "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial", "abstract": ["BACKGROUND: This is the first randomised controlled trial for assessment of the immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate dose of the candidate vaccine for an efficacy study.", "METHODS: This randomised, double-blind, placebo-controlled, phase 2 trial of the Ad5-vectored COVID-19 vaccine was done in a single centre in Wuhan, China.", "Healthy adults aged 18 years or older, who were HIV-negative and previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-free, were eligible to participate and were randomly assigned to receive the vaccine at a dose of 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 viral particles per mL or 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles per mL, or placebo.", "Investigators allocated participants at a ratio of 2:1:1 to receive a single injection intramuscularly in the arm.", "The randomisation list (block size 4) was generated by an independent statistician.", "Participants, investigators, and staff undertaking laboratory analyses were masked to group allocation.", "The primary endpoints for immunogenicity were the geometric mean titres (GMTs) of specific ELISA antibody responses to the receptor binding domain (RBD) and neutralising antibody responses at day 28.", "The primary endpoint for safety evaluation was the incidence of adverse reactions within 14 days.", "All recruited participants who received at least one dose were included in the primary and safety analyses.", "This study is registered with ClinicalTrials.gov, NCT04341389.", "FINDINGS: 603 volunteers were recruited and screened for eligibility between April 11 and 16, 2020.", "508 eligible participants (50% male; mean age 39\u00b77 years, SD 12\u00b75) consented to participate in the trial and were randomly assigned to receive the vaccine (1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 viral particles n=253; 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles n=129) or placebo (n=126).", "In the 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 and 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles dose groups, the RBD-specific ELISA antibodies peaked at 656\u00b75 (95% CI 575\u00b72-749\u00b72) and 571\u00b70 (467\u00b76-697\u00b73), with seroconversion rates at 96% (95% CI 93-98) and 97% (92-99), respectively, at day 28.", "Both doses of the vaccine induced significant neutralising antibody responses to live SARS-CoV-2, with GMTs of 19\u00b75 (95% CI 16\u00b78-22\u00b77) and 18\u00b73 (14\u00b74-23\u00b73) in participants receiving 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 and 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles, respectively.", "Specific interferon \u00ce\u00b3 enzyme-linked immunospot assay responses post vaccination were observed in 227 (90%, 95% CI 85-93) of 253 and 113 (88%, 81-92) of 129 participants in the 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 and 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles dose groups, respectively.", "Solicited adverse reactions were reported by 183 (72%) of 253 and 96 (74%) of 129 participants in the 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 and 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles dose groups, respectively.", "Severe adverse reactions were reported by 24 (9%) participants in the 1\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881011 viral particles dose group and one (1%) participant in the 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles dose group.", "No serious adverse reactions were documented.", "INTERPRETATION: The Ad5-vectored COVID-19 vaccine at 5\u00e2\u0080\u0088\u00d7\u00e2\u0080\u00881010 viral particles is safe, and induced significant immune responses in the majority of recipients after a single immunisation.", "FUNDING: National Key R&D Programme of China, National Science and Technology Major Project, and CanSino Biologics."]}
{"cord_id": "s6s51y4w", "title": "Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020", "abstract": ["Older adults are susceptible to severe coronavirus disease 2019 (COVID-19) outcomes as a consequence of their age and, in some cases, underlying health conditions (1).", "A COVID-19 outbreak in a long-term care skilled nursing facility (SNF) in King County, Washington that was first identified on February 28, 2020, highlighted the potential for rapid spread among residents of these types of facilities (2).", "On March 1, a health care provider at a second long-term care skilled nursing facility (facility A) in King County, Washington, had a positive test result for SARS-CoV-2, the novel coronavirus that causes COVID-19, after working while symptomatic on February 26 and 28.", "By March 6, seven residents of this second facility were symptomatic and had positive test results for SARS-CoV-2.", "On March 13, CDC performed symptom assessments and SARS-CoV-2 testing for 76 (93%) of the 82 facility A residents to evaluate the utility of symptom screening for identification of COVID-19 in SNF residents.", "Residents were categorized as asymptomatic or symptomatic at the time of testing, based on the absence or presence of fever, cough, shortness of breath, or other symptoms on the day of testing or during the preceding 14 days.", "Among 23 (30%) residents with positive test results, 10 (43%) had symptoms on the date of testing, and 13 (57%) were asymptomatic.", "Seven days after testing, 10 of these 13 previously asymptomatic residents had developed symptoms and were recategorized as presymptomatic at the time of testing.", "The reverse transcription-polymerase chain reaction (RT-PCR) testing cycle threshold (Ct) values indicated large quantities of viral RNA in asymptomatic, presymptomatic, and symptomatic residents, suggesting the potential for transmission regardless of symptoms.", "Symptom-based screening in SNFs could fail to identify approximately half of residents with COVID-19.", "Long-term care facilities should take proactive steps to prevent introduction of SARS-CoV-2 (3).", "Once a confirmed case is identified in an SNF, all residents should be placed on isolation precautions if possible (3), with considerations for extended use or reuse of personal protective equipment (PPE) as needed (4)."]}
{"cord_id": "nr0fu2qb", "title": "Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China", "abstract": ["INTRODUCTION: Transmission of COVID-19 within families and close contacts accounts for the majority of epidemic growth.", "Community mask wearing, hand washing and social distancing are thought to be effective but there is little evidence to inform or support community members on COVID-19 risk reduction within families.", "METHODS: A retrospective cohort study of 335 people in 124 families and with at least one laboratory confirmed COVID-19 case was conducted from 28 February to 27 March 2020, in Beijing, China.", "The outcome of interest was secondary transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the family.", "Characteristics and practices of primary cases, of well family contacts and household hygiene practices were analysed as predictors of secondary transmission.", "RESULTS: The secondary attack rate in families was 23.0% (77/335).", "Face mask use by the primary case and family contacts before the primary case developed symptoms was 79% effective in reducing transmission (OR=0.21, 95% CI 0.06 to 0.79).", "Daily use of chlorine or ethanol based disinfectant in households was 77% effective (OR=0.23, 95% CI 0.07 to 0.84).", "Wearing a mask after illness onset of the primary case was not significantly protective.", "The risk of household transmission was 18 times higher with frequent daily close contact with the primary case (OR=18.26, 95% CI 3.93 to 84.79), and four times higher if the primary case had diarrhoea (OR=4.10, 95% CI 1.08 to 15.60).", "Household crowding was not significant.", "CONCLUSION: The study confirms the highest risk of transmission prior to symptom onset, and provides the first evidence of the effectiveness of mask use, disinfection and social distancing in preventing COVID-19.", "We also found evidence of faecal transmission.", "This can inform guidelines for community prevention in settings of intense COVID-19 epidemics."]}
{"cord_id": "n2c2typl", "title": "Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic resulted in 5,817,385 reported cases and 362,705 deaths worldwide through May, 30, 2020,\u0086 including 1,761,503 aggregated reported cases and 103,700 deaths in the United States.\u00a7 Previous analyses during February-early April 2020 indicated that age &#8805;65 years and underlying health conditions were associated with a higher risk for severe outcomes, which were less common among children aged <18 years (1-3).", "This report describes demographic characteristics, underlying health conditions, symptoms, and outcomes among 1,320,488 laboratory-confirmed COVID-19 cases individually reported to CDC during January 22-May 30, 2020.", "Cumulative incidence, 403.6 cases per 100,000 persons,\u00b6 was similar among males (401.1) and females (406.0) and highest among persons aged &#8805;80 years (902.0).", "Among 599,636 (45%) cases with known information, 33% of persons were Hispanic or Latino of any race (Hispanic), 22% were non-Hispanic black (black), and 1.3% were non-Hispanic American Indian or Alaska Native (AI/AN).", "Among 287,320 (22%) cases with sufficient data on underlying health conditions, the most common were cardiovascular disease (32%), diabetes (30%), and chronic lung disease (18%).", "Overall, 184,673 (14%) patients were hospitalized, 29,837 (2%) were admitted to an intensive care unit (ICU), and 71,116 (5%) died.", "Hospitalizations were six times higher among patients with a reported underlying condition (45.4%) than those without reported underlying conditions (7.6%).", "Deaths were 12 times higher among patients with reported underlying conditions (19.5%) compared with those without reported underlying conditions (1.6%).", "The COVID-19 pandemic continues to be severe, particularly in certain population groups.", "These preliminary findings underscore the need to build on current efforts to collect and analyze case data, especially among those with underlying health conditions.", "These data are used to monitor trends in COVID-19 illness, identify and respond to localized incidence increase, and inform policies and practices designed to reduce transmission in the United States."]}
{"cord_id": "2b2evno8", "title": "The effect of large-scale anti-contagion policies on the COVID-19 pandemic.", "abstract": ["Governments around the world are responding to the novel coronavirus (COVID-19) pandemic1 with unprecedented policies designed to slow the growth rate of infections.", "Many actions, such as closing schools and restricting populations to their homes, impose large and visible costs on society, but their benefits cannot be directly observed and are currently understood only through process-based simulations2-4.", "Here, we compile new data on 1,717 local, regional, and national non-pharmaceutical interventions deployed in the ongoing pandemic across localities in China, South Korea, Italy, Iran, France, and the United States (US).", "We then apply reduced-form econometric methods, commonly used to measure the effect of policies on economic growth5,6, to empirically evaluate the effect that these anti-contagion policies have had on the growth rate of infections.", "In the absence of policy actions, we estimate that early infections of COVID-19 exhibit exponential growth rates of roughly 38% per day.", "We find that anti-contagion policies have significantly and substantially slowed this growth.", "Some policies have different impacts on different populations, but we obtain consistent evidence that the policy packages now deployed are achieving large, beneficial, and measurable health outcomes.", "We estimate that across these six countries, interventions prevented or delayed on the order of 62 million confirmed cases, corresponding to averting roughly 530 million total infections.", "These findings may help inform whether or when these policies should be deployed, intensified, or lifted, and they can support decision-making in the other 180+ countries where COVID-19 has been reported7."]}
{"cord_id": "3vvsa2wi", "title": "Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial", "abstract": ["BACKGROUND: There is no proven specific pharmacological treatment for patients with the acute respiratory distress syndrome (ARDS).", "The efficacy of corticosteroids in ARDS remains controversial.", "We aimed to assess the effects of dexamethasone in ARDS, which might change pulmonary and systemic inflammation and result in a decrease in duration of mechanical ventilation and mortality.", "METHODS: We did a multicentre, randomised controlled trial in a network of 17 intensive care units (ICUs) in teaching hospitals across Spain in patients with established moderate-to-severe ARDS (defined by a ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 mm Hg or less assessed with a positive end-expiratory pressure of 10 cm H2O or more and FiO2 of 0\u00b75 or more at 24 h after ARDS onset).", "Patients with brain death, terminal-stage disease, or receiving corticosteroids or immunosuppressive drugs were excluded.", "Eligible patients were randomly assigned based on balanced treatment assignments with a computerised randomisation allocation sequence using blocks of 10 opaque, sealed envelopes to receive immediate treatment with dexamethasone or continued routine intensive care (control group).", "Patients in the dexamethasone group received an intravenous dose of 20 mg once daily from day 1 to day 5, which was reduced to 10 mg once daily from day 6 to day 10.", "Patients in both groups were ventilated with lung-protective mechanical ventilation.", "Allocation concealment was maintained at all sites during the trial.", "Primary outcome was the number of ventilator-free days at 28 days, defined as the number of days alive and free from mechanical ventilation from day of randomisation to day 28.", "Secondary outcome was all-cause mortality 60 days after randomisation.", "All analyses were done according to the intention-to-treat principle.", "This study is registered with ClinicalTrials.gov, NCT01731795.", "FINDINGS: Between March 28, 2013, and Dec 31, 2018, we enrolled 277 patients and randomly assigned 139 patients to the dexamethasone group and 138 to the control group.", "The trial was stopped by the data safety monitoring board due to low enrolment rate after enrolling more than 88% (277/314) of the planned sample size.", "The mean number of ventilator-free days was higher in the dexamethasone group than in the control group (between-group difference 4\u00b78 days [95% CI 2\u00b757 to 7\u00b703]; p<0\u00b70001).", "At 60 days, 29 (21%) patients in the dexamethasone group and 50 (36%) patients in the control group had died (between-group difference -15\u00b73% [-25\u00b79 to -4\u00b79]; p=0\u00b70047).", "The proportion of adverse events did not differ significantly between the dexamethasone group and control group.", "The most common adverse events were hyperglycaemia in the ICU (105 [76%] patients in the dexamethasone group vs 97 [70%] patients in the control group), new infections in the ICU (eg, pneumonia or sepsis; 33 [24%] vs 35 [25%]), and barotrauma (14 [10%] vs 10 [7%]).", "INTERPRETATION: Early administration of dexamethasone could reduce duration of mechanical ventilation and overall mortality in patients with established moderate-to-severe ARDS.", "FUNDING: Fundaci\u00f3n Mutua Madrile\u00f1a, Instituto de Salud Carlos III, The European Regional Development's Funds, Asociaci\u00f3n Cient\u00edfica Pulm\u00f3n y Ventilaci\u00f3n Mec\u00e1nica."]}
{"cord_id": "a4jsvdhe", "title": "Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020", "abstract": ["On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic (1).", "As of March 28, 2020, a total of 571,678 confirmed COVID-19 cases and 26,494 deaths have been reported worldwide (2).", "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions (3,4).", "U.S. older adults, including those aged &#8805;65 years and particularly those aged &#8805;85 years, also appear to be at higher risk for severe COVID-19-associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported (5).", "As of March 28, 2020, U.S. states and territories have reported 122,653 U.S. COVID-19 cases to CDC, including 7,162 (5.8%) for whom data on underlying health conditions and other known risk factors for severe outcomes from respiratory infections were reported.", "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%).", "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "These preliminary findings suggest that in the United States, persons with underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections appear to be at a higher risk for severe disease from COVID-19 than are persons without these conditions."]}
{"cord_id": "akbq0ogs", "title": "Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report", "abstract": ["Abstract In March 2020, the WHO declared a pandemic of coronavirus disease 2019 (COVID-19), due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "With >8.8 million cases and >450,000 deaths reported globally, a vaccine is urgently needed.", "We report the available safety, tolerability, and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose escalation study among healthy adults, 18-55 years of age, randomized to receive 2 doses, separated by 21 days, of 10 g, 30 g, or 100 g of BNT162b1, a lipid nanoparticle-formulated, nucleoside-modified, mRNA vaccine that encodes trimerized SARS-CoV-2 spike glycoprotein RBD.", "Local reactions and systemic events were dose-dependent, generally mild to moderate, and transient.", "RBD-binding IgG concentrations and SARS-CoV-2 neutralizing titers in sera increased with dose level and after a second dose.", "Geometric mean neutralizing titers reached 1.8- to 2.8-fold that of a panel of COVID-19 convalescent human sera.", "These results support further evaluation of this mRNA vaccine candidate."]}
{"cord_id": "guvlwi3p", "title": "COVID-19 Outbreak Among College Students After a Spring Break Trip to Mexico - Austin, Texas, March 26-April 5, 2020", "abstract": ["On March 27, 2020, a University of Texas at Austin student with cough, sore throat, and shortness of breath had a positive test result for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).", "On March 28, two more symptomatic students had positive test results, alerting the COVID-19 Center at the University of Texas Health Austin (UTHA) to a potential outbreak; the center initiated an outbreak investigation the same day.", "UTHA conducted contact tracing, which linked the students' infections to a spring break trip to Cabo San Lucas, Mexico, during March 14-19.", "Among 231 persons tested for SARS-CoV-2 in this investigation, 64 (28%) had positive test results, including 60 (33%) of 183 Cabo San Lucas travelers, one of 13 (8%) household contacts of Cabo San Lucas travelers, and three (9%) of 35 community contacts of Cabo San Lucas travelers.", "Approximately one fifth of persons with positive test results were asymptomatic; no persons needed hospitalization, and none died.", "This COVID-19 outbreak among a young, healthy population with no or mild symptoms was controlled with a coordinated public health response that included rapid contact tracing and testing of all exposed persons.", "A coordinated response with contact tracing and testing of all contacts, including those who are asymptomatic, is important in controlling future COVID-19 outbreaks that might occur as schools and universities consider reopening."]}
{"cord_id": "16ff3c7m", "title": "The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin", "abstract": ["We report the change in the QT interval in 84 adult patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin combination.", "QTc prolonged maximally from baseline between days 3 and 4. in 30% of patients QTc increased by greater than 40ms.", "In 11% of patients QTc increased to >500 ms, representing high risk group for arrhythmia.", "The development of acute renal failure but not baseline QTc was a strong predictor of extreme QTc prolongation."]}
{"cord_id": "jtwb17u8", "title": "Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China", "abstract": ["BACKGROUND: The COVID-19 outbreak containment strategies in China based on non-pharmaceutical interventions (NPIs) appear to be effective.", "Quantitative research is still needed however to assess the efficacy of different candidate NPIs and their timings to guide ongoing and future responses to epidemics of this emerging disease across the World.", "METHODS: We built a travel network-based susceptible-exposed-infectious-removed (SEIR) model to simulate the outbreak across cities in mainland China.", "We used epidemiological parameters estimated for the early stage of outbreak in Wuhan to parameterise the transmission before NPIs were implemented.", "To quantify the relative effect of various NPIs, daily changes of delay from illness onset to the first reported case in each county were used as a proxy for the improvement of case identification and isolation across the outbreak.", "Historical and near-real time human movement data, obtained from Baidu location-based service, were used to derive the intensity of travel restrictions and contact reductions across China.", "The model and outputs were validated using daily reported case numbers, with a series of sensitivity analyses conducted.", "RESULTS: We estimated that there were a total of 114,325 COVID-19 cases (interquartile range [IQR] 76,776 \u2013 164,576) in mainland China as of February 29, 2020, and these were highly correlated (p<0.001, R(2)=0.86) with reported incidence.", "Without NPIs, the number of COVID-19 cases would likely have shown a 67-fold increase (IQR: 44 \u2013 94), with the effectiveness of different interventions varying.", "The early detection and isolation of cases was estimated to prevent more infections than travel restrictions and contact reductions, but integrated NPIs would achieve the strongest and most rapid effect.", "If NPIs could have been conducted one week, two weeks, or three weeks earlier in China, cases could have been reduced by 66%, 86%, and 95%, respectively, together with significantly reducing the number of affected areas.", "However, if NPIs were conducted one week, two weeks, or three weeks later, the number of cases could have shown a 3-fold, 7-fold, and 18-fold increase across China, respectively.", "Results also suggest that the social distancing intervention should be continued for the next few months in China to prevent case numbers increasing again after travel restrictions were lifted on February 17, 2020.", "CONCLUSION: The NPIs deployed in China appear to be effectively containing the COVID-19 outbreak, but the efficacy of the different interventions varied, with the early case detection and contact reduction being the most effective.", "Moreover, deploying the NPIs early is also important to prevent further spread.", "Early and integrated NPI strategies should be prepared, adopted and adjusted to minimize health, social and economic impacts in affected regions around the World."]}
{"cord_id": "msc9qsop", "title": "COVID-19 in a Long-Term Care Facility - King County, Washington, February 27-March 9, 2020", "abstract": ["On February 28, 2020, a case of coronavirus disease (COVID-19) was identified in a woman resident of a long-term care skilled nursing facility (facility A) in King County, Washington.", "* Epidemiologic investigation of facility A identified 129 cases of COVID-19 associated with facility A, including 81 of the residents, 34 staff members, and 14 visitors; 23 persons died.", "Limitations in effective infection control and prevention and staff members working in multiple facilities contributed to intra- and interfacility spread.", "COVID-19 can spread rapidly in long-term residential care facilities, and persons with chronic underlying medical conditions are at greater risk for COVID-19-associated severe disease and death.", "Long-term care facilities should take proactive steps to protect the health of residents and preserve the health care workforce by identifying and excluding potentially infected staff members and visitors, ensuring early recognition of potentially infected patients, and implementing appropriate infection control measures."]}
{"cord_id": "zpv5f8pr", "title": "COVID-19 Antibody Seroprevalence in Santa Clara County, California", "abstract": ["Background Addressing COVID-19 is a pressing health and social concern.", "To date, many epidemic projections and policies addressing COVID-19 have been designed without seroprevalence data to inform epidemic parameters.", "We measured the seroprevalence of antibodies to SARS-CoV-2 in Santa Clara County.", "Methods On 4/3-4/4, 2020, we tested county residents for antibodies to SARS-CoV-2 using a lateral flow immunoassay.", "Participants were recruited using Facebook ads targeting a representative sample of the county by demographic and geographic characteristics.", "We report the prevalence of antibodies to SARS-CoV-2 in a sample of 3,330 people, adjusting for zip code, sex, and race/ethnicity.", "We also adjust for test performance characteristics using 3 different estimates: (i) the test manufacturer's data, (ii) a sample of 37 positive and 30 negative controls tested at Stanford, and (iii) a combination of both.", "Results The unadjusted prevalence of antibodies to SARS-CoV-2 in Santa Clara County was 1.5% (exact binomial 95CI 1.11-1.97%), and the population-weighted prevalence was 2.81% (95CI 2.24-3.37%).", "Under the three scenarios for test performance characteristics, the population prevalence of COVID-19 in Santa Clara ranged from 2.49% (95CI 1.80-3.17%) to 4.16% (2.58-5.70%).", "These prevalence estimates represent a range between 48,000 and 81,000 people infected in Santa Clara County by early April, 50-85-fold more than the number of confirmed cases.", "Conclusions The population prevalence of SARS-CoV-2 antibodies in Santa Clara County implies that the infection is much more widespread than indicated by the number of confirmed cases.", "Population prevalence estimates can now be used to calibrate epidemic and mortality projections."]}
{"cord_id": "w25jpub7", "title": "The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity", "abstract": ["SARS coronavirus 2 (SARS-CoV-2) isolates encoding a D614G mutation in the viral spike (S) protein predominate over time in locales where it is found, implying that this change enhances viral transmission.", "We therefore compared the functional properties of the S proteins with aspartic acid (S(D614)) and glycine (S(G614)) at residue 614.", "We observed that retroviruses pseudotyped with S(G614) infected ACE2-expressing cells markedly more efficiently than those with S(D614).", "This greater infectivity was correlated with less S1 shedding and greater incorporation of the S protein into the pseudovirion.", "Similar results were obtained using the virus-like particles produced with SARS-CoV-2 M, N, E, and S proteins.", "However, S(G614) did not bind ACE2 more efficiently than S(D614), and the pseudoviruses containing these S proteins were neutralized with comparable efficiencies by convalescent plasma.", "These results show S(G614) is more stable than S(D614), consistent with epidemiological data suggesting that viruses with S(G614) transmit more efficiently."]}
{"cord_id": "0phcscz8", "title": "Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region", "abstract": ["Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic.", "The percentage of infected individuals who seroconvert is still an open question.", "In addition, it has been shown in some individuals that viral genome can still be detected at considerable time post symptom resolution.", "Here we investigated both seroconversion and PCR-positivity in a large cohort of convalescent serum donors in New York City.", "Methods: Individuals with confirmed or suspected SARS-CoV-2 infection were screened via PCR for presence of viral genome and via enzyme-linked immunosorbent assay for presence of anti SARS-CoV-2 spike antibodies.", "Results: All but three confirmed SARS-CoV-2 patients seroconverted to the SARS-CoV-2 spike while only 37.4% of suspected SARS-CoV-2 patients seroconverted.", "PCR-positivity was detected up to 28 days from symptom resolution.", "Conclusions: Here we show that the vast majority of confirmed COVID19 patients seroconvert, potentially providing immunity to reinfection.", "We also report that in a large proportion of individuals, viral genome can be detected via PCR in the upper respiratory tract for weeks post symptom resolution, but it is unclear if this signal represents infectious virus."]}
{"cord_id": "4s57ls6y", "title": "Identification of natural compounds with antiviral activities against SARS-associated coronavirus", "abstract": ["More than 200 Chinese medicinal herb extracts were screened for antiviral activities against Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay for virus-induced cytopathic effect (CPE).", "Four of these extracts showed moderate to potent antiviral activities against SARS-CoV with 50% effective concentration (EC(50)) ranging from 2.4 \u00b1 0.2 to 88.2 \u00b1 7.7 \u03bcg/ml.", "Out of the four, Lycoris radiata was most potent.", "To identify the active component, L. radiata extract was subjected to further fractionation, purification, and CPE/MTS assays.", "This process led to the identification of a single substance lycorine as an anti-SARS-CoV component with an EC(50) value of 15.7 \u00b1 1.2 nM.", "This compound has a CC(50) value of 14980.0 \u00b1 912.0 nM in cytotoxicity assay and a selective index (SI) greater than 900.", "The results suggested that four herbal extracts and the compound lycorine are candidates for the development of new anti-SARS-CoV drugs in the treatment of SARS."]}
{"cord_id": "rvxkt60m", "title": "The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study", "abstract": ["Summary Background In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, emerged in Wuhan, China.", "Since then, the city of Wuhan has taken unprecedented measures in response to the outbreak, including extended school and workplace closures.", "We aimed to estimate the effects of physical distancing measures on the progression of the COVID-19 epidemic, hoping to provide some insights for the rest of the world.", "Methods To examine how changes in population mixing have affected outbreak progression in Wuhan, we used synthetic location-specific contact patterns in Wuhan and adapted these in the presence of school closures, extended workplace closures, and a reduction in mixing in the general community.", "Using these matrices and the latest estimates of the epidemiological parameters of the Wuhan outbreak, we simulated the ongoing trajectory of an outbreak in Wuhan using an age-structured susceptible-exposed-infected-removed (SEIR) model for several physical distancing measures.", "We fitted the latest estimates of epidemic parameters from a transmission model to data on local and internationally exported cases from Wuhan in an age-structured epidemic framework and investigated the age distribution of cases.", "We also simulated lifting of the control measures by allowing people to return to work in a phased-in way and looked at the effects of returning to work at different stages of the underlying outbreak (at the beginning of March or April).", "Findings Our projections show that physical distancing measures were most effective if the staggered return to work was at the beginning of April; this reduced the median number of infections by more than 92% (IQR 66\u201397) and 24% (13\u201390) in mid-2020 and end-2020, respectively.", "There are benefits to sustaining these measures until April in terms of delaying and reducing the height of the peak, median epidemic size at end-2020, and affording health-care systems more time to expand and respond.", "However, the modelled effects of physical distancing measures vary by the duration of infectiousness and the role school children have in the epidemic.", "Interpretation Restrictions on activities in Wuhan, if maintained until April, would probably help to delay the epidemic peak.", "Our projections suggest that premature and sudden lifting of interventions could lead to an earlier secondary peak, which could be flattened by relaxing the interventions gradually.", "However, there are limitations to our analysis, including large uncertainties around estimates of R 0 and the duration of infectiousness.", "Funding Bill & Melinda Gates Foundation, National Institute for Health Research, Wellcome Trust, and Health Data Research UK."]}
{"cord_id": "v6frcc5r", "title": "Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis", "abstract": ["Background: COVID-19 patients with chronic diseases such as hypertension, diabetes and coronary heart diseases is more likely to worsen, but with mixed results for COVID-19 severity.", "This meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and COVID-19 disease severity.", "Methods: Available data from PubMed, Web of Science, China National Knowledge Infrastructure Database, WanFang Database and VIP Database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (OR) with 95% CIs.", "Funnel plots and Begg's were used to assess publication bias.", "Findings: Of 182 articles found following our initial search, we assessed 34 full-text articles, of which 9 articles with 1936 COVID-19 patients met all selection criteria for our meta-analysis.", "No significant heterogeneity between studies.", "There were significant correlations between COVID-19 severity and hypertension [OR=2.3 [95% CI (1.76, 3.00), P<0.01], diabetes [OR=2.67, 95% CI (1.91, 3.74), P<0.01], coronary heart disease [OR=2.85 [95% CI (1.68, 4.84), P<0.01].", "Most of the studies in the funnel plot are on the upper part and few on the base part, and are roughly symmetrical left and right.", "Begg's test: hypertension (Z=-0.1, P=1.0), diabetes (Z=0.73, P=0.466), coronary heart disease (Z=0.38, P=0.707), all found no publication bias.", "Interpretation: Hypertension, diabetes, and coronary heart disease can affect the severity of COVID-19.", "It may be related to the imbalance of angiotensin-converting enzyme 2 (ACE2) and the cytokine storm induced by Glucolipid metabolic disorders (GLMD)."]}
{"cord_id": "1ul8owic", "title": "Air pollution and case fatality of SARS in the People's Republic of China: an ecologic study", "abstract": ["BACKGROUND: Severe acute respiratory syndrome (SARS) has claimed 349 lives with 5,327 probable cases reported in mainland China since November 2002.", "SARS case fatality has varied across geographical areas, which might be partially explained by air pollution level.", "METHODS: Publicly accessible data on SARS morbidity and mortality were utilized in the data analysis.", "Air pollution was evaluated by air pollution index (API) derived from the concentrations of particulate matter, sulfur dioxide, nitrogen dioxide, carbon monoxide and ground-level ozone.", "Ecologic analysis was conducted to explore the association and correlation between air pollution and SARS case fatality via model fitting.", "Partially ecologic studies were performed to assess the effects of long-term and short-term exposures on the risk of dying from SARS.", "RESULTS: Ecologic analysis conducted among 5 regions with 100 or more SARS cases showed that case fatality rate increased with the increment of API (case fatality = - 0.063 + 0.001 * API).", "Partially ecologic study based on short-term exposure demonstrated that SARS patients from regions with moderate APIs had an 84% increased risk of dying from SARS compared to those from regions with low APIs (RR = 1.84, 95% CI: 1.41\u20132.40).", "Similarly, SARS patients from regions with high APIs were twice as likely to die from SARS compared to those from regions with low APIs.", "(RR = 2.18, 95% CI: 1.31\u20133.65).", "Partially ecologic analysis based on long-term exposure to ambient air pollution showed the similar association.", "CONCLUSION: Our studies demonstrated a positive association between air pollution and SARS case fatality in Chinese population by utilizing publicly accessible data on SARS statistics and air pollution indices.", "Although ecologic fallacy and uncontrolled confounding effect might have biased the results, the possibility of a detrimental effect of air pollution on the prognosis of SARS patients deserves further investigation."]}
{"cord_id": "ws0s2qk1", "title": "Smoking is Associated with COVID-19 Progression: A Meta-Analysis", "abstract": ["Objective: To determine the association between smoking and progression of COVID-19.", "Design: A meta-analysis of 12 published papers.", "Data Source: PubMed database was searched on April 6, 2020.", "Eligibility criteria and data analysis: We included studies reporting smoking behavior of COVID-19 patients and progression of disease.", "Search terms included smoking, smoker*, characteristics, risk factors, outcomes, and COVID-19, COVID, coronavirus, sar cov-2, sar cov 2.", "There were no language limitations.", "One author extracted information for each study, screened the abstract or the full text, with questions resolved through discussion among both authors.", "A random effects meta-analysis was applied.", "Main Outcome Measures: The study outcome was progression of COVID-19 among people who already had the disease.", "Results: We identified 12 papers with a total of 9,025 COVID-19 patients, 878 (9.7%) with severe disease and 495 with a history of smoking (5.5%).", "The meta-analysis showed a significant association between smoking and progression of COVID-19 (OR 2.25, 95% CI 1.49-3.39, p=0.001).", "Limitations in the 12 papers suggest that the actual risk of smoking may be higher.", "Conclusions: Smoking is a risk factor for progression of COVID-19, with smokers having higher odds of COVID-19 progression than never smokers.", "Physicians and public health professionals should collect data on smoking as part of clinical management and add smoking cessation to the list of practices to blunt the COVID-19 pandemic."]}
{"cord_id": "lafh3w44", "title": "Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019", "abstract": ["This cohort study examines the clinical characteristics of men with coronavirus disease 2019 whose semen tested positive for severe acute respiratory syndrome coronavirus 2."]}
{"cord_id": "1zbsbcdd", "title": "Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States", "abstract": ["Detection of SARS-CoV-2 infections to date has relied heavily on RT-PCR testing.", "However, limited test availability, high false-negative rates, and the existence of asymptomatic or sub-clinical infections have resulted in an under-counting of the true prevalence of SARS-CoV-2.", "Here, we show how influenza-like illness (ILI) outpatient surveillance data can be used to estimate the prevalence of SARS-CoV-2.", "We found a surge of non-influenza ILI above the seasonal average in March 2020 and showed that this surge correlated with COVID-19 case counts across states.", "If 1/3 of patients infected with SARS-CoV-2 in the US sought care, this ILI surge would have corresponded to more than 8.7 million new SARS-CoV-2 infections across the US during the three-week period from March 8 to March 28, 2020.", "Combining excess ILI counts with the date of onset of community transmission in the US, we also show that the early epidemic in the US was unlikely to have been doubling slower than every 4 days.", "Together these results suggest a conceptual model for the COVID-19 epidemic in the US characterized by rapid spread across the US with over 80% infected patients remaining undetected.", "We emphasize the importance of testing these findings with seroprevalence data and discuss the broader potential to use syndromic surveillance for early detection and understanding of emerging infectious diseases."]}
{"cord_id": "doq1w0gx", "title": "Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020", "abstract": ["As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States (1,2).", "In the United States, 22% of the population is made up of infants, children, and adolescents aged <18 years (children) (3).", "Data from China suggest that pediatric COVID-19 cases might be less severe than cases in adults and that children might experience different symptoms than do adults (4,5); however, disease characteristics among pediatric patients in the United States have not been described.", "Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12-April 2, 2020 were analyzed.", "Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years.", "Data were available for a small proportion of patients on many important variables, including symptoms (9.4%), underlying conditions (13%), and hospitalization status (33%).", "Among those with available information, 73% of pediatric patients had symptoms of fever, cough, or shortness of breath compared with 93% of adults aged 18-64 years during the same period; 5.7% of all pediatric patients, or 20% of those for whom hospitalization status was known, were hospitalized, lower than the percentages hospitalized among all adults aged 18-64 years (10%) or those with known hospitalization status (33%).", "Three deaths were reported among the pediatric cases included in this analysis.", "These data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults (4).", "Whereas most COVID-19 cases in children are not severe, serious COVID-19 illness resulting in hospitalization still occurs in this age group.", "Social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission (6,7)."]}
{"cord_id": "v0gngwzx", "title": "Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome", "abstract": ["Abstract Objective This study was undertaken to evaluate the pregnancy and perinatal outcomes of pregnant women with severe acute respiratory syndrome (SARS).", "Study design All pregnant women (12) who presented with SARS in Hong Kong between February 1 and July 31, 2003, were included.", "The pregnancy and perinatal outcomes were collected.", "Evidence of perinatal transmission of virus was assessed with the SARS-associated coronavirus reverse-transcriptase polymerase chain reaction on cord blood, placenta tissue, and subsequent follow-up of the neonate on serology.", "Results Three deaths occurred among the 12 patients, giving a case fatality rate of 25%.", "Four of the 7 patients (57%) who presented in the first trimester had spontaneous miscarriage.", "Four of the 5 patients who presented after 24 weeks were delivered preterm.", "Two mothers recovered without delivery, but their ongoing pregnancies were complicated by intrauterine growth restriction.", "No newborn infant had clinical SARS and all investigations were negative for SARS.", "Conclusion SARS during pregnancy is associated with high incidences of spontaneous miscarriage, preterm delivery, and intrauterine growth restriction.", "There is no evidence of perinatal SARS infection among infants born to these mothers."]}
{"cord_id": "nwwutduy", "title": "Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model", "abstract": ["Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic global impact on public health, social, and economic infrastructures.", "Here, we assess immunogenicity and anamnestic protective efficacy in rhesus macaques of the intradermal (ID)-delivered SARS-CoV-2 spike DNA vaccine, INO-4800.", "INO-4800 is an ID-delivered DNA vaccine currently being evaluated in clinical trials.", "Vaccination with INO-4800 induced T cell responses and neutralizing antibody responses against both the D614 and G614 SARS-CoV-2 spike proteins.", "Several months after vaccination, animals were challenged with SARS-CoV-2 resulting in rapid recall of anti-SARS-CoV-2 spike protein T and B cell responses.", "These responses were associated with lower viral loads in the lung and with faster nasal clearance of virus.", "These studies support the immune impact of INO-4800 for inducing both humoral and cellular arms of the adaptive immune system which are likely important for providing durable protection against COVID-19 disease."]}
{"cord_id": "43ocdbp5", "title": "Autoantibodies against type I IFNs in patients with life-threatening COVID-19", "abstract": ["Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast.", "We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-\u03c9 (IFN-\u03c9) (13 patients), against the 13 types of IFN-\u03b1 (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs.", "The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro.", "These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals.", "Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men.", "A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men."]}
{"cord_id": "puwaty70", "title": "SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months", "abstract": ["SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities.", "Questions regarding the robustness, functionality and longevity of the antibody response to the virus remain unanswered.", "Here we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, based on a dataset of 19,860 individuals screened at Mount Sinai Health System in New York City.", "We also show that titers are stable for at least a period approximating three months, and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.", "Our data suggests that more than 90% of seroconverters make detectible neutralizing antibody responses and that these titers are stable for at least the near-term future."]}
{"cord_id": "hmkqnply", "title": "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial", "abstract": ["BACKGROUND: This is the first randomised controlled trial for assessment of the immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate dose of the candidate vaccine for an efficacy study.", "METHODS: This randomised, double-blind, placebo-controlled, phase 2 trial of the Ad5-vectored COVID-19 vaccine was done in a single centre in Wuhan, China.", "Healthy adults aged 18 years or older, who were HIV-negative and previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-free, were eligible to participate and were randomly assigned to receive the vaccine at a dose of 1 \u00d7 10(11) viral particles per mL or 5 \u00d7 10(10) viral particles per mL, or placebo.", "Investigators allocated participants at a ratio of 2:1:1 to receive a single injection intramuscularly in the arm.", "The randomisation list (block size 4) was generated by an independent statistician.", "Participants, investigators, and staff undertaking laboratory analyses were masked to group allocation.", "The primary endpoints for immunogenicity were the geometric mean titres (GMTs) of specific ELISA antibody responses to the receptor binding domain (RBD) and neutralising antibody responses at day 28.", "The primary endpoint for safety evaluation was the incidence of adverse reactions within 14 days.", "All recruited participants who received at least one dose were included in the primary and safety analyses.", "This study is registered with ClinicalTrials.gov, NCT04341389.", "FINDINGS: 603 volunteers were recruited and screened for eligibility between April 11 and 16, 2020.", "508 eligible participants (50% male; mean age 39\u00b77 years, SD 12\u00b75) consented to participate in the trial and were randomly assigned to receive the vaccine (1 \u00d7 10(11) viral particles n=253; 5 \u00d7 10(10) viral particles n=129) or placebo (n=126).", "In the 1 \u00d7 10(11) and 5 \u00d7 10(10) viral particles dose groups, the RBD-specific ELISA antibodies peaked at 656\u00b75 (95% CI 575\u00b72\u2013749\u00b72) and 571\u00b70 (467\u00b76\u2013697\u00b73), with seroconversion rates at 96% (95% CI 93\u201398) and 97% (92\u201399), respectively, at day 28.", "Both doses of the vaccine induced significant neutralising antibody responses to live SARS-CoV-2, with GMTs of 19\u00b75 (95% CI 16\u00b78\u201322\u00b77) and 18\u00b73 (14\u00b74\u201323\u00b73) in participants receiving 1 \u00d7 10(11) and 5 \u00d7 10(10) viral particles, respectively.", "Specific interferon \u03b3 enzyme-linked immunospot assay responses post vaccination were observed in 227 (90%, 95% CI 85\u201393) of 253 and 113 (88%, 81\u201392) of 129 participants in the 1 \u00d7 10(11) and 5 \u00d7 10(10) viral particles dose groups, respectively.", "Solicited adverse reactions were reported by 183 (72%) of 253 and 96 (74%) of 129 participants in the 1 \u00d7 10(11) and 5 \u00d7 10(10) viral particles dose groups, respectively.", "Severe adverse reactions were reported by 24 (9%) participants in the 1 \u00d7 10(11) viral particles dose group and one (1%) participant in the 5 \u00d7 10(10) viral particles dose group.", "No serious adverse reactions were documented.", "INTERPRETATION: The Ad5-vectored COVID-19 vaccine at 5 \u00d7 10(10) viral particles is safe, and induced significant immune responses in the majority of recipients after a single immunisation.", "FUNDING: National Key R&D Programme of China, National Science and Technology Major Project, and CanSino Biologics."]}
{"cord_id": "9dfaqsv7", "title": "Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection", "abstract": ["There is an urgent need to develop efficacious vaccines against SARS-CoV-2 that also address the issues of deployment, equitable access, and vaccine acceptance.", "Ideally, the vaccine would prevent virus infection and transmission as well as preventing COVID-19 disease.", "We previously developed an oral adenovirus-based vaccine technology that induces both mucosal and systemic immunity in humans.", "Here we investigate the immunogenicity of a range of candidate adenovirusbased vaccines, expressing full or partial sequences of the spike and nucleocapsid proteins, in mice.", "We demonstrate that, compared to expression of the S1 domain or a stabilized spike antigen, the full length, wild-type spike antigen induces significantly higher neutralizing antibodies in the periphery and in the lungs, when the vaccine is administered mucosally.", "Antigen-specific CD4+ and CD8+ T cells were induced by this leading vaccine candidate at low and high doses.", "This fulllength spike antigen plus nucleocapsid adenovirus construct has been prioritized for further clinical development."]}
{"cord_id": "n3swuykg", "title": "Multisystem inflammatory syndrome in children: A systematic review", "abstract": ["BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that is temporally associated with coronavirus disease 2019 (COVID-19).", "We aimed to describe the typical presentation and outcomes of children diagnosed with this hyperinflammatory condition.", "METHODS: We conducted a systematic review to communicate the clinical signs and symptoms, laboratory findings, imaging results, and outcomes of individuals with MIS-C. We searched four medical databases to encompass studies characterizing MIS-C from January 1st, 2020 to July 25th, 2020.", "Two independent authors screened articles, extracted data, and assessed risk of bias.", "This review was registered with PROSPERO CRD42020191515.", "FINDINGS: Our search yielded 39 observational studies (n = 662 patients).", "While 71\u00b70% of children (n = 470) were admitted to the intensive care unit, only 11 deaths (1\u00b77%) were reported.", "Average length of hospital stay was 7\u00b79 \u00b1 0\u00b76 days.", "Fever (100%, n = 662), abdominal pain or diarrhea (73\u00b77%, n = 488), and vomiting (68\u00b73%, n = 452) were the most common clinical presentation.", "Serum inflammatory, coagulative, and cardiac markers were considerably abnormal.", "Mechanical ventilation and extracorporeal membrane oxygenation were necessary in 22\u00b72% (n = 147) and 4\u00b74% (n = 29) of patients, respectively.", "An abnormal echocardiograph was observed in 314 of 581 individuals (54\u00b70%) with depressed ejection fraction (45\u00b71%, n = 262 of 581) comprising the most common aberrancy.", "INTERPRETATION: Multisystem inflammatory syndrome is a new pediatric disease associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is dangerous and potentially lethal.", "With prompt recognition and medical attention, most children will survive but the long-term outcomes from this condition are presently unknown.", "FUNDING: Parker B. Francis and pilot grant from 2R25-HL126140.", "Funding agencies had no involvement in the study"]}
{"cord_id": "8f76vhyz", "title": "Age-dependent effects in the transmission and control of COVID-19 epidemics", "abstract": ["The COVID-19 pandemic has shown a markedly low proportion of cases among children.", "Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms, or both.", "We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from six countries.", "We estimate that clinical symptoms occur in 25% (95% CrI: 19-32%) of infections in 10-19-year-olds, rising to 76% (68-82%) in over-70s, and that susceptibility to infection in under-20s is approximately half that of older adults.", "Accordingly, we find that interventions aimed at children may have a relatively small impact on total cases, particularly if the transmissibility of subclinical infections is low.", "The age-specific clinical fraction and susceptibility we have estimated has implications for the expected global burden of COVID-19 because of demographic differences across settings: in younger populations, the expected clinical attack rate would be lower, although it is likely that comorbidities in low-income countries will affect disease severity.", "Without effective control measures, regions with older populations may see disproportionally more clinical cases, particularly in the later stages of the pandemic."]}
{"cord_id": "q44yuued", "title": "Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance", "abstract": ["The COVID-19 pandemic has created a public health crisis.", "Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central.", "After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential growth of virus, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance.", "Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time.", "These results demonstrate that effective surveillance, including time to first detection and outbreak control, depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity.", "We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary."]}
{"cord_id": "opckeugf", "title": "Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients", "abstract": ["OBJECTIVES: Because detection of SARS-CoV-2 RNA in aerosols but failure to isolate viable (infectious) virus are commonly reported, there is substantial controversy whether SARS-CoV-2 can be transmitted through aerosols.", "This conundrum occurs because common air samplers can inactivate virions through their harsh collection processes.", "We sought to resolve the question whether viable SARS-CoV-2 can occur in aerosols using VIVAS air samplers that operate on a gentle water-vapor condensation principle.", "METHODS: Air samples collected in the hospital room of two COVID-19 patients, one ready for discharge, the other newly admitted, were subjected to RT-qPCR and virus culture.", "The genomes of the SARS-CoV-2 collected from the air and isolated in cell culture were sequenced.", "RESULTS: Viable SARS-CoV-2 was isolated from air samples collected 2 to 4.8 m away from the patients.", "The genome sequence of the SARS-CoV-2 strain isolated from the material collected by the air samplers was identical to that isolated from the newly admitted patient.", "Estimates of viable viral concentrations ranged from 6 to 74 TCID(50) units/L of air.", "CONCLUSIONS: Patients with respiratory manifestations of COVID-19 produce aerosols in the absence of aerosol-generating procedures that contain viable SARS-CoV-2, and these aerosols may serve as a source of transmission of the virus."]}
{"cord_id": "3z0ejutr", "title": "Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea", "abstract": ["Importance: There is limited information describing the full spectrum of coronavirus disease 2019 (COVID-19) and the duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detection in children.", "Objective: To analyze the full clinical course and the duration of SARS-CoV-2 RNA detectability in children confirmed with COVID-19 in the Republic of Korea, where rigorous public health interventions have been implemented.", "Design, Setting, and Participants: This case series of children with COVID-19 was conducted in 20 hospitals and 2 nonhospital isolation facilities across the country from February 18, 2020, to March 31, 2020.", "Children younger than 19 years who had COVID-19 were included.", "Exposures: Confirmed COVID-19, detected via SARS-CoV-2 RNA in a combined nasopharyngeal and oropharyngeal swab or sputum by real-time reverse transcription-polymerase chain reaction.", "Main Outcomes and Measures: Clinical manifestations during the observation period, including the time and duration of symptom occurrence.", "The duration of SARS-CoV-2 RNA detection was also analyzed.", "Results: A total of 91 children with COVID-19 were included (median [range] age, 11 [0-18] years; 53 boys [58%]).", "Twenty children (22%) were asymptomatic during the entire observation period.", "Among 71 symptomatic cases, 47 children (66%) had unrecognized symptoms before diagnosis, 18 (25%) developed symptoms after diagnosis, and only 6 (9%) were diagnosed at the time of symptom onset.", "Twenty-two children (24%) had lower respiratory tract infections.", "The mean (SD) duration of the presence of SARS-CoV-2 RNA in upper respiratory samples was 17.6 (6.7) days.", "Virus RNA was detected for a mean (SD) of 14.1 (7.7) days in asymptomatic individuals.", "There was no difference in the duration of virus RNA detection between children with upper respiratory tract infections and lower respiratory tract infections (mean [SD], 18.7 [5.8] days vs 19.9 [5.6] days; P = .54).", "Fourteen children (15%) were treated with lopinavir-ritonavir and/or hydroxychloroquine.", "All recovered, without any fatal cases.", "Conclusions and Relevance: In this case series study, inapparent infections in children may have been associated with silent COVID-19 transmission in the community.", "Heightened surveillance using laboratory screening will allow detection in children with unrecognized SARS-CoV-2 infection."]}
{"cord_id": "461ey6hw", "title": "Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial", "abstract": ["Importance: Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19), but further data from randomized clinical trials are needed.", "Objective: To evaluate the efficacy and adverse effects of convalescent plasma therapy for patients with COVID-19.", "Design, Setting, and Participants: Open-label, multicenter, randomized clinical trial performed in 7 medical centers in Wuhan, China, from February 14, 2020, to April 1, 2020, with final follow-up April 28, 2020.", "The trial included 103 participants with laboratory-confirmed COVID-19 that was severe (respiratory distress and/or hypoxemia) or life-threatening (shock, organ failure, or requiring mechanical ventilation).", "The trial was terminated early after 103 of a planned 200 patients were enrolled.", "Intervention: Convalescent plasma in addition to standard treatment (n = 52) vs standard treatment alone (control) (n = 51), stratified by disease severity.", "Main Outcomes and Measures: Primary outcome was time to clinical improvement within 28 days, defined as patient discharged alive or reduction of 2 points on a 6-point disease severity scale (ranging from 1 [discharge] to 6 [death]).", "Secondary outcomes included 28-day mortality, time to discharge, and the rate of viral polymerase chain reaction (PCR) results turned from positive at baseline to negative at up to 72 hours.", "Results: Of 103 patients who were randomized (median age, 70 years; 60 [58.3%] male), 101 (98.1%) completed the trial.", "Clinical improvement occurred within 28 days in 51.9% (27/52) of the convalescent plasma group vs 43.1% (22/51) in the control group (difference, 8.8% [95% CI, -10.4% to 28.0%]; hazard ratio [HR], 1.40 [95% CI, 0.79-2.49]; P = .26).", "Among those with severe disease, the primary outcome occurred in 91.3% (21/23) of the convalescent plasma group vs 68.2% (15/22) of the control group (HR, 2.15 [95% CI, 1.07-4.32]; P = .03); among those with life-threatening disease the primary outcome occurred in 20.7% (6/29) of the convalescent plasma group vs 24.1% (7/29) of the control group (HR, 0.88 [95% CI, 0.30-2.63]; P = .83) (P for interaction = .17).", "There was no significant difference in 28-day mortality (15.7% vs 24.0%; OR, 0.59 [95% CI, 0.22-1.59]; P = .30) or time from randomization to discharge (51.0% vs 36.0% discharged by day 28; HR, 1.61 [95% CI, 0.88-2.95]; P = .12).", "Convalescent plasma treatment was associated with a negative conversion rate of viral PCR at 72 hours in 87.2% of the convalescent plasma group vs 37.5% of the control group (OR, 11.39 [95% CI, 3.91-33.18]; P < .001).", "Two patients in the convalescent plasma group experienced adverse events within hours after transfusion that improved with supportive care.", "Conclusion and Relevance: Among patients with severe or life-threatening COVID-19, convalescent plasma therapy added to standard treatment, compared with standard treatment alone, did not result in a statistically significant improvement in time to clinical improvement within 28 days.", "Interpretation is limited by early termination of the trial, which may have been underpowered to detect a clinically important difference.", "Trial Registration: Chinese Clinical Trial Registry: ChiCTR2000029757."]}
{"cord_id": "qtzhfnr6", "title": "Coronavirus Disease Outbreak in Call Center, South Korea", "abstract": ["We describe the epidemiology of a coronavirus disease (COVID-19) outbreak in a call center in South Korea.", "We obtained information on demographic characteristics by using standardized epidemiologic investigation forms.", "We performed descriptive analyses and reported the results as frequencies and proportions for categoric variables.", "Of 1,143 persons who were tested for COVID-19, a total of 97 (8.5%, 95% CI 7.0%\u201310.3%) had confirmed cases.", "Of these, 94 were working in an 11th-floor call center with 216 employees, translating to an attack rate of 43.5% (95% CI 36.9%\u201350.4%).", "The household secondary attack rate among symptomatic case-patients was 16.2% (95% CI 11.6%\u2013 22.0%).", "Of the 97 persons with confirmed COVID-19, only 4 (1.9%) remained asymptomatic within 14 days of quarantine, and none of their household contacts acquired secondary infections.", "Extensive contact tracing, testing all contacts, and early quarantine blocked further transmission and might be effective for containing rapid outbreaks in crowded work settings."]}
{"cord_id": "tl39u0h9", "title": "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial", "abstract": ["BACKGROUND: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination.", "We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of SARS-CoV-2.", "METHODS: We did a phase 1/2, single-blind, randomised controlled trial in five trial sites in the UK of a chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19) expressing the SARS-CoV-2 spike protein compared with a meningococcal conjugate vaccine (MenACWY) as control.", "Healthy adults aged 18\u201355 years with no history of laboratory confirmed SARS-CoV-2 infection or of COVID-19-like symptoms were randomly assigned (1:1) to receive ChAdOx1 nCoV-19 at a dose of 5 \u00d7 10(10) viral particles or MenACWY as a single intramuscular injection.", "A protocol amendment in two of the five sites allowed prophylactic paracetamol to be administered before vaccination.", "Ten participants assigned to a non-randomised, unblinded ChAdOx1 nCoV-19 prime-boost group received a two-dose schedule, with the booster vaccine administered 28 days after the first dose.", "Humoral responses at baseline and following vaccination were assessed using a standardised total IgG ELISA against trimeric SARS-CoV-2 spike protein, a muliplexed immunoassay, three live SARS-CoV-2 neutralisation assays (a 50% plaque reduction neutralisation assay [PRNT(50)]; a microneutralisation assay [MNA(50), MNA(80), and MNA(90)]; and Marburg VN), and a pseudovirus neutralisation assay.", "Cellular responses were assessed using an ex-vivo interferon-\u03b3 enzyme-linked immunospot assay.", "The co-primary outcomes are to assess efficacy, as measured by cases of symptomatic virologically confirmed COVID-19, and safety, as measured by the occurrence of serious adverse events.", "Analyses were done by group allocation in participants who received the vaccine.", "Safety was assessed over 28 days after vaccination.", "Here, we report the preliminary findings on safety, reactogenicity, and cellular and humoral immune responses.", "The study is ongoing, and was registered at ISRCTN, 15281137, and ClinicalTrials.gov, NCT04324606.", "FINDINGS: Between April 23 and May 21, 2020, 1077 participants were enrolled and assigned to receive either ChAdOx1 nCoV-19 (n=543) or MenACWY (n=534), ten of whom were enrolled in the non-randomised ChAdOx1 nCoV-19 prime-boost group.", "Local and systemic reactions were more common in the ChAdOx1 nCoV-19 group and many were reduced by use of prophylactic paracetamol, including pain, feeling feverish, chills, muscle ache, headache, and malaise (all p<0\u00b705).", "There were no serious adverse events related to ChAdOx1 nCoV-19.", "In the ChAdOx1 nCoV-19 group, spike-specific T-cell responses peaked on day 14 (median 856 spot-forming cells per million peripheral blood mononuclear cells, IQR 493\u20131802; n=43).", "Anti-spike IgG responses rose by day 28 (median 157 ELISA units [EU], 96\u2013317; n=127), and were boosted following a second dose (639 EU, 360\u2013792; n=10).", "Neutralising antibody responses against SARS-CoV-2 were detected in 32 (91%) of 35 participants after a single dose when measured in MNA(80) and in 35 (100%) participants when measured in PRNT(50).", "After a booster dose, all participants had neutralising activity (nine of nine in MNA(80) at day 42 and ten of ten in Marburg VN on day 56).", "Neutralising antibody responses correlated strongly with antibody levels measured by ELISA (R(2)=0\u00b767 by Marburg VN; p<0\u00b7001).", "INTERPRETATION: ChAdOx1 nCoV-19 showed an acceptable safety profile, and homologous boosting increased antibody responses.", "These results, together with the induction of both humoral and cellular immune responses, support large-scale evaluation of this candidate vaccine in an ongoing phase 3 programme.", "FUNDING: UK Research and Innovation, Coalition for Epidemic Preparedness Innovations, National Institute for Health Research (NIHR), NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and the German Center for Infection Research (DZIF), Partner site Gie\u00dfen-Marburg-Langen."]}
{"cord_id": "y5j08qu7", "title": "Dynamics and significance of the antibody response to SARS-CoV-2 infection", "abstract": ["BACKGROUND: Characterizing the humoral immune response to SARS-CoV-2 and developing accurate serologic assays are needed for diagnostic purposes and estimating population-level seroprevalence.", "METHODS: We measured the kinetics of early antibody responses to the receptor-binding domain (RBD) of the spike (S) protein of SARS-CoV-2 in a cohort of 259 symptomatic North American patients infected with SARS-CoV-2 (up to 75 days after symptom onset) compared to antibody levels in 1548 individuals whose blood samples were obtained prior to the pandemic.", "RESULTS: Between 14\u201328 days from onset of symptoms, IgG, IgA, or IgM antibody responses to RBD were all accurate in identifying recently infected individuals, with 100% specificity and a sensitivity of 97%, 91%, and 81% respectively.", "Although the estimated median time to becoming seropositive was similar across isotypes, IgA and IgM antibodies against RBD were short-lived with most individuals estimated to become seronegative again by 51 and 47 days after symptom onset, respectively.", "IgG antibodies against RBD lasted longer and persisted through 75 days post-symptoms.", "IgG antibodies to SARS-CoV-2 RBD were highly correlated with neutralizing antibodies targeting the S protein.", "No cross-reactivity of the SARS-CoV-2 RBD-targeted antibodies was observed with several known circulating coronaviruses, HKU1, OC 229 E, OC43, and NL63.", "CONCLUSIONS: Among symptomatic SARS-CoV-2 cases, RBD-targeted antibodies can be indicative of previous and recent infection.", "IgG antibodies are correlated with neutralizing antibodies and are possibly a correlate of protective immunity."]}
{"cord_id": "k7sg7gzd", "title": "Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure", "abstract": ["We conducted an extensive serological study to quantify population-level exposure and define correlates of immunity against SARS-CoV-2.", "We found that relative to mild COVID-19 cases, individuals with severe disease exhibited elevated authentic virus-neutralizing titers and antibody levels against nucleocapsid (N) and the receptor binding domain (RBD) and the S2 region of spike protein.", "Unlike disease severity, age and sex played lesser roles in serological responses.", "All cases, including asymptomatic individuals, seroconverted by 2 weeks post-PCR confirmation.", "RBD- and S2-specific and neutralizing antibody titers remained elevated and stable for at least 2\u20133 months post-onset, whereas those against N were more variable with rapid declines in many samples.", "Testing of 5882 self-recruited members of the local community demonstrated that 1.24% of individuals showed antibody reactivity to RBD.", "However, 18% (13/73) of these putative seropositive samples failed to neutralize authentic SARS-CoV-2 virus.", "Each of the neutralizing, but only 1 of the non-neutralizing samples, also displayed potent reactivity to S2.", "Thus, inclusion of multiple independent assays markedly improved the accuracy of antibody tests in low seroprevalence communities and revealed differences in antibody kinetics depending on the viral antigen.", "In contrast to other reports, we conclude that immunity is durable for at least several months after SARS-CoV-2 infection."]}
{"cord_id": "5dbuxvc4", "title": "Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques", "abstract": ["Coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic.", "It currently remains unclear whether convalescing patients have a risk of reinfection.", "We generated a rhesus macaque model of SARS-CoV-2 infection that was characterized by interstitial pneumonia and systemic viral dissemination mainly in the respiratory and gastrointestinal tracts.", "Rhesus macaques reinfected with the identical SARS-CoV-2 strain during the early recovery phase of the initial SARS-CoV-2 infection did not show detectable viral dissemination, clinical manifestations of viral disease, or histopathological changes.", "Comparing the humoral and cellular immunity between primary infection and rechallenge revealed notably enhanced neutralizing antibody and immune responses.", "Our results suggest that primary SARS-CoV-2 exposure protects against subsequent reinfection in rhesus macaques."]}
{"cord_id": "jincu9xx", "title": "Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions", "abstract": ["We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome.", "Although we performed experiment only once across several laboratories, our findings suggest retained infectivity and virion integrity for up to 16 hours in respirable-sized aerosols."]}
{"cord_id": "eflwztji", "title": "Temporal dynamics in viral shedding and transmissibility of COVID-19", "abstract": ["We report temporal patterns of viral shedding in 94 laboratory-confirmed COVID-19 patients and modelled COVID-19 infectiousness profile from a separate sample of 77 infector-infectee transmission pairs.", "We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset.", "We estimated that 44% of transmission could occur before first symptoms of the index.", "Disease control measures should be adjusted to account for probable substantial pre-symptomatic transmission."]}
{"cord_id": "wdvuweiq", "title": "Efficacy of Face Shields Against Cough Aerosol Droplets from a Cough Simulator", "abstract": ["Health care workers are exposed to potentially infectious airborne particles while providing routine care to coughing patients.", "However, much is not understood about the behavior of these aerosols and the risks they pose.", "We used a coughing patient simulator and a breathing worker simulator to investigate the exposure of health care workers to cough aerosol droplets, and to examine the efficacy of face shields in reducing this exposure.", "Our results showed that 0.9% of the initial burst of aerosol from a cough can be inhaled by a worker 46 cm (18 inches) from the patient.", "During testing of an influenza-laden cough aerosol with a volume median diameter (VMD) of 8.5 \u03bcm, wearing a face shield reduced the inhalational exposure of the worker by 96% in the period immediately after a cough.", "The face shield also reduced the surface contamination of a respirator by 97%.", "When a smaller cough aerosol was used (VMD = 3.4 \u03bcm), the face shield was less effective, blocking only 68% of the cough and 76% of the surface contamination.", "In the period from 1 to 30 minutes after a cough, during which the aerosol had dispersed throughout the room and larger particles had settled, the face shield reduced aerosol inhalation by only 23%.", "Increasing the distance between the patient and worker to 183 cm (72 inches) reduced the exposure to influenza that occurred immediately after a cough by 92%.", "Our results show that health care workers can inhale infectious airborne particles while treating a coughing patient.", "Face shields can substantially reduce the short-term exposure of health care workers to large infectious aerosol particles, but smaller particles can remain airborne longer and flow around the face shield more easily to be inhaled.", "Thus, face shields provide a useful adjunct to respiratory protection for workers caring for patients with respiratory infections.", "However, they cannot be used as a substitute for respiratory protection when it is needed."]}
{"cord_id": "soa71kwx", "title": "The implications of silent transmission for the control of COVID-19 outbreaks", "abstract": ["Since the emergence of coronavirus disease 2019 (COVID-19), unprecedented movement restrictions and social distancing measures have been implemented worldwide.", "The socioeconomic repercussions have fueled calls to lift these measures.", "In the absence of population-wide restrictions, isolation of infected individuals is key to curtailing transmission.", "However, the effectiveness of symptom-based isolation in preventing a resurgence depends on the extent of presymptomatic and asymptomatic transmission.", "We evaluate the contribution of presymptomatic and asymptomatic transmission based on recent individual-level data regarding infectiousness prior to symptom onset and the asymptomatic proportion among all infections.", "We found that the majority of incidences may be attributable to silent transmission from a combination of the presymptomatic stage and asymptomatic infections.", "Consequently, even if all symptomatic cases are isolated, a vast outbreak may nonetheless unfold.", "We further quantified the effect of isolating silent infections in addition to symptomatic cases, finding that over one-third of silent infections must be isolated to suppress a future outbreak below 1% of the population.", "Our results indicate that symptom-based isolation must be supplemented by rapid contact tracing and testing that identifies asymptomatic and presymptomatic cases, in order to safely lift current restrictions and minimize the risk of resurgence."]}
{"cord_id": "mdsbicqo", "title": "Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection", "abstract": ["Recent reports highlight a new clinical syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1-multisystem inflammatory syndrome in children (MIS-C)-which comprises multiorgan dysfunction and systemic inflammation2-13.", "We performed peripheral leukocyte phenotyping in 25 children with MIS-C, in the acute (n = 23; worst illness within 72 h of admission), resolution (n = 14; clinical improvement) and convalescent (n = 10; first outpatient visit) phases of the illness and used samples from seven age-matched healthy controls for comparisons.", "Among the MIS-C cohort, 17 (68%) children were SARS-CoV-2 seropositive, suggesting previous SARS-CoV-2 infections14,15, and these children had more severe disease.", "In the acute phase of MIS-C, we observed high levels of interleukin-1\u00df (IL-1\u00df), IL-6, IL-8, IL-10, IL-17, interferon-\u00ce\u00b3 and differential T and B cell subset lymphopenia.", "High CD64 expression on neutrophils and monocytes, and high HLA-DR expression on \u00ce\u00b3\u00ce\u00b4 and CD4+CCR7+ T cells in the acute phase, suggested that these immune cell populations were activated.", "Antigen-presenting cells had low HLA-DR and CD86 expression, potentially indicative of impaired antigen presentation.", "These features normalized over the resolution and convalescence phases.", "Overall, MIS-C presents as an immunopathogenic illness1 and appears distinct from Kawasaki disease."]}
{"cord_id": "2dt758qj", "title": "Smoking Is Associated With COVID-19 Progression: A Meta-analysis", "abstract": ["INTRODUCTION: Smoking depresses pulmonary immune function and is a risk factor contracting other infectious diseases and more serious outcomes among people who become infected.", "This paper presents a meta-analysis of the association between smoking and progression of the infectious disease COVID-19.", "METHODS: PubMed was searched on April 28, 2020, with search terms \u201csmoking\u201d, \u201csmoker*\u201d, \u201ccharacteristics\u201d, \u201crisk factors\u201d, \u201coutcomes\u201d, and \u201cCOVID-19\u201d, \u201cCOVID\u201d, \u201ccoronavirus\u201d, \u201csar cov-2\u201d, \u201csar cov 2\u201d.", "Studies reporting smoking behavior of COVID-19 patients and progression of disease were selected for the final analysis.", "The study outcome was progression of COVID-19 among people who already had the disease.", "A random effects meta-analysis was applied.", "RESULTS: We identified 19 peer-reviewed papers with a total of 11,590 COVID-19 patients, 2,133 (18.4%) with severe disease and 731 (6.3%) with a history of smoking.", "A total of 218 patients with a history of smoking (29.8%) experienced disease progression, compared with 17.6% of non-smoking patients.", "The meta-analysis showed a significant association between smoking and progression of COVID-19 (OR 1.91, 95% confidence interval [CI] 1.42-2.59, p = 0.001).", "Limitations in the 19 papers suggest that the actual risk of smoking may be higher.", "CONCLUSIONS: Smoking is a risk factor for progression of COVID-19, with smokers having higher odds of COVID-19 progression than never smokers.", "IMPLICATIONS: Physicians and public health professionals should collect data on smoking as part of clinical management and add smoking cessation to the list of practices to blunt the COVID-19 pandemic."]}
{"cord_id": "hqwqm1u3", "title": "Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19", "abstract": ["PURPOSE: This study aimed to assess whether youth cigarette and electronic cigarette (e-cigarette) use are associated with coronavirus disease 2019 (COVID-19) symptoms, testing, and diagnosis.", "METHODS: An online national survey of adolescents and young adults (n = 4,351) aged 13-24 years was conducted in May 2020.", "Multivariable logistic regression assessed relationships among COVID-19-related symptoms, testing, and diagnosis and cigarettes only, e-cigarettes only and dual use, sociodemographic factors, obesity, and complying with shelter-in-place.", "RESULTS: COVID-19 diagnosis was five times more likely among ever-users of e-cigarettes only (95% confidence interval [CI]: 1.82-13.96), seven times more likely among ever-dual-users (95% CI: 1.98-24.55), and 6.8 times more likely among past 30-day dual-users (95% CI: 2.40-19.55).", "Testing was nine times more likely among past 30-day dual-users (95% CI: 5.43-15.47) and 2.6 times more likely among past 30-day e-cigarette only users (95% CI: 1.33-4.87).", "Symptoms were 4.7 times more likely among past 30-day dual-users (95% CI: 3.07-7.16).", "CONCLUSIONS: COVID-19 is associated with youth use of e-cigarettes only and dual use of e-cigarettes and cigarettes, suggesting the need for screening and education."]}
{"cord_id": "y40s45iv", "title": "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia", "abstract": ["BACKGROUND: We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (rAd26-S and rAd5-S).", "We aimed to assess the safety and immunogenicity of two formulations (frozen and lyophilised) of this vaccine.", "METHODS: We did two open, non-randomised phase 1/2 studies at two hospitals in Russia.", "We enrolled healthy adult volunteers (men and women) aged 18\u201360 years to both studies.", "In phase 1 of each study, we administered intramuscularly on day 0 either one dose of rAd26-S or one dose of rAd5-S and assessed the safety of the two components for 28 days.", "In phase 2 of the study, which began no earlier than 5 days after phase 1 vaccination, we administered intramuscularly a prime-boost vaccination, with rAd26-S given on day 0 and rAd5-S on day 21.", "Primary outcome measures were antigen-specific humoral immunity (SARS-CoV-2-specific antibodies measured by ELISA on days 0, 14, 21, 28, and 42) and safety (number of participants with adverse events monitored throughout the study).", "Secondary outcome measures were antigen-specific cellular immunity (T-cell responses and interferon-\u03b3 concentration) and change in neutralising antibodies (detected with a SARS-CoV-2 neutralisation assay).", "These trials are registered with ClinicalTrials.gov, NCT04436471 and NCT04437875.", "FINDINGS: Between June 18 and Aug 3, 2020, we enrolled 76 participants to the two studies (38 in each study).", "In each study, nine volunteers received rAd26-S in phase 1, nine received rAd5-S in phase 1, and 20 received rAd26-S and rAd5-S in phase 2.", "Both vaccine formulations were safe and well tolerated.", "The most common adverse events were pain at injection site (44 [58%]), hyperthermia (38 [50%]), headache (32 [42%]), asthenia (21 [28%]), and muscle and joint pain (18 [24%]).", "Most adverse events were mild and no serious adverse events were detected.", "All participants produced antibodies to SARS-CoV-2 glycoprotein.", "At day 42, receptor binding domain-specific IgG titres were 14 703 with the frozen formulation and 11 143 with the lyophilised formulation, and neutralising antibodies were 49\u00b725 with the frozen formulation and 45\u00b795 with the lyophilised formulation, with a seroconversion rate of 100%.", "Cell-mediated responses were detected in all participants at day 28, with median cell proliferation of 2\u00b75% CD4(+) and 1\u00b73% CD8(+) with the frozen formulation, and a median cell proliferation of 1\u00b73% CD4(+) and 1\u00b71% CD8(+) with the lyophilised formulation.", "INTERPRETATION: The heterologous rAd26 and rAd5 vector-based COVID-19 vaccine has a good safety profile and induced strong humoral and cellular immune responses in participants.", "Further investigation is needed of the effectiveness of this vaccine for prevention of COVID-19.", "FUNDING: Ministry of Health of the Russian Federation."]}
{"cord_id": "hwb5byja", "title": "Blood type and outcomes in patients with COVID-19", "abstract": ["This study aimed to determine if there is an association between ABO blood type and severity of COVID-19 defined by intubation or death as well as ascertain if there is variability in testing positive for COVID-19 between blood types.", "In a multi-institutional study, all adult patients who tested positive for COVID-19 across five hospitals were identified and included from March 6th to April 16th, 2020.", "Hospitalization, intubation, and death were evaluated for association with blood type.", "Univariate analysis was conducted using standard techniques and logistic regression was used to determine the independent effect of blood type on intubation and/or death and positive testing.", "During the study period, there were 7648 patients who received COVID-19 testing throughout the institutions.", "Of these, 1289 tested positive with a known blood type.", "A total of 484 (37.5%) were admitted to hospital, 123 (9.5%) were admitted to the ICU, 108 (8.4%) were intubated, 3 (0.2%) required ECMO, and 89 (6.9%) died.", "Of the 1289 patients who tested positive, 440 (34.2%) were blood type A, 201 (15.6%) were blood type B, 61 (4.7%) were blood type AB, and 587 (45.5%) were blood type O.", "On univariate analysis, there was no association between blood type and any of the peak inflammatory markers (peak WBC, p = 0.25; peak LDH, p = 0.40; peak ESR, p = 0.16; peak CRP, p = 0.14) nor between blood type and any of the clinical outcomes of severity (admission p = 0.20, ICU admission p = 0.94, intubation p = 0.93, proning while intubated p = 0.58, ECMO p = 0.09, and death p = 0.49).", "After multivariable analysis, blood type was not independently associated with risk of intubation or death (referent blood type A; blood type B: AOR: 0.72, 95% CI: 0.42\u20131.26, blood type AB: AOR: 0.78, CI: 0.33\u20131.87, blood type O: AOR: 0.77, CI: 0.51\u20131.16), rhesus factor positive (Rh+): AOR: 1.03, CI: 0.93\u20131.86.", "Blood type A had no correlation with positive testing (AOR: 1.00, CI: 0.88\u20131.13), blood type B was associated with higher odds of testing positive for disease (AOR: 1.28, CI: 1.08\u20131.52), AB was also associated with higher odds of testing positive (AOR: 1.37, CI: 1.02\u20131.83), and O was associated with a lower risk of testing positive (AOR: 0.84, CI: 0.75\u20130.95).", "Rh+ status was associated with higher odds of testing positive (AOR: 1.23, CI: 1.003\u20131.50).", "Blood type was not associated with risk of intubation or death in patients with COVID-19.", "Patients with blood types B and AB who received a test were more likely to test positive and blood type O was less likely to test positive.", "Rh+ patients were more likely to test positive."]}
{"cord_id": "h6amrprt", "title": "Travel restrictions and SARS-CoV-2 transmission: an effective distance approach to estimate impact", "abstract": ["OBJECTIVE: To estimate the effect of airline travel restrictions on the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) importation.", "METHODS: We extracted passenger volume data for the entire global airline network, as well as the dates of the implementation of travel restrictions and the observation of the first case of coronavirus disease (COVID-19) in each country or territory, from publicly available sources.", "We calculated effective distance between every airport and the city of Wuhan, China.", "We modelled the risk of SARS-CoV-2 importation by estimating survival probability, expressing median time of importation as a function of effective distance.", "We calculated the relative change in importation risk under three different hypothetical scenarios that all resulted in different passenger volumes.", "FINDINGS: We identified 28 countries with imported cases of COVID-19 as at 26 February 2020.", "The arrival time of the virus at these countries ranged from 39 to 80 days since identification of the first case in Wuhan.", "Our analysis of relative change in risk indicated that strategies of reducing global passenger volume and imposing travel restrictions at a further 10 hub airports would be equally effective in reducing the risk of importation of SARS-CoV-2; however, this reduction is very limited with a close-to-zero median relative change in risk.", "CONCLUSION: The hypothetical variations in observed travel restrictions were not sufficient to prevent the global spread of SARS-CoV-2; further research should also consider travel by land and sea.", "Our study highlights the importance of strengthening local capacities for disease monitoring and control."]}
{"cord_id": "ksgdjdh1", "title": "Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City", "abstract": ["IMPORTANCE: Black and Hispanic populations have higher rates of coronavirus disease 2019 (COVID-19) hospitalization and mortality than White populations but lower in-hospital case-fatality rates.", "The extent to which neighborhood characteristics and comorbidity explain these disparities is unclear.", "Outcomes in Asian American populations have not been explored.", "OBJECTIVE: To compare COVID-19 outcomes based on race and ethnicity and assess the association of any disparities with comorbidity and neighborhood characteristics.", "DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted within the New York University Langone Health system, which includes over 260 outpatient practices and 4 acute care hospitals.", "All patients within the system\u2019s integrated health record who were tested for severe acute respiratory syndrome coronavirus 2 between March 1, 2020, and April 8, 2020, were identified and followed up through May 13, 2020.", "Data were analyzed in June 2020.", "Among 11 547 patients tested, outcomes were compared by race and ethnicity and examined against differences by age, sex, body mass index, comorbidity, insurance type, and neighborhood socioeconomic status.", "EXPOSURES: Race and ethnicity categorized using self-reported electronic health record data (ie, non-Hispanic White, non-Hispanic Black, Hispanic, Asian, and multiracial/other patients).", "MAIN OUTCOMES AND MEASURES: The likelihood of receiving a positive test, hospitalization, and critical illness (defined as a composite of care in the intensive care unit, use of mechanical ventilation, discharge to hospice, or death).", "RESULTS: Among 9722 patients (mean [SD] age, 50.7 [17.5] years; 58.8% women), 4843 (49.8%) were positive for COVID-19; 2623 (54.2%) of those were admitted for hospitalization (1047 [39.9%] White, 375 [14.3%] Black, 715 [27.3%] Hispanic, 180 [6.9%] Asian, 207 [7.9%] multiracial/other).", "In fully adjusted models, Black patients (odds ratio [OR], 1.3; 95% CI, 1.2-1.6) and Hispanic patients (OR, 1.5; 95% CI, 1.3-1.7) were more likely than White patients to test positive.", "Among those who tested positive, odds of hospitalization were similar among White, Hispanic, and Black patients, but higher among Asian (OR, 1.6, 95% CI, 1.1-2.3) and multiracial patients (OR, 1.4; 95% CI, 1.0-1.9) compared with White patients.", "Among those hospitalized, Black patients were less likely than White patients to have severe illness (OR, 0.6; 95% CI, 0.4-0.8) and to die or be discharged to hospice (hazard ratio, 0.7; 95% CI, 0.6-0.9).", "CONCLUSIONS AND RELEVANCE: In this cohort study of patients in a large health system in New York City, Black and Hispanic patients were more likely, and Asian patients less likely, than White patients to test positive; once hospitalized, Black patients were less likely than White patients to have critical illness or die after adjustment for comorbidity and neighborhood characteristics.", "This supports the assertion that existing structural determinants pervasive in Black and Hispanic communities may explain the disproportionately higher out-of-hospital deaths due to COVID-19 infections in these populations."]}
{"cord_id": "mi0akyes", "title": "Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial", "abstract": ["BACKGROUND: As part of the accelerated development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we report a dose-finding and adjuvant justification study of SCB-2019, a protein subunit vaccine candidate containing a stabilised trimeric form of the spike (S)-protein (S-Trimer) combined with two different adjuvants.", "METHODS: Our study is a phase 1, randomised, double-blind placebo-controlled trial at a specialised clinical trials centre in Australia.", "We enrolled healthy adult volunteers in two age groups: younger adults (aged 18-54 years) and older adults (aged 55-75 years).", "Participants were randomly allocated either vaccine or placebo using a list prepared by the study funder.", "Participants were to receive two doses of SCB-2019 (either 3 \u00b5g, 9 \u00b5g, or 30 \u00b5g) or a placebo (0\u00b79% NaCl) 21 days apart.", "SCB-2019 either had no adjuvant (S-Trimer protein alone) or was adjuvanted with AS03 or CpG/Alum.", "The assigned treatment was administered in opaque syringes to maintain masking of assignments.", "Reactogenicity was assessed for 7 days after each vaccination.", "Humoral responses were measured as SCB-2019 binding IgG antibodies and ACE2-competitive blocking IgG antibodies by ELISA and as neutralising antibodies by wild-type SARS-CoV-2 microneutralisation assay.", "Cellular responses to pooled S-protein peptides were measured by flow-cytometric intracellular cytokine staining.", "This trial is registered with ClinicalTrials.gov, NCT04405908; this is an interim analysis and the study is continuing.", "FINDINGS: Between June 19 and Sept 23, 2020, 151 volunteers were enrolled; three people withdrew, two for personal reasons and one with an unrelated serious adverse event (pituitary adenoma).", "148 participants had at least 4 weeks of follow-up after dose two and were included in this analysis (database lock, Oct 23, 2020).", "Vaccination was well tolerated, with two grade 3 solicited adverse events (pain in 9 \u00b5g AS03-adjuvanted and 9 \u00b5g CpG/Alum-adjuvanted groups).", "Most local adverse events were mild injection-site pain, and local events were more frequent with SCB-2019 formulations containing AS03 adjuvant (44-69%) than with those containing CpG/Alum adjuvant (6-44%) or no adjuvant (3-13%).", "Systemic adverse events were more frequent in younger adults (38%) than in older adults (17%) after the first dose but increased to similar levels in both age groups after the second dose (30% in older and 34% in younger adults).", "SCB-2019 with no adjuvant elicited minimal immune responses (three seroconversions by day 50), but SCB-2019 with fixed doses of either AS03 or CpG/Alum adjuvants induced high titres and seroconversion rates of binding and neutralising antibodies in both younger and older adults (anti-SCB-2019 IgG antibody geometric mean titres at day 36 were 1567-4452 with AS03 and 174-2440 with CpG/Alum).", "Titres in all AS03 dose groups and the CpG/Alum 30 \u00b5g group were higher than were those recorded in a panel of convalescent serum samples from patients with COVID-19.", "Both adjuvanted SCB-2019 formulations elicited T-helper-1-biased CD4+ T-cell responses.", "INTERPRETATION: The SCB-2019 vaccine, comprising S-Trimer protein formulated with either AS03 or CpG/Alum adjuvants, elicited robust humoral and cellular immune responses against SARS-CoV-2, with high viral neutralising activity.", "Both adjuvanted vaccine formulations were well tolerated and are suitable for further clinical development.", "FUNDING: Clover Biopharmaceuticals and the Coalition for Epidemic Preparedness Innovations."]}
{"cord_id": "qxtcbksp", "title": "JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality", "abstract": ["Using AI, we identified baricitinib as having antiviral and anticytokine efficacy.", "We now show a 71% (95% CI 0.15 to 0.58) mortality benefit in 83 patients with moderate-severe SARS-CoV-2 pneumonia with few drug-induced adverse events, including a large elderly cohort (median age, 81 years).", "An additional 48 cases with mild-moderate pneumonia recovered uneventfully.", "Using organotypic 3D cultures of primary human liver cells, we demonstrate that interferon-\u03b12 increases ACE2 expression and SARS-CoV-2 infectivity in parenchymal cells by greater than fivefold.", "RNA-seq reveals gene response signatures associated with platelet activation, fully inhibited by baricitinib.", "Using viral load quantifications and superresolution microscopy, we found that baricitinib exerts activity rapidly through the inhibition of host proteins (numb-associated kinases), uniquely among antivirals.", "This reveals mechanistic actions of a Janus kinase-1/2 inhibitor targeting viral entry, replication, and the cytokine storm and is associated with beneficial outcomes including in severely ill elderly patients, data that incentivize further randomized controlled trials."]}
{"cord_id": "u7fa84th", "title": "Anti-inflammatory therapy for COVID-19 infection: the case for colchicine", "abstract": ["The search for effective COVID-19 management strategies continues to evolve.", "Current understanding of SARS-CoV-2 mechanisms suggests a central role for exaggerated activation of the innate immune system as an important contributor to COVID-19 adverse outcomes.", "The actions of colchicine, one of the oldest anti-inflammatory therapeutics, target multiple mechanisms associated with COVID-19 excessive inflammation.", "While many COVID-19 trials have sought to manipulate SARS-CoV-2 or dampen the inflammatory response once patients are hospitalised, few examine therapeutics to prevent the need for hospitalisation.", "Colchicine is easily administered, generally well tolerated and inexpensive, and holds particular promise to reduce the risk of hospitalisation and mortality due to COVID-19 in the outpatient setting.", "Successful outpatient treatment of COVID-19 could greatly reduce morbidity, mortality and the demand for rare or expensive care resources (front-line healthcare workers, hospital beds, ventilators, biological therapies), to the benefit of both resource-replete and resource-poor regions."]}
{"cord_id": "gy3w9uvz", "title": "Mobility network models of COVID-19 explain inequities and inform reopening", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic markedly changed human mobility patterns, necessitating epidemiological models that can capture the effects of these changes in mobility on the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1.", "Here we introduce a metapopulation susceptible-exposed-infectious-removed (SEIR) model that integrates fine-grained, dynamic mobility networks to simulate the spread of SARS-CoV-2 in ten of the largest US metropolitan areas.", "Our mobility networks are derived from mobile phone data and map the hourly movements of 98 million people from neighbourhoods (or census block groups) to points of interest such as restaurants and religious establishments, connecting 56,945 census block groups to 552,758 points of interest with 5.4 billion hourly edges.", "We show that by integrating these networks, a relatively simple SEIR model can accurately fit the real case trajectory, despite substantial changes in the behaviour of the population over time.", "Our model predicts that a small minority of 'superspreader' points of interest account for a large majority of the infections, and that restricting the maximum occupancy at each point of interest is more effective than uniformly reducing mobility.", "Our model also correctly predicts higher infection rates among disadvantaged racial and socioeconomic groups2-8 solely as the result of differences in mobility: we find that disadvantaged groups have not been able to reduce their mobility as sharply, and that the points of interest that they visit are more crowded and are therefore associated with higher risk.", "By capturing who is infected at which locations, our model supports detailed analyses that can inform more-effective and equitable policy responses to COVID-19."]}
{"cord_id": "5oy0q6ca", "title": "Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic", "abstract": ["IMPORTANCE: Although strain on hospital capacity has been associated with increased mortality in nonpandemic settings, studies are needed to examine the association between coronavirus disease 2019 (COVID-19) critical care capacity and mortality.", "OBJECTIVE: To examine whether COVID-19 mortality was associated with COVID-19 intensive care unit (ICU) strain.", "DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted among veterans with COVID-19, as confirmed by polymerase chain reaction or antigen testing in the laboratory from March through August 2020, cared for at any Department of Veterans Affairs (VA) hospital with 10 or more patients with COVID-19 in the ICU.", "The follow-up period was through November 2020.", "Data were analyzed from March to November 2020.", "EXPOSURES: Receiving treatment for COVID-19 in the ICU during a period of increased COVID-19 ICU load, with load defined as mean number of patients with COVID-19 in the ICU during the patient\u2019s hospital stay divided by the number of ICU beds at that facility, or increased COVID-19 ICU demand, with demand defined as mean number of patients with COVID-19 in the ICU during the patient\u2019s stay divided by the maximum number of patients with COVID-19 in the ICU.", "MAIN OUTCOMES AND MEASURES: All-cause mortality was recorded through 30 days after discharge from the hospital.", "RESULTS: Among 8516 patients with COVID-19 admitted to 88 VA hospitals, 8014 (94.1%) were men and mean (SD) age was 67.9 (14.2) years.", "Mortality varied over time, with 218 of 954 patients (22.9%) dying in March, 399 of 1594 patients (25.0%) dying in April, 143 of 920 patients (15.5%) dying in May, 179 of 1314 patients (13.6%) dying in June, 297 of 2373 patients (12.5%) dying in July, and 174 of 1361 (12.8%) patients dying in August (P < .001).", "Patients with COVID-19 who were treated in the ICU during periods of increased COVID-19 ICU demand had increased risk of mortality compared with patients treated during periods of low COVID-19 ICU demand (ie, demand of \u226425%); the adjusted hazard ratio for all-cause mortality was 0.99 (95% CI, 0.81-1.22; P = .93) for patients treated when COVID-19 ICU demand was more than 25% to 50%, 1.19 (95% CI, 0.95-1.48; P = .13) when COVID-19 ICU demand was more than 50% to 75%, and 1.94 (95% CI, 1.46-2.59; P < .001) when COVID-19 ICU demand was more than 75% to 100%.", "No association between COVID-19 ICU demand and mortality was observed for patients with COVID-19 not in the ICU.", "The association between COVID-19 ICU load and mortality was not consistent over time (ie, early vs late in the pandemic).", "CONCLUSIONS AND RELEVANCE: This cohort study found that although facilities augmented ICU capacity during the pandemic, strains on critical care capacity were associated with increased COVID-19 ICU mortality.", "Tracking COVID-19 ICU demand may be useful to hospital administrators and health officials as they coordinate COVID-19 admissions across hospitals to optimize outcomes for patients with this illness."]}
{"cord_id": "ecg4zbuw", "title": "Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients", "abstract": ["While the antibody response to SARS-CoV-2 has been extensively studied in blood, relatively little is known about the antibody response in saliva and its relationship to systemic antibody levels.", "Here, we profiled by enzyme-linked immunosorbent assays (ELISAs) IgG, IgA and IgM responses to the SARS-CoV-2 spike protein (full length trimer) and its receptor-binding domain (RBD) in serum and saliva of acute and convalescent patients with laboratory-diagnosed COVID-19 ranging from 3-115 days post-symptom onset (PSO), compared to negative controls.", "Anti-SARS-CoV-2 antibody responses were readily detected in serum and saliva, with peak IgG levels attained by 16-30 days PSO.", "Longitudinal analysis revealed that anti-SARS-CoV-2 IgA and IgM antibodies rapidly decayed, while IgG antibodies remained relatively stable up to 105 days PSO in both biofluids.", "Lastly, IgG, IgM and to a lesser extent IgA responses to spike and RBD in the serum positively correlated with matched saliva samples.", "This study confirms that serum and saliva IgG antibodies to SARS-CoV-2 are maintained in the majority of COVID-19 patients for at least 3 months PSO.", "IgG responses in saliva may serve as a surrogate measure of systemic immunity to SARS-CoV-2 based on their correlation with serum IgG responses."]}
{"cord_id": "nvphu1fm", "title": "The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity", "abstract": ["SARS-CoV-2 can mutate to evade immunity, with consequences for the efficacy of emerging vaccines and antibody therapeutics.", "Herein we demonstrate that the immunodominant SARS-CoV-2 spike (S) receptor binding motif (RBM) is the most divergent region of S, and provide epidemiological, clinical, and molecular characterization of a prevalent RBM variant, N439K.", "We demonstrate that N439K S protein has enhanced binding affinity to the hACE2 receptor, and that N439K virus has similar clinical outcomes and in vitro replication fitness as compared to wild- type.", "We observed that the N439K mutation resulted in immune escape from a panel of neutralizing monoclonal antibodies, including one in clinical trials, as well as from polyclonal sera from a sizeable fraction of persons recovered from infection.", "Immune evasion mutations that maintain virulence and fitness such as N439K can emerge within SARS-CoV-2 S, highlighting the need for ongoing molecular surveillance to guide development and usage of vaccines and therapeutics."]}
{"cord_id": "5nr1zej7", "title": "A human coronavirus evolves antigenically to escape antibody immunity", "abstract": ["There is intense interest in antibody immunity to coronaviruses.", "However, it is unknown if coronaviruses evolve to escape such immunity, and if so, how rapidly.", "Here we address this question by characterizing the historical evolution of human coronavirus 229E.", "We identify human sera from the 1980s and 1990s that have neutralizing titers against contemporaneous 229E that are comparable to the anti-SARS-CoV-2 titers induced by SARS-CoV-2 infection or vaccination.", "We test these sera against 229E strains isolated after sera collection, and find that neutralizing titers are lower against these \u201cfuture\u201d viruses.", "In some cases, sera that neutralize contemporaneous 229E viral strains with titers >1:100 do not detectably neutralize strains isolated 8\u201317 years later.", "The decreased neutralization of \u201cfuture\u201d viruses is due to antigenic evolution of the viral spike, especially in the receptor-binding domain.", "If these results extrapolate to other coronaviruses, then it may be advisable to periodically update SARS-CoV-2 vaccines."]}
{"cord_id": "7w1ls63r", "title": "Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults \u226518 Years in 11 Outpatient Health Care Facilities - United States, July 2020", "abstract": ["Community and close contact exposures continue to drive the coronavirus disease 2019 (COVID-19) pandemic.", "CDC and other public health authorities recommend community mitigation strategies to reduce transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2).", "Characterization of community exposures can be difficult to assess when widespread transmission is occurring, especially from asymptomatic persons within inherently interconnected communities.", "Potential exposures, such as close contact with a person with confirmed COVID-19, have primarily been assessed among COVID-19 cases, without a non-COVID-19 comparison group (3,4).", "To assess community and close contact exposures associated with COVID-19, exposures reported by case-patients (154) were compared with exposures reported by control-participants (160).", "Case-patients were symptomatic adults (persons aged &#8805;18 years) with SARS-CoV-2 infection confirmed by reverse transcription-polymerase chain reaction (RT-PCR) testing.", "Control-participants were symptomatic outpatient adults from the same health care facilities who had negative SARS-CoV-2 test results.", "Close contact with a person with known COVID-19 was more commonly reported among case-patients (42%) than among control-participants (14%).", "Case-patients were more likely to have reported dining at a restaurant (any area designated by the restaurant, including indoor, patio, and outdoor seating) in the 2 weeks preceding illness onset than were control-participants (adjusted odds ratio [aOR] = 2.4; 95% confidence interval [CI] = 1.5-3.8).", "Restricting the analysis to participants without known close contact with a person with confirmed COVID-19, case-patients were more likely to report dining at a restaurant (aOR = 2.8, 95% CI = 1.9-4.3) or going to a bar/coffee shop (aOR = 3.9, 95% CI = 1.5-10.1) than were control-participants.", "Exposures and activities where mask use and social distancing are difficult to maintain, including going to places that offer on-site eating or drinking, might be important risk factors for acquiring COVID-19.", "As communities reopen, efforts to reduce possible exposures at locations that offer on-site eating and drinking options should be considered to protect customers, employees, and communities."]}
{"cord_id": "jn74ur5v", "title": "Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity", "abstract": ["Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect.", "We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences.", "Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection.", "Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage.", "We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients.", "Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant."]}
{"cord_id": "ytly6twq", "title": "WHO Coronavirus Disease (COVID-19) Dashboard", "abstract": ["Globally, as of 10:47am CEST, 28 May 2020, there have been 5,556,679 confirmed cases of COVID-19, including 351,866 deaths, reported to WHO"]}
{"cord_id": "txuz5lxs", "title": "Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021", "abstract": ["On December 14, 2020, the United Kingdom reported a SARS-CoV-2 variant of concern (VOC), lineage B.1.1.7, also referred to as VOC 202012/01 or 20I/501Y.V1.", "* The B.1.1.7 variant is estimated to have emerged in September 2020 and has quickly become the dominant circulating SARS-CoV-2 variant in England (1).", "B.1.1.7 has been detected in over 30 countries, including the United States.", "As of January 13, 2021, approximately 76 cases of B.1.1.7 have been detected in 12 U.S. states.\u0086 Multiple lines of evidence indicate that B.1.1.7 is more efficiently transmitted than are other SARS-CoV-2 variants (1-3).", "The modeled trajectory of this variant in the U.S. exhibits rapid growth in early 2021, becoming the predominant variant in March.", "Increased SARS-CoV-2 transmission might threaten strained health care resources, require extended and more rigorous implementation of public health strategies (4), and increase the percentage of population immunity required for pandemic control.", "Taking measures to reduce transmission now can lessen the potential impact of B.1.1.7 and allow critical time to increase vaccination coverage.", "Collectively, enhanced genomic surveillance combined with continued compliance with effective public health measures, including vaccination, physical distancing, use of masks, hand hygiene, and isolation and quarantine, will be essential to limiting the spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).", "Strategic testing of persons without symptoms but at higher risk of infection, such as those exposed to SARS-CoV-2 or who have frequent unavoidable contact with the public, provides another opportunity to limit ongoing spread."]}
{"cord_id": "o78vcy90", "title": "Functional SARS-CoV-2-specific immune memory persists after mild COVID-19", "abstract": ["The recently emerged SARS-CoV-2 virus is currently causing a global pandemic and cases continue to rise.", "The majority of infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that might contribute to herd immunity.", "Thus, we performed a longitudinal assessment of individuals recovered from mildly symptomatic COVID-19 to determine if they develop and sustain immunological memory against the virus.", "We found that recovered individuals developed SARS-CoV-2-specific IgG antibody and neutralizing plasma, as well as virus-specific memory B and T cells that not only persisted, but in some cases increased numerically over three months following symptom onset.", "Furthermore, the SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral immunity: memory T cells secreted IFN-{gamma} and expanded upon antigen re-encounter, while memory B cells expressed receptors capable of neutralizing virus when expressed as antibodies.", "These findings demonstrate that mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks associated with antiviral protective immunity."]}
{"cord_id": "b2oi45ei", "title": "Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2", "abstract": ["A long-standing question in infectious disease dynamics concerns the role of transmission heterogeneities, which are driven by demography, behavior, and interventions.", "On the basis of detailed patient and contact-tracing data in Hunan, China, we find that 80% of secondary infections traced back to 15% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primary infections, which indicates substantial transmission heterogeneities.", "Transmission risk scales positively with the duration of exposure and the closeness of social interactions and is modulated by demographic and clinical factors.", "The lockdown period increases transmission risk in the family and households, whereas isolation and quarantine reduce risks across all types of contacts.", "The reconstructed infectiousness profile of a typical SARS-CoV-2 patient peaks just before symptom presentation.", "Modeling indicates that SARS-CoV-2 control requires the synergistic efforts of case isolation, contact quarantine, and population-level interventions because of the specific transmission kinetics of this virus."]}
{"cord_id": "y1v8wzxq", "title": "Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters", "abstract": ["COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) since 2012.", "Treatment options for CoVs are largely lacking.", "Here, we show that clofazimine, an anti-leprosy drug with a favorable safety and pharmacokinetics profile, possesses pan-coronaviral inhibitory activity, and can antagonize SARS-CoV-2 replication in multiple in vitro systems, including the human embryonic stem cell-derived cardiomyocytes and ex vivo lung cultures.", "The FDA-approved molecule was found to inhibit multiple steps of viral replication, suggesting multiple underlying antiviral mechanisms.", "In a hamster model of SARS-CoV-2 pathogenesis, prophylactic or therapeutic administration of clofazimine significantly reduced viral load in the lung and fecal viral shedding, and also prevented cytokine storm associated with viral infection.", "Additionally, clofazimine exhibited synergy when administered with remdesivir.", "Since clofazimine is orally bioavailable and has a comparatively low manufacturing cost, it is an attractive clinical candidate for outpatient treatment and remdesivir-based combinatorial therapy for hospitalized COVID-19 patients, particularly in developing countries.", "Taken together, our data provide evidence that clofazimine may have a role in the control of the current pandemic SARS-CoV-2, endemic MERS-CoV in the Middle East, and, possibly most importantly, emerging CoVs of the future."]}
{"cord_id": "1l0vrbi0", "title": "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail", "abstract": ["Neutralizing antibodies have become an important tool in treating infectious diseases.", "Recently, two separate approaches yielded successful antibody treatments for Ebola \u2013 one from genetically-humanized mice, and the other from a human survivor.", "Here, we describe parallel efforts using both humanized mice and convalescent patients to generate antibodies against the SARS-CoV-2 spike protein, yielding a large collection of fully-human antibodies that were characterized for binding, neutralization and three dimensional structure.", "Based on these criteria, we selected pairs of highly-potent individual antibodies that simultaneously bind the receptor-binding domain of the spike protein, providing ideal partners for a therapeutic antibody cocktail that aims to decrease the potential for virus escape mutants that might arise in response to selective pressure from a single antibody treatment."]}
{"cord_id": "ba5h6uhu", "title": "Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic has led to a large increase in mortality in the United States and around the world, leaving many grieving the sudden loss of family members.", "We created an indicator\u2014the COVID-19 bereavement multiplier\u2014that estimates the average number of individuals who will experience the death of a close relative (defined as a grandparent, parent, sibling, spouse, or child) for each COVID-19 death.", "Using demographic microsimulation-based estimates of kinship networks in the United States, the clear age gradient in COVID-19 mortality seen across contexts, and several hypothetical infection prevalence scenarios, we estimate COVID-19 bereavement multipliers for White and Black individuals in the United States.", "Our analysis shows that for every COVID-19 death, approximately nine surviving Americans will lose a grandparent, parent, sibling, spouse, or child.", "These estimates imply, for example, that if 190,000 Americans die from COVID-19, as some models project, then \u223c1.7 million will experience the death of a close relative.", "We demonstrate that our estimates of the bereavement multiplier are stable across epidemiological realities, including infection scenarios, total number of deaths, and the distribution of deaths, which means researchers can estimate the bereavement burden over the course of the epidemic in lockstep with rising death tolls.", "In addition, we provide estimates of bereavement multipliers by age group, types of kin loss, and race to illuminate prospective disparities.", "The bereavement multiplier is a useful indicator for tracking COVID-19\u2019s multiplicative impact as it reverberates across American families and can be tailored to other causes of death."]}
{"cord_id": "ijcx6cgv", "title": "Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy", "abstract": ["SARS-CoV-2 control in the United States is hampered by limited testing capacity.", "We evaluated a simple, outdoor, mobile RT-LAMP assay workflow where self-collected saliva is tested for SARS-CoV-2 RNA.", "195 volunteers were tested over 8 days.", "Testing results were 100% concordant with qRT-PCR, with all but one person testing SARS-CoV-2-negative."]}
{"cord_id": "hq6eecxc", "title": "Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial", "abstract": ["Importance: The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide.", "Tocilizumab has shown promising results in retrospective studies in patients with COVID-19 pneumonia with a good safety profile.", "Objective: To evaluate the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia.", "Design, Setting, and Participants: Prospective, open-label, randomized clinical trial that randomized patients hospitalized between March 31 and June 11, 2020, with COVID-19 pneumonia to receive tocilizumab or standard of care in 24 hospitals in Italy.", "Cases of COVID-19 were confirmed by polymerase chain reaction method with nasopharyngeal swab.", "Eligibility criteria included COVID-19 pneumonia documented by radiologic imaging, partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2/Fio2) ratio between 200 and 300 mm Hg, and an inflammatory phenotype defined by fever and elevated C-reactive protein.", "Interventions: Patients in the experimental arm received intravenous tocilizumab within 8 hours from randomization (8 mg/kg up to a maximum of 800 mg), followed by a second dose after 12 hours.", "Patients in the control arm received supportive care following the protocols of each clinical center until clinical worsening and then could receive tocilizumab as a rescue therapy.", "Main Outcome and Measures: The primary composite outcome was defined as entry into the intensive care unit with invasive mechanical ventilation, death from all causes, or clinical aggravation documented by the finding of a Pao2/Fio2 ratio less than 150 mm Hg, whichever came first.", "Results: A total of 126 patients were randomized (60 to the tocilizumab group; 66 to the control group).", "The median (interquartile range) age was 60.0 (53.0-72.0) years, and the majority of patients were male (77 of 126, 61.1%).", "Three patients withdrew from the study, leaving 123 patients available for the intention-to-treat analyses.", "Seventeen patients of 60 (28.3%) in the tocilizumab arm and 17 of 63 (27.0%) in the standard care group showed clinical worsening within 14 days since randomization (rate ratio, 1.05; 95% CI, 0.59-1.86).", "Two patients in the experimental group and 1 in the control group died before 30 days from randomization, and 6 and 5 patients were intubated in the 2 groups, respectively.", "The trial was prematurely interrupted after an interim analysis for futility.", "Conclusions and Relevance: In this randomized clinical trial of hospitalized adult patients with COVID-19 pneumonia and Pao2/Fio2 ratio between 200 and 300 mm Hg who received tocilizumab, no benefit on disease progression was observed compared with standard care.", "Further blinded, placebo-controlled randomized clinical trials are needed to confirm the results and to evaluate possible applications of tocilizumab in different stages of the disease.", "Trial Registration: ClinicalTrials.gov Identifier: NCT04346355; EudraCT Identifier: 2020-001386-37."]}
{"cord_id": "pua14ogz", "title": "The Effects of Air Pollution on COVID-19 Related Mortality in Northern Italy", "abstract": ["Long-term exposure to ambient air pollutant concentrations is known to cause chronic lung inflammation, a condition that may promote increased severity of COVID-19 syndrome caused by the novel coronavirus (SARS-CoV-2).", "In this paper, we empirically investigate the ecologic association between long-term concentrations of area-level fine particulate matter (PM(2.5)) and excess deaths in the first quarter of 2020 in municipalities of Northern Italy.", "The study accounts for potentially spatial confounding factors related to urbanization that may have influenced the spreading of SARS-CoV-2 and related COVID-19 mortality.", "Our epidemiological analysis uses geographical information (e.g., municipalities) and negative binomial regression to assess whether both ambient PM(2.5) concentration and excess mortality have a similar spatial distribution.", "Our analysis suggests a positive association of ambient PM(2.5) concentration on excess mortality in Northern Italy related to the COVID-19 epidemic.", "Our estimates suggest that a one-unit increase in PM(2.5) concentration (\u00b5g/m(3)) is associated with a 9% (95% confidence interval: 6\u201312%) increase in COVID-19 related mortality."]}
{"cord_id": "4ctio6cy", "title": "SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease", "abstract": ["We investigated 68 respiratory specimens from 35 coronavirus disease patients in Hong Kong, of whom 32 had mild disease.", "We found that severe acute respiratory syndrome coronavirus 2 and subgenomic RNA were rarely detectable beyond 8 days after onset of illness.", "However, virus RNA was detectable for many weeks by reverse transcription PCR."]}
{"cord_id": "eveo8yle", "title": "Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea", "abstract": ["Importance: There is limited information about the clinical course and viral load in asymptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Objective: To quantitatively describe SARS-CoV-2 molecular viral shedding in asymptomatic and symptomatic patients.", "Design, Setting, and Participants: A retrospective evaluation was conducted for a cohort of 303 symptomatic and asymptomatic patients with SARS-CoV-2 infection between March 6 and March 26, 2020.", "Participants were isolated in a community treatment center in Cheonan, Republic of Korea.", "Main Outcomes and Measures: Epidemiologic, demographic, and laboratory data were collected and analyzed.", "Attending health care personnel carefully identified patients' symptoms during isolation.", "The decision to release an individual from isolation was based on the results of reverse transcription-polymerase chain reaction (RT-PCR) assay from upper respiratory tract specimens (nasopharynx and oropharynx swab) and lower respiratory tract specimens (sputum) for SARS-CoV-2.", "This testing was performed on days 8, 9, 15, and 16 of isolation.", "On days 10, 17, 18, and 19, RT-PCR assays from the upper or lower respiratory tract were performed at physician discretion.", "Cycle threshold (Ct) values in RT-PCR for SARS-CoV-2 detection were determined in both asymptomatic and symptomatic patients.", "Results: Of the 303 patients with SARS-CoV-2 infection, the median (interquartile range) age was 25 (22-36) years, and 201 (66.3%) were women.", "Only 12 (3.9%) patients had comorbidities (10 had hypertension, 1 had cancer, and 1 had asthma).", "Among the 303 patients with SARS-CoV-2 infection, 193 (63.7%) were symptomatic at the time of isolation.", "Of the 110 (36.3%) asymptomatic patients, 21 (19.1%) developed symptoms during isolation.", "The median (interquartile range) interval of time from detection of SARS-CoV-2 to symptom onset in presymptomatic patients was 15 (13-20) days.", "The proportions of participants with a negative conversion at day 14 and day 21 from diagnosis were 33.7% and 75.2%, respectively, in asymptomatic patients and 29.6% and 69.9%, respectively, in symptomatic patients (including presymptomatic patients).", "The median (SE) time from diagnosis to the first negative conversion was 17 (1.07) days for asymptomatic patients and 19.5 (0.63) days for symptomatic (including presymptomatic) patients (P = .07).", "The Ct values for the envelope (env) gene from lower respiratory tract specimens showed that viral loads in asymptomatic patients from diagnosis to discharge tended to decrease more slowly in the time interaction trend than those in symptomatic (including presymptomatic) patients (\u00df = -0.065 [SE, 0.023]; P = .005).", "Conclusions and Relevance: In this cohort study of symptomatic and asymptomatic patients with SARS-CoV-2 infection who were isolated in a community treatment center in Cheonan, Republic of Korea, the Ct values in asymptomatic patients were similar to those in symptomatic patients.", "Isolation of asymptomatic patients may be necessary to control the spread of SARS-CoV-2."]}
{"cord_id": "pyz2tnhk", "title": "Individuals with obesity and COVID\u201019: A global perspective on the epidemiology and biological relationships", "abstract": ["The linkage of individuals with obesity and COVID\u201019 is controversial and lacks systematic reviews.", "After a systematic search of the Chinese and English language literature on COVID\u201019, 75 studies were used to conduct a series of meta\u2010analyses on the relationship of individuals with obesity\u2013COVID\u201019 over the full spectrum from risk to mortality.", "A systematic review of the mechanistic pathways for COVID\u201019 and individuals with obesity is presented.", "Pooled analysis show individuals with obesity were more at risk for COVID\u201019 positive, >46.0% higher (OR = 1.46; 95% CI, 1.30\u20131.65; p < 0.0001); for hospitalization, 113% higher (OR = 2.13; 95% CI, 1.74\u20132.60; p < 0.0001); for ICU admission, 74% higher (OR = 1.74; 95% CI, 1.46\u20132.08); and for mortality, 48% increase in deaths (OR = 1.48; 95% CI, 1.22\u20131.80; p < 0.001).", "Mechanistic pathways for individuals with obesity are presented in depth for factors linked with COVID\u201019 risk, severity and their potential for diminished therapeutic and prophylactic treatments among these individuals.", "Individuals with obesity are linked with large significant increases in morbidity and mortality from COVID\u201019.", "There are many mechanisms that jointly explain this impact.", "A major concern is that vaccines will be less effective for the individuals with obesity."]}
{"cord_id": "22l36xkv", "title": "Descriptive epidemiology of 16,780 hospitalized COVID-19 patients in the United States", "abstract": ["BACKGROUND: Despite the significant morbidity and mortality caused by the 2019 novel coronavirus disease (COVID-19), our understanding of basic disease epidemiology remains limited.", "This study aimed to describe key patient characteristics, comorbidities, treatments, and outcomes of a large U.S.-based cohort of patients hospitalized with COVD-19 using electronic health records (EHR).", "METHODS: We identified patients in the Optum De-identified COVID-19 EHR database who had laboratory-confirmed COVID-19 or a presumptive diagnosis between 20 February 2020 and 6 June 2020.", "We included hospitalizations that occurred 7 days prior to, or within 21 days after, COVID-19 diagnosis.", "Among hospitalized patients we describe the following: vital statistics and laboratory results on admission, relevant comorbidities (using diagnostic, procedural, and revenue codes), medications (NDC, HCPC codes), ventilation, intensive care unit (ICU) stay, length of stay (LOS), and mortality.", "RESULTS: We identified 76,819 patients diagnosed with COVID-19, 16,780 of whom met inclusion criteria for COVID-related hospitalization.", "Over half the cohort was over age 50 (74.5%), overweight or obese (72.1%), or had hypertension (58.1%).", "At admission, 29.1% of patients presented with fever (>38 C) and 30.6% had low oxygen saturation (<90%).", "Among the 16,099 patients with complete hospital records, we observed that 58.9% had hypoxia, 23.4% had an ICU stay during hospitalization, 18.1% were ventilated, and 16.2% died.", "The median LOS was 6 days (IQR: 4, 11).", "CONCLUSIONS: To our knowledge, this is the largest descriptive study of patients hospitalized with COVID-19 in the United States.", "We report summary statistics of key clinical outcomes that provide insights to better understand COVID-19 disease epidemiology."]}
{"cord_id": "jj7qlcfn", "title": "Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection", "abstract": ["IMPORTANCE: Published data suggest that there are increased hospitalizations, placental abnormalities, and rare neonatal transmission among pregnant women with coronavirus disease 2019 (COVID-19).", "OBJECTIVES: To evaluate adverse outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy and to describe clinical management, disease progression, hospital admission, placental abnormalities, and neonatal outcomes.", "DESIGN, SETTING, AND PARTICIPANTS: This observational cohort study of maternal and neonatal outcomes among delivered women with and without SARS-CoV-2 during pregnancy was conducted from March 18 through August 22, 2020, at Parkland Health and Hospital System (Dallas, Texas), a high-volume prenatal clinic system and public maternity hospital with widespread access to SARS-CoV-2 testing in outpatient, emergency department, and inpatient settings.", "Women were included if they were tested for SARS-CoV-2 during pregnancy and delivered.", "For placental analysis, the pathologist was blinded to illness severity.", "EXPOSURES: SARS-CoV-2 infection during pregnancy.", "MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of preterm birth, preeclampsia with severe features, or cesarean delivery for abnormal fetal heart rate among women delivered after 20 weeks of gestation.", "Maternal illness severity, neonatal infection, and placental abnormalities were described.", "RESULTS: From March 18 through August 22, 2020, 3374 pregnant women (mean [SD] age, 27.6 [6] years) tested for SARS-CoV-2 were delivered, including 252 who tested positive for SARS-CoV-2 and 3122 who tested negative.", "The cohort included 2520 Hispanic (75%), 619 Black (18%), and 125 White (4%) women.", "There were no differences in age, parity, body mass index, or diabetes among women with or without SARS-CoV-2.", "SARS-CoV-2 positivity was more common among Hispanic women (230 [91%] positive vs 2290 [73%] negative; difference, 17.9%; 95% CI, 12.3%-23.5%; P < .001).", "There was no difference in the composite primary outcome (52 women [21%] vs 684 women [23%]; relative risk, 0.94; 95% CI, 0.73-1.21; P = .64).", "Early neonatal SARS-CoV-2 infection occurred in 6 of 188 tested infants (3%), primarily born to asymptomatic or mildly symptomatic women.", "There were no placental pathologic differences by illness severity.", "Maternal illness at initial presentation was asymptomatic or mild in 239 women (95%), and 6 of those women (3%) developed severe or critical illness.", "Fourteen women (6%) were hospitalized for the indication of COVID-19.", "CONCLUSIONS AND RELEVANCE: In a large, single-institution cohort study, SARS-CoV-2 infection during pregnancy was not associated with adverse pregnancy outcomes.", "Neonatal infection may be as high as 3% and may occur predominantly among asymptomatic or mildly symptomatic women.", "Placental abnormalities were not associated with disease severity, and hospitalization frequency was similar to rates among nonpregnant women."]}
{"cord_id": "t5veknxr", "title": "Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020", "abstract": ["As of October 15, 216,025 deaths from coronavirus disease 2019 (COVID-19) have been reported in the United States*; however, this number might underestimate the total impact of the pandemic on mortality.", "Measures of excess deaths have been used to estimate the impact of public health pandemics or disasters, particularly when there are questions about underascertainment of deaths directly attributable to a given event or cause (1-6).\u0086 Excess deaths are defined as the number of persons who have died from all causes, in excess of the expected number of deaths for a given place and time.", "This report describes trends and demographic patterns in excess deaths during January 26-October 3, 2020.", "Expected numbers of deaths were estimated using overdispersed Poisson regression models with spline terms to account for seasonal patterns, using provisional mortality data from CDC's National Vital Statistics System (NVSS) (7).", "Weekly numbers of deaths by age group and race/ethnicity were assessed to examine the difference between the weekly number of deaths occurring in 2020 and the average number occurring in the same week during 2015-2019 and the percentage change in 2020.", "Overall, an estimated 299,028 excess deaths have occurred in the United States from late January through October 3, 2020, with two thirds of these attributed to COVID-19.", "The largest percentage increases were seen among adults aged 25-44 years and among Hispanic or Latino (Hispanic) persons.", "These results provide information about the degree to which COVID-19 deaths might be underascertained and inform efforts to prevent mortality directly or indirectly associated with the COVID-19 pandemic, such as efforts to minimize disruptions to health care."]}
{"cord_id": "gdrkw7pe", "title": "Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19", "abstract": ["The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease.", "Moreover, thromboembolic events throughout the body, including in the CNS, have been described.", "Given the neurological symptoms observed in a large majority of individuals with COVID-19, SARS-CoV-2 penetrance of the CNS is likely.", "By various means, we demonstrate the presence of SARS-CoV-2 RNA and protein in anatomically distinct regions of the nasopharynx and brain.", "Furthermore, we describe the morphological changes associated with infection such as thromboembolic ischemic infarction of the CNS and present evidence of SARS-CoV-2 neurotropism.", "SARS-CoV-2 can enter the nervous system by crossing the neural-mucosal interface in olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue, including delicate olfactory and sensory nerve endings.", "Subsequently, SARS-CoV-2 appears to follow neuroanatomical structures, penetrating defined neuroanatomical areas including the primary respiratory and cardiovascular control center in the medulla oblongata."]}
{"cord_id": "0isi7yd4", "title": "Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection", "abstract": ["Importance: As countermeasures against the economic downturn caused by the coronavirus 2019 (COVID-19) pandemic, many countries have introduced or considering financial incentives for people to engage in economic activities such as travel and use restaurants.", "Japan has implemented a large-scale, nationwide government-funded program that subsidizes up to 50% of all travel expenses since July 2020 with the aim of reviving the travel industry.", "However, it remains unknown as to how such provision of government subsidies for travel impacted the COVID-19 pandemic.", "Objective: To investigate the association between participation in government subsidies for domestic travel in Japan and the incidence of COVID-19 infections.", "Design, Setting, and Participants: Using the data from a large internet survey conducted between August 25 and September 30, 2020, in Japan, we examined whether individuals who used subsidies experienced a higher likelihood of symptoms indicative of the COVID-19 infection.", "Exposure: Participation in the government subsidy program for domestic travel.", "Main Outcomes and Measures: Five symptoms indicative of the COVID-19 infection (high fever, throat pain, cough, headache, and smell and taste disorder) within the past one month of the survey.", "Results: Of the 25,482 respondents (50.3% [12,809] women; mean [SD] age, 48.4 [17.4] years), 3,289 (12.9%) participated in the subsidy program at the time of survey.", "After adjusting for potential confounders, we found that the participants of the subsidy program exhibited higher incidence of high fever (adjusted rate, 4.8% for participants vs. 3.7% for non-participants; adjusted odds ratio [aOR], 1.90; 95%CI, 1.40-2.56; p<0.001), throat pain (20.0% vs. 11.3%; aOR, 2.13; 95%CI, 1.39-3.26; p=0.002), cough (19.2% vs. 11.2%; aOR 1.97; 95%CI, 1.28-3.03; p=0.004), headache (29.4% vs. 25.5%; aOR, 1.26; 95%CI, 1.09=1.46; p=0.005), and smell and taste disorder (2.6% vs. 1.7%; aOR 1.66; 95%CI; 1.16-3.49; p=0.01) compared with the non-participants.", "Conclusion and Relevance: The participants of government subsidies for domestic travel experienced a higher incidence of symptoms indicative of the COVID-19 infection."]}
{"cord_id": "n2rec4i8", "title": "Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study", "abstract": ["BACKGROUND: Concerns regarding potential neurological complications of COVID-19 are being increasingly reported, primarily in small series.", "Larger studies have been limited by both geography and specialty.", "Comprehensive characterisation of clinical syndromes is crucial to allow rational selection and evaluation of potential therapies.", "The aim of this study was to investigate the breadth of complications of COVID-19 across the UK that affected the brain.", "METHODS: During the exponential phase of the pandemic, we developed an online network of secure rapid-response case report notification portals across the spectrum of major UK neuroscience bodies, comprising the Association of British Neurologists (ABN), the British Association of Stroke Physicians (BASP), and the Royal College of Psychiatrists (RCPsych), and representing neurology, stroke, psychiatry, and intensive care.", "Broad clinical syndromes associated with COVID-19 were classified as a cerebrovascular event (defined as an acute ischaemic, haemorrhagic, or thrombotic vascular event involving the brain parenchyma or subarachnoid space), altered mental status (defined as an acute alteration in personality, behaviour, cognition, or consciousness), peripheral neurology (defined as involving nerve roots, peripheral nerves, neuromuscular junction, or muscle), or other (with free text boxes for those not meeting these syndromic presentations).", "Physicians were encouraged to report cases prospectively and we permitted recent cases to be notified retrospectively when assigned a confirmed date of admission or initial clinical assessment, allowing identification of cases that occurred before notification portals were available.", "Data collected were compared with the geographical, demographic, and temporal presentation of overall cases of COVID-19 as reported by UK Government public health bodies.", "FINDINGS: The ABN portal was launched on April 2, 2020, the BASP portal on April 3, 2020, and the RCPsych portal on April 21, 2020.", "Data lock for this report was on April 26, 2020.", "During this period, the platforms received notification of 153 unique cases that met the clinical case definitions by clinicians in the UK, with an exponential growth in reported cases that was similar to overall COVID-19 data from UK Government public health bodies.", "Median patient age was 71 years (range 23\u201394; IQR 58\u201379).", "Complete clinical datasets were available for 125 (82%) of 153 patients.", "77 (62%) of 125 patients presented with a cerebrovascular event, of whom 57 (74%) had an ischaemic stroke, nine (12%) an intracerebral haemorrhage, and one (1%) CNS vasculitis.", "39 (31%) of 125 patients presented with altered mental status, comprising nine (23%) patients with unspecified encephalopathy and seven (18%) patients with encephalitis.", "The remaining 23 (59%) patients with altered mental status fulfilled the clinical case definitions for psychiatric diagnoses as classified by the notifying psychiatrist or neuropsychiatrist, and 21 (92%) of these were new diagnoses.", "Ten (43%) of 23 patients with neuropsychiatric disorders had new-onset psychosis, six (26%) had a neurocognitive (dementia-like) syndrome, and four (17%) had an affective disorder.", "18 (49%) of 37 patients with altered mental status were younger than 60 years and 19 (51%) were older than 60 years, whereas 13 (18%) of 74 patients with cerebrovascular events were younger than 60 years versus 61 (82%) patients older than 60 years.", "INTERPRETATION: To our knowledge, this is the first nationwide, cross-specialty surveillance study of acute neurological and psychiatric complications of COVID-19.", "Altered mental status was the second most common presentation, comprising encephalopathy or encephalitis and primary psychiatric diagnoses, often occurring in younger patients.", "This study provides valuable and timely data that are urgently needed by clinicians, researchers, and funders to inform immediate steps in COVID-19 neuroscience research and health policy.", "FUNDING: None."]}
{"cord_id": "vg12z0on", "title": "Psychotic symptoms in COVID-19 patients. A retrospective descriptive study", "abstract": ["Psychotic symptoms have been related to other coronavirus infections.", "We conducted a single-centre retrospective and observational study to describe new-onset psychotic episodes in COVID-19 patients.", "Ten patients infected by the novel coronavirus with psychotic symptoms and no previous history of psychosis were identified by the emergency and liaison psychiatry departments.", "Nine of the cases presented with psychotic symptoms at least two weeks after the first somatic manifestations attributed to COVID-19 and receiving pharmacological treatment.", "Structured delusions mixed with confusional features were the most frequent clinical presentations.", "Hence, COVID-19 patients can develop psychotic symptoms as a consequence of multiple concurrent factors."]}
{"cord_id": "0oxy9b1p", "title": "Vitamin D concentrations and COVID-19 infection in UK Biobank", "abstract": ["BACKGROUND AND AIMS: COVID-19 and low levels of vitamin D appear to disproportionately affect black and minority ethnic individuals.", "We aimed to establish whether blood 25-hydroxyvitamin D (25(OH)D) concentration was associated with COVID-19 risk, and whether it explained the higher incidence of COVID-19 in black and South Asian people.", "METHODS: UK Biobank recruited 502,624 participants aged 37\u201373 years between 2006 and 2010.", "Baseline exposure data, including 25(OH)D concentration and ethnicity, were linked to COVID-19 test results.", "Univariable and multivariable logistic regression analyses were performed for the association between 25(OH)D and confirmed COVID-19, and the association between ethnicity and both 25(OH)D and COVID-19.", "RESULTS: Complete data were available for 348,598 UK Biobank participants.", "Of these, 449 had confirmed COVID-19 infection.", "Vitamin D was associated with COVID-19 infection univariably (OR = 0.99; 95% CI 0.99\u20130.999; p = 0.013), but not after adjustment for confounders (OR = 1.00; 95% CI = 0.998\u20131.01; p = 0.208).", "Ethnicity was associated with COVID-19 infection univariably (blacks versus whites OR = 5.32, 95% CI = 3.68\u20137.70, p-value<0.001; South Asians versus whites OR = 2.65, 95% CI = 1.65\u20134.25, p-value<0.001).", "Adjustment for 25(OH)D concentration made little difference to the magnitude of the association.", "CONCLUSIONS: Our findings do not support a potential link between vitamin D concentrations and risk of COVID-19 infection, nor that vitamin D concentration may explain ethnic differences in COVID-19 infection."]}
{"cord_id": "ipfux7vm", "title": "Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19", "abstract": ["Importance: Therapies that improve survival in critically ill patients with coronavirus disease 2019 (COVID-19) are needed.", "Tocilizumab, a monoclonal antibody against the interleukin 6 receptor, may counteract the inflammatory cytokine release syndrome in patients with severe COVID-19 illness.", "Objective: To test whether tocilizumab decreases mortality in this population.", "Design, Setting, and Participants: The data for this study were derived from a multicenter cohort study of 4485 adults with COVID-19 admitted to participating intensive care units (ICUs) at 68 hospitals across the US from March 4 to May 10, 2020.", "Critically ill adults with COVID-19 were categorized according to whether they received or did not receive tocilizumab in the first 2 days of admission to the ICU.", "Data were collected retrospectively until June 12, 2020.", "A Cox regression model with inverse probability weighting was used to adjust for confounding.", "Exposures: Treatment with tocilizumab in the first 2 days of ICU admission.", "Main Outcomes and Measures: Time to death, compared via hazard ratios (HRs), and 30-day mortality, compared via risk differences.", "Results: Among the 3924 patients included in the analysis (2464 male [62.8%]; median age, 62 [interquartile range {IQR}, 52-71] years), 433 (11.0%) received tocilizumab in the first 2 days of ICU admission.", "Patients treated with tocilizumab were younger (median age, 58 [IQR, 48-65] vs 63 [IQR, 52-72] years) and had a higher prevalence of hypoxemia on ICU admission (205 of 433 [47.3%] vs 1322 of 3491 [37.9%] with mechanical ventilation and a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen of <200 mm Hg) than patients not treated with tocilizumab.", "After applying inverse probability weighting, baseline and severity-of-illness characteristics were well balanced between groups.", "A total of 1544 patients (39.3%) died, including 125 (28.9%) treated with tocilizumab and 1419 (40.6%) not treated with tocilizumab.", "In the primary analysis, during a median follow-up of 27 (IQR, 14-37) days, patients treated with tocilizumab had a lower risk of death compared with those not treated with tocilizumab (HR, 0.71; 95% CI, 0.56-0.92).", "The estimated 30-day mortality was 27.5% (95% CI, 21.2%-33.8%) in the tocilizumab-treated patients and 37.1% (95% CI, 35.5%-38.7%) in the non-tocilizumab-treated patients (risk difference, 9.6%; 95% CI, 3.1%-16.0%).", "Conclusions and Relevance: Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the first 2 days of ICU admission compared with patients whose treatment did not include early use of tocilizumab.", "However, the findings may be susceptible to unmeasured confounding, and further research from randomized clinical trials is needed."]}
{"cord_id": "to9awvi9", "title": "Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19)", "abstract": ["IMPORTANCE: Coronavirus disease 2019 (COVID-19) infection has resulted in a global crisis.", "Investigating the potential association of climate and seasonality with the spread of this infection could aid in preventive and surveillance strategies.", "OBJECTIVE: To examine the association of climate with the spread of COVID-19 infection.", "DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined climate data from 50 cities worldwide with and without substantial community spread of COVID-19.", "Eight cities with substantial spread of COVID-19 (Wuhan, China; Tokyo, Japan; Daegu, South Korea; Qom, Iran; Milan, Italy; Paris, France; Seattle, US; and Madrid, Spain) were compared with 42 cities that have not been affected or did not have substantial community spread.", "Data were collected from January to March 10, 2020.", "MAIN OUTCOMES AND MEASURES: Substantial community transmission was defined as at least 10 reported deaths in a country as of March 10, 2020.", "Climate data (latitude, mean 2-m temperature, mean specific humidity, and mean relative humidity) were obtained from ERA-5 reanalysis.", "RESULTS: The 8 cities with substantial community spread as of March 10, 2020, were located on a narrow band, roughly on the 30\u00b0 N to 50\u00b0 N corridor.", "They had consistently similar weather patterns, consisting of mean temperatures of between 5 and 11 \u00b0C, combined with low specific humidity (3-6 g/kg) and low absolute humidity (4-7 g/m(3)).", "There was a lack of substantial community establishment in expected locations based on proximity.", "For example, while Wuhan, China (30.8\u00b0 N) had 3136 deaths and 80 757 cases, Moscow, Russia (56.0\u00b0 N), had 0 deaths and 10 cases and Hanoi, Vietnam (21.2\u00b0 N), had 0 deaths and 31 cases.", "CONCLUSIONS AND RELEVANCE: In this study, the distribution of substantial community outbreaks of COVID-19 along restricted latitude, temperature, and humidity measurements was consistent with the behavior of a seasonal respiratory virus.", "Using weather modeling, it may be possible to estimate the regions most likely to be at a higher risk of substantial community spread of COVID-19 in the upcoming weeks, allowing for concentration of public health efforts on surveillance and containment."]}
{"cord_id": "69epieku", "title": "Age-specific mortality and immunity patterns of SARS-CoV-2", "abstract": ["Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is made challenging by inconsistencies in the available data.", "The number of deaths associated with COVID-19 is often used as a key indicator for the size of the epidemic, but the observed number of deaths represents only a minority of all infections1,2.", "In addition, the heterogeneous burdens in nursing homes and the variable reporting of deaths of older individuals can hinder direct comparisons of mortality rates and the underlying levels of transmission across countries3.", "Here we use age-specific COVID-19-associated death data from 45 countries and the results of 22 seroprevalence studies to investigate the consistency of infection and fatality patterns across multiple countries.", "We find that the age distribution of deaths in younger age groups (less than 65 years of age) is very consistent across different settings and demonstrate how these data can provide robust estimates of the share of the population that has been infected.", "We estimate that the infection fatality ratio is lowest among 5-9-year-old children, with a log-linear increase by age among individuals older than 30 years.", "Population age structures and heterogeneous burdens in nursing homes explain some but not all of the heterogeneity between countries in infection fatality ratios.", "Among the 45 countries included in our analysis, we estimate that approximately 5% of these populations had been infected by 1 September 2020, and that much higher transmission rates have probably occurred in a number of Latin American countries.", "This simple modelling framework can help countries to assess the progression of the pandemic and can be applied in any scenario for which reliable age-specific death data are available."]}
{"cord_id": "wuazkwsi", "title": "The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission causing coronavirus disease 2019 (COVID-19) may occur through multiple routes.", "We collected aerosol samples around six patients admitted into mixed acuity wards in April of 2020 to identify the risk of airborne SARS-CoV-2.", "Measurements were made to characterize the size distribution of aerosol particles, and size-fractionated, aerosol samples were collected to assess the presence of infectious virus in particles sizes of >4.1 m, 1-4 m, and <1 m in the patient environment.", "Samples were analyzed by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR), cell culture, western blot, and transmission electron microscopy (TEM).", "SARS-CoV-2 RNA was detected in all six rooms in all particle size fractions (>4.1 m, 1-4 m, and <1 m).", "Increases in viral RNA during cell culture of the virus from recovered aerosol samples demonstrated the presence of infectious, replicating virions in three <1 m aerosol samples (P<0.05).", "Viral replication of aerosol was also observed in the 1-4 m stage but did not reach statistical significance (0.05<P<0.10).", "Western blot and TEM analysis of these samples also showed evidence of viral proteins and intact virions.", "The infectious nature of aerosol collected in this study further suggests that airborne transmission of COVID-19 is possible, and that aerosol prevention measures are necessary to effectively stem the spread of SARS-CoV-2."]}
{"cord_id": "lydvs1n1", "title": "SARS-CoV-2 viral load is associated with increased disease severity and mortality", "abstract": ["The relationship between SARS-CoV-2 viral load and risk of disease progression remains largely undefined in coronavirus disease 2019 (COVID-19).", "Here, we quantify SARS-CoV-2 viral load from participants with a diverse range of COVID-19 disease severity, including those requiring hospitalization, outpatients with mild disease, and individuals with resolved infection.", "We detected SARS-CoV-2 plasma RNA in 27% of hospitalized participants, and 13% of outpatients diagnosed with COVID-19.", "Amongst the participants hospitalized with COVID-19, we report that a higher prevalence of detectable SARS-CoV-2 plasma viral load is associated with worse respiratory disease severity, lower absolute lymphocyte counts, and increased markers of inflammation, including C-reactive protein and IL-6.", "SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.", "Our data show that SARS-CoV-2 viral loads may aid in the risk stratification of patients with COVID-19, and therefore its role in disease pathogenesis should be further explored."]}
{"cord_id": "mup5hr7e", "title": "Diverse Functional Autoantibodies in Patients with COVID-19", "abstract": ["COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses(1\u20138).", "While pathological innate immune activation is well documented in severe disease(1), the impact of autoantibodies on disease progression is less defined.", "Here, we used a high-throughput autoantibody discovery technique called Rapid Extracellular Antigen Profiling (REAP) to screen a cohort of 194 SARS-CoV-2 infected COVID-19 patients and healthcare workers for autoantibodies against 2,770 extracellular and secreted proteins (the \u201cexoproteome\u201d).", "We found that COVID-19 patients exhibit dramatic increases in autoantibody reactivities compared to uninfected controls, with a high prevalence of autoantibodies against immunomodulatory proteins including cytokines, chemokines, complement components, and cell surface proteins.", "We established that these autoantibodies perturb immune function and impair virological control by inhibiting immunoreceptor signaling and by altering peripheral immune cell composition, and found that murine surrogates of these autoantibodies exacerbate disease severity in a mouse model of SARS-CoV-2 infection.", "Analysis of autoantibodies against tissue-associated antigens revealed associations with specific clinical characteristics and disease severity.", "In summary, these findings implicate a pathological role for exoproteome-directed autoantibodies in COVID-19 with diverse impacts on immune functionality and associations with clinical outcomes."]}
{"cord_id": "gjbqr1ti", "title": "Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis", "abstract": ["OBJECTIVE: Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking.", "We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza.", "DESIGN: Multinational network cohort study SETTING: Electronic health records data from Columbia University Irving Medical Center (CUIMC) (NYC, United States [US]), Optum [US], Department of Veterans Affairs (VA) (US), Information System for Research in Primary Care-Hospitalisation Linked Data (SIDIAP-H) (Spain), and claims data from IQVIA Open Claims (US) and Health Insurance and Review Assessment (HIRA) (South Korea).", "PARTICIPANTS: All patients with prevalent autoimmune diseases, diagnosed and/or hospitalised between January and June 2020 with COVID-19, and similar patients hospitalised with influenza in 2017\u20132018 were included.", "MAIN OUTCOME MEASURES: 30-day complications during hospitalisation and death RESULTS: We studied 133,589 patients diagnosed and 48,418 hospitalised with COVID-19 with prevalent autoimmune diseases.", "The majority of participants were female (60.5% to 65.9%) and aged \u226550 years.", "The most prevalent autoimmune conditions were psoriasis (3.5 to 32.5%), rheumatoid arthritis (3.9 to 18.9%), and vasculitis (3.3 to 17.6%).", "Amongst hospitalised patients, Type 1 diabetes was the most common autoimmune condition (4.8% to 7.5%) in US databases, rheumatoid arthritis in HIRA (18.9%), and psoriasis in SIDIAP-H (26.4%).", "Compared to 70,660 hospitalised with influenza, those admitted with COVID-19 had more respiratory complications including pneumonia and acute respiratory distress syndrome, and higher 30-day mortality (2.2% to 4.3% versus 6.3% to 24.6%).", "CONCLUSIONS: Patients with autoimmune diseases had high rates of respiratory complications and 30-day mortality following a hospitalization with COVID-19.", "Compared to influenza, COVID-19 is a more severe disease, leading to more complications and higher mortality.", "Future studies should investigate predictors of poor outcomes in COVID-19 patients with autoimmune diseases."]}
{"cord_id": "26c2bf4i", "title": "Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics", "abstract": ["We measured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA concentrations in primary sewage sludge in the New Haven, Connecticut, USA, metropolitan area during the Coronavirus Disease 2019 (COVID-19) outbreak in Spring 2020.", "SARS-CoV-2 RNA was detected throughout the more than 10-week study and, when adjusted for time lags, tracked the rise and fall of cases seen in SARS-CoV-2 clinical test results and local COVID-19 hospital admissions.", "Relative to these indicators, SARS-CoV-2 RNA concentrations in sludge were 0-2 d ahead of SARS-CoV-2 positive test results by date of specimen collection, 0-2 d ahead of the percentage of positive tests by date of specimen collection, 1-4 d ahead of local hospital admissions and 6-8 d ahead of SARS-CoV-2 positive test results by reporting date.", "Our data show the utility of viral RNA monitoring in municipal wastewater for SARS-CoV-2 infection surveillance at a population-wide level.", "In communities facing a delay between specimen collection and the reporting of test results, immediate wastewater results can provide considerable advance notice of infection dynamics."]}
{"cord_id": "28fu4ptm", "title": "6-month consequences of COVID-19 in patients discharged from hospital: a cohort study", "abstract": ["BACKGROUND: The long-term health consequences of COVID-19 remain largely unclear.", "The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.", "METHODS: We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020.", "Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded.", "All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests.", "A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5\u20136, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography.", "Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests.", "Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.", "FINDINGS: In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded.", "Patients had a median age of 57\u00b70 (IQR 47\u00b70\u201365\u00b70) years and 897 (52%) were men.", "The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186\u00b70 (175\u00b70\u2013199\u00b70) days.", "Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms.", "Anxiety or depression was reported among 23% (367 of 1617) of patients.", "The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5\u20136.", "The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5\u20136, and median CT scores were 3\u00b70 (IQR 2\u00b70\u20135\u00b70) for severity scale 3, 4\u00b70 (3\u00b70\u20135\u00b70) for scale 4, and 5\u00b70 (4\u00b70\u20136\u00b70) for scale 5\u20136.", "After multivariable adjustment, patients showed an odds ratio (OR) 1\u00b761 (95% CI 0\u00b780\u20133\u00b725) for scale 4 versus scale 3 and 4\u00b760 (1\u00b785\u201311\u00b748) for scale 5\u20136 versus scale 3 for diffusion impairment; OR 0\u00b788 (0\u00b766\u20131\u00b717) for scale 4 versus scale 3 and OR 1\u00b777 (1\u00b705\u20132\u00b797) for scale 5\u20136 versus scale 3 for anxiety or depression, and OR 0\u00b774 (0\u00b758\u20130\u00b796) for scale 4 versus scale 3 and 2\u00b769 (1\u00b746\u20134\u00b796) for scale 5\u20136 versus scale 3 for fatigue or muscle weakness.", "Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96\u00b72% vs 58\u00b75%) and median titres (19\u00b70 vs 10\u00b70) of the neutralising antibodies were significantly lower compared with at the acute phase.", "107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1\u00b773 m(2) or more at acute phase had eGFR less than 90 mL/min per 1\u00b773 m(2) at follow-up.", "INTERPRETATION: At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression.", "Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.", "FUNDING: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation."]}
{"cord_id": "ekgqdjlk", "title": "Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study", "abstract": ["BACKGROUND: Many patients receiving dialysis in the USA share the socioeconomic characteristics of underserved communities, and undergo routine monthly laboratory testing, facilitating a practical, unbiased, and repeatable assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence.", "METHODS: For this cross-sectional study, in partnership with a central laboratory that receives samples from approximately 1300 dialysis facilities across the USA, we tested the remainder plasma of 28 503 randomly selected adult patients receiving dialysis in July, 2020, using a spike protein receptor binding domain total antibody chemiluminescence assay (100% sensitivity, 99\u00b78% specificity).", "We extracted data on age, sex, race and ethnicity, and residence and facility ZIP codes from the anonymised electronic health records, linking patient-level residence data with cumulative and daily cases and deaths per 100 000 population and with nasal swab test positivity rates.", "We standardised prevalence estimates according to the overall US dialysis and adult population, and present estimates for four prespecified strata (age, sex, region, and race and ethnicity).", "FINDINGS: The sampled population had similar age, sex, and race and ethnicity distribution to the US dialysis population, with a higher proportion of older people, men, and people living in majority Black and Hispanic neighbourhoods than in the US adult population.", "Seroprevalence of SARS-CoV-2 was 8\u00b70% (95% CI 7\u00b77\u20138\u00b74) in the sample, 8\u00b73% (8\u00b70\u20138\u00b76) when standardised to the US dialysis population, and 9\u00b73% (8\u00b78\u20139\u00b79) when standardised to the US adult population.", "When standardised to the US dialysis population, seroprevalence ranged from 3\u00b75% (3\u00b71\u20133\u00b79) in the west to 27\u00b72% (25\u00b79\u201328\u00b75) in the northeast.", "Comparing seroprevalent and case counts per 100 000 population, we found that 9\u00b72% (8\u00b77\u20139\u00b78) of seropositive patients were diagnosed.", "When compared with other measures of SARS-CoV-2 spread, seroprevalence correlated best with deaths per 100 000 population (Spearman's \u03c1=0\u00b777).", "Residents of non-Hispanic Black and Hispanic neighbourhoods experienced higher odds of seropositivity (odds ratio 3\u00b79 [95% CI 3\u00b74\u20134\u00b76] and 2\u00b73 [1\u00b79\u20132\u00b76], respectively) compared with residents of predominantly non-Hispanic white neighbourhoods.", "Residents of neighbourhoods in the highest population density quintile experienced increased odds of seropositivity (10\u00b73 [8\u00b77\u201312\u00b72]) compared with residents of the lowest density quintile.", "County mobility restrictions that reduced workplace visits by at least 5% in early March, 2020, were associated with lower odds of seropositivity in July, 2020 (0\u00b74 [0\u00b73\u20130\u00b75]) when compared with a reduction of less than 5%.", "INTERPRETATION: During the first wave of the COVID-19 pandemic, fewer than 10% of the US adult population formed antibodies against SARS-CoV-2, and fewer than 10% of those with antibodies were diagnosed.", "Public health efforts to limit SARS-CoV-2 spread need to especially target racial and ethnic minority and densely populated communities.", "FUNDING: Ascend Clinical Laboratories."]}
{"cord_id": "fqseywjg", "title": "COVID-19-Associated Hospitalizations Among Health Care Personnel - COVID-NET, 13 States, March 1-May 31, 2020", "abstract": ["Health care personnel (HCP) can be exposed to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), both within and outside the workplace, increasing their risk for infection.", "Among 6,760 adults hospitalized during March 1-May 31, 2020, for whom HCP status was determined by the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), 5.9% were HCP.", "Nursing-related occupations (36.3%) represented the largest proportion of HCP hospitalized with COVID-19.", "Median age of hospitalized HCP was 49 years, and 89.8% had at least one underlying medical condition, of which obesity was most commonly reported (72.5%).", "A substantial proportion of HCP with COVID-19 had indicators of severe disease: 27.5% were admitted to an intensive care unit (ICU), 15.8% required invasive mechanical ventilation, and 4.2% died during hospitalization.", "HCP can have severe COVID-19-associated illness, highlighting the need for continued infection prevention and control in health care settings as well as community mitigation efforts to reduce transmission."]}
{"cord_id": "y2g0hpeo", "title": "Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats", "abstract": ["The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached nearly every country in the world with extraordinary person-to-person transmission.", "The most likely original source of the virus was spillover from an animal reservoir and subsequent adaptation to humans sometime during the winter of 2019 in Wuhan Province, China.", "Because of its genetic similarity to SARS-CoV-1, it is probable that this novel virus has a similar host range and receptor specificity.", "Due to concern for human-pet transmission, we investigated the susceptibility of domestic cats and dogs to infection and potential for infected cats to transmit to naive cats.", "We report that cats are highly susceptible to infection, with a prolonged period of oral and nasal viral shedding that is not accompanied by clinical signs, and are capable of direct contact transmission to other cats.", "These studies confirm that cats are susceptible to productive SARS-CoV-2 infection, but are unlikely to develop clinical disease.", "Further, we document that cats developed a robust neutralizing antibody response that prevented reinfection following a second viral challenge.", "Conversely, we found that dogs do not shed virus following infection but do seroconvert and mount an antiviral neutralizing antibody response.", "There is currently no evidence that cats or dogs play a significant role in human infection; however, reverse zoonosis is possible if infected owners expose their domestic pets to the virus during acute infection.", "Resistance to reinfection holds promise that a vaccine strategy may protect cats and, by extension, humans."]}
{"cord_id": "r4btmprw", "title": "Frequent neurologic manifestations and encephalopathy\u2010associated morbidity in Covid\u201019 patients", "abstract": ["OBJECTIVE: Covid\u201019 can involve multiple organs including the nervous system.", "We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid\u201019.", "METHODS: We examined neurologic manifestations in 509 consecutive patients admitted with confirmed Covid\u201019 within a hospital network in Chicago, Illinois.", "We compared the severity of Covid\u201019 and outcomes in patients with and without neurologic manifestations.", "We also identified independent predictors of any neurologic manifestations, encephalopathy, and functional outcome using binary logistic regression.", "RESULTS: Neurologic manifestations were present at Covid\u201019 onset in 215 (42.2%), at hospitalization in 319 (62.7%), and at any time during the disease course in 419 patients (82.3%).", "The most frequent neurologic manifestations were myalgias (44.8%), headaches (37.7%), encephalopathy (31.8%), dizziness (29.7%), dysgeusia (15.9%), and anosmia (11.4%).", "Strokes, movement disorders, motor and sensory deficits, ataxia, and seizures were uncommon (0.2 to 1.4% of patients each).", "Severe respiratory disease requiring mechanical ventilation occurred in 134 patients (26.3%).", "Independent risk factors for developing any neurologic manifestation were severe Covid\u201019 (OR 4.02; 95% CI 2.04\u20138.89; P < 0.001) and younger age (OR 0.982; 95% CI 0.968\u20130.996; P = 0.014).", "Of all patients, 362 (71.1%) had a favorable functional outcome at discharge (modified Rankin Scale 0\u20132).", "However, encephalopathy was independently associated with worse functional outcome (OR 0.22; 95% CI 0.11\u20130.42; P < 0.001) and higher mortality within 30 days of hospitalization (35 [21.7%] vs. 11 [3.2%] patients; P < 0.001).", "INTERPRETATION: Neurologic manifestations occur in most hospitalized Covid\u201019 patients.", "Encephalopathy was associated with increased morbidity and mortality, independent of respiratory disease severity."]}
{"cord_id": "s6sp3rme", "title": "Jumping back and forth: anthropozoonotic and zoonotic transmission of SARS-CoV-2 on mink farms", "abstract": ["The zoonotic origin of the SARS-CoV-2 pandemic is still unknown.", "Animal experiments have shown that non-human primates, cats, ferrets, hamsters, rabbits and bats can be infected by SARS-CoV-2.", "In addition, SARS-CoV-2 RNA has been detected in felids, mink and dogs in the field.", "Here, we describe an in-depth investigation of outbreaks on 16 mink farms and humans living or working on these farms, using whole genome sequencing.", "We conclude that the virus was initially introduced from humans and has evolved, most likely reflecting widespread circulation among mink in the beginning of the infection period several weeks prior to detection.", "At the moment, despite enhanced biosecurity, early warning surveillance and immediate culling of infected farms, there is ongoing transmission between mink farms with three big transmission clusters with unknown modes of transmission.", "We also describe the first animal to human transmissions of SARS-CoV-2 in mink farms.", "One sentence summary SARS-CoV-2 transmission on mink farms."]}
{"cord_id": "1q703zre", "title": "Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states", "abstract": ["Population based data on COVID-19 are essential for guiding policy.", "We report on the first wave of seroprevalence surveys relying upon on household probabilistic samples of 133 large sentinel cities in Brazil, including 25,025 participants from all 26 states and the Federal District.", "Seroprevalence of antibodies to SARS-CoV-2, assessed using a lateral flow rapid test, varied markedly across the cities and regions, from below 1% in most cities in the South and Center-West regions to up to 25% in the city of Breves in the Amazon (North) region.", "Eleven of the 15 cities with the highest seroprevalence were located in the North, including the six cities with highest prevalence which were located along a 2,000 km stretch of the Amazon river.", "Overall seroprevalence for the 90 cities with sample size of 200 or greater was 1.4% (95% CI 1.3-1.6).", "Extrapolating this figure to the population of these cities, which represent 25% of the country population, led to an estimate of 760,000 cases, as compared to the 104,782 cases reported in official statistics.", "Seroprevalence did not vary significantly between infancy and age 79 years, but fell by approximately two-thirds after age 80 years.", "Prevalence was highest among indigenous people (3.7%) and lowest among whites (0.6%), a difference which was maintained when analyses were restricted to the North region, where most indigenous people live.", "Our results suggest that pandemic is highly heterogenous, with rapid escalation in the North and Northeast, and slow progression in the South and Center-West regions."]}
{"cord_id": "up53a0k4", "title": "High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020", "abstract": ["Our analysis of coronavirus disease prevalence in 9 long-term care facilities demonstrated a high proportion (40.7%) of asymptomatic infections among residents and staff members.", "Infection control measures in congregate settings should include mass testing\u2013based strategies in concert with symptom screening for greater effectiveness in preventing the spread of severe acute respiratory syndrome coronavirus 2."]}
{"cord_id": "lrqt2gcw", "title": "A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants", "abstract": ["The magnitude of the COVID-19 pandemic underscores the urgency for a safe and effective vaccine.", "Many vaccine candidates focus on the Spike protein, as it is targeted by neutralizing antibodies and plays a key role in viral entry.", "Here we investigate the diversity seen in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences and compare it to the sequence on which most vaccine candidates are based.", "Using 18,514 sequences, we perform phylogenetic, population genetics, and structural bioinformatics analyses.", "We find limited diversity across SARS-CoV-2 genomes: Only 11 sites show polymorphisms in >5% of sequences; yet two mutations, including the D614G mutation in Spike, have already become consensus.", "Because SARS-CoV-2 is being transmitted more rapidly than it evolves, the viral population is becoming more homogeneous, with a median of seven nucleotide substitutions between genomes.", "There is evidence of purifying selection but little evidence of diversifying selection, with substitution rates comparable across structural versus nonstructural genes.", "Finally, the Wuhan-Hu-1 reference sequence for the Spike protein, which is the basis for different vaccine candidates, matches optimized vaccine inserts, being identical to an ancestral sequence and one mutation away from the consensus.", "While the rapid spread of the D614G mutation warrants further study, our results indicate that drift and bottleneck events can explain the minimal diversity found among SARS-CoV-2 sequences.", "These findings suggest that a single vaccine candidate should be efficacious against currently circulating lineages."]}
{"cord_id": "33c0802r", "title": "Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic", "abstract": ["IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic and the policies to contain it have been a near ubiquitous exposure in the US with unknown effects on depression symptoms.", "OBJECTIVE: To estimate the prevalence of and risk factors associated with depression symptoms among US adults during vs before the COVID-19 pandemic.", "DESIGN, SETTING, AND PARTICIPANTS: This nationally representative survey study used 2 population-based surveys of US adults aged 18 or older.", "During COVID-19, estimates were derived from the COVID-19 and Life Stressors Impact on Mental Health and Well-being study, conducted from March 31, 2020, to April 13, 2020.", "Before COVID-19 estimates were derived from the National Health and Nutrition Examination Survey, conducted from 2017 to 2018.", "Data were analyzed from April 15 to 20, 2020.", "EXPOSURES: The COVID-19 pandemic and outcomes associated with the measures to mitigate it.", "MAIN OUTCOMES AND MEASURES: Depression symptoms, defined using the Patient Health Questionnaire-9 cutoff of 10 or higher.", "Categories of depression symptoms were defined as none (score, 0-4), mild (score, 5-9), moderate (score, 10-14), moderately severe (score, 15-19), and severe (score, \u226520).", "RESULTS: A total of 1470 participants completed the COVID-19 and Life Stressors Impact on Mental Health and Well-being survey (completion rate, 64.3%), and after removing those with missing data, the final during\u2013COVID-19 sample included 1441 participants (619 participants [43.0%] aged 18-39 years; 723 [50.2%] men; 933 [64.7%] non-Hispanic White).", "The pre\u2013COVID-19 sample included 5065 participants (1704 participants [37.8%] aged 18-39 years; 2588 [51.4%] women; 1790 [62.9%] non-Hispanic White).", "Depression symptom prevalence was higher in every category during COVID-19 compared with before (mild: 24.6% [95% CI, 21.8%-27.7%] vs 16.2% [95% CI, 15.1%-17.4%]; moderate: 14.8% [95% CI, 12.6%-17.4%] vs 5.7% [95% CI, 4.8%-6.9%]; moderately severe: 7.9% [95% CI, 6.3%-9.8%] vs 2.1% [95% CI, 1.6%-2.8%]; severe: 5.1% [95% CI, 3.8%-6.9%] vs 0.7% [95% CI, 0.5%-0.9%]).", "Higher risk of depression symptoms during COVID-19 was associated with having lower income (odds ratio, 2.37 [95% CI, 1.26-4.43]), having less than $5000 in savings (odds ratio, 1.52 [95% CI, 1.02-2.26]), and exposure to more stressors (odds ratio, 3.05 [95% CI, 1.95-4.77]).", "CONCLUSIONS AND RELEVANCE: These findings suggest that prevalence of depression symptoms in the US was more than 3-fold higher during COVID-19 compared with before the COVID-19 pandemic.", "Individuals with lower social resources, lower economic resources, and greater exposure to stressors (eg, job loss) reported a greater burden of depression symptoms.", "Post\u2013COVID-19 plans should account for the probable increase in mental illness to come, particularly among at-risk populations."]}
{"cord_id": "as3oqva3", "title": "Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health challenges related to the morbidity and mortality caused by the disease and to mitigation activities, including the impact of physical distancing and stay-at-home orders.", "* Symptoms of anxiety disorder and depressive disorder increased considerably in the United States during April-June of 2020, compared with the same period in 2019 (1,2).", "To assess mental health, substance use, and suicidal ideation during the pandemic, representative panel surveys were conducted among adults aged &#8805;18 years across the United States during June 24-30, 2020.", "Overall, 40.9% of respondents reported at least one adverse mental or behavioral health condition, including symptoms of anxiety disorder or depressive disorder (30.9%), symptoms of a trauma- and stressor-related disorder (TSRD) related to the pandemic\u0086 (26.3%), and having started or increased substance use to cope with stress or emotions related to COVID-19 (13.3%).", "The percentage of respondents who reported having seriously considered suicide in the 30 days before completing the survey (10.7%) was significantly higher among respondents aged 18-24 years (25.5%), minority racial/ethnic groups (Hispanic respondents [18.6%], non-Hispanic black [black] respondents [15.1%]), self-reported unpaid caregivers for adults\u00a7 (30.7%), and essential workers\u00b6 (21.7%).", "Community-level intervention and prevention efforts, including health communication strategies, designed to reach these groups could help address various mental health conditions associated with the COVID-19 pandemic."]}
{"cord_id": "rzvws6op", "title": "Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China", "abstract": ["Importance: Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019.", "However, information on cardiac injury in patients affected by COVID-19 is limited.", "Objective: To explore the association between cardiac injury and mortality in patients with COVID-19.", "Design, Setting, and Participants: This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; the final date of follow-up was February 15, 2020.", "All consecutive inpatients with laboratory-confirmed COVID-19 were included in this study.", "Main Outcomes and Measures: Clinical laboratory, radiological, and treatment data were collected and analyzed.", "Outcomes of patients with and without cardiac injury were compared.", "The association between cardiac injury and mortality was analyzed.", "Results: A total of 416 hospitalized patients with COVID-19 were included in the final analysis; the median age was 64 years (range, 21-95 years), and 211 (50.7%) were female.", "Common symptoms included fever (334 patients [80.3%]), cough (144 [34.6%]), and shortness of breath (117 [28.1%]).", "A total of 82 patients (19.7%) had cardiac injury, and compared with patients without cardiac injury, these patients were older (median [range] age, 74 [34-95] vs 60 [21-90] years; P < .001); had more comorbidities (eg, hypertension in 49 of 82 [59.8%] vs 78 of 334 [23.4%]; P < .001); had higher leukocyte counts (median [interquartile range (IQR)], 9400 [6900-13\u00e2\u0080\u00af800] vs 5500 [4200-7400] cells/\u00b5L) and levels of C-reactive protein (median [IQR], 10.2 [6.4-17.0] vs 3.7 [1.0-7.3] mg/dL), procalcitonin (median [IQR], 0.27 [0.10-1.22] vs 0.06 [0.03-0.10] ng/mL), creatinine kinase-myocardial band (median [IQR], 3.2 [1.8-6.2] vs 0.9 [0.6-1.3] ng/mL), myohemoglobin (median [IQR], 128 [68-305] vs 39 [27-65] \u00b5g/L), high-sensitivity troponin I (median [IQR], 0.19 [0.08-1.12] vs <0.006 [<0.006-0.009] \u00b5g/L), N-terminal pro-B-type natriuretic peptide (median [IQR], 1689 [698-3327] vs 139 [51-335] pg/mL), aspartate aminotransferase (median [IQR], 40 [27-60] vs 29 [21-40] U/L), and creatinine (median [IQR], 1.15 [0.72-1.92] vs 0.64 [0.54-0.78] mg/dL); and had a higher proportion of multiple mottling and ground-glass opacity in radiographic findings (53 of 82 patients [64.6%] vs 15 of 334 patients [4.5%]).", "Greater proportions of patients with cardiac injury required noninvasive mechanical ventilation (38 of 82 [46.3%] vs 13 of 334 [3.9%]; P < .001) or invasive mechanical ventilation (18 of 82 [22.0%] vs 14 of 334 [4.2%]; P < .001) than those without cardiac injury.", "Complications were more common in patients with cardiac injury than those without cardiac injury and included acute respiratory distress syndrome (48 of 82 [58.5%] vs 49 of 334 [14.7%]; P < .001), acute kidney injury (7 of 82 [8.5%] vs 1 of 334 [0.3%]; P < .001), electrolyte disturbances (13 of 82 [15.9%] vs 17 of 334 [5.1%]; P = .003), hypoproteinemia (11 of 82 [13.4%] vs 16 of 334 [4.8%]; P = .01), and coagulation disorders (6 of 82 [7.3%] vs 6 of 334 [1.8%]; P = .02).", "Patients with cardiac injury had higher mortality than those without cardiac injury (42 of 82 [51.2%] vs 15 of 334 [4.5%]; P < .001).", "In a Cox regression model, patients with vs those without cardiac injury were at a higher risk of death, both during the time from symptom onset (hazard ratio, 4.26 [95% CI, 1.92-9.49]) and from admission to end point (hazard ratio, 3.41 [95% CI, 1.62-7.16]).", "Conclusions and Relevance: Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality."]}
{"cord_id": "qijtlymg", "title": "Misconceptions about weather and seasonality must not misguide COVID-19 response", "abstract": ["Weather may marginally affect COVID-19 dynamics, but misconceptions about the way that climate and weather drive exposure and transmission have adversely shaped risk perceptions for both policymakers and citizens.", "Future scientific work on this politically-fraught topic needs a more careful approach."]}
{"cord_id": "3hazdvbl", "title": "SARS-CoV2 Testing: The Limit of Detection Matters", "abstract": ["Resolving the COVID-19 pandemic requires diagnostic testing to determine which individuals are infected and which are not.", "The current gold standard is to perform RT-PCR on nasopharyngeal samples.", "Best-in-class assays demonstrate a limit of detection (LoD) of ~100 copies of viral RNA per milliliter of transport media.", "However, LoDs of currently approved assays vary over 10,000-fold.", "Assays with higher LoDs will miss more infected patients, resulting in more false negatives.", "However, the false-negative rate for a given LoD remains unknown.", "Here we address this question using over 27,500 test results for patients from across our healthcare network tested using the Abbott RealTime SARS-CoV-2 EUA.", "These results suggest that each 10-fold increase in LoD is expected to increase the false negative rate by 13%, missing an additional one in eight infected patients.", "The highest LoDs on the market will miss a majority of infected patients, with false negative rates as high as 70%.", "These results suggest that choice of assay has meaningful clinical and epidemiological consequences.", "The limit of detection matters."]}
{"cord_id": "wxti06ng", "title": "Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals", "abstract": ["Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures.", "Using HLA class I and II predicted peptide \"megapools,\" circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in \u00e2\u0088\u00bc70% and 100% of COVID-19 convalescent patients, respectively.", "CD4+ T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers.", "The M, spike, and N proteins each accounted for 11%-27% of the total CD4+ response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others.", "For CD8+ T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted.", "Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in \u00e2\u0088\u00bc40%-60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating \"common cold\" coronaviruses and SARS-CoV-2."]}
{"cord_id": "gof2of9o", "title": "Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals", "abstract": ["During the COVID-19 pandemic, SARS-CoV-2 infected millions of people and claimed hundreds of thousands of lives.", "Virus entry into cells depends on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein (S).", "Although there is no vaccine, it is likely that antibodies will be essential for protection.", "However, little is known about the human antibody response to SARS-CoV-2(1\u20135).", "Here we report on 149 COVID-19 convalescent individuals.", "Plasmas collected an average of 39 days after the onset of symptoms had variable half-maximal pseudovirus neutralizing titers: less than 1:50 in 33% and below 1:1000 in 79%, while only 1% showed titers >1:5000.", "Antibody sequencing revealed expanded clones of RBD-specific memory B cells expressing closely related antibodies in different individuals.", "Despite low plasma titers, antibodies to three distinct epitopes on RBD neutralized at half-maximal inhibitory concentrations (IC(50)s) as low as single digit ng/mL.", "Thus, most convalescent plasmas obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity.", "Nevertheless, rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective."]}
{"cord_id": "g7kbmsrr", "title": "Temperature screening has negligible value for control of COVID\u201019", "abstract": ["OBJECTIVE: To report the incidence of fever among patients who tested positive for SARS\u2010CoV\u20102.", "METHODS: Retrospective cohort study of patients who tested positive for SARS\u2010Cov\u20102 at a single centre.", "Temperature at time of testing and on repeat testing within 24 h were collected.", "RESULTS: At the time of testing, fever was detected (sensitivity) in 16 of 86 (19%; 95% CI: 11\u201328) episodes of positive tests for SARS\u2010CoV\u20102.", "With repeat testing, fever was detected in 18 of 75 (24%; 95% CI: 15\u201335) episodes.", "CONCLUSIONS: In an Australian hospital, screening for fever lacked sensitivity for detection of people with SARS\u2010CoV\u20102.", "This article is protected by copyright.", "All rights reserved."]}
{"cord_id": "so9uy899", "title": "Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience", "abstract": ["Importance: Passive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system.", "In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the efficacy remains uncertain.", "Objective: To explore potential signals of efficacy of COVID-19 convalescent plasma.", "Design: Open-label, Expanded Access Program (EAP) for the treatment of COVID-19 patients with human convalescent plasma.", "Setting: Multicenter, including 2,807 acute care facilities in the US and territories.", "Participants: Adult participants enrolled and transfused under the purview of the US Convalescent Plasma EAP program between April 4 and July 4, 2020 who were hospitalized with (or at risk of) severe or life threatening acute COVID-19 respiratory syndrome.", "Intervention: Transfusion of at least one unit of human COVID-19 convalescent plasma using standard transfusion guidelines at any time during hospitalization.", "Convalescent plasma was donated by recently-recovered COVID-19 survivors, and the antibody levels in the units collected were unknown at the time of transfusion.", "Main Outcomes and Measures: Seven and thirty-day mortality.", "Results: The 35,322 transfused patients had heterogeneous demographic and clinical characteristics.", "This cohort included a high proportion of critically-ill patients, with 52.3% in the intensive care unit (ICU) and 27.5% receiving mechanical ventilation at the time of plasma transfusion.", "The seven-day mortality rate was 8.7% [95% CI 8.3%-9.2%] in patients transfused within 3 days of COVID-19 diagnosis but 11.9% [11.4%-12.2%] in patients transfused 4 or more days after diagnosis (p<0.001).", "Similar findings were observed in 30-day mortality (21.6% vs. 26.7%, p<0.0001).", "Importantly, a gradient of mortality was seen in relation to IgG antibody levels in the transfused plasma.", "For patients who received high IgG plasma (>18.45 S/Co), seven-day mortality was 8.9% (6.8%, 11.7%); for recipients of medium IgG plasma (4.62 to 18.45 S/Co) mortality was 11.6% (10.3%, 13.1%); and for recipients of low IgG plasma (<4.62 S/Co) mortality was 13.7% (11.1%, 16.8%) (p=0.048).", "This unadjusted dose-response relationship with IgG was also observed in thirty-day mortality (p=0.021).", "The pooled relative risk of mortality among patients transfused with high antibody level plasma units was 0.65 [0.47-0.92] for 7 days and 0.77 [0.63-0.94] for 30 days compared to low antibody level plasma units.", "Conclusions and Relevance: The relationships between reduced mortality and both earlier time to transfusion and higher antibody levels provide signatures of efficacy for convalescent plasma in the treatment of hospitalized COVID-19 patients.", "This information may be informative for the treatment of COVID-19 and design of randomized clinical trials involving convalescent plasma.", "Trial Registration: ClinicalTrials.gov Identifier: NCT04338360"]}
{"cord_id": "j028lftw", "title": "Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection", "abstract": ["We investigated the kinetics of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in 7 asymptomatic persons and 11 patients with pneumonia.", "The geometric mean titer of neutralizing antibodies declined from 219.4 at 2 months to 143.7 at 5 months after infection, indicating a waning antibody response."]}
{"cord_id": "o77nnu3f", "title": "Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact", "abstract": ["Objective.", "To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health.", "Design.", "International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020.", "Setting.", "Survey distribution via online COVID-19 support groups and social media Participants.", "3,762 respondents from 56 countries completed the survey.", "1166 (33.7%) were 40-49 years old, 937 (27.1%) were 50-59 years old, and 905 (26.1%) were 30-39 years old.", "2961 (78.9%) were women, 718 (19.1%) were men, and 63 (1.7%) were nonbinary.", "8.4% reported being hospitalized.", "27% reported receiving a laboratory-confirmed diagnosis of COVID-19.", "96% reported symptoms beyond 90 days.", "Results.", "Prevalence of 205 symptoms in 10 organ systems was estimated in this cohort, with 66 symptoms traced over seven months.", "Respondents experienced symptoms in an average of 9.08 (95% confidence interval 9.04 to 9.13) organ systems.", "The most frequent symptoms reported after month 6 were: fatigue (77.7%, 74.9% to 80.3%), post-exertional malaise (72.2%, 69.3% to 75.0%), and cognitive dysfunction (55.4%, 52.4% to 58.8%).", "These three symptoms were also the three most commonly reported overall.", "In those who recovered in less than 90 days, the average number of symptoms peaked at week 2 (11.4, 9.4 to 13.6), and in those who did not recover in 90 days, the average number of symptoms peaked at month 2 (17.2, 16.5 to 17.8).", "Respondents with symptoms over 6 months experienced an average of 13.8 (12.7 to 14.9) symptoms in month 7.", "94.9% (94.1% to 95.6%) experienced relapses, with exercise, physical or mental activity, and stress as the main triggers.", "86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents.", "45.2% (42.9% to 47.2%) reported requiring a reduced work schedule compared to pre-illness and 22.3% (20.5% to 24.3%) were not working at the time of survey due to their health conditions.", "Conclusions.", "Patients with Long COVID report prolonged multisystem involvement and significant disability.", "Most had not returned to previous levels of work by 6 months.", "Many patients are not recovered by 7 months, and continue to experience significant symptom burden."]}
{"cord_id": "bjvg2ivr", "title": "Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations", "abstract": ["COVID-19 has resulted in a staggering death toll in the US: over 180,000 by the end of August 2020, according to the National Center for Health Statistics.", "Black and Latino Americans have experienced a disproportionate burden of COVID-19 morbidity and mortality, reflecting persistent structural inequalities that increase risk of exposure to COVID-19 and mortality risk for those infected.", "We estimate life expectancy at birth and at age 65 for 2020, for the total US population and by race and ethnicity, using four scenarios of deaths \u2013 one in which the COVID-19 pandemic had not occurred and three including COVID-19 mortality projections produced by the Institute for Health Metrics and Evaluation.", "Our most likely estimate indicates a reduction in US life expectancy at birth of 1.41 years.", "This decline results in a life expectancy of 77.2 years, a value last observed in 2003.", "We also project a 1.08-year reduction in life expectancy at age 65.", "The Black and Latino populations are estimated to experience declines in life expectancy at birth of 2.69 and 3.66 years, respectively, both of which are several times the 0.84-year reduction for whites.", "These projections imply an increase of over 50% in the Black-white life expectancy gap, from 3.6 to 5.5 years, thereby eliminating twenty years of progress made in reducing this differential.", "Latinos, who have consistently experienced lower mortality than whites (a phenomenon known as the Latino or Hispanic paradox), would see their more than three-year survival advantage almost eliminated."]}
{"cord_id": "ipoqrqm7", "title": "Mortality among Adults Ages 25-44 in the United States During the COVID-19 Pandemic", "abstract": ["IntroductionCoronavirus disease-19 (COVID-19) has caused a marked increase in all-cause deaths in the United States, mostly among adults aged 65 and older.", "Because younger adults have far lower infection fatality rates, less attention has been focused on the mortality burden of COVID-19 in this demographic.", "MethodsWe performed an observational cohort study using public data from the National Center for Health Statistics at the United States Centers for Disease Control and Prevention, and CDC Wonder.", "We analyzed all-cause mortality among adults ages 25-44 during the COVID-19 pandemic in the United States.", "Further, we compared COVID-19-related deaths in this age group during the pandemic period to all drug overdose deaths and opioid-specific overdose deaths in each of the ten Health and Human Services (HHS) regions during the corresponding period of 2018, the most recent year for which data are available.", "ResultsAs of September 6, 2020, 74,027 all-cause deaths occurred among persons ages 25-44 years during the period from March 1st to July 31st, 2020, 14,155 more than during the same period of 2019, a 23% relative increase (incident rate ratio 1.23; 95% CI 1.21-1.24), with a peak of 30% occurring in May (IRR 1.30; 95% CI 1.27-1.33).", "In HHS Region 2 (New York, New Jersey), HHS Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, Texas), and HHS Region 9 (Arizona, California, Hawaii, Nevada), COVID-19 deaths exceeded 2018 unintentional opioid overdose deaths during at least one month.", "Combined, 2,450 COVID-19 deaths were recorded in these three regions during the pandemic period, compared to 2,445 opioid deaths during the same period of 2018.", "MeaningWe find that COVID-19 has likely become the leading cause of death--surpassing unintentional overdoses--among young adults aged 25-44 in some areas of the United States during substantial COVID-19 outbreaks.", "NoteThe data presented here have since been updated.", "As a result, an additional 1,902 all-cause deaths occurring among US adults ages 25-44 during the period of interest are not accounted for in this manuscript."]}
{"cord_id": "9cr4sxik", "title": "The Impact of Vocalization Loudness on COVID-19 Transmission in Indoor Spaces", "abstract": ["There have been several documented outbreaks of COVID-19 associated with vocalization, either by speech or by singing, in indoor confined spaces.", "Here, we model the risk of in-room airborne disease transmission via expiratory particle emission versus the average loudness of vocalization and for variable room ventilation rates.", "The model indicates that a 6-decibel reduction in average vocalization intensity yields a reduction in aerosol transmission probability equivalent to doubling the room ventilation rate.", "The results suggest that public health authorities should consider implementing\"quiet zones\"in high-risk indoor environments, such as hospital waiting rooms or dining facilities, to mitigate transmission of COVID-19 and other airborne respiratory diseases."]}
{"cord_id": "dpui273b", "title": "Assessing differential impacts of COVID-19 on black communities", "abstract": ["Purpose: Given incomplete data reporting by race, we used data on COVID-19 cases and deaths in U.S. counties to describe racial disparities in COVID-19 disease and death and associated determinants.", "Methods: Using publicly available data (accessed April 13, 2020), predictors of COVID-19 cases and deaths were compared between disproportionately (&#8805;13%) black and all other (<13% black) counties.", "Rate ratios were calculated, and population attributable fractions were estimated using COVID-19 cases and deaths via zero-inflated negative binomial regression model.", "National maps with county-level data and an interactive scatterplot of COVID-19 cases were generated.", "Results: Nearly 90% of disproportionately black counties (656/677) reported a case and 49% (330/677) reported a death versus 81% (1987/2465) and 28% (684/2465), respectively, for all other counties.", "Counties with higher proportions of black people have higher prevalence of comorbidities and greater air pollution.", "Counties with higher proportions of black residents had more COVID-19 diagnoses (Rate Ratio (RR): 1.24, 95% confidence interval: 1.17-1.33) and deaths (RR: 1.18, 95% confidence interval: 1.00-1.40), after adjusting for county-level characteristics such as age, poverty, comorbidities, and epidemic duration.", "COVID-19 deaths were higher in disproportionally black rural and small metro counties.", "The population attributable fraction of COVID-19 diagnosis due to lack of health insurance was 3.3% for counties with less than 13% black residents and 4.2% for counties with greater than or equal to 13% black residents.", "Conclusions: Nearly 20% of U.S. counties are disproportionately black, and they accounted for 52% of COVID-19 diagnoses and 58% of COVID-19 deaths nationally.", "County-level comparisons can both inform COVID-19 responses and identify epidemic hot spots.", "Social conditions, structural racism, and other factors elevate risk for COVID-19 diagnoses and deaths in black communities."]}
{"cord_id": "ex3s7ytv", "title": "Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States", "abstract": ["IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic poses an existential threat to many US residential colleges; either they open their doors to students in September or they risk serious financial consequences.", "OBJECTIVE: To define severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening performance standards that would permit the safe return of students to US residential college campuses for the fall 2020 semester.", "DESIGN, SETTING, AND PARTICIPANTS: This analytic modeling study included a hypothetical cohort of 4990 students without SARS-CoV-2 infection and 10 with undetected, asymptomatic SARS-CoV-2 infection at the start of the semester.", "The decision and cost-effectiveness analyses were linked to a compartmental epidemic model to evaluate symptom-based screening and tests of varying frequency (ie, every 1, 2, 3, and 7 days), sensitivity (ie, 70%-99%), specificity (ie, 98%-99.7%), and cost (ie, $10/test-$50/test).", "Reproductive numbers (R(t)) were 1.5, 2.5, and 3.5, defining 3 epidemic scenarios, with additional infections imported via exogenous shocks.", "The model assumed a symptomatic case fatality risk of 0.05% and a 30% probability that infection would eventually lead to observable COVID-19\u2013defining symptoms in the cohort.", "Model projections were for an 80-day, abbreviated fall 2020 semester.", "This study adhered to US government guidance for parameterization data.", "MAIN OUTCOMES AND MEASURES: Cumulative tests, infections, and costs; daily isolation dormitory census; incremental cost-effectiveness; and budget impact.", "RESULTS: At the start of the semester, the hypothetical cohort of 5000 students included 4990 (99.8%) with no SARS-CoV-2 infection and 10 (0.2%) with SARS-CoV-2 infection.", "Assuming an R(t) of 2.5 and daily screening with 70% sensitivity, a test with 98% specificity yielded 162 cumulative student infections and a mean isolation dormitory daily census of 116, with 21 students (18%) with true-positive results.", "Screening every 2 days resulted in 243 cumulative infections and a mean daily isolation census of 76, with 28 students (37%) with true-positive results.", "Screening every 7 days resulted in 1840 cumulative infections and a mean daily isolation census of 121 students, with 108 students (90%) with true-positive results.", "Across all scenarios, test frequency was more strongly associated with cumulative infection than test sensitivity.", "This model did not identify symptom-based screening alone as sufficient to contain an outbreak under any of the scenarios we considered.", "Cost-effectiveness analysis selected screening with a test with 70% sensitivity every 2, 1, or 7 days as the preferred strategy for an R(t) of 2.5, 3.5, or 1.5, respectively, implying screening costs of $470, $910, or $120, respectively, per student per semester.", "CONCLUSIONS AND RELEVANCE: In this analytic modeling study, screening every 2 days using a rapid, inexpensive, and even poorly sensitive (>70%) test, coupled with strict behavioral interventions to keep R(t) less than 2.5, is estimated to maintain a controllable number of COVID-19 infections and permit the safe return of students to campus."]}
{"cord_id": "e4xjtjw4", "title": "Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV", "abstract": ["Abstract Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by a novel coronavirus termed SARS-CoV.", "Due to the severity of this disease, the World Health Organization (WHO) recommends that manipulation of active viral cultures of SARS-CoV be performed in containment laboratories at biosafety level 3 (BSL3).", "The virus was inactivated by ultraviolet light (UV) at 254nm, heat treatment of 65\u00b0C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments.", "We describe the kinetics of these efficient viral inactivation methods, which will allow research with SARS-CoV containing materials, that are rendered non-infectious, to be conducted at reduced safety levels."]}
{"cord_id": "bzeqs5oh", "title": "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial", "abstract": ["BACKGROUND: No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19).", "Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models.", "METHODS: We did a randomised, double-blind, placebo-controlled, multicentre trial at ten hospitals in Hubei, China.", "Eligible patients were adults (aged \u226518 years) admitted to hospital with laboratory-confirmed SARS-CoV-2 infection, with an interval from symptom onset to enrolment of 12 days or less, oxygen saturation of 94% or less on room air or a ratio of arterial oxygen partial pressure to fractional inspired oxygen of 300 mm Hg or less, and radiologically confirmed pneumonia.", "Patients were randomly assigned in a 2:1 ratio to intravenous remdesivir (200 mg on day 1 followed by 100 mg on days 2\u201310 in single daily infusions) or the same volume of placebo infusions for 10 days.", "Patients were permitted concomitant use of lopinavir\u2013ritonavir, interferons, and corticosteroids.", "The primary endpoint was time to clinical improvement up to day 28, defined as the time (in days) from randomisation to the point of a decline of two levels on a six-point ordinal scale of clinical status (from 1=discharged to 6=death) or discharged alive from hospital, whichever came first.", "Primary analysis was done in the intention-to-treat (ITT) population and safety analysis was done in all patients who started their assigned treatment.", "This trial is registered with ClinicalTrials.gov, NCT04257656.", "FINDINGS: Between Feb 6, 2020, and March 12, 2020, 237 patients were enrolled and randomly assigned to a treatment group (158 to remdesivir and 79 to placebo); one patient in the placebo group who withdrew after randomisation was not included in the ITT population.", "Remdesivir use was not associated with a difference in time to clinical improvement (hazard ratio 1\u00b723 [95% CI 0\u00b787\u20131\u00b775]).", "Although not statistically significant, patients receiving remdesivir had a numerically faster time to clinical improvement than those receiving placebo among patients with symptom duration of 10 days or less (hazard ratio 1\u00b752 [0\u00b795\u20132\u00b743]).", "Adverse events were reported in 102 (66%) of 155 remdesivir recipients versus 50 (64%) of 78 placebo recipients.", "Remdesivir was stopped early because of adverse events in 18 (12%) patients versus four (5%) patients who stopped placebo early.", "INTERPRETATION: In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits.", "However, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.", "FUNDING: Chinese Academy of Medical Sciences Emergency Project of COVID-19, National Key Research and Development Program of China, the Beijing Science and Technology Project."]}
{"cord_id": "7d3akn8u", "title": "COVID-19: in the footsteps of Ernest Shackleton", "abstract": ["We describe what we believe is the first instance of complete COVID-19 testing of all passengers and crew on an isolated cruise ship during the current COVID-19 pandemic.", "Of the 217 passengers and crew on board, 128 tested positive for COVID-19 on reverse transcription\u2013PCR (59%).", "Of the COVID-19-positive patients, 19% (24) were symptomatic; 6.2% (8) required medical evacuation; 3.1% (4) were intubated and ventilated; and the mortality was 0.8% (1).", "The majority of COVID-19-positive patients were asymptomatic (81%, 104 patients).", "We conclude that the prevalence of COVID-19 on affected cruise ships is likely to be significantly underestimated, and strategies are needed to assess and monitor all passengers to prevent community transmission after disembarkation."]}
{"cord_id": "841c0g1c", "title": "Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study", "abstract": ["BACKGROUND: The risk of vertical and perinatal transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, which causes COVID-19), the most appropriate management, and the neonate's risk of developing COVID-19 during the perinatal period are unknown.", "Therefore, we aimed to elucidate best practices regarding infection control in mother\u2013newborn dyads, and identify potential risk factors associated with transmission.", "METHODS: In this observational cohort study, we identified all neonates born between March 22 and May 17, 2020, at three New York Presbyterian Hospitals in New York City (NY, USA) to mothers positive for SARS-CoV-2 at delivery.", "Mothers could practice skin-to-skin care and breastfeed in the delivery room, but had to wear a surgical mask when near their neonate and practice proper hand hygiene before skin-to-skin contact, breastfeeding, and routine care.", "Unless medically required, neonates were kept in a closed Giraffe isolette in the same room as their mothers, and were held by mothers for feeding after appropriate hand hygiene, breast cleansing, and placement of a surgical mask.", "Neonates were tested for SARS-CoV-2 by use of real-time PCR on nasopharyngeal swabs taken at 24 h, 5\u20137 days, and 14 days of life, and were clinically evaluated by telemedicine at 1 month of age.", "We recorded demographics, neonatal, and maternal clinical presentation, as well as infection control practices in the hospital and at home.", "FINDINGS: Of 1481 deliveries, 116 (8%) mothers tested positive for SARS-CoV-2; 120 neonates were identified.", "All neonates were tested at 24 h of life and none were positive for SARS-CoV-2.", "82 (68%) neonates completed follow-up at day 5\u20137 of life.", "Of the 82 neonates, 68 (83%) roomed in with the mothers.", "All mothers were allowed to breastfeed; at 5\u20137 days of life, 64 (78%) were still breastfeeding.", "79 (96%) of 82 neonates had a repeat PCR at 5\u20137 days of life, which was negative in all; 72 (88%) neonates were also tested at 14 days of life and none were positive.", "None of the neonates had symptoms of COVID-19.", "INTERPRETATION: Our data suggest that perinatal transmission of COVID-19 is unlikely to occur if correct hygiene precautions are undertaken, and that allowing neonates to room in with their mothers and direct breastfeeding are safe procedures when paired with effective parental education of infant protective strategies.", "FUNDING: None."]}
{"cord_id": "b2fwktld", "title": "Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate", "abstract": ["The development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans.", "However, to date, studies on protective immunity have only been performed in animal models and correlates of protection have not been established in humans.", "Here, we describe an outbreak of SARS-CoV-2 on a fishing vessel associated with a high attack rate.", "Predeparture serological and viral RT-PCR testing along with repeat testing after return to shore was available for 120 of the 122 persons on board over a median follow-up of 32.5 days (range 18.8 to 50.5 days).", "A total of 104 individuals had an RT-PCR positive viral test with Ct <35 or seroconverted during the follow-up period, yielding an attack rate on board of 85.2% (104/122 individuals).", "Metagenomic sequencing of 39 viral genomes suggested the outbreak originated largely from a single viral clade.", "Only three crewmembers tested seropositive prior to the boat\u2019s departure in initial serological screening and also had neutralizing and spike-reactive antibodies in follow-up assays.", "None of these crewmembers with neutralizing antibody titers showed evidence of bona fide viral infection or experienced any symptoms during the viral outbreak.", "Therefore, the presence of neutralizing antibodies from prior infection was significantly associated with protection against re-infection (Fisher\u2019s exact test, p=0.002)."]}
{"cord_id": "cc332omp", "title": "Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution", "abstract": ["The recent emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has posed formidable challenges for clinical laboratories seeking reliable laboratory diagnostic confirmation.", "The swift advance of the crisis in the United States has led to Emergency Use Authorization (EUA) facilitating the availability of molecular diagnostic assays without the more rigorous examination to which tests are normally subjected prior to FDA approval.", "Our laboratory currently uses two real-time reverse transcription-PCR (RT-PCR) platforms, the Roche Cobas SARS-CoV2 and the Cepheid Xpert Xpress SARS-CoV-2.", "The two platforms demonstrate comparable performances; however, the run times for each assay are 3.5 h and 45 min, respectively.", "In search for a platform with a shorter turnaround time, we sought to evaluate the recently released Abbott ID Now COVID-19 assay, which is capable of producing positive results in as little as 5 min.", "We present here the results of comparisons between Abbott ID Now COVID-19 and Cepheid Xpert Xpress SARS-CoV-2 using nasopharyngeal swabs transported in viral transport media and comparisons between Abbott ID Now COVID-19 and Cepheid Xpert Xpress SARS-CoV-2 using nasopharyngeal swabs transported in viral transport media for Cepheid and dry nasal swabs for Abbott ID Now.", "Regardless of method of collection and sample type, Abbott ID Now COVID-19 had negative results in a third of the samples that tested positive by Cepheid Xpert Xpress when using nasopharyngeal swabs in viral transport media and 45% when using dry nasal swabs."]}
{"cord_id": "30pl5tx3", "title": "A modelling framework to assess the likely effectiveness of facemasks in combination with \u2018lock-down\u2019 in managing the COVID-19 pandemic", "abstract": ["COVID-19 is characterized by an infectious pre-symptomatic period, when newly infected individuals can unwittingly infect others.", "We are interested in what benefits facemasks could offer as a non-pharmaceutical intervention, especially in the settings where high-technology interventions, such as contact tracing using mobile apps or rapid case detection via molecular tests, are not sustainable.", "Here, we report the results of two mathematical models and show that facemask use by the public could make a major contribution to reducing the impact of the COVID-19 pandemic.", "Our intention is to provide a simple modelling framework to examine the dynamics of COVID-19 epidemics when facemasks are worn by the public, with or without imposed \u2018lock-down\u2019 periods.", "Our results are illustrated for a number of plausible values for parameter ranges describing epidemiological processes and mechanistic properties of facemasks, in the absence of current measurements for these values.", "We show that, when facemasks are used by the public all the time (not just from when symptoms first appear), the effective reproduction number, R(e), can be decreased below 1, leading to the mitigation of epidemic spread.", "Under certain conditions, when lock-down periods are implemented in combination with 100% facemask use, there is vastly less disease spread, secondary and tertiary waves are flattened and the epidemic is brought under control.", "The effect occurs even when it is assumed that facemasks are only 50% effective at capturing exhaled virus inoculum with an equal or lower efficiency on inhalation.", "Facemask use by the public has been suggested to be ineffective because wearers may touch their faces more often, thus increasing the probability of contracting COVID-19.", "For completeness, our models show that facemask adoption provides population-level benefits, even in circumstances where wearers are placed at increased risk.", "At the time of writing, facemask use by the public has not been recommended in many countries, but a recommendation for wearing face-coverings has just been announced for Scotland.", "Even if facemask use began after the start of the first lock-down period, our results show that benefits could still accrue by reducing the risk of the occurrence of further COVID-19 waves.", "We examine the effects of different rates of facemask adoption without lock-down periods and show that, even at lower levels of adoption, benefits accrue to the facemask wearers.", "These analyses may explain why some countries, where adoption of facemask use by the public is around 100%, have experienced significantly lower rates of COVID-19 spread and associated deaths.", "We conclude that facemask use by the public, when used in combination with physical distancing or periods of lock-down, may provide an acceptable way of managing the COVID-19 pandemic and re-opening economic activity.", "These results are relevant to the developed as well as the developing world, where large numbers of people are resource poor, but fabrication of home-made, effective facemasks is possible.", "A key message from our analyses to aid the widespread adoption of facemasks would be: \u2018my mask protects you, your mask protects me\u2019."]}
{"cord_id": "drzphrqj", "title": "Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020", "abstract": ["Seasonal variation in COVID-19 incidence could impact the trajectory of the pandemic.", "Using global line-list data on COVID-19 cases reported until 29th February 2020 and global gridded temperature data, and after adjusting for surveillance capacity and time since first imported case, higher average temperature was strongly associated with lower COVID-19 incidence for temperatures of 1\u00b0C and higher.", "However, temperature explained a relatively modest amount of the total variation in COVID-19 incidence.", "These preliminary findings support stringent containment efforts in Europe and elsewhere."]}
{"cord_id": "h0h0d93t", "title": "Quantifying bias of COVID-19 prevalence and severity estimates in Wuhan, China that depend on reported cases in international travelers", "abstract": ["Risk of COVID-19 infection in Wuhan has been estimated using imported case counts of international travelers, often under the assumption that all cases in travelers are ascertained.", "Recent work indicates variation among countries in detection capacity for imported cases.", "Singapore has historically had very strong epidemiological surveillance and contact-tracing capacity and has shown in the COVID-19 epidemic evidence of a high sensitivity of case detection.", "We therefore used a Bayesian modeling approach to estimate the relative imported case detection capacity for other countries compared to that of Singapore.", "We estimate that the global ability to detect imported cases is 38% (95% HPDI 22% \u2013 64%) of Singapore\u2019s capacity.", "Equivalently, an estimate of 2.8 (95% HPDI 1.5 \u2013 4.4) times the current number of imported cases, could have been detected, if all countries had had the same detection capacity as Singapore.", "Using the second component of the Global Health Security index to stratify likely case-detection capacities, we found that the ability to detect imported cases relative to Singapore among high surveillance locations is 40% (95% HPDI 22% \u2013 67%), among intermediate surveillance locations it is 37% (95% HPDI 18% \u2013 68%), and among low surveillance locations it is 11% (95% HPDI 0% \u2013 42%).", "Using a simple mathematical model, we further find that treating all travelers as if they were residents (rather than accounting for the brief stay of some of these travelers in Wuhan) can modestly contribute to underestimation of prevalence as well.", "We conclude that estimates of case counts in Wuhan based on assumptions of perfect detection in travelers may be underestimated by several fold, and severity correspondingly overestimated by several fold.", "Undetected cases are likely in countries around the world, with greater risk in countries of low detection capacity and high connectivity to the epicenter of the outbreak."]}
{"cord_id": "2z5pchyq", "title": "Governor partisanship explains the adoption of statewide mandates to wear face coverings", "abstract": ["Public mask use has emerged as a key tool in response to COVID-19.", "We develop and document a classification of statewide mask mandates that reveals variation in their scope and timing.", "Some U.S. states quickly mandated the wearing of face coverings in most public spaces, whereas others issued narrow mandates or no mandate at all.", "We consider how differences in COVID-19 epidemiological indicators, state capacity, and partisan politics affect when states adopted broad mask mandates.", "The most important predictor is whether a state is led by a Republican governor.", "These states were much slower to adopt mandates, if they did so at all.", "COVID-19 indicators such as confirmed cases or deaths per million are much less important predictors of statewide mask mandates.", "This finding highlights a key challenge to public efforts to increase mask-wearing, widely believed to be one of the most effective tools for preventing the spread of SARS-CoV-2 while restoring economic activity."]}
{"cord_id": "ys4h7dw5", "title": "An evidence review of face masks against COVID-19", "abstract": ["The science around the use of masks by the public to impede COVID-19 transmission is advancing rapidly.", "In this narrative review, we develop an analytical framework to examine mask usage, synthesizing the relevant literature to inform multiple areas: population impact, transmission characteristics, source control, wearer protection, sociological considerations, and implementation considerations.", "A primary route of transmission of COVID-19 is via respiratory particles, and it is known to be transmissible from presymptomatic, paucisymptomatic, and asymptomatic individuals.", "Reducing disease spread requires two things: limiting contacts of infected individuals via physical distancing and other measures and reducing the transmission probability per contact.", "The preponderance of evidence indicates that mask wearing reduces transmissibility per contact by reducing transmission of infected respiratory particles in both laboratory and clinical contexts.", "Public mask wearing is most effective at reducing spread of the virus when compliance is high.", "Given the current shortages of medical masks, we recommend the adoption of public cloth mask wearing, as an effective form of source control, in conjunction with existing hygiene, distancing, and contact tracing strategies.", "Because many respiratory particles become smaller due to evaporation, we recommend increasing focus on a previously overlooked aspect of mask usage: mask wearing by infectious people (\"source control\") with benefits at the population level, rather than only mask wearing by susceptible people, such as health care workers, with focus on individual outcomes.", "We recommend that public officials and governments strongly encourage the use of widespread face masks in public, including the use of appropriate regulation."]}
{"cord_id": "3kjckx8o", "title": "Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in Manaus, the capital of Amazonas state in northern Brazil.", "The attack rate there is an estimate of the final size of the largely unmitigated epidemic that occurred in Manaus.", "We use a convenience sample of blood donors to show that by June 2020, 1 month after the epidemic peak in Manaus, 44% of the population had detectable immunoglobulin G (IgG) antibodies.", "Correcting for cases without a detectable antibody response and for antibody waning, we estimate a 66% attack rate in June, rising to 76% in October.", "This is higher than in S\u00e3o Paulo, in southeastern Brazil, where the estimated attack rate in October was 29%.", "These results confirm that when poorly controlled, COVID-19 can infect a large proportion of the population, causing high mortality."]}
{"cord_id": "tlyak9tg", "title": "The effectiveness of interventions to reduce COVID-19 transmission in a large urban jail", "abstract": ["Objectives: To estimate the impact of various mitigation strategies on COVID-19 transmission in a U.S. jail beyond those offered in national guidelines.", "Methods: We developed a stochastic dynamic transmission model of COVID-19 in one large urban U.S. jail among staff and incarcerated individuals.", "We divided the outbreak into four intervention phases: the start of the outbreak, depopulation of the jail, increased proportion of people in single cells, and asymptomatic testing.", "We used the next generation method to estimate the basic reproduction ratio, R0, in each phase.", "We estimated the fraction of new cases, hospitalizations, and deaths averted by these interventions along with the standard measures of sanitization, masking, and social distancing interventions.", "Results: For the first outbreak phase, the estimated R0 was 8.23 (95% CrI: 5.01-12.90), and for the subsequent phases, R0, phase 2 = 3.58 (95% CrI: 2.46-5.08), R0, phase 3 = 1.72 (95% CrI: 1.41-2.12), and R0, phase 4 = 0.45 (95% CrI: 0.32-0.59).", "In total, the jail's interventions prevented approximately 83% of projected cases and hospitalizations and 89% of deaths over 83 days.", "Conclusions: Depopulation, single celling, and asymptomatic testing within jails can be effective strategies to mitigate COVID-19 transmission in addition to standard public health measures.", "Policy Implications: Decision-makers should prioritize reductions in the jail population, single celling, and testing asymptomatic populations, as additional measures to manage COVID-19 within correctional settings."]}
{"cord_id": "5sx04n3x", "title": "Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data", "abstract": ["The SARS-CoV-2 lineage B.1.1.7, now designated Variant of Concern 202012/01 (VOC) by Public Health England, originated in the UK in late Summer to early Autumn 2020.", "We examine epidemiological evidence for this VOC having a transmission advantage from several perspectives.", "First, whole genome sequence data collected from community-based diagnostic testing provides an indication of changing prevalence of different genetic variants through time.", "Phylodynamic modelling additionally indicates that genetic diversity of this lineage has changed in a manner consistent with exponential growth.", "Second, we find that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S-gene target failures (SGTF) in community-based diagnostic PCR testing.", "Third, we examine growth trends in SGTF and non-SGTF case numbers at local area level across England, and show that the VOC has higher transmissibility than non-VOC lineages, even if the VOC has a different latent period or generation time.", "Available SGTF data indicate a shift in the age composition of reported cases, with a larger share of under 20 year olds among reported VOC than non-VOC cases.", "Fourth, we assess the association of VOC frequency with independent estimates of the overall SARS-CoV-2 reproduction number through time.", "Finally, we fit a semi-mechanistic model directly to local VOC and non-VOC case incidence to estimate the reproduction numbers over time for each.", "There is a consensus among all analyses that the VOC has a substantial transmission advantage, with the estimated difference in reproduction numbers between VOC and non-VOC ranging between 0.4 and 0.7, and the ratio of reproduction numbers varying between 1.4 and 1.8.", "We note that these estimates of transmission advantage apply to a period where high levels of social distancing were in place in England; extrapolation to other transmission contexts therefore requires caution."]}
{"cord_id": "ybzrcyw3", "title": "Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis", "abstract": ["OBJECTIVE: To analyze the premarket purchase commitments for coronavirus disease 2019 (covid-19) vaccines from leading manufacturers to recipient countries.", "DESIGN: Cross sectional analysis.", "DATA SOURCES: World Health Organization\u2019s draft landscape of covid-19 candidate vaccines, along with company disclosures to the US Securities and Exchange Commission, company and foundation press releases, government press releases, and media reports.", "ELIGIBILITY CRITERIA AND DATA ANALYSIS: Premarket purchase commitments for covid-19 vaccines, publicly announced by 15 November 2020.", "MAIN OUTCOME MEASURES: Premarket purchase commitments for covid-19 vaccine candidates and price per course, vaccine platform, and stage of research and development, as well as procurement agent and recipient country.", "RESULTS: As of 15 November 2020, several countries have made premarket purchase commitments totaling 7.48 billion doses, or 3.76 billion courses, of covid-19 vaccines from 13 vaccine manufacturers.", "Just over half (51%) of these doses will go to high income countries, which represent 14% of the world\u2019s population.", "The US has reserved 800 million doses but accounts for a fifth of all covid-19 cases globally (11.02 million cases), whereas Japan, Australia, and Canada have collectively reserved more than one billion doses but do not account for even 1% of current global covid-19 cases globally (0.45 million cases).", "If these vaccine candidates were all successfully scaled, the total projected manufacturing capacity would be 5.96 billion courses by the end of 2021.", "Up to 40% (or 2.34 billion) of vaccine courses from these manufacturers might potentially remain for low and middle income countries\u2013less if high income countries exercise scale-up options and more if high income countries share what they have procured.", "Prices for these vaccines vary by more than 10-fold, from $6.00 (\u00a34.50; \u20ac4.90) per course to as high as $74 per course.", "With broad country participation apart from the US and Russia, the COVAX Facility\u2014the vaccines pillar of the World Health Organization\u2019s Access to COVID-19 Tools (ACT) Accelerator\u2014has secured at least 500 million doses, or 250 million courses, and financing for half of the targeted two billion doses by the end of 2021 in efforts to support globally coordinated access to covid-19 vaccines.", "CONCLUSIONS: This study provides an overview of how high income countries have secured future supplies of covid-19 vaccines but that access for the rest of the world is uncertain.", "Governments and manufacturers might provide much needed assurances for equitable allocation of covid-19 vaccines through greater transparency and accountability over these arrangements."]}
{"cord_id": "tg4bwxvf", "title": "Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area", "abstract": ["We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region with 7 million residents.", "The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston and from viruses recovered in an ongoing massive second wave of infections.", "The virus was originally introduced into Houston many times independently.", "Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity.", "Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis.", "We found little evidence of a significant relationship between virus genotype and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics.", "Some regions of the spike protein\u2014the primary target of global vaccine efforts\u2014are replete with amino acid replacements, perhaps indicating the action of selection.", "We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR3022.", "Our report represents the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region.", "The findings will help us to understand the origin, composition, and trajectory of future infection waves and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution."]}
{"cord_id": "1yxxe5d3", "title": "Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest", "abstract": ["Background: SARS-CoV-2 and its associated disease, COVID-19, has infected over seven million people world-wide, including two million people in the United States.", "While many people recover from the virus uneventfully, a subset of patients will require hospital admission, some with intensive care needs including intubation, and mechanical ventilation.", "To date there is no cure and no vaccine is available.", "Passive immunotherapy by the transfusion of convalescent plasma donated by COVID-19 recovered patients might be an effective option to combat the virus, especially if used early in the course of disease.", "Here we report our experience of using convalescent plasma at a tertiary care center in a mid-size, midwestern city that did not experience an overwhelming patient surge.", "Methods: Hospitalized COVID-19 patients categorized as having Severe or Life-Threatening disease according to the Mayo Clinic Emergency Access Protocol were screened, consented, and treated with convalescent plasma collected from local donors recovered from COVID-19 infection.", "Clinical data and outcomes were collected retrospectively.", "Results: 31 patients were treated, 16 severe patients and 15 life-threatened patients.", "Overall mortality was 27% (4/31) but only patients with life-threatening disease died.", "94% of transfused patients with severe disease avoided escalation to ICU care and mechanical ventilation.", "67% of patients with life-threatening disease were able to be extubated.", "Most transfused patients had a rapid decrease in their respiratory support requirements on or about day 7 following convalescent plasma transfusion.", "Conclusion: Our results demonstrate that convalescent plasma is associated with reducing ventilatory requirements in patients with both severe and life-threatening disease, but appears to be most beneficial when administered early in the course of disease when patients meet the criteria for severe illness."]}
{"cord_id": "0mwz8kwo", "title": "Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer", "abstract": ["Although the benefit of population-level public facial masking to protect others during the COVID-19 pandemic has received a great deal of attention, we discuss for one of the first times the hypothesis that universal masking reduces the \u201cinoculum\u201d or dose of the virus for the mask-wearer, leading to more mild and asymptomatic infection manifestations.", "Masks, depending on type, filter out the majority of viral particles, but not all.", "We first discuss the near-century-old literature around the viral inoculum and severity of disease (conceptualized as the LD50 or lethal dose of the virus).", "We include examples of rising rates of asymptomatic infection with population-level masking, including in closed settings (e.g., cruise ships) with and without universal masking.", "Asymptomatic infections may be harmful for spread but could actually be beneficial if they lead to higher rates of exposure.", "Exposing society to SARS-CoV-2 without the unacceptable consequences of severe illness with public masking could lead to greater community-level immunity and slower spread as we await a vaccine.", "This theory of viral inoculum and mild or asymptomatic disease with SARS-CoV-2 in light of population-level masking has received little attention so this is one of the first perspectives to discuss the evidence supporting this theory."]}
{"cord_id": "d7rz240a", "title": "Interregional SARS-CoV-2 spread from a single introduction outbreak in a meat-packing plant in northeast Iowa", "abstract": ["SARS-CoV-2 spread has proven to be especially difficult to mitigate in high risk settings, including nursing homes, cruises, prisons and various industrial settings.", "Among industrial settings, meat processing facilities in the United States have experienced particularly challenging outbreaks.", "We have sequenced SARS-CoV-2 whole viral genomes from individuals testing positive in an integrated regional healthcare system serving 21 counties in southwestern Wisconsin, northeastern Iowa and southeastern Minnesota, providing an overview of SARS-CoV-2 introduction and spread in a region spanning multiple jurisdictions with differing mitigation policies.", "While most viral introductions we detected were contained with only minor transmission chains, a striking exception was an outbreak associated with a meatpacking plant in Postville, IA.", "In this case, a single viral introduction led to unrestrained spread within the facility, affecting many staff and members of their households.", "Importantly, by surveilling viral sequences from the surrounding counties, we have documented the spread of this SARS-CoV-2 substrain from this epicenter to individuals in 13 cities in 7 counties in Iowa, Wisconsin and Minnesota, a region spanning 185 square miles.", "This study highlights the regional public health consequences of failures to rapidly act to mitigate viral spread in a single industrial setting."]}
{"cord_id": "o2619pri", "title": "Global shifts in mammalian population trends reveal key predictors of virus spillover risk", "abstract": ["Emerging infectious diseases in humans are frequently caused by pathogens originating from animal hosts, and zoonotic disease outbreaks present a major challenge to global health.", "To investigate drivers of virus spillover, we evaluated the number of viruses mammalian species have shared with humans.", "We discovered that the number of zoonotic viruses detected in mammalian species scales positively with global species abundance, suggesting that virus transmission risk has been highest from animal species that have increased in abundance and even expanded their range by adapting to human-dominated landscapes.", "Domesticated species, primates and bats were identified as having more zoonotic viruses than other species.", "Among threatened wildlife species, those with population reductions owing to exploitation and loss of habitat shared more viruses with humans.", "Exploitation of wildlife through hunting and trade facilitates close contact between wildlife and humans, and our findings provide further evidence that exploitation, as well as anthropogenic activities that have caused losses in wildlife habitat quality, have increased opportunities for animal\u2013human interactions and facilitated zoonotic disease transmission.", "Our study provides new evidence for assessing spillover risk from mammalian species and highlights convergent processes whereby the causes of wildlife population declines have facilitated the transmission of animal viruses to humans."]}
{"cord_id": "apj6hgzw", "title": "Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020", "abstract": ["An estimated 30 million passengers are transported on 272 cruise ships worldwide each year* (1).", "Cruise ships bring diverse populations into proximity for many days, facilitating transmission of respiratory illness (2).", "SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) was first identified in Wuhan, China, in December 2019 and has since spread worldwide to at least 187 countries and territories.", "Widespread COVID-19 transmission on cruise ships has been reported as well (3).", "Passengers on certain cruise ship voyages might be aged &#8805;65 years, which places them at greater risk for severe consequences of SARS-CoV-2 infection (4).", "During February-March 2020, COVID-19 outbreaks associated with three cruise ship voyages have caused more than 800 laboratory-confirmed cases among passengers and crew, including 10 deaths.", "Transmission occurred across multiple voyages of several ships.", "This report describes public health responses to COVID-19 outbreaks on these ships.", "COVID-19 on cruise ships poses a risk for rapid spread of disease, causing outbreaks in a vulnerable population, and aggressive efforts are required to contain spread.", "All persons should defer all cruise travel worldwide during the COVID-19 pandemic."]}
{"cord_id": "elartlro", "title": "Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient", "abstract": ["SARS-CoV-2 caused a major outbreak of severe pneumonia (COVID-19) in humans.", "Viral RNA was detected in multiple organs in COVID-19 patients.", "However, infectious SARS-CoV-2 was only isolated from respiratory specimens.", "Here, infectious SARS-CoV-2 was successfully isolated from urine of a COVID-19 patient.", "The virus isolated could infect new susceptible cells and was recognized by its\u2019 own patient sera.", "Appropriate precautions should be taken to avoid transmission from urine."]}
{"cord_id": "spvp7bwz", "title": "Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans", "abstract": ["Coronavirus disease 2019 (COVID-19) represents a global crisis, yet major knowledge gaps remain about human immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "We analyzed immune responses in 76 COVID-19 patients and 69 healthy individuals from Hong Kong and Atlanta, Georgia, United States.", "In the peripheral blood mononuclear cells (PBMCs) of COVID-19 patients, we observed reduced expression of human leukocyte antigen class DR (HLA-DR) and proinflammatory cytokines by myeloid cells as well as impaired mammalian target of rapamycin (mTOR) signaling and interferon-\u03b1 (IFN-\u03b1) production by plasmacytoid dendritic cells.", "By contrast, we detected enhanced plasma levels of inflammatory mediators\u2014including EN-RAGE, TNFSF14, and oncostatin M\u2014which correlated with disease severity and increased bacterial products in plasma.", "Single-cell transcriptomics revealed a lack of type I IFNs, reduced HLA-DR in the myeloid cells of patients with severe COVID-19, and transient expression of IFN-stimulated genes.", "This was consistent with bulk PBMC transcriptomics and transient, low IFN-\u03b1 levels in plasma during infection.", "These results reveal mechanisms and potential therapeutic targets for COVID-19."]}
{"cord_id": "tdl6tav6", "title": "Sex differences in immune responses that underlie COVID-19 disease outcomes", "abstract": ["There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more severe symptoms and higher mortality among men than among women1-5.", "However, whether immune responses against severe acute respiratory syndrome coronavirus (SARS-CoV-2) differ between sexes, and whether such differences correlate with the sex difference in the disease course of COVID-19, is currently unknown.", "Here we examined sex differences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cell phenotyping in patients with moderate COVID-19 who had not received immunomodulatory medications.", "Male patients had higher plasma levels of innate immune cytokines such as IL-8 and IL-18 along with more robust induction of non-classical monocytes.", "By contrast, female patients had more robust T cell activation than male patients during SARS-CoV-2 infection.", "Notably, we found that a poor T cell response negatively correlated with patients' age and was associated with worse disease outcome in male patients, but not in female patients.", "By contrast, higher levels of innate immune cytokines were associated with worse disease progression in female patients, but not in male patients.", "These findings provide a possible explanation for the observed sex biases in COVID-19, and provide an important basis for the development of a sex-based approach to the treatment and care of male and female patients with COVID-19."]}
{"cord_id": "ex1ahuc6", "title": "Double Whammy: Why the Underrepresentation of Women among Workplace and Political Decision Makers Matters in Pandemic Times", "abstract": ["In this article, we explore whether women's underrepresentation among political and workplace decision makers may subject female citizens and employees to COVID-19-related decisions that are at odds with their preferences.", "We find that women overall, as well as female political party members, workers, and workplace leaders in particular, share a distinctively female perspective that more heavily emphasizes caution with respect to COVID-19 compared with men.", "Given the limited representation of women leaders across most industries and in politics, COVID-19 regulations are thus likely to be less cautious than would be the case if there were an equitable representation of women across leadership roles.", "We argue that female employees, in particular, face a representational \u201cdouble whammy\u201d for COVID-19: gender imbalances in workplace leadership create inequities that are compounded\u2014rather than redressed\u2014by unequal political representation.", "We conclude by addressing how this dynamic may enhance the movement of women away from Republican candidates moving forward."]}
